Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.6833234710588925,-2.7225024826016817,0.0,0.0,0.0,16/50,13.04%,XCL1;RPS27A;ITGB1;ZFP36L1;JUN;FOS;BAMBI;ENG;PTPRK;LRRC32;WNT10A;TGFBR3;OVOL2;FURIN;SMAD1;SMAD5
gsea,regulation of cell cycle phase transition (GO:1901987),0.7230403797690275,2.657353803605325,0.0,0.0,0.0,35/59,18.41%,CDKN1A;PSMA3;UBE2C;PSMB6;CDK1;ATP2B4;PSMB2;UBE2S;PSME2;FBXO5;ANAPC5;MAD2L1;PSMA4;PSMD14;PSMA5;PSMB5;BUB3;CCNB1;PLK1;ANAPC15;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;FZR1;PSMD12;BUB1B;PSMD6;PSMC5;PSME3;GTSE1;PSMD3;PSMD2;PSMC4
gsea,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.7521451867752293,2.6367202074619445,0.0,0.0,0.0,14/31,11.67%,ACTB;CDKN1A;CDKN3;CCNG1;CCNA2;CCNB2;CAMK2N1;CCND3;CCNE1;PKMYT1;CDKN2C;CDC6;CCNB1;CDKN2B
gsea,regulation of protein serine/threonine kinase activity (GO:0071900),0.6285742391833057,2.626674314455439,0.0,0.0,0.0,19/59,11.67%,ACTB;CDKN1A;IFNG;CDKN3;CCNG1;CCNA2;AKT1;CCNB2;INCENP;LTF;CCND3;PIH1D1;CCNE1;PKMYT1;CDKN2C;CDC6;CCNB1;DAB2IP;CDKN2B
gsea,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.6454267600995971,2.5904366718893233,0.0,0.0,0.0,59/98,24.26%,TUBB4B;TUBA4A;PSMA3;PSMB6;CDK1;PSMB2;YWHAE;PSME2;CENPF;FBXO5;TUBA1A;TPX2;HMMR;PSMA4;PSMD14;HSP90AA1;PSMA5;CNTRL;PSMB5;HAUS4;TUBG1;NEK2;CCNB1;PLK4;ACTR1A;PLK1;PSMA6;CEP57;PSMD1;PSMC1;PSMB7;CENPJ;CKAP5;HAUS8;PSMC2;PSMD12;ODF2;DYNC1I2;CEP250;HAUS6;PSMD6;PSMC5;PSME3;NEDD1;CDC7;AURKA;PSMD3;DCTN1;PSMD2;KIF14;PSMC4;PSMD11;HAUS5;CEP192;YWHAG;DTL;CSNK1E;RAD51C;CCP110
gsea,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.6320393138066052,-2.5667715306276704,0.0,0.0,0.0,14/50,13.04%,RPS27A;ITGB1;JUN;PDCD4;FOS;BAMBI;ENG;PTPRK;LRRC32;HIVEP1;TGFBR3;FURIN;SMAD1;SMAD5
gsea,translation (GO:0006412),-0.6815464107470368,-2.5531105820057083,0.0,0.0,0.0,39/102,13.06%,RPLP1;RPS27A;RPL13;RPLP0;RPL10A;EEF1B2;RPL8;RPSA;RPS18;RPL41;RPL15;RPL10;RPS8;MRPS6;RPS26;EEF1A1;RPL3;RPL7;RPS25;RPS2;RPL4;RPL14;RPL5;RPS6;EEF2;EEF1G;TNIP1;RPL7A;RPS17;RPS15;FARS2;RPL31;LARS2;RPL23A;WARS2;EEF1D;PABPC4;RPL22L1;FASTKD2
gsea,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.6897148260750426,-2.5316087646619083,0.0,0.0,0.0,29/78,8.85%,RPLP1;RPS27A;RPL13;RPLP0;ZFP36L1;RPL10A;RPL8;RPSA;RPS18;RPL41;RPL15;RPL10;RPS8;RPS26;RPL3;RPL7;RPS25;RPS2;RPL4;RPL14;RPL5;RPS6;RPL7A;RPS17;SMG6;ZC3H12A;PABPC1;RPS15;RPL31
gsea,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.6634104662909763,-2.5221415291726577,0.0,0.0,0.0,12/39,13.04%,RPS27A;ITGB1;JUN;FOS;BAMBI;ENG;PTPRK;LRRC32;TGFBR3;FURIN;SMAD1;SMAD5
gsea,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.6683532255069395,2.50724420477345,0.0,0.0,0.0,20/45,17.33%,ACTB;CDKN2A;CDKN1A;CDKN3;CCNG1;CCNA2;AKT1;CCNB2;CCND3;CCNE1;PKMYT1;CDKN2C;CDC6;CCNB1;PLK1;CDKN2B;HHEX;ADAM17;CCNF;PDGFB
gsea,regulation of immune response (GO:0050776),-0.5847949085931717,-2.5057782030768325,0.0,0.0,0.0,26/70,16.72%,ITGB1;SLAMF6;SELL;CD160;CRTAM;CD200;CD81;BCL6;SH2D1A;FOXP1;ITGB7;CLEC2D;CD33;CD226;TNFSF4;ICAM2;JAML;BIRC3;VCAM1;TREML2;MADCAM1;AHR;PLSCR1;CXCL13;NECTIN2;CD40LG
gsea,cellular senescence (GO:0090398),0.8110699837187727,2.503875012889381,0.0,0.0,0.0,8/18,11.96%,ID2;CDKN2A;CDKN1A;CALR;SMC6;HRAS;CDKN2B;SMC5
gsea,cell junction organization (GO:0034330),0.7783159542029311,2.457259500302981,0.0,0.0,0.0,7/24,8.54%,ACTB;ACTG1;FLNA;SH3BP1;CTNND2;L1CAM;PIN1
gsea,peptide biosynthetic process (GO:0043043),-0.726262794183362,-2.4503540162238933,0.0,0.0,0.0,29/65,8.85%,RPLP1;RPS27A;RPL13;RPLP0;RPL10A;RPL8;RPSA;RPS18;RPL41;RPL15;RPL10;RPS8;MRPS6;RPS26;EEF1A1;RPL3;RPL7;RPS25;RPS2;RPL4;RPL14;RPL5;PCSK1;RPS6;TNIP1;RPL7A;RPS17;RPS15;RPL31
gsea,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.6456122072174947,-2.4495573987937806,0.0,0.0,0.0,10/36,9.55%,EMB;ITGB1;SELL;CRTAM;PECAM1;CLDN10;MPZL2;JAML;ALCAM;VCAM1
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.7250723329660663,2.444408693604265,0.0,0.0,0.0,28/38,20.94%,FCER1G;PDIA3;PSMA3;VAMP8;PSMB6;TAP2;PSMB2;PSME2;CALR;PSMA4;PSMD14;PSMA5;PSMB5;IFI30;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4;NCF2;PSMD11
gsea,mitotic sister chromatid segregation (GO:0000070),0.6962018577202386,2.4328368111599517,0.0,0.0,0.0,47/70,20.98%,RAN;PRC1;SMC2;CDK1;CDCA8;NCAPG;SET;DLGAP5;KIFC1;NUSAP1;SMC1A;KIF22;CENPE;CEP55;NCAPH;TUBG1;KNSTRN;NCAPH2;RAD21;NCAPD2;KIF23;KMT5A;CCNB1;NCAPG2;PLK1;NDC80;KIF2C;NUP62;KIF18A;NUDC;CENPK;CDCA5;SGO1;NCAPD3;RRS1;SPAG5;KIF18B;NAA50;RB1;NSL1;KIF14;HASPIN;ESPL1;KPNB1;MIS12;ZW10;DSN1
gsea,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.7329666188593931,2.4286939373924157,0.0,0.0001230668647274021,0.001,23/35,18.41%,PSMA3;PSMB6;NABP1;PSMB2;PSME2;AURKB;PSMA4;PSMD14;PSMA5;PSMB5;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;AURKA;PSMD3;PSMD2;PSMC4
gsea,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.6496982561205252,2.4060731479493684,0.0,0.0001118789679340019,0.001,28/48,22.17%,PSMA3;PSMB6;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;FBXO31;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;CCNF;FBXW4;PSMD3;PSMD2;KIF14;PSMC4;NCCRP1;PSMD11;FBXL14;FBXL8
gsea,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.7634250284661196,-2.3888914864635793,0.0,7.9607536486514e-05,0.001,27/49,8.85%,RPLP1;RPS27A;RPL13;RPLP0;RPL10A;RPL8;RPSA;RPS18;RPL41;RPL15;RPL10;RPS8;RPS26;RPL3;RPL7;RPS25;RPS2;RPL4;RPL14;RPL5;RPS6;RPL7A;RPS17;SMG6;PABPC1;RPS15;RPL31
gsea,positive regulation of transport (GO:0051050),0.6571384003903422,2.3874628130532454,0.0,0.00010255572060616841,0.001,18/49,15.25%,ACTB;FCER1G;ANXA2;IFNG;ANXA1;BAX;CHCHD10;BAK1;CALR;SMPD1;LMAN2;RAB27A;SYNGR3;LYAR;HIP1R;FLOT1;IL15RA;SPAG5
gsea,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.8049094864366524,2.38592176540704,0.0,9.466681902107853e-05,0.001,9/16,10.81%,FCER1G;ABCB9;PDIA3;TAP2;CALR;SEC24D;CANX;IFI30;IDE
gsea,stress-activated protein kinase signaling cascade (GO:0031098),-0.7628667760004065,-2.3842476855820274,0.0,7.164678283786259e-05,0.001,3/17,2.18%,RPS27A;NFKB1;MAP3K8
gsea,mitotic spindle organization (GO:0007052),0.6339729154536557,2.382653705043111,0.0,8.790490337671578e-05,0.001,76/118,23.32%,STMN1;RAN;PRC1;FLNA;BIRC5;SPC24;CENPF;AURKB;CDCA8;MAD2L1;TPX2;KIF11;DLGAP5;KNL1;KIFC1;SPC25;PMF1;SMC1A;BUB1;CENPE;INCENP;NUF2;BUB3;SKA1;TUBG1;SKA2;KIF23;SMC3;CCNB1;CENPT;STIL;CENPS;CENPH;PLK1;NDC80;KIF2C;CENPA;AAAS;TTK;RANGAP1;RANBP2;KIF18A;NUDC;CENPK;CENPN;GPSM2;KNTC1;CKAP5;SGO1;NUP85;DYNC1LI2;DYNC1I2;BUB1B;XPO1;NUP107;NUP43;CENPQ;MAP4;MAP9;AURKA;NSL1;ERCC6L;KPNB1;ZWILCH;MIS12;ZW10;CDC20;DSN1;STAG1;MAD1L1;NEK6;CEP192;DYNLL2;CENPI;NUP160;NUP37
gsea,regulation of primary metabolic process (GO:0080090),0.59967422789302,2.3825409047971022,0.0,8.204457648493473e-05,0.001,37/71,20.94%,ID2;FDPS;PSMA3;PSMB6;NCOR2;PSMB2;PSME2;PSMA4;PSMD14;HMGCS1;PSMA5;PSMB5;FDFT1;SREBF2;SC5D;PMVK;LDLR;SQLE;HMGCR;PSMA6;PSMD1;PSMC1;PSMB7;DHCR7;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;TBL1XR1;LSS;PSMD3;PSMD2;NFYB;PSMC4;MVK;PSMD11
gsea,mitotic cell cycle phase transition (GO:0044772),0.5508895111993691,2.377132434394419,0.0,7.691679045462631e-05,0.001,67/139,24.81%,CDKN2A;CDKN1A;CDK6;CDKN3;CCNG1;CCNA2;TUBB4B;TUBA4A;UBE2C;TACC3;CDK1;CCNB2;YWHAE;UBE2S;TUBA1A;PLK3;HSP90AA1;CNTRL;E2F1;HAUS4;CCND3;CCNE1;PKMYT1;CDKN2C;TUBG1;CDK14;MASTL;NEK2;CCNB1;PLK4;PHLDA1;ACTR1A;PLK1;OPTN;CEP57;CDKN2B;CENPJ;CKAP5;HAUS8;FOXM1;ODF2;CDC34;DYNC1I2;CEP250;HAUS6;NEDD1;CCNF;RB1;NASP;CDC7;AURKA;DCTN1;USP37;POLE;USH1C;CCNE2;HAUS5;EIF4E;CEP192;E2F3;FBXL8;YWHAG;DBF4;GSPT1;CSNK1E;CCP110;CHEK2
gsea,regulation of mitotic cell cycle phase transition (GO:1901990),0.5651365592015692,2.371878448991977,0.0,7.239227336906005e-05,0.001,72/129,21.35%,ID2;TUBB4B;TUBA4A;PSMA3;UBE2C;PSMB6;CDK1;PSMB2;YWHAE;UBE2S;PSME2;CENPF;FBXO5;TUBA1A;ANAPC5;MAD2L1;TPX2;HMMR;PSMA4;PSMD14;HSP90AA1;PSMA5;CNTRL;CENPE;PSMB5;BUB3;E2F1;HAUS4;TUBG1;CDC6;NEK2;ANLN;CCNB1;PLK4;ACTR1A;PLK1;PTPN6;ANAPC15;PSMA6;CEP57;PSMD1;PSMC1;PSMB7;CENPJ;KNTC1;CKAP5;HAUS8;PSMC2;FZR1;PSMD12;ODF2;DYNC1I2;CEP250;BUB1B;HAUS6;PSMD6;PSMC5;PSME3;NEDD1;AURKA;PSMD3;DCTN1;CDC14A;PSMD2;KIF14;PSMC4;ZW10;CDC20;PSMD11;NEK6;HAUS5;CEP192
gsea,cell junction assembly (GO:0034329),0.7202689351556341,2.3710836814550054,0.0,6.837048040411227e-05,0.001,9/26,11.25%,ACTB;ACTG1;FLNA;SH3BP1;PKP3;CTNND2;PLXND1;DSCAM;RYK
gsea,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.7541267278184328,2.361533441385501,0.0,6.477203406705374e-05,0.001,15/25,12.98%,ID2;RRM2;PCNA;FBXO5;TYMS;E2F7;E2F1;CCNE1;TFDP1;POLA1;CDK14;CDC6;CDC45;DHFR;ORC1
gsea,DNA replication (GO:0006260),0.6331711728335832,2.357067594673709,0.0,6.153343236370104e-05,0.001,49/89,19.99%,DUT;PCLAF;RPA2;NAP1L1;CDK1;MCM5;CLSPN;MCM4;BAZ1A;ORC6;RPA3;MCM3;RFC2;SET;TIPIN;MCM2;MCM6;MCM7;UPF1;RPA1;BARD1;FEN1;TOPBP1;POLA1;CDC6;RFC5;RFC3;BRIP1;RFC4;POLD2;RAD50;CDC45;FAM111A;POLD1;BRCA1;ORC1;POLE3;RAD9A;POLE2;RBBP8;MCM8;WDHD1;POLA2;CDC7;MCM10;TIMELESS;HUS1;POLE;TICRR
gsea,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.7386634624875964,2.3518201107396663,0.0,5.860326891781052e-05,0.001,21/31,18.41%,PSMA3;PSMB6;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;AURKA;PSMD3;PSMD2;PSMC4
gsea,cell cycle G2/M phase transition (GO:0044839),0.5758879838238157,2.3474175109844575,0.0,5.593948396700095e-05,0.001,47/88,26.94%,CDKN1A;CCNA2;TUBB4B;TUBA4A;CDK1;CCNB2;YWHAE;TUBA1A;PLK3;HSP90AA1;CNTRL;HAUS4;PKMYT1;TUBG1;CDK14;MASTL;NEK2;CCNB1;PLK4;PHLDA1;ACTR1A;PLK1;OPTN;CEP57;CDKN2B;CENPJ;CKAP5;HAUS8;FOXM1;ODF2;DYNC1I2;CEP250;HAUS6;NEDD1;AURKA;DCTN1;USH1C;HAUS5;CEP192;FBXL8;YWHAG;CSNK1E;CCP110;CHEK2;CDC25C;HAUS7;NDE1
gsea,regulation of endothelial cell apoptotic process (GO:2000351),-0.6656231473791832,-2.3398078446346164,0.0,0.0002605337557740458,0.004,6/26,5.75%,CD160;PDCD4;RGCC;TNFAIP3;SERPINE1;NFE2L2
gsea,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.6394877990283488,2.3374685963970436,0.0,5.3507332490174825e-05,0.001,68/100,23.32%,STMN1;RAN;BIRC5;TACC3;SPC24;CENPF;AURKB;CDCA8;MAD2L1;KIF11;DLGAP5;KNL1;SPC25;PMF1;NUSAP1;BUB1;CENPE;INCENP;NUF2;BUB3;SKA1;TUBG1;SKA2;CCNB1;CENPT;STIL;CENPS;CENPH;PLK1;NDC80;KIF2C;CENPA;TTK;RANGAP1;RANBP2;KIF18A;NUDC;CENPK;CENPN;GPSM2;KNTC1;CKAP5;SGO1;NUP85;DYNC1LI2;DYNC1I2;BUB1B;XPO1;NUP107;NUP43;CENPQ;MAP4;AURKA;NSL1;ERCC6L;ESPL1;KPNB1;ZWILCH;MIS12;ZW10;CDC20;DSN1;MAD1L1;NEK6;DYNLL2;CENPI;NUP160;NUP37
gsea,protein targeting to ER (GO:0045047),-0.8581626113072328,-2.3360599983158923,0.0,0.0002985282618244275,0.005,25/34,8.85%,RPLP1;RPS27A;RPL13;RPLP0;RPL10A;RPL8;RPSA;RPS18;RPL41;RPL15;RPL10;RPS8;RPS26;RPL3;RPL7;RPS25;RPS2;RPL4;RPL14;RPL5;RPS6;RPL7A;RPS17;RPS15;RPL31
gsea,cotranslational protein targeting to membrane (GO:0006613),-0.875967367604386,-2.3335147426470533,0.0,0.0002755645493763946,0.005,25/32,8.85%,RPLP1;RPS27A;RPL13;RPLP0;RPL10A;RPL8;RPSA;RPS18;RPL41;RPL15;RPL10;RPS8;RPS26;RPL3;RPL7;RPS25;RPS2;RPL4;RPL14;RPL5;RPS6;RPL7A;RPS17;RPS15;RPL31
gsea,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.6080730407741236,2.3332204474500537,0.0,5.127786030308421e-05,0.001,22/46,18.29%,ID2;CDKN2A;CDKN1A;CDK6;ANXA1;AKT1;RBL2;PSME2;E2F7;E2F1;CCND3;CDKN2C;TFDP1;RBL1;PTPN6;CDKN2B;DCUN1D3;RDX;PSME3;ADAM17;RB1;KIF14
gsea,G2/M transition of mitotic cell cycle (GO:0000086),0.5717717130462364,2.332985532336032,0.0,4.922674589096084e-05,0.001,52/88,29.72%,CDKN1A;CCNA2;TUBB4B;TUBA4A;CDK1;CCNB2;YWHAE;TUBA1A;PLK3;HSP90AA1;CNTRL;HAUS4;PKMYT1;TUBG1;CDK14;MASTL;NEK2;CCNB1;PLK4;PHLDA1;ACTR1A;PLK1;OPTN;CEP57;CDKN2B;CENPJ;CKAP5;HAUS8;FOXM1;ODF2;DYNC1I2;CEP250;HAUS6;NEDD1;AURKA;DCTN1;USH1C;HAUS5;CEP192;FBXL8;YWHAG;CSNK1E;CCP110;CHEK2;CDC25C;HAUS7;NDE1;OFD1;BACH1;CEP76;KDM8;TAF2
gsea,Fc-gamma receptor signaling pathway (GO:0038094),0.6537452769000779,2.332820332571474,0.0,4.7333409510539264e-05,0.001,13/37,13.17%,ACTB;ACTG1;FCER1G;MYO10;ELMO2;ACTR2;LYN;MYO1G;PRKCE;HSP90AA1;CYFIP1;BAIAP2;PLCG2
gsea,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.9017230864848618,-2.330195076435156,0.0,0.0002558813672780807,0.005,25/30,8.85%,RPLP1;RPS27A;RPL13;RPLP0;RPL10A;RPL8;RPSA;RPS18;RPL41;RPL15;RPL10;RPS8;RPS26;RPL3;RPL7;RPS25;RPS2;RPL4;RPL14;RPL5;RPS6;RPL7A;RPS17;RPS15;RPL31
gsea,regulation of establishment of planar polarity (GO:0090175),0.6765729956307956,2.3298497420530273,0.0,9.116064053881637e-05,0.001,27/42,20.94%,PFN1;PSMA3;PSMB6;PSMB2;PSME2;CLTC;PSMA4;PSMD14;PSMA5;PSMB5;SAPCD2;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;AP2A2;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4;FZD4;WNT11;PSMD11
gsea,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.7160400678318394,2.327683231946849,0.0,8.790490337671578e-05,0.001,26/35,20.94%,PDIA3;PSMA3;VAMP8;PSMB6;TAP2;PSMB2;PSME2;CALR;PSMA4;PSMD14;PSMA5;PSMB5;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4;NCF2;PSMD11
gsea,carbohydrate catabolic process (GO:0016052),0.7985172541204518,2.3243963673475596,0.0,8.487369981200144e-05,0.001,7/20,2.57%,ALDOA;GAPDH;ENO1;LDHA;PKM;TPI1;PGK1
gsea,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.6758197960829408,2.3175100231255965,0.0,0.0001230668647274021,0.002,27/42,20.94%,PFN1;PSMA3;PSMB6;PSMB2;PSME2;CLTC;PSMA4;PSMD14;PSMA5;PSMB5;PSMA6;RYK;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;AP2A2;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4;FZD4;WNT11;PSMD11
gsea,nuclear export (GO:0051168),0.6142371975319958,2.3170203338530637,0.0,0.00011909696586522783,0.002,29/59,22.75%,ALYREF;MAGOHB;RAN;SRSF3;SRSF2;CALR;SRSF7;MALT1;EIF4A3;RBM8A;U2AF1;ATXN1;DDX39B;NUTF2;RNPS1;NUP62;SRSF9;MAGOH;HNRNPA1;NCBP2;XPO1;U2AF2;ANKLE1;SRSF6;SRSF1;SRRM1;EIF4E;SARNP;THOC6
gsea,cortical cytoskeleton organization (GO:0030865),0.7213017525181764,2.3120385274266497,0.0,0.00011537518568193945,0.002,6/20,7.21%,PLEK;LCP1;RHOQ;EZR;RHOF;RHOC
gsea,synapse organization (GO:0050808),0.6288869173463498,2.3102097614709782,0.0,0.0001118789679340019,0.002,12/40,11.25%,NEDD4;F2R;CHCHD10;CX3CR1;CTNND2;PLXND1;L1CAM;CYFIP1;PIN1;DSCAM;UNC13B;RYK
gsea,DNA-dependent DNA replication (GO:0006261),0.6117526614752778,2.3047265415195635,0.0022675736961451248,0.00010858841005359008,0.002,59/96,19.25%,RPA2;PSMA3;PSMB6;MCM5;MCM4;BAZ1A;PSMB2;ORC6;RPA3;PSME2;MCM3;RFC2;GMNN;PRIM1;RAD51;MCM2;MCM6;MCM7;GINS2;PSMA4;PSMD14;RPA1;PSMA5;PSMB5;TOPBP1;POLA1;CDC6;RFC5;RFC3;RFC4;GINS3;POLD2;CDC45;GINS4;POLD1;PSMA6;PSMD1;PSMC1;PRIM2;PSMB7;ORC1;POLE3;POLE2;PSMC2;PSMD12;CDC34;MCM8;PSMD6;PSMC5;PSME3;WDHD1;POLA2;CDC7;MCM10;PSMD3;POLD3;PSMD2;PSMC4;POLE
gsea,DNA replication initiation (GO:0006270),0.7479604274778624,2.302256050680789,0.0,0.00010548588405205893,0.002,25/34,17.09%,RPA2;MCM5;MCM4;ORC6;RPA3;MCM3;GMNN;PRIM1;MCM2;MCM6;MCM7;RPA1;TOPBP1;POLA1;CDC6;CDC45;PRIM2;ORC1;POLE3;POLE2;CDC34;MCM8;POLA2;CDC7;MCM10
gsea,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.777232846571883,-2.2995531497840362,0.0,0.00028658713135145037,0.006,1/16,0.12%,RPS27A
gsea,RNA export from nucleus (GO:0006405),0.5943843382793232,2.2977461961990637,0.0,0.0001025557206061684,0.002,44/77,27.55%,ALYREF;MAGOHB;RAN;SRSF3;SRSF2;HNRNPA2B1;SLBP;SRSF7;UPF1;EIF4A3;RBM8A;U2AF1;DDX39B;NDC1;RNPS1;AAAS;NUP93;NUP62;RANBP2;HHEX;SRSF9;MAGOH;HNRNPA1;NUP85;NCBP2;NUP107;NUP43;U2AF2;SRSF6;CPSF2;SRSF1;SRRM1;NUP35;EIF4E;SARNP;THOC6;NUP160;NUP37;NUP210;NUP54;RBM15B;GLE1;NUP133;NCBP1
gsea,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.6475086527221209,2.296801318239649,0.0,9.978394437356926e-05,0.002,9/35,9.67%,SUB1;CEBPB;CDKN2A;CDKN1A;BAX;CDK1;MED30;RUNX2;CCNB1
gsea,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.7354016889800999,-2.290039419798093,0.0,0.00026867543564198474,0.006,8/20,11.02%,XCL1;SLAMF6;CD160;CRTAM;LAMP1;CD226;IL23A;RASGRP1
gsea,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.5887570671837277,2.2863710468964342,0.0,0.00016193008516763433,0.003,42/74,27.55%,ALYREF;MAGOHB;SRSF3;SRSF2;HNRNPA2B1;SLBP;SRSF7;UPF1;EIF4A3;RBM8A;U2AF1;DDX39B;NDC1;RNPS1;AAAS;NUP93;NUP62;RANBP2;HHEX;SRSF9;MAGOH;NUP85;NCBP2;NUP107;NUP43;U2AF2;SRSF6;CPSF2;SRSF1;SRRM1;NUP35;EIF4E;SARNP;THOC6;NUP160;NUP37;NUP210;NUP54;RBM15B;GLE1;NUP133;NCBP1
gsea,regulation of cell cycle G1/S phase transition (GO:1902806),0.7114980392726735,2.2820258291706317,0.0,0.00015777803170179754,0.003,10/20,18.29%,ID2;CDKN1A;ATP2B4;PSME2;FAM83D;E2F1;PTPN6;PLCG2;PSME3;KIF14
gsea,positive regulation of innate immune response (GO:0045089),0.7567818883062067,2.27862136157544,0.0,0.00015383358090925262,0.003,3/15,5.37%,CCL5;ADAM8;ZBP1
gsea,glycolytic process through glucose-6-phosphate (GO:0061620),0.8132451751028094,2.2764771259472907,0.0,0.00015008154235049035,0.003,7/17,2.57%,ALDOA;GAPDH;ENO1;PKM;TPI1;PFKP;PGK1
gsea,negative regulation of viral process (GO:0048525),0.6215842898636594,2.273583591731882,0.0,0.00017580980675343155,0.004,19/38,25.62%,CCL5;PPIA;ISG20;ISG15;BANF1;IFITM3;LTF;IFITM1;ZFP36;FAM111A;RNASEL;BST2;IFITM2;LARP7;EIF2AK2;PARP10;STAT1;SRPK1;IFIT1
gsea,cytoplasmic translation (GO:0002181),-0.8384365024404079,-2.2726489633231295,0.0,0.00025287099825127974,0.006,25/35,8.85%,RPLP1;RPS27A;RPL13;RPLP0;RPL10A;RPL8;RPSA;RPS18;RPL41;RPL15;RPL10;RPS8;RPS26;RPL3;RPL7;RPS25;RPS2;RPL4;RPL14;RPL5;RPS6;RPL7A;RPS17;RPS15;RPL31
gsea,mRNA export from nucleus (GO:0006406),0.5774261630646875,2.271897942602098,0.0,0.000171721206596375,0.004,42/77,27.55%,ALYREF;MAGOHB;SRSF3;SRSF2;HNRNPA2B1;SLBP;SRSF7;UPF1;EIF4A3;RBM8A;U2AF1;DDX39B;NDC1;RNPS1;AAAS;NUP93;NUP62;RANBP2;HHEX;SRSF9;MAGOH;NUP85;NCBP2;NUP107;NUP43;U2AF2;SRSF6;CPSF2;SRSF1;SRRM1;NUP35;EIF4E;SARNP;THOC6;NUP160;NUP37;NUP210;NUP54;RBM15B;GLE1;NUP133;NCBP1
gsea,defense response to Gram-positive bacterium (GO:0050830),0.8362664146802508,2.2695167056932424,0.0,0.00016781845190100284,0.004,6/15,3.98%,PGLYRP1;GBP7;HMGB2;GBP4;PGLYRP2;GBP6
gsea,mitotic nuclear division (GO:0140014),0.651597033758245,2.26736945939996,0.0,0.00019143734513151435,0.004,32/54,21.35%,RAN;FLNA;UBE2C;UBE2S;CDCA8;TPX2;KIF11;KIFC1;NUSAP1;SMC1A;TUBG1;KNSTRN;SMC3;NCAPG2;PLK1;NDC80;AAAS;NUP62;KIF18A;CENPK;SGO1;SPAG5;KIF18B;MAP9;NSL1;ESPL1;KPNB1;MIS12;ZW10;DSN1;STAG1;CEP192
gsea,post-translational protein modification (GO:0043687),0.47853215724114184,2.263511962933567,0.0,0.0002675366624508741,0.007,63/168,25.31%,LGALS1;HSP90B1;SPP1;CSF1;EPAS1;LAMC1;PSMA3;ASB2;PSMB6;PDIA6;UBE2M;CISH;ELOC;PSMB2;PSME2;RCN1;PSMA4;PSMD14;PSMA5;PSMB5;COPS4;UCHL3;KEAP1;ESCO2;P4HB;RBBP5;FBXO31;PSMA6;STT3A;PSMD1;PSMC1;PSMB7;DSCC1;WDR5;COPS5;DCUN1D3;GAN;ANKRD9;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;CCNF;LRR1;FBXW4;PSMD3;PSMD2;PSMC4;ASB1;FBXO30;PRKCSH;KLHL25;PSMD11;FBXL14;UBA3;GOLM1;FBXL8;DTL;SOCS2;KLHL20;COPS3;DCAF13
gsea,neutrophil mediated immunity (GO:0002446),0.4740017438936817,2.2622167598869027,0.0,0.00026184439303702573,0.007,92/220,25.03%,PLAC8;S100A11;CTSD;ADAM8;GLIPR1;FGL2;ARSB;PGLYRP1;ALDOA;FCER1G;ANXA2;LGALS3;PPIA;ATP8B4;DGAT1;PKM;PADI2;SLC2A3;HMGB1;ALAD;TUBB4B;VAMP8;DDOST;ACTR2;DIAPH1;IMPDH1;CD55;NBEAL2;RHOF;PSMD14;FABP5;HSP90AA1;APRT;PSMA5;RAB27A;CD14;LTF;MAGT1;MIF;NRAS;PLEKHO2;CYFIP1;ENPP4;ITGAM;PA2G4;PTPN6;PSMD1;IQGAP2;PSMB7;ADGRG3;CEACAM1;SVIP;ALDOC;AP1M1;CCT8;PSMC2;MVP;PSMD12;CPNE1;AGPAT2;AP2A2;PSMD6;HSPA1B;ADAM17;CD93;LAIR1;PDAP1;PSMD3;SYNGR1;PSMD2;HSPA1A;VAMP7;KCNAB2;KPNB1;PGRMC1;GCA;MOSPD2;PSMD11;DSN1;BST2;SLC11A1;HSPA8;ACLY;HPSE;CPPED1;GALNS;RAB3D;ANXA3;IDH1;HK3;ILF2;PTPRJ
gsea,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.47647964087356726,2.259955362744195,0.0,0.000256389301515421,0.007,71/168,27.07%,HSP90B1;NEDD4;TBX21;PSMA3;UBE2C;PSMB6;CDK1;PSMB2;UBE2S;PSME2;AURKB;HSPA5;EDEM1;FBXO5;ANAPC5;MAD2L1;PSMA4;PSMD14;PSMA5;PSMB5;DERL2;BUB3;KCTD17;CCNB1;RAD23A;PLK1;ANAPC15;FBXO31;PSMA6;MDM2;PSMD1;PSMC1;RNF126;PSMB7;FAF1;ANKRD9;RNF5;PSMC2;FZR1;STUB1;PSMD12;CDC34;BUB1B;PSMD6;PSMC5;PSME3;CCNF;RB1;TBL1XR1;AURKA;FBXW4;PSMD3;PSMD2;KIF14;PSMC4;FOXRED2;NCCRP1;CDC20;PSMD11;FBXL14;FBXL8;LTN1;FBXO45;BIRC2;KLHL20;HECTD3;UBXN11;KCTD13;PSMC6;TMEM129;ZFAND2A
gsea,cholesterol metabolic process (GO:0008203),0.6437148197508457,2.2593132367191067,0.0,0.0002511568667906165,0.007,21/35,24.13%,MT3;FDPS;LBR;HMGCS1;MSMO1;FDFT1;HSD17B7;PMVK;FDX1;SQLE;HMGCR;DHCR7;DHCR24;LSS;OSBPL5;SOAT1;MVK;NSDHL;INSIG1;ACLY;IDI1
gsea,axon development (GO:0061564),0.7034239844976812,2.259232241925721,0.0,0.0002461337294548042,0.007,7/24,13.49%,S100A6;ACTB;L1CAM;DHFR;RYK;BAIAP2;AFG3L2
gsea,regulation of DNA replication (GO:0006275),0.6586242756555308,2.2585026598434097,0.0,0.00024130757789686685,0.007,14/35,13.41%,S100A11;CCNA2;ZBTB38;PCNA;GMNN;FBXO5;CDC6;SMC3;NUCKS1;ESCO2;EHMT2;DSCC1;FAF1;ATAD5
gsea,neutrophil degranulation (GO:0043312),0.472794047654072,2.2578499659742697,0.0,0.00023666704755269632,0.007,91/219,25.03%,PLAC8;S100A11;CTSD;ADAM8;GLIPR1;FGL2;ARSB;PGLYRP1;ALDOA;FCER1G;ANXA2;LGALS3;PPIA;ATP8B4;DGAT1;PKM;PADI2;SLC2A3;HMGB1;ALAD;TUBB4B;VAMP8;DDOST;ACTR2;DIAPH1;IMPDH1;CD55;NBEAL2;RHOF;PSMD14;FABP5;HSP90AA1;APRT;PSMA5;RAB27A;CD14;LTF;MAGT1;MIF;NRAS;PLEKHO2;CYFIP1;ENPP4;ITGAM;PA2G4;PTPN6;PSMD1;IQGAP2;PSMB7;ADGRG3;CEACAM1;SVIP;ALDOC;AP1M1;CCT8;PSMC2;MVP;PSMD12;CPNE1;AGPAT2;AP2A2;PSMD6;HSPA1B;CD93;LAIR1;PDAP1;PSMD3;SYNGR1;PSMD2;HSPA1A;VAMP7;KCNAB2;KPNB1;PGRMC1;GCA;MOSPD2;PSMD11;DSN1;BST2;SLC11A1;HSPA8;ACLY;HPSE;CPPED1;GALNS;RAB3D;ANXA3;IDH1;HK3;ILF2;PTPRJ
gsea,negative regulation of DNA metabolic process (GO:0051053),0.7775800321026647,2.255147631059361,0.0,0.000232201631561136,0.007,2/15,0.54%,SUB1;CDKN1A
gsea,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.5462256050117552,2.253213795108164,0.0,0.0002279016013470409,0.007,86/156,31.75%,ALYREF;MAGOHB;SRSF3;PCBP1;SRSF2;SNRPD1;HNRNPA2B1;HNRNPD;LSM2;HNRNPA3;SNRPD3;LSM8;SNRPA1;YBX1;SRSF7;HNRNPF;HNRNPU;EIF4A3;SNRPB;RBM8A;U2AF1;RBMX2;POLR2C;DDX39B;SYNCRIP;SNRPA;SNRPE;RNPS1;TFIP11;SRSF9;MAGOH;HNRNPA1;PPIL1;LSM3;CACTIN;POLR2F;POLR2L;SNU13;SMU1;PTBP1;NCBP2;NONO;SNRNP70;U2AF2;SF3A2;U2SURP;DHX9;DDX46;GTF2F1;HNRNPM;SRSF6;HNRNPUL1;CPSF2;SRSF1;SRSF10;RBM14;SF3B2;USP39;SRRM1;PRPF19;PPIH;PRPF3;CWC25;HSPA8;HNRNPK;SNRPF;RBMX;AQR;PNN;DHX15;RBM15B;PRPF38A;BUD31;SF3B4;NCBP1;RSRC1;SRRT;PPWD1;PRPF8;SNRNP40;EFTUD2;METTL14;CPSF1;PHF5A;GTF2F2;GCFC2
gsea,cell-matrix adhesion (GO:0007160),-0.5767676858605619,-2.250267628803718,0.0,0.00039803768243256994,0.01,14/37,14.70%,ITGB1;ACTN1;ITGB7;TIAM1;PTPRK;VCL;ITGB8;CD44;VCAM1;BCAM;MADCAM1;DLC1;SORBS1;ITGA7
gsea,neutrophil activation involved in immune response (GO:0002283),0.4686707107635588,2.243021121571871,0.0,0.0002908853166284049,0.009,91/221,25.03%,PLAC8;S100A11;CTSD;ADAM8;GLIPR1;FGL2;ARSB;PGLYRP1;ALDOA;FCER1G;ANXA2;LGALS3;PPIA;ATP8B4;DGAT1;PKM;PADI2;SLC2A3;HMGB1;ALAD;TUBB4B;VAMP8;DDOST;ACTR2;DIAPH1;IMPDH1;CD55;NBEAL2;RHOF;PSMD14;FABP5;HSP90AA1;APRT;PSMA5;RAB27A;CD14;LTF;MAGT1;MIF;NRAS;PLEKHO2;CYFIP1;ENPP4;ITGAM;PA2G4;PTPN6;PSMD1;IQGAP2;PSMB7;ADGRG3;CEACAM1;SVIP;ALDOC;AP1M1;CCT8;PSMC2;MVP;PSMD12;CPNE1;AGPAT2;AP2A2;PSMD6;HSPA1B;CD93;LAIR1;PDAP1;PSMD3;SYNGR1;PSMD2;HSPA1A;VAMP7;KCNAB2;KPNB1;PGRMC1;GCA;MOSPD2;PSMD11;DSN1;BST2;SLC11A1;HSPA8;ACLY;HPSE;CPPED1;GALNS;RAB3D;ANXA3;IDH1;HK3;ILF2;PTPRJ
gsea,substantia nigra development (GO:0021762),0.7635824021154397,2.241029825399053,0.0,0.00028569093597432627,0.009,6/15,7.40%,ACTB;PADI2;YWHAE;HSPA5;GNB4;SYNGR3
gsea,canonical glycolysis (GO:0061621),0.8164676483751165,2.240412181750004,0.0,0.0002758395243890047,0.009,7/16,2.57%,ALDOA;GAPDH;ENO1;PKM;TPI1;PFKP;PGK1
gsea,glucose catabolic process to pyruvate (GO:0061718),0.8164676483751165,2.240412181750004,0.0,0.0002758395243890047,0.009,7/16,2.57%,ALDOA;GAPDH;ENO1;PKM;TPI1;PFKP;PGK1
gsea,negative regulation of cellular protein metabolic process (GO:0032269),0.5764037817299599,2.239667572216928,0.0,0.0002711642782129199,0.009,16/51,12.50%,GZMB;GAPDH;SERPINE2;AKT1;CAMK2N1;CALR;TYMS;YBX1;EIF4A3;GRB7;SYNCRIP;DAB2IP;DHFR;EIF2AK3;MRPL13;CNOT9
gsea,response to organic cyclic compound (GO:0014070),0.6994494789717434,2.2371826493225138,0.0,0.00026664487357603786,0.009,8/26,10.86%,CCL5;CCL3;SPP1;GLDC;ANXA1;STAT3;TIPARP;DHFR
gsea,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.6259279171857398,2.236892495076667,0.0,0.0002622736461403651,0.009,12/36,13.17%,ACTB;ACTG1;MYO10;ELMO2;ACTR2;LYN;MYO1G;PRKCE;HSP90AA1;CYFIP1;BAIAP2;PLCG2
gsea,cell morphogenesis involved in neuron differentiation (GO:0048667),0.6697186713757701,2.233807550701706,0.0,0.00029774241466306954,0.009,11/27,22.85%,S100A6;ACTB;RYK;BAIAP2;MEF2C;AFG3L2;RB1;MAP2;APBB1;NEFH;MINK1
gsea,glycolytic process (GO:0006096),0.8164290777083113,2.232096753020925,0.0,0.00029301634458905255,0.009,7/17,2.57%,ALDOA;GAPDH;ENO1;LDHA;PKM;TPI1;PGK1
gsea,negative regulation of neuron projection development (GO:0010977),0.7121841895571593,2.2319486380349334,0.0,0.0002884379642048486,0.009,2/19,1.75%,MT3;ARHGDIA
gsea,global genome nucleotide-excision repair (GO:0070911),-0.7281398822676692,-2.2318313781637036,0.0,0.0005279236630158297,0.014,2/18,6.75%,RPS27A;USP45
gsea,cellular divalent inorganic cation homeostasis (GO:0072503),0.5885004656527846,2.2252497326470997,0.0,0.0003029338208674513,0.01,10/42,12.53%,CCL5;MT3;CCL3;CCR2;ATP2B4;CALR;ATP2A2;CCR1;SLC39A6;STOML2
gsea,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.7099473932000601,2.224545128233139,0.0,0.00029834391449067173,0.01,9/19,11.76%,GZMB;BAX;CHCHD10;BAK1;YWHAE;E2F1;TFDP1;SFN;HIP1R
gsea,defense response to bacterium (GO:0042742),0.677281799294057,2.2233372788872847,0.0,0.0002938910202445423,0.01,12/42,7.96%,CEBPB;PGLYRP1;FCER1G;GBP7;HMGB2;GBP4;LYST;PGLYRP2;GBP6;ISG15;LTF;SPN
gsea,mRNA processing (GO:0006397),0.5185590722512396,2.2202721268867633,0.0,0.00030766716181850523,0.011,93/181,31.75%,ALYREF;MAGOHB;SRSF3;PCBP1;SRSF2;SNRPD1;HNRNPA2B1;HNRNPD;LSM2;HNRNPA3;SNRPD3;LSM8;SNRPA1;YBX1;SRSF7;HNRNPF;HNRNPU;EIF4A3;ERN1;SNRPB;RBM8A;U2AF1;RBMX2;POLR2C;DDX39B;SYNCRIP;SNRPA;SNRPE;RNPS1;TFIP11;SRSF9;MAGOH;HNRNPA1;PPIL1;LSM3;CACTIN;POLR2F;POLR2L;SNU13;SMU1;PTBP1;TCERG1;NCBP2;NONO;SNRNP70;U2AF2;SF3A2;U2SURP;DHX9;DDX46;GTF2F1;HNRNPM;SRSF6;HNRNPUL1;CPSF2;SRSF1;SRSF10;RBM14;SF3B2;USP39;SRRM1;PRPF19;PPIH;PRPF3;CWC25;HSPA8;SARNP;THOC6;HNRNPK;GEMIN2;SNRPF;RBMX;AQR;PNN;DHX15;RBM15B;PRPF38A;BUD31;SF3B4;NCBP1;RSRC1;RPRD1B;SRRT;PPWD1;PRPF8;SNRNP40;EFTUD2;METTL14;CPSF1;PHF5A;CMTR1;GTF2F2;GCFC2
gsea,double-strand break repair via homologous recombination (GO:0000724),0.5877725303670598,2.2180892562884176,0.0,0.0003210439949410489,0.012,40/70,26.06%,RPA2;MCM5;NABP1;MCM4;RPA3;MCM3;RAD51;MCM2;MCM6;MCM7;GINS2;PSMD14;SMC6;RPA1;FEN1;RAD21;NUCKS1;AUNIP;RAD51AP1;RAD50;CDC45;GINS4;MMS22L;RAD54L;BRCA2;BRCA1;SMC5;UBE2N;RBBP8;MCM8;CDC7;SPIDR;HUS1;PALB2;GEN1;RAD51C;RECQL;RAD54B;TONSL;RFWD3
gsea,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.587772252338017,2.217431857897382,0.0,0.0003164576521561768,0.012,11/38,9.29%,CTSD;MT3;F2R;HMGB1;CYCS;AKT1;YWHAE;MALT1;CASP1;ARL6IP1;SFN
gsea,protein-DNA complex assembly (GO:0065004),0.5787601040106752,2.2148211395054647,0.0,0.0003120005021258081,0.012,46/82,22.24%,HMGB2;RPA2;PSMA3;NAP1L1;PSMB6;MCM5;MCM4;PSMB2;ORC6;RPA3;PSME2;MCM3;GMNN;CHAF1B;RAD51;MCM2;MCM6;MCM7;PSMA4;PSMD14;RPA1;PSMA5;PSMB5;CDC6;CENPV;CHAF1A;PSMA6;PSMD1;PSMC1;PSMB7;ORC1;PSMC2;NAP1L3;PSMD12;MCM8;PSMD6;PSMC5;PSME3;PSMD3;ANP32B;PSMD2;PSMC4;NAP1L4;PSMD11;CDT1;BRD2
gsea,"mRNA splicing, via spliceosome (GO:0000398)",0.5308123373999453,2.2120120277659407,0.0,0.00034185240202056134,0.013,92/171,31.75%,ALYREF;MAGOHB;SRSF3;PCBP1;SRSF2;SNRPD1;HNRNPA2B1;HNRNPD;LSM2;HNRNPA3;SNRPD3;LSM8;SNRPA1;YBX1;SRSF7;HNRNPF;HNRNPU;EIF4A3;SNRPB;RBM8A;U2AF1;RBMX2;POLR2C;DDX39B;SYNCRIP;SNRPA;SNRPE;RNPS1;TFIP11;SRSF9;CELF4;MAGOH;HNRNPA1;PPIL1;LSM3;CACTIN;POLR2F;POLR2L;SNU13;SMU1;PTBP1;NCBP2;NONO;DDX20;SNRNP70;U2AF2;SF3A2;U2SURP;DHX9;DDX46;GTF2F1;HNRNPM;SRSF6;HNRNPUL1;CPSF2;SRSF1;SRSF10;RBM14;SF3B2;USP39;SRRM1;PRPF19;PPIH;PRPF3;CWC25;HSPA8;HNRNPK;STRAP;GEMIN2;SNRPF;SRPK1;RBMX;AQR;PNN;DHX15;RBM15B;PRPF38A;BUD31;SF3B4;NCBP1;RSRC1;SRRT;PPWD1;PRPF8;SNRNP40;CLNS1A;EFTUD2;METTL14;CPSF1;PHF5A;GTF2F2;GCFC2
gsea,regulation of humoral immune response (GO:0002920),-0.7857798969965768,-2.21111827522188,0.0,0.0007881146112164886,0.021,2/17,1.17%,CCR7;CD81
gsea,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.6100111721881757,2.2110002782810243,0.0,0.00033716949240384134,0.013,13/38,13.17%,ACTB;ACTG1;FCER1G;MYO10;ELMO2;ACTR2;LYN;MYO1G;PRKCE;HSP90AA1;CYFIP1;BAIAP2;PLCG2
gsea,positive regulation of cellular metabolic process (GO:0031325),0.5966006148105868,2.2083977514612214,0.0,0.0003326131479118975,0.013,12/49,9.67%,CCL5;MT3;CDKN1A;ANXA2;IFNG;PRELID1;CSF1;AKT1;CDK1;UHRF1;STARD4;CCNB1
gsea,gluconeogenesis (GO:0006094),0.715566940165249,2.2083922069802533,0.0,0.0003281783059397389,0.013,10/22,14.82%,ALDOA;GAPDH;ENO1;TPI1;PGK1;MDH2;PCK2;ALDOC;SLC25A10;GOT1
gsea,mitotic DNA damage checkpoint signaling (GO:0044773),0.6085308778454774,2.2067183257767122,0.0022727272727272726,0.00032386017033526866,0.013,21/39,26.06%,CDKN1A;RPS27L;RPA2;CDK1;CLSPN;TIPIN;TOPBP1;PLK1;FBXO31;BRCA1;RAD9A;FZR1;FANCD2;EME1;BRCC3;HUS1;TICRR;DTL;CHEK2;CHEK1;RFWD3
gsea,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.6297137335165585,2.20527871885866,0.0,0.0003196541940971483,0.013,38/54,20.94%,PSMA3;UBE2C;PSMB6;CDK1;PSMB2;UBE2S;PSME2;AURKB;FBXO5;ANAPC5;MAD2L1;PSMA4;PSMD14;PSMA5;PSMB5;BUB3;CCNB1;PLK1;ANAPC15;FBXO31;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;FZR1;PSMD12;BUB1B;PSMD6;PSMC5;PSME3;RB1;AURKA;PSMD3;PSMD2;PSMC4;CDC20;PSMD11
gsea,regulation of cell cycle G2/M phase transition (GO:1902749),0.5814493404811022,2.2041869239197878,0.0,0.0003155560634035951,0.013,36/63,24.26%,TUBB4B;TUBA4A;CDK1;YWHAE;CENPF;TUBA1A;TPX2;HMMR;HSP90AA1;CNTRL;HAUS4;TUBG1;NEK2;PLK4;ACTR1A;PLK1;CEP57;CENPJ;CKAP5;ATAD5;HAUS8;ODF2;DYNC1I2;CEP250;HAUS6;GTSE1;NEDD1;AURKA;DCTN1;KIF14;DYRK3;HAUS5;CEP192;YWHAG;CSNK1E;CCP110
gsea,G1/S transition of mitotic cell cycle (GO:0000082),0.5667833178037356,2.1997755693818117,0.0,0.0003427178511396008,0.014,32/60,23.80%,CDKN2A;CDKN1A;CDK6;CDKN3;RRM2;PCNA;FBXO5;TYMS;PLK3;E2F1;CCNE1;CDKN2C;TFDP1;POLA1;CDK14;CDC6;CDC45;DHFR;ORC1;CDC34;RB1;NASP;CDC7;USP37;POLE;NPAT;CCNE2;EIF4E;E2F3;CDT1;DBF4;GSPT1
gsea,positive regulation of protein catabolic process (GO:0045732),0.5763492892491574,2.1975084302990253,0.0,0.00036920059418220623,0.015,14/41,14.37%,ADAM8;NEDD4;SNX9;IFNG;EZR;PLK3;HSP90AA1;BARD1;TIPARP;DAB2IP;IDE;FAF1;RDX;FZR1
gsea,nucleobase-containing small molecule interconversion (GO:0015949),0.7815000467872433,2.1945194960015324,0.0,0.00036464256215526546,0.015,8/18,6.42%,GLRX;DUT;GSR;RRM2;TXNRD1;RRM1;TYMS;NME1
gsea,hexose biosynthetic process (GO:0019319),0.6904126775898592,2.193907614092221,0.0,0.0003902120101112749,0.017,11/24,14.82%,ALDOA;GAPDH;ENO1;TPI1;PGK1;MDH2;PCK2;SORD;ALDOC;SLC25A10;GOT1
gsea,stress-activated MAPK cascade (GO:0051403),-0.6191433393039135,-2.1904314303540997,0.0,0.0008529378909269358,0.024,6/30,3.17%,RPS27A;ZFP36L1;NFKB1;RIPK2;MAP3K8;TRIB1
gsea,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.5869980900248812,2.1883200291351406,0.0,0.00041516532679123594,0.019,32/55,18.41%,CDKN2A;CDKN1A;CDK6;PSMA3;PSMB6;RBL2;PSMB2;PSME2;FBXO5;E2F7;PSMA4;PSMD14;PSMA5;PSMB5;CDKN2C;RBL1;PSMA6;CDKN2B;PSMD1;PSMC1;PSMB7;DCUN1D3;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;RB1;AURKA;PSMD3;PSMD2;PSMC4
gsea,cellular metal ion homeostasis (GO:0006875),0.5897984029970035,2.1820452960674643,0.0,0.00043952451688357885,0.02,9/41,12.53%,CCL5;MT3;CCL3;CCR2;ATP2B4;CALR;ATP2A2;CCR1;STOML2
gsea,mitotic cytokinesis (GO:0000281),0.6920779119584098,2.18178223025383,0.0022172949002217295,0.00043435364021436027,0.02,16/29,13.62%,SNX9;STMN1;RACGAP1;NUSAP1;CIT;TRIM36;CEP55;INCENP;RHOC;KIF23;ANLN;CKAP2;KIF20A;PLK1;CENPA;ECT2
gsea,RNA 3'-end processing (GO:0031123),0.5977805318767299,2.1816636272728864,0.0,0.0004293030164909375,0.02,20/45,22.75%,ALYREF;MAGOHB;SRSF3;SRSF2;SRSF7;EIF4A3;RBM8A;U2AF1;DDX39B;RNPS1;SRSF9;MAGOH;NCBP2;U2AF2;SRSF6;CPSF2;SRSF1;SRRM1;SARNP;THOC6
gsea,cytoskeleton-dependent cytokinesis (GO:0061640),0.6908240193541357,2.1810619442641266,0.0022624434389140274,0.00043851411569534077,0.021,17/31,13.62%,SNX9;STMN1;AURKB;RACGAP1;NUSAP1;CIT;TRIM36;CEP55;INCENP;RHOC;KIF23;ANLN;CKAP2;KIF20A;PLK1;CENPA;ECT2
gsea,sister chromatid segregation (GO:0000819),0.7171708812408671,2.180898966538867,0.0,0.0004335310007442573,0.021,22/29,20.98%,RAN;TOP2A;CDCA8;KIFC1;NUSAP1;SMC1A;TUBG1;KNSTRN;NCAPG2;PLK1;NDC80;KIF18A;CENPK;SGO1;SPAG5;KIF18B;RB1;NSL1;ESPL1;MIS12;ZW10;DSN1
gsea,mRNA 3'-end processing (GO:0031124),0.5724906446638613,2.17321908031118,0.0,0.0004839708163437161,0.024,23/51,23.36%,ALYREF;MAGOHB;SRSF3;SRSF2;SLBP;SRSF7;EIF4A3;RBM8A;U2AF1;DDX39B;RNPS1;SRSF9;MAGOH;NCBP2;U2AF2;SRSF6;CPSF2;SRSF1;SRRM1;SARNP;LEO1;THOC6;AHCYL1
gsea,proteasomal protein catabolic process (GO:0010498),0.4766173070424242,2.1728481226307435,0.0,0.0004785933628287859,0.024,43/102,27.07%,NEDD4;TBX21;PSMA3;PSMB6;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;KCTD17;RAD23A;PSMA6;MDM2;PSMD1;PSMC1;RNF126;PSMB7;FAF1;ANKRD9;RNF5;PSMC2;STUB1;PSMD12;CDC34;PSMD6;PSMC5;PSME3;TBL1XR1;PSMD3;PSMD2;KIF14;PSMC4;PRPF19;PSMD11;FBXO45;BIRC2;KLHL20;HECTD3;UBXN11;KCTD13;PSMC6;ZFAND2A
gsea,positive regulation of response to biotic stimulus (GO:0002833),0.6728431680631028,2.1725606118953413,0.0,0.00047333409510539264,0.024,2/22,0.32%,CCL5;ADAM8
gsea,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.5537488354433757,-2.169113086029433,0.0,0.001172401900983206,0.033,16/41,14.58%,CD74;JAK2;CD81;RIPK2;NRP1;PECAM1;PRNP;BST1;CD44;LIF;PTPN11;ENPP2;IL23A;IL3;RAP2B;ABL1
gsea,positive regulation of metabolic process (GO:0009893),0.5754366443606015,2.1681597513677295,0.0,0.0005216964917792045,0.025,9/54,8.09%,PLAC8;CEBPB;IFNG;ACADL;CCR2;EPAS1;ADRB1;FABP5;GATM
gsea,regulation of JNK cascade (GO:0046328),-0.5278883734929267,-2.165927880931278,0.0,0.001277181781022768,0.036,19/52,13.84%,CCR7;MAP4K4;TRAF1;MFHAS1;GADD45B;PINK1;PER1;HIPK2;NCF1;SH3RF1;DUSP10;PHLPP1;RASSF2;F2RL1;TRAF4;TGFBR3;RASGRP1;PJA2;UNC5CL
gsea,purine ribonucleotide metabolic process (GO:0009150),0.614427334385691,2.1644400694398835,0.0,0.0005293198482899014,0.026,5/29,3.36%,TPST2;RAN;GIMAP7;RHOQ;HINT1
gsea,metal ion transport (GO:0030001),0.5956186816889278,2.164148378034356,0.0,0.0005236887860740515,0.026,8/34,13.01%,CCL5;CCR5;MT3;CCL3;SLC3A2;MAGT1;CCR1;TRPC1
gsea,calcium ion homeostasis (GO:0055074),0.6000196071485686,2.1636735009103916,0.0,0.0005311306793498406,0.026,10/38,12.53%,CCL5;CCL3;CCR2;ATP2B4;SELENON;CALR;FAM20A;ATP2A2;CCR1;STOML2
gsea,positive regulation of ion transport (GO:0043270),0.6847075428283658,2.1633598201238464,0.0,0.0005255980681066131,0.026,8/22,13.55%,CCL5;CCL4;CCL3;F2R;VAMP8;CCR1;SCN1B;KIF5B
gsea,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.6062020657491042,2.16074771446148,0.0,0.0005582414482480095,0.029,16/41,17.32%,HAVCR2;ADAM8;CCL3;IFNG;CCR2;HMGB1;STAT3;CD14;MIF;SPN;DDX58;PLCG2;CD86;FRMD8;DHX9;IL33
gsea,negative regulation of translation (GO:0017148),0.5370192440674503,2.1543546541052043,0.0,0.0006655656969951337,0.032,12/50,12.50%,GZMB;GAPDH;CALR;TYMS;YBX1;EIF4A3;GRB7;SYNCRIP;DHFR;EIF2AK3;MRPL13;CNOT9
gsea,negative regulation of cellular amide metabolic process (GO:0034249),0.5547058830123386,2.153343276650865,0.0,0.0006588428111669,0.032,13/49,12.50%,GZMB;GAPDH;CALR;TYMS;YBX1;EIF4A3;GRB7;PIN1;SYNCRIP;DHFR;EIF2AK3;MRPL13;CNOT9
gsea,negative regulation of T cell activation (GO:0050868),0.6672073105832232,2.1508480009858,0.0,0.0006645610695279713,0.033,9/24,13.46%,HAVCR2;CEBPB;LGALS3;GLMN;SPN;PAG1;TNFRSF21;CD86;CEACAM1
gsea,non-canonical Wnt signaling pathway (GO:0035567),0.5789010717767524,2.1494971173000215,0.0,0.0006579812569583875,0.033,30/59,20.97%,PFN1;PSMA3;PSMB6;PSMB2;PSME2;CLTC;PSMA4;PSMD14;PSMA5;PSMB5;CCDC88C;PSMA6;RYK;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;AP2A2;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4;FRZB;FZD4;WNT11;PSMD11;SFRP4
gsea,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.6522192127047322,-2.14349955901129,0.0,0.0015224941353045801,0.045,4/19,7.72%,EMB;ITGB1;PECAM1;MPZL2
gsea,base-excision repair (GO:0006284),0.6281507815902647,2.139920068216128,0.0,0.0007480534914802872,0.036,19/37,26.53%,RPA2;LIG1;RPA3;PCNA;RFC2;RPA1;FEN1;RFC5;RFC3;RFC4;POLD2;POLD1;NEIL3;POLD3;POLE;DNA2;APEX2;MBD4;RFC1
gsea,regulation of mitotic cell cycle (GO:0007346),0.5321739117715143,2.139404096106685,0.0,0.0007527390755171195,0.036,48/100,21.33%,CKS1B;PSMA3;UBE2C;PSMB6;ASNS;CDK1;MKI67;PSMB2;UBE2S;PSME2;FBXO5;ANAPC5;MAD2L1;DLGAP5;PSMA4;PSMD14;HNRNPU;PSMA5;PSMB5;BUB3;PKMYT1;PIN1;NEK2;CCNB1;PLK1;ANAPC15;PSMA6;MDM2;PSMD1;PSMC1;PSMB7;PSMC2;FZR1;PSMD12;BUB1B;PSMD6;PSMC5;PSME3;RB1;DUSP3;PSMD3;KIF20B;PSMD2;PSMC4;CDC20;PSMD11;NEK6;EIF4E
gsea,RNA splicing (GO:0008380),0.5738844340963793,2.1384019795647573,0.002288329519450801,0.0007573345521686282,0.036,34/60,29.73%,MAGOHB;SRSF2;SNRPD1;SNRPD3;SNRPA1;SRSF7;SNRPB;RBM8A;PPIG;U2AF1;DDX39B;SYNCRIP;RNPS1;MAGOH;SMU1;PTBP1;TCERG1;NCBP2;NONO;SRSF10;SF3B2;TARDBP;USP39;SRRM1;PRPF3;GEMIN2;SNRPF;SRPK1;DHX15;SF3B4;NCBP1;RSRC1;PRPF8;SNRNP40
gsea,positive regulation of biosynthetic process (GO:0009891),0.6542798461174691,2.1370371246809228,0.0,0.0007618424959315367,0.037,6/22,8.26%,CCL5;VIM;F2R;AKT1;RAB27A;CREB3L1
gsea,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5963899968704264,2.133580785634445,0.0,0.0008127057104639761,0.039,5/33,8.68%,CCL5;RGS16;PLEK;RGS2;METAP2
gsea,rRNA metabolic process (GO:0016072),-0.5914977996339496,-2.133367034473752,0.0,0.0018054989275141375,0.053,23/108,8.85%,RPLP1;RPL13;RPLP0;RPL10A;RPL8;RPL41;RPL15;RPL10;RPL3;RPL7;RPS25;RPS2;RPL4;RPL14;RPL5;RPS6;WDR12;RCL1;RPL7A;RPS17;UTP14A;RPS15;RPL31
gsea,cation transport (GO:0006812),-0.5326905626711471,-2.1305802523971193,0.0,0.0017911695709465648,0.054,13/35,19.11%,SLC9B2;TRPM1;KCNN4;KCNMB4;SLC7A1;ATP1B1;SLC6A6;SLC41A1;PIEZO1;FGF13;ANO10;SLC12A2;SGK1
gsea,chromosome condensation (GO:0030261),0.7354349792067387,2.129142671894055,0.0,0.0008741197868488373,0.042,18/26,16.68%,SMC2;TOP2A;CDK1;NCAPG;SET;BANF1;NUSAP1;INCENP;NCAPH;NCAPH2;NCAPD2;KMT5A;CCNB1;NCAPG2;PLK1;CDCA5;NCAPD3;RB1
gsea,granulocyte chemotaxis (GO:0071621),0.6561017483057107,2.1276350801828263,0.0,0.0008888162452534595,0.042,7/32,2.09%,CCL5;FCER1G;CCL4;CCL3;LGALS3;PPIA;ANXA1
gsea,negative regulation of gene expression (GO:0010629),0.44353790948692257,2.1267712336468825,0.0,0.0008919525058224555,0.043,63/176,26.21%,GZMB;HAVCR2;ID2;CCL3;IFNG;GAPDH;TLE5;ATP2B4;DNMT1;LSM2;NCOR2;RBL2;CALR;HELLS;TYMS;YBX1;HRAS;OLFM1;EIF4A3;ERN1;MIF;HDAC1;CREB3L1;GRB7;TIPARP;SYNCRIP;ZFP36;RBL1;FLOT2;CCR1;CENPV;ANXA7;DHFR;EIF2AK3;SLC7A5;MRPL13;CNOT9;MEF2C;PICALM;PARK7;PTBP1;CPNE1;HSPA1B;PPHLN1;RB1;MYADM;PDGFB;AURKA;ASB1;HSPA1A;RBBP4;TARDBP;FMR1;SLC11A1;EIF2AK2;PARP10;NANOS1;CAPRIN1;MOV10;IL10;NCL;VEGFA;PARP14
gsea,cellular component assembly (GO:0022607),0.49651945263585423,2.126575520846823,0.0,0.0008838438466786151,0.043,41/110,21.64%,ACTB;ACTG1;NEDD9;SNX9;LCP1;LAMC1;FLNA;RHOQ;CHCHD10;TINF2;EZR;SH3BP1;SLC2A1;PTK2B;CHAF1B;CAPG;SYCE2;CAPZA2;LPXN;TUBGCP2;CYFIP1;ARL6IP1;RAD21;TRIP13;CHAF1A;NOC2L;MDM2;BAIAP2;KNTC1;AFG3L2;PICALM;PPID;TRAF2;TSPAN4;RBBP4;USH1C;ADD1;ZW10;KPNA3;PPIH;NEFH
gsea,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.696098621313896,2.1247515300629116,0.0,0.0008680609208450683,0.043,3/17,6.53%,RPA2;RPA3;RPA1
gsea,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.696098621313896,2.1247515300629116,0.0,0.0008680609208450683,0.043,3/17,6.53%,RPA2;RPA3;RPA1
gsea,cellular response to lectin (GO:1990858),0.5482028388818774,2.1240379953207045,0.0,0.0008454158533447622,0.043,26/56,18.41%,FCER1G;PSMA3;PSMB6;PSMB2;LYN;PSME2;PSMA4;PSMD14;HRAS;PSMA5;PSMB5;MALT1;NRAS;PSMA6;PSMD1;PSMC1;PSMB7;PLCG2;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4
gsea,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.5482028388818774,2.1240379953207045,0.0,0.0008454158533447622,0.043,26/56,18.41%,FCER1G;PSMA3;PSMB6;PSMB2;LYN;PSME2;PSMA4;PSMD14;HRAS;PSMA5;PSMB5;MALT1;NRAS;PSMA6;PSMD1;PSMC1;PSMB7;PLCG2;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4
gsea,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.5482028388818774,2.1240379953207045,0.0,0.0008454158533447622,0.043,26/56,18.41%,FCER1G;PSMA3;PSMB6;PSMB2;LYN;PSME2;PSMA4;PSMD14;HRAS;PSMA5;PSMB5;MALT1;NRAS;PSMA6;PSMD1;PSMC1;PSMB7;PLCG2;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4
gsea,positive regulation of B cell activation (GO:0050871),-0.5760334083137535,-2.1219722981320737,0.0,0.001884045030180831,0.059,11/33,7.33%,CD74;CD81;GPR183;TNFRSF4;BCL2;IRS2;TNFRSF13C;VAV3;BST1;CD320;TNFSF4
gsea,mitotic G2/M transition checkpoint (GO:0044818),0.6233292904154035,2.1154875459345006,0.0023148148148148147,0.0009336106979320159,0.045,13/29,19.99%,CDKN1A;CDK1;NABP1;CLSPN;TOPBP1;CDC6;PLK1;BRCA1;ORC1;FZR1;BRCC3;HUS1;TICRR
gsea,regulation of cellular amino acid metabolic process (GO:0006521),0.6833296793055107,2.1141534279431817,0.002242152466367713,0.0009466681902107853,0.046,23/29,22.37%,PSMA3;PSMB6;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;PSMD3;BCKDK;PSMD2;PSMC4;PSMD11;AZIN1
gsea,cellular calcium ion homeostasis (GO:0006874),0.5206178471148718,2.111798620039886,0.0,0.0010012219503246272,0.051,15/57,13.49%,CCL5;CCL3;CCR2;BAX;ATP2B4;BAK1;YWHAE;CALR;CALCA;KCTD17;ATP2A2;CCR1;STOML2;TRPC1;AFG3L2
gsea,ubiquitin-dependent protein catabolic process (GO:0006511),0.4385616100601554,2.10903112993204,0.0,0.0009928083204899664,0.051,73/168,27.23%,NEDD4;TBX21;PSMA3;ASB2;UBE2C;PSMB6;ELOC;PSMB2;UBE2S;PSME2;AURKB;ANAPC5;MAD2L1;PSMA4;PSMD14;PSMA5;PSMB5;BUB3;UBE2L6;KCTD17;UHRF1;KEAP1;RAD23A;PLK1;ANAPC15;PSMA6;MDM2;XBP1;PSMD1;PSMC1;RNF130;RNF126;PSMB7;FAF1;ANKRD9;RNF5;PSMC2;RNF168;FZR1;STUB1;PSMD12;CDC34;BUB1B;PSMD6;PSMC5;PSME3;UBA1;TBL1XR1;AURKA;FBXW4;PSMD3;PSMD2;KIF14;PSMC4;MVB12B;CDC20;KLHL25;PSMD11;ADRM1;FBXL14;UBA6;DTL;FBXO45;BIRC2;KLHL20;HECTD3;UBXN11;COPS3;KCTD13;WDR81;PSMC6;ZFAND2A;VPS37C
gsea,positive regulation of protein kinase activity (GO:0045860),0.4979559807199017,2.106013479663561,0.0,0.001025557206061684,0.052,32/74,23.60%,CCL5;CDKN1A;NEDD9;MAP2K3;SNX9;IFNG;CSF1;EGR1;CLSPN;PTK2B;TPX2;CALCA;HSP90AA1;CENPE;INCENP;LTF;LRP8;RIPK3;PIH1D1;DAB2IP;ECT2;PAK4;PDGFB;DUSP19;ADRB2;KIF14;ALS2;SLC27A1;SLC11A1;MINK1;ETAA1;PRKAG2
gsea,DNA strand elongation involved in DNA replication (GO:0006271),0.7990432508404202,2.104958314794816,0.0,0.001027252341939472,0.052,16/17,20.24%,LIG1;MCM4;PCNA;MCM3;MCM7;GINS2;POLA1;RFC3;RFC4;GINS3;POLD2;GINS4;POLE3;POLD3;POLE;GINS1
gsea,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.529210529535382,2.1029116856500614,0.0,0.0010390071366329849,0.053,32/72,20.97%,TLE5;PSMA3;PSMB6;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;HDAC1;DKKL1;DAB2IP;CCDC88C;PSMA6;PSMD1;PSMC1;PSMB7;FRMD8;KREMEN2;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4;FRZB;FZD4;WNT11;PSMD11;SFRP4
gsea,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.660724258658624,2.099067811125337,0.0,0.00109059254108023,0.056,10/22,13.19%,CDKN2A;CDKN1A;CDK6;RBL2;PLK3;E2F7;CDKN2C;RBL1;CDKN2B;DCUN1D3
gsea,positive regulation of B cell proliferation (GO:0030890),-0.6754337796047922,-2.098138793182326,0.0,0.0027379306298754634,0.087,10/20,6.43%,CD74;CD81;GPR183;TNFRSF4;BCL2;IRS2;TNFRSF13C;VAV3;BST1;CD320
gsea,mitotic metaphase plate congression (GO:0007080),0.663588059894605,2.0976997778487307,0.0,0.0011016469342533576,0.057,20/30,21.75%,CDCA8;KIFC1;KIF22;CENPE;CEP55;NUF2;CCNB1;NDC80;KIF2C;NUP62;KIF18A;NUDC;CDCA5;RRS1;KIF14;KPNB1;MIS12;ZW10;MAD1L1;CDT1
gsea,response to cytokine (GO:0034097),-0.4759195615872205,-2.097456248943428,0.0,0.0026435192288452748,0.087,27/84,17.95%,CCR7;AFF3;REL;CD74;PRKCA;JAK2;IFNAR2;IL18R1;BCL2;GCH1;LEF1;TIMP2;NFAT5;CXCR4;RELB;SIGIRR;PTPN11;IL6ST;TRIM56;IKBKE;MAPK8;SELP;NUB1;PTPN13;PLSCR1;TAF9;KYNU
gsea,sterol biosynthetic process (GO:0016126),0.6790656403739567,2.0974342087199966,0.0019646365422396855,0.0010928337587793307,0.057,19/24,24.13%,FDPS;LBR;HMGCS1;MSMO1;FDFT1;HSD17B7;SC5D;PMVK;SQLE;HMGCR;DHCR7;DHCR24;LSS;MVK;NSDHL;INSIG1;ACLY;PRKAG2;IDI1
gsea,pre-replicative complex assembly (GO:0036388),0.6311448664944251,2.0965293859749896,0.0022222222222222222,0.0011134621094383997,0.059,31/42,18.41%,PSMA3;PSMB6;MCM5;MCM4;PSMB2;ORC6;PSME2;MCM3;GMNN;MCM2;MCM6;MCM7;PSMA4;PSMD14;PSMA5;PSMB5;CDC6;PSMA6;PSMD1;PSMC1;PSMB7;ORC1;PSMC2;PSMD12;MCM8;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4
gsea,negative regulation of TOR signaling (GO:0032007),-0.6226732823414748,-2.093902310113399,0.003952569169960474,0.002627048704054962,0.088,7/23,18.40%,SESN3;CASTOR1;DDIT4;SESN1;ARNTL;SESN2;RNF152
gsea,cholesterol biosynthetic process (GO:0006695),0.691205136438427,2.092383861893525,0.004132231404958678,0.0011725268214185553,0.063,18/22,24.13%,FDPS;LBR;HMGCS1;MSMO1;FDFT1;HSD17B7;SC5D;PMVK;SQLE;HMGCR;DHCR7;DHCR24;LSS;MVK;NSDHL;INSIG1;ACLY;IDI1
gsea,response to ionizing radiation (GO:0010212),0.5277354120682967,2.0922323877499895,0.0,0.0011633664556262228,0.063,19/51,19.99%,CDKN1A;ANXA1;NABP1;RAD51;SMPD1;TOPBP1;FIGNL1;RAD51AP1;BRCA1;DCUN1D3;ECT2;RAD9A;RNF168;FANCD2;AEN;SPIDR;BRCC3;HUS1;TICRR
gsea,Wnt signaling pathway (GO:0016055),-0.5135023823710515,-2.0913985223696083,0.0,0.0026578645246303867,0.093,18/45,29.20%,TCF7;RPS27A;LEF1;WNT10A;CTNNB1;LRRK2;USP34;DDX3X;RARG;DVL2;CSNK1G1;WLS;CPE;DVL1;FZD7;BTRC;AXIN1;WNT6
gsea,neutrophil chemotaxis (GO:0030593),0.6500374343612352,2.090136777088849,0.0,0.001173428245075229,0.065,6/31,1.07%,CCL5;FCER1G;CCL4;CCL3;LGALS3;PPIA
gsea,"base-excision repair, gap-filling (GO:0006287)",0.6791152328008716,2.088247128130561,0.0,0.0011928019196655894,0.068,12/26,10.95%,RPA2;LIG1;RPA3;PCNA;RFC2;RPA1;FEN1;RFC5;RFC3;RFC4;POLD2;POLD1
gsea,regulation of signal transduction by p53 class mediator (GO:1901796),0.4904753149429819,2.0864534572319386,0.0022727272727272726,0.0011930909786549667,0.069,54/99,30.41%,RPA2;PRDM1;CCNG1;AKT1;PRR5;CDK1;RPA3;RFC2;AURKB;TPX2;PLK3;RPA1;BARD1;TOPBP1;HDAC1;PIN1;RFC5;RFC3;BRIP1;KMT5A;TAF15;RFC4;RAD50;EHMT2;NOC2L;MDM2;BRCA1;BANP;RAD9A;RBBP8;RRS1;AURKA;RBBP4;HUS1;BRPF1;DNA2;MLST8;SMYD2;MTOR;PRKAG2;RPF2;CHEK2;PIP4K2B;CHEK1;EXO1;MTA2;RMI2;TAF3;RBBP7;ING5;SSRP1;BLM;TAF2;BOP1
gsea,cellular response to interferon-gamma (GO:0071346),0.5492222651016387,2.085702786620188,0.0,0.0012026989052905204,0.071,15/57,9.76%,CCL5;IRF8;CCL4;CCL3;IFNG;GAPDH;GBP7;GBP3;GBP4;IL12RB1;GBP6;IFI30;CASP1;SYNCRIP;SP100
gsea,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.5198624898974096,-2.08174465696973,0.0,0.00315693636879332,0.107,13/45,9.76%,CD74;JAK2;RACK1;IFNAR2;TRAF1;TNFAIP3;SOCS3;SOCS1;SIGIRR;BIRC3;PTPN11;IFNGR2;IL3
gsea,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.40682048623333267,2.0799318093885875,0.0,0.0012584280904456152,0.075,76/277,27.12%,GZMB;S100A11;ID2;MT3;CDKN2A;CDKN1A;IFNG;GAPDH;ENO1;TLE5;TBX21;HMGB2;BIRC5;ZBTB38;CD38;NCOR2;TMPRSS6;CENPF;NAB1;GMNN;CALR;SET;KLF10;TYMS;CBX3;YBX1;CALCA;E2F1;EIF4A3;HDAC1;CREB3L1;GRB7;CDC6;ATXN1;SYNCRIP;KMT5A;RUNX2;NFIL3;PA2G4;DAB2IP;CBX5;DHFR;EIF2AK3;MDM2;CTCF;BRCA1;HHEX;MRPL13;CNOT9;FOXM1;SMARCC2;NONO;RB1;PDGFB;SUV39H2;TIMELESS;NR3C1;SMARCA4;SHC1;WNT11;FMR1;HSPA8;TRERF1;SBNO2;EIF2AK2;RARA;SUV39H1;NANOS1;ENPP1;CAPRIN1;NCL;RBM15B;ELK3;PDS5A;SFMBT1;SAMD1
gsea,glial cell development (GO:0021782),0.7261298552922448,2.078722154948119,0.0,0.0012674050248045886,0.077,2/15,1.25%,MT3;CDK6
gsea,blood circulation (GO:0008015),-0.6174587963858507,-2.078716721024914,0.0,0.0032783830934900765,0.11,10/19,25.28%,GUCY1A1;CXCL10;ADORA2A;SCPEP1;GPX1;GUCY1B1;PLN;ADCY6;ROCK1;OLR1
gsea,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.6741669491957385,-2.0772268792316027,0.0023584905660377358,0.00326625039407903,0.114,5/16,7.55%,CCR7;KIT;PIK3R2;PIK3IP1;PIK3R1
gsea,response to interferon-gamma (GO:0034341),0.5879170320534914,2.07528286299139,0.0,0.0012853650315973106,0.08,15/46,9.76%,CCL5;IRF8;CCL4;CCL3;GAPDH;GBP7;GBP3;GBP4;IL12RB1;GBP6;IFITM3;CASP1;IFITM1;SYNCRIP;SP100
gsea,regulation of viral genome replication (GO:0045069),0.5771969805336632,2.0736706662805915,0.001834862385321101,0.0012940118864719484,0.081,20/40,25.62%,CCL5;PPIA;ISG20;ISG15;BANF1;IFITM3;LTF;IFITM1;RAD23A;FAM111A;PPID;RNASEL;HACD3;PPIH;BST2;IFITM2;EIF2AK2;PARP10;SRPK1;IFIT1
gsea,regulation of cellular amine metabolic process (GO:0033238),0.684364189146051,2.0730797074892955,0.0022271714922048997,0.0012935495270617445,0.082,22/27,22.37%,PSMA3;PSMB6;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4;PSMD11;AZIN1
gsea,modulation by host of symbiont process (GO:0051851),0.6421135892411258,2.0715712912521322,0.0,0.0013109296460092831,0.083,6/19,9.66%,CCL5;CCL4;CCL3;CX3CR1;HDAC1;NUCKS1
gsea,actin filament bundle assembly (GO:0051017),0.7144906504664811,2.069415634631627,0.0,0.001336913422578253,0.086,4/20,3.75%,HSP90B1;NEDD9;LCP1;EZR
gsea,regulation of actin filament bundle assembly (GO:0032231),0.6686115163107204,2.0665266491890124,0.0,0.001371316492676766,0.088,5/19,13.27%,ACTG1;PFN1;PLEK;SYNPO2;RDX
gsea,regulation of interleukin-4 production (GO:0032673),0.6832903534706941,2.0637301102852046,0.0,0.0014052315759653714,0.09,3/17,0.57%,HAVCR2;CEBPB;FCER1G
gsea,ciliary basal body-plasma membrane docking (GO:0097711),0.5154479028048354,2.0632778874252473,0.0,0.0013953355789515307,0.09,41/67,33.61%,TUBB4B;TUBA4A;CDK1;YWHAE;TUBA1A;HSP90AA1;CNTRL;HAUS4;TUBG1;NEK2;PLK4;ACTR1A;PLK1;CEP57;CENPJ;CKAP5;HAUS8;ODF2;DYNC1I2;CEP250;HAUS6;NEDD1;DCTN1;HAUS5;CEP192;YWHAG;CSNK1E;CCP110;KIF24;HAUS7;NDE1;OFD1;TCTN3;CEP83;CEP76;HAUS2;SDCCAG8;SCLT1;CEP70;PCNT;CEP89
gsea,cellular response to lipopolysaccharide (GO:0071222),0.5513096258389705,2.0605389326940218,0.0,0.0014544265831420247,0.095,19/62,13.99%,CCL5;CCR5;VIM;CCL3;HMGB2;HMGB1;CX3CR1;LYN;PRKCE;UPF1;CD14;CASP1;ZFP36;DAB2IP;XBP1;MEF2C;CD86;MTDH;CACTIN
gsea,glucose metabolic process (GO:0006006),0.5875628993587284,2.058290100085431,0.0,0.001512696878940984,0.098,16/32,25.32%,ALDOA;GAPDH;ENO1;TPI1;PGK1;MDH2;PCK2;SORD;ALDOC;SLC25A10;GOT1;TKTL1;GOT2;DCXR;SLC39A14;ATF4
gsea,positive regulation of cold-induced thermogenesis (GO:0120162),0.5799161885724585,2.0578838630300624,0.0,0.0015022644866724253,0.098,8/45,8.09%,PLAC8;CEBPB;ACADL;CCR2;EPAS1;ADRB1;FABP5;GATM
gsea,calcium ion transmembrane import into cytosol (GO:0097553),-0.6536827097341603,-2.05496312969663,0.0,0.0044216300265652346,0.148,3/17,5.96%,CCR7;XCL1;ITPR1
gsea,secondary alcohol biosynthetic process (GO:1902653),0.6865343329504924,2.0548978665904856,0.002036659877800407,0.0015594089023677662,0.101,17/21,24.13%,FDPS;LBR;HMGCS1;MSMO1;FDFT1;HSD17B7;PMVK;SQLE;HMGCR;DHCR7;DHCR24;LSS;MVK;NSDHL;INSIG1;ACLY;IDI1
gsea,positive regulation of viral genome replication (GO:0045070),0.6880424415779209,2.053908658747976,0.0,0.0015488006785421352,0.101,3/19,2.75%,CCL5;PPIA;TOP2A
gsea,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.647380553903345,2.0538453560174634,0.0,0.001538335809092526,0.101,10/22,16.68%,CDKN2A;CDKN1A;CDK6;RBL2;E2F7;CDKN2C;RBL1;CDKN2B;DCUN1D3;RB1
gsea,DNA metabolic process (GO:0006259),0.47160450017710176,2.0525882853314723,0.0022371364653243847,0.001536270928811865,0.102,111/204,32.94%,HMGB2;RPA2;HMGB1;RAN;LIG1;TOP2A;CDK1;TINF2;MCM5;NABP1;DNMT1;MCM4;ORC6;RPA3;PCNA;MCM3;RFC2;GMNN;PRIM1;HELLS;RAD51;PTGES3;TYMS;MCM2;MCM6;MCM7;KPNA2;SMC1A;UPF1;RPA1;BARD1;FEN1;TOPBP1;POLA1;UHRF1;CDC6;RFC5;RAD21;RFC3;RFC4;SP100;RAD51AP1;POLD2;CENPS;RAD50;CDC45;POLD1;DCTPP1;NEIL3;RAD54L;BRCA1;CNBP;PRIM2;TSN;UBE2N;ORC1;POLE3;RAD9A;PARK7;POLE2;RBBP8;CDC34;UBE2T;NSMCE4A;MCM8;WDHD1;RIF1;POLA2;CDC7;MCM10;POLD3;TIMELESS;HUS1;POLE;POLH;TICRR;FANCG;CDT1;DNA2;GEN1;HMGB3;DBF4;FANCA;FANCL;CSNK1E;RAD51C;RECQL;CHEK1;PWWP3A;EXO1;MBD4;RFC1;PDS5A;SMARCB1;RMI2;RTEL1;RNASEH1;BACH1;NUDT1;BLM;RNASEH2A;XRCC2;HELB;RAD18;PSME4;LRWD1;CTC1;DDB1;DCLRE1B;RAD51D;CDK2
gsea,double-strand break repair (GO:0006302),0.47944642413290156,2.0522784503451654,0.0,0.0015342335802682795,0.103,56/116,31.24%,HMGB2;RPA2;HMGB1;NABP1;RPA3;RAD51;KPNA2;PSMD14;SMC6;RPA1;BARD1;FEN1;POLA1;HPF1;RAD21;BRIP1;TRIP13;NSD2;NUCKS1;AUNIP;RAD51AP1;RAD50;MMS22L;BRCA2;BRCA1;SMC5;UBE2N;CDCA5;RNF168;RBBP8;MCM8;RIF1;SPIDR;EME1;BRCC3;HUS1;APBB1;PRPF19;PALB2;BAZ1B;DNA2;GEN1;RAD51C;RECQL;CHEK2;POLM;RAD54B;TONSL;RFWD3;PAXIP1;TDP2;PPP5C;BLM;XRCC2;HELQ;SMARCA5
gsea,regulation of monocyte chemotaxis (GO:0090025),0.6989713709606162,2.0522319398732543,0.0,0.0015240730929817344,0.103,5/16,9.95%,CCL5;CCR2;HMGB1;LYN;CCR1
gsea,negative regulation of viral genome replication (GO:0045071),0.6108141927371463,2.051723278267939,0.001937984496124031,0.0015221428005757628,0.103,16/28,25.62%,CCL5;ISG20;ISG15;BANF1;IFITM3;LTF;IFITM1;FAM111A;RNASEL;BST2;IFITM2;RESF1;EIF2AK2;PARP10;SRPK1;IFIT1
gsea,ncRNA processing (GO:0034470),-0.5270731344373524,-2.0511204810991828,0.0,0.004577433347974554,0.156,31/138,15.66%,RPLP1;RPL13;RPLP0;RPL10A;RPL8;RPL41;RPL15;RPL10;RPL3;RPL7;RPS25;RPS2;RPL4;RPL14;RPL5;RPS6;WDR12;RCL1;RPL7A;RPS17;UTP14A;RPS15;FARS2;RPL31;RPL23A;MDN1;SMAD1;INTS6;LAS1L;THG1L;RRP12
gsea,canonical Wnt signaling pathway (GO:0060070),-0.5453331992659385,-2.0502099495381265,0.0,0.004473082928526015,0.156,7/34,13.17%,TCF7;LEF1;SCYL2;FRAT2;WNT10A;CTNNB1;LRRK2
gsea,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5858988822867522,2.0501717956755248,0.0,0.0015443684985399478,0.107,7/28,7.23%,CTSD;F2R;HMGB1;CYCS;BAK1;MALT1;CASP1
gsea,beta-catenin-TCF complex assembly (GO:1904837),-0.6261127440035958,-2.049638784797214,0.0,0.004393079052953153,0.158,8/23,14.49%,TCF7;LEF1;TLE3;TLE4;AXIN2;CTNNB1;MYC;CREBBP
gsea,steroid biosynthetic process (GO:0006694),0.645475399766487,2.048404504232378,0.0,0.0015503228413711692,0.109,14/23,23.60%,HSD11B1;LBR;MSMO1;FDFT1;SC5D;PMVK;SQLE;HMGCR;DHCR7;LSS;DHRS11;OSBPL9;INSIG1;PRKAG2
gsea,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.5344675788346358,2.0476750940458714,0.0,0.0015562003539723102,0.111,27/46,27.74%,CDKN1A;RPS27L;RPA2;BAX;CDK1;RBL2;PCNA;PLK3;E2F7;E2F1;TFDP1;E2F4;SFN;CCNB1;FBXO31;MDM2;CNOT9;E2F8;GTSE1;AURKA;PCBP4;CHEK2;PIDD1;CDC25C;RFWD3;ARID3A;PRMT1
gsea,RNA processing (GO:0006396),0.4949590410809646,2.046205829728055,0.004705882352941176,0.0015777803170179754,0.114,53/108,32.46%,MAGOHB;SRSF2;SNRPD1;HNRNPA2B1;HNRNPD;SNRPD3;SNRPA1;SRSF7;HNRNPF;HNRNPU;SNRPB;RBM8A;PPIG;U2AF1;ATXN1;DDX39B;SYNCRIP;RNPS1;TFIP11;SRSF9;MAGOH;LSM3;SMU1;PTBP1;TCERG1;NCBP2;NONO;DDX20;RNASEL;U2AF2;SF3A2;HNRNPUL1;SRSF1;SF3B2;TARDBP;USP39;SRRM1;PRPF3;HNRNPK;PIWIL2;GEMIN2;SNRPF;SRPK1;DHX15;SF3B4;NCBP1;RSRC1;PRPF8;SNRNP40;BICD1;PPP1R9B;KHSRP;MRPL44
gsea,double-strand break repair via nonhomologous end joining (GO:0006303),0.5580113126592053,2.0421715111110714,0.0,0.001669633260314436,0.12,14/40,20.80%,HMGB2;HMGB1;PSMD14;BARD1;POLA1;NSD2;RAD50;BRCA1;SMC5;UBE2N;RNF168;RIF1;BRCC3;PRPF19
gsea,organic hydroxy compound biosynthetic process (GO:1901617),0.6694664381108621,2.039632024992006,0.0,0.0016746440453412309,0.121,12/20,23.60%,LBR;MSMO1;PSAT1;SC5D;PMVK;SQLE;HMGCR;DHCR7;PARK7;OSBPL9;INSIG1;PRKAG2
gsea,cellular response to UV (GO:0034644),0.5275233651164941,2.0358383638573105,0.0,0.001772472454250005,0.131,16/45,25.51%,CDKN1A;NEDD4;CRIP1;BAK1;PCNA;AURKB;EIF2S1;SMPD1;NOC2L;POLD1;PPID;FMR1;IMPACT;RUVBL2;ATF4;CHEK1
gsea,mitotic chromosome condensation (GO:0007076),0.7143646269161856,2.0348973154346446,0.0,0.0017998528966382554,0.132,15/22,16.68%,SMC2;CDK1;NCAPG;SET;NUSAP1;NCAPH;NCAPH2;NCAPD2;KMT5A;CCNB1;NCAPG2;PLK1;CDCA5;NCAPD3;RB1
gsea,regulation of cellular ketone metabolic process (GO:0010565),0.6310061018929393,2.03448843834481,0.0,0.0018039614953830367,0.132,24/32,23.60%,PSMA3;PSMB6;NCOR2;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4;PSMD11;AZIN1;PRKAG2
gsea,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.7041548271435519,2.0333844639485776,0.0,0.0018156160907314258,0.135,3/16,1.10%,ADAM8;SNX9;IFNG
gsea,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.5985086646100817,2.033245290826076,0.0,0.0018044773417085337,0.135,7/24,9.29%,GZMB;YWHAE;E2F1;SREBF2;SAE1;TFDP1;SFN
gsea,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.5484719947351835,2.0324312193224965,0.0,0.0017934744310883597,0.135,21/41,19.77%,CTSD;FCER1G;KIF11;RACGAP1;CLTC;SEC24D;CANX;KIF22;CAPZA2;CENPE;IFI30;KIF23;ACTR1A;KIF2C;KIF18A;AP1M1;DYNC1LI2;AP2A2;DYNC1I2;DCTN1;KLC1
gsea,nuclear membrane reassembly (GO:0031468),0.6273579798984856,2.0315699148991166,0.002242152466367713,0.001804980682668564,0.137,18/32,23.32%,RAN;CDK1;CCNB2;REEP4;LMNA;BANF1;LBR;CCNB1;NDC1;NUP93;RANGAP1;NUP85;NUP107;NUP43;KPNB1;NUP35;NUP160;NUP37
gsea,rRNA processing (GO:0006364),-0.5528681488534732,-2.028938041146224,0.0018181818181818182,0.0058052265068627125,0.202,24/121,8.85%,RPLP1;RPL13;RPLP0;RPL10A;RPL8;RPL41;RPL15;RPL10;RPL3;RPL7;RPS25;RPS2;RPL4;RPL14;SRFBP1;RPL5;RPS6;WDR12;RCL1;RPL7A;RPS17;UTP14A;RPS15;RPL31
gsea,neutrophil migration (GO:1990266),0.626126888461672,2.02790987719048,0.0,0.0019053123033097794,0.141,6/32,1.07%,CCL5;FCER1G;CCL4;CCL3;LGALS3;PPIA
gsea,cellular protein metabolic process (GO:0044267),-0.4444748636659861,-2.0277541120182008,0.0,0.0058033894098668696,0.206,58/171,22.98%,RPLP1;RPS27A;RPL13;RPLP0;RPL10A;RPL8;RPSA;RPS18;RPL41;RPL15;RPL10;RPS8;MRPS6;RPS26;EEF1A1;RPL3;RPL7;CCN1;RPS25;RPS2;RPL4;HTRA2;IGFBP2;RPL14;ST8SIA4;ST3GAL1;RPL5;SERP1;RPS6;TNIP1;SERPINC1;CKAP4;ADORA2A;RPL7A;RPS17;RPS15;IGFBP7;RPL31;PSEN2;FDXR;KTN1;RPL23A;FURIN;CST3;PABPC4;PPP4R2;ABL1;CSF2RA;ADPRH;YARS2;HBS1L;MRPL37;MIA3;D2HGDH;FARSB;MFGE8;PIGH;FBXO11
gsea,regulation of neuron projection development (GO:0010975),0.49948879948764147,2.0270604604007665,0.0,0.001923380340949218,0.142,12/62,15.99%,ARSB;MT3;CFL1;AKT1;SIPA1L1;LYN;ABI3;PTK2B;KIF13B;DAB2IP;SCN1B;CAMK2G
gsea,muscle contraction (GO:0006936),0.5526864461189952,2.0254592954825736,0.0,0.0019412332829024735,0.144,7/38,11.64%,VIM;ALDOA;TPM3;NEB;TPM4;ITGA1;SMTN
gsea,pyruvate metabolic process (GO:0006090),0.6105340386365311,2.0231492177502206,0.002136752136752137,0.0019588749474361636,0.146,13/30,16.67%,ALDOA;GAPDH;ENO1;LDHA;PKM;TPI1;PGK1;ME2;SLC16A3;PCK2;ALDOC;DLAT;HK1
gsea,replication fork processing (GO:0031297),0.6076508208987123,2.0222263462580172,0.0,0.0019618306083015275,0.148,19/29,29.44%,ALYREF;PCNA;RAD51;NUCKS1;CENPS;FAM111A;MMS22L;BRCA2;EME1;ZGRF1;DNA2;GEN1;ETAA1;TONSL;RFWD3;TRAIP;RTEL1;FANCM;BLM
gsea,tRNA transport (GO:0051031),0.6235149498550864,2.018973450238396,0.0,0.0020079330560786655,0.15,21/30,32.07%,RAN;YBX1;SSB;NDC1;AAAS;NUP93;NUP62;RANBP2;XPOT;NUP85;NUP107;NUP43;NUP35;NUP160;NUP37;NUP210;NUP54;NUP133;NUP88;NUP205;NUP155
gsea,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.5700498619095582,2.018563681491136,0.0,0.0019962590266828593,0.15,28/44,27.55%,SRSF3;DAZAP1;SRSF7;HNRNPU;RBM8A;MBNL3;RNPS1;SRSF9;CELF4;MAGOH;HNRNPA1;SMU1;PTBP1;U2AF2;SRSF6;SRSF10;RBMXL1;PCBP4;FMR1;LARP7;HNRNPK;SRPK1;RBMX;NCL;RBM15B;JMJD6;SF3B4;NCBP1
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.549939707454658,2.0148801612545864,0.0,0.002079405645394035,0.156,21/40,19.77%,CTSD;FCER1G;KIF11;RACGAP1;CLTC;SEC24D;CANX;KIF22;CAPZA2;CENPE;IFI30;KIF23;ACTR1A;KIF2C;KIF18A;AP1M1;DYNC1LI2;AP2A2;DYNC1I2;DCTN1;KLC1
gsea,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.549939707454658,2.0148801612545864,0.0,0.002079405645394035,0.156,21/40,19.77%,CTSD;FCER1G;KIF11;RACGAP1;CLTC;SEC24D;CANX;KIF22;CAPZA2;CENPE;IFI30;KIF23;ACTR1A;KIF2C;KIF18A;AP1M1;DYNC1LI2;AP2A2;DYNC1I2;DCTN1;KLC1
gsea,positive regulation of protein-containing complex assembly (GO:0031334),0.47715040235860934,2.0146672075616814,0.0,0.002067523327420355,0.156,29/74,23.10%,LGALS3;IFNG;PLEK;LCP1;RPA2;BAX;BAK1;RPA3;ISG15;CAPG;HSP90AA1;RPA1;RHOC;PIH1D1;TFRC;DAB2IP;BCL2L11;UNC13B;FAF1;PARK7;PSMC2;STUB1;PSMC5;SPIDR;PSMC4;BID;CDT1;SLF1;EIF4G1
gsea,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.73899255609686,2.0132672339479596,0.0,0.0021047230842584108,0.158,13/17,21.08%,CENPF;FBXO5;MAD2L1;BUB1;BUB3;TRIP13;PLK1;TTK;KNTC1;BUB1B;ZW10;CDC20;MAD1L1
gsea,mitotic nuclear membrane reassembly (GO:0007084),0.635449618810896,2.0130542012715997,0.0022522522522522522,0.0020949022478877993,0.159,18/30,23.32%,RAN;CDK1;CCNB2;REEP4;LMNA;BANF1;LBR;CCNB1;NDC1;NUP93;RANGAP1;NUP85;NUP107;NUP43;KPNB1;NUP35;NUP160;NUP37
gsea,mitotic nuclear membrane organization (GO:0101024),0.635449618810896,2.0130542012715997,0.0022522522522522522,0.0020949022478877993,0.159,18/30,23.32%,RAN;CDK1;CCNB2;REEP4;LMNA;BANF1;LBR;CCNB1;NDC1;NUP93;RANGAP1;NUP85;NUP107;NUP43;KPNB1;NUP35;NUP160;NUP37
gsea,platelet aggregation (GO:0070527),0.6979158979973643,2.0106608765004728,0.0,0.0021038246148930187,0.159,6/17,4.53%,ACTB;ACTG1;PPIA;PLEK;FLNA;MYH9
gsea,mitotic spindle assembly (GO:0090307),0.6188794808611191,2.0105580038838804,0.004484304932735426,0.0020989737484062468,0.159,15/31,21.35%,PRC1;FLNA;AURKB;TPX2;KIF11;RACGAP1;KIFC1;SMC1A;KIF23;SMC3;AAAS;MAP9;KPNB1;STAG1;CEP192
gsea,T cell activation (GO:0042110),-0.5591458114341554,-2.010206965737558,0.0,0.007112253808539042,0.243,15/35,11.72%,CCR7;CRTAM;CD74;TNFRSF4;KIT;TNFSF14;DPP4;TNFSF4;CD44;JAML;NCK2;F2RL1;RASGRP1;TREML2;SOX4
gsea,"protein localization to chromosome, centromeric region (GO:0071459)",0.7562908089256504,2.009441458461547,0.002277904328018223,0.0021145743055371296,0.163,13/15,20.73%,CDK1;AURKB;KNL1;BUB3;CENPA;TTK;CTCF;MTBP;RB1;HASPIN;ZWILCH;MIS12;ZW10
gsea,regulation of fibroblast proliferation (GO:0048145),0.6066904292397184,2.0088710322054726,0.0,0.002130003427974267,0.167,6/27,10.14%,S100A6;CDKN1A;CDK6;E2F1;MIF;DAB2IP
gsea,"positive regulation of gene expression, epigenetic (GO:0045815)",0.5436869998347655,2.008190054690851,0.0,0.002138538960836823,0.168,9/36,16.54%,ACTB;PADI2;DEK;ATAD2;ELOF1;CDCA4;POLR2F;POLR2L;ZMIZ1
gsea,positive regulation of cell cycle process (GO:0090068),0.540815987313268,2.0058086059374225,0.001984126984126984,0.0022004890486584396,0.172,30/62,23.47%,RANBP1;AURKB;MAD2L1;RACGAP1;E2F7;PRKCE;NUSAP1;CIT;FEN1;CDC6;RAD21;KIF23;CCNB1;PLK4;CENPV;NDC80;NUP62;GPSM2;ECT2;SPAG5;E2F8;CDC7;PDGFB;AURKA;KIF20B;CDC14A;KIF14;GEN1;GIPC1;DBF4
gsea,activation of GTPase activity (GO:0090630),-0.49554171112945494,-2.0043437452972586,0.0,0.007522912197975572,0.261,16/50,16.51%,CCR7;TBC1D4;NTRK3;TIAM1;TBC1D1;ARHGAP24;TBC1D30;SYDE2;GRTP1;RASGRP1;RABGAP1;USP6NL;CXCL13;TBC1D14;ADPRH;SCRIB
gsea,negative regulation of DNA biosynthetic process (GO:2000279),0.676012792545116,2.0031345957872166,0.0019083969465648854,0.002281726194675617,0.179,4/17,12.74%,CDKN1A;TINF2;HNRNPU;HNRNPA1
gsea,positive regulation of ATP metabolic process (GO:1903580),0.6428219730423632,2.0029143652259838,0.0,0.0022694588495429527,0.179,3/18,1.17%,TMSB4X;IFNG;ENO1
gsea,DNA strand elongation (GO:0022616),0.7695168799157657,2.0026892012692183,0.0,0.002257322705962509,0.179,11/15,10.68%,MCM4;MCM3;MCM7;GINS2;POLA1;RFC3;RFC4;GINS3;POLD2;RAD50;GINS4
gsea,positive regulation of intracellular protein transport (GO:0090316),0.47863074738783384,2.0024274242769304,0.0,0.0022649539997702728,0.18,21/71,18.67%,GZMB;IFNG;RAN;FLNA;YWHAE;PLK3;HRAS;E2F1;SREBF2;SAE1;TFDP1;PRR5L;SFN;ITGAM;ZDHHC2;ECT2;GTSE1;ANP32B;KIF20B;NMT1;BID
gsea,histone mRNA metabolic process (GO:0008334),0.6570815941428745,2.0000774447406306,0.0,0.0023050619107672136,0.184,13/19,27.55%,SNRPD3;SLBP;UPF1;SNRPB;SSB;SNRPE;ERI1;NCBP2;CPSF2;SNRPF;LSM11;EXOSC4;NCBP1
gsea,negative regulation of cell cycle process (GO:0010948),0.5734719324230559,1.9999564679662516,0.002242152466367713,0.002292930005973702,0.184,25/41,28.72%,RRM2;AURKB;FBXO5;RAD51;CBX3;E2F7;E2F1;TFDP1;NEK2;DAB2IP;CBX5;EHMT2;BRCA1;PCGF2;RBBP8;E2F8;CDC7;RBBP4;ESPL1;CCP110;CHEK1;APAF1;EED;RBBP7;NME6
gsea,positive regulation of viral process (GO:0048524),0.5601051959652962,1.9989332101995094,0.0,0.0023002550108734317,0.185,16/35,25.62%,CCL5;PPIA;NELFE;KPNA2;POLR2C;RAD23A;POLR2F;POLR2L;PPID;DHX9;GTF2F1;HACD3;PPIH;KPNA6;SRPK1;IFIT1
gsea,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.5322693309593298,1.994023043901747,0.0,0.0024100594342449577,0.193,21/41,26.42%,TMED2;KIF11;RACGAP1;KDELR2;LMAN2;KIF22;CENPE;KIF23;KIF2C;KIF18A;COPB2;COPG1;PITPNB;BICD2;KLC1;KDELR3;ZW10;ARCN1;BNIP1;KIF3A;KIF1C
gsea,regulation of cellular senescence (GO:2000772),0.6187459609374588,1.9937626779681314,0.004366812227074236,0.0023975720796633776,0.193,9/21,12.43%,CDKN2A;CDK6;ABI3;FBXO5;YBX1;CGAS;RSL1D1;RBL1;VASH1
gsea,positive regulation of vasculature development (GO:1904018),-0.4858975281771098,-1.9928215211631628,0.0,0.008131076749971381,0.28,16/51,22.74%,ITGB1;PRKCA;HIF1A;NINJ1;PIK3R6;SERPINE1;HIPK2;ITGB8;ZC3H12A;PRKCB;ECM1;TWIST1;FGF2;PLCG1;HK2;PRKD2
gsea,spindle assembly checkpoint signaling (GO:0071173),0.7324474827838572,1.9921351981422348,0.0,0.0024236637645294492,0.198,12/16,21.08%,CENPF;MAD2L1;BUB1;BUB3;TRIP13;PLK1;TTK;KNTC1;BUB1B;ZW10;CDC20;MAD1L1
gsea,mitotic spindle checkpoint signaling (GO:0071174),0.7324474827838572,1.9921351981422348,0.0,0.0024236637645294492,0.198,12/16,21.08%,CENPF;MAD2L1;BUB1;BUB3;TRIP13;PLK1;TTK;KNTC1;BUB1B;ZW10;CDC20;MAD1L1
gsea,mitotic spindle assembly checkpoint signaling (GO:0007094),0.7324474827838572,1.9921351981422348,0.0,0.0024236637645294492,0.198,12/16,21.08%,CENPF;MAD2L1;BUB1;BUB3;TRIP13;PLK1;TTK;KNTC1;BUB1B;ZW10;CDC20;MAD1L1
gsea,regulation of endopeptidase activity (GO:0052548),0.6216160681064322,1.9914426571665143,0.0,0.002442596147635239,0.201,8/25,7.79%,SERPINB9;GAPDH;PRELID1;SERPINE2;AKT1;PSMA3;PSME2;HDAC1
gsea,negative regulation of endopeptidase activity (GO:0010951),0.6990449116149009,1.9901462451487268,0.0,0.002455121796329486,0.202,6/18,7.20%,SERPINB9;MT3;GAPDH;SERPINE2;AKT1;LTF
gsea,positive regulation of tumor necrosis factor production (GO:0032760),0.566242340469323,1.9897325955195455,0.0,0.00244896876542971,0.203,14/39,17.32%,HAVCR2;CCL3;IFNG;CCR2;HMGB1;STAT3;CD14;MIF;SPN;DDX58;PLCG2;FRMD8;DHX9;IL33
gsea,embryonic organ development (GO:0048568),-0.5915221982428656,-1.9896127993752277,0.0,0.00822309666661832,0.286,7/21,15.92%,RPL10;ZFPM1;SH2B3;KIT;IL3;KMT2A;PBX4
gsea,negative regulation of macromolecule metabolic process (GO:0010605),0.463390160397661,1.9895333810870393,0.0,0.002442877264838931,0.204,31/97,17.60%,HAVCR2;ID2;SUB1;CCL3;IFNG;TLE5;ATP2B4;DNMT1;RBL2;HRAS;OLFM1;MIF;HDAC1;CREB3L1;TIPARP;LDLR;RBL1;FLOT2;CCR1;ANXA7;OPTN;SLC7A5;MEF2C;PICALM;PARK7;CPNE1;RB1;MYADM;PDGFB;AURKA;WDR54
gsea,tRNA export from nucleus (GO:0006409),0.618987699991445,1.9892154269381344,0.0,0.0024186903612266647,0.204,20/28,32.07%,RAN;SSB;NDC1;AAAS;NUP93;NUP62;RANBP2;XPOT;NUP85;NUP107;NUP43;NUP35;NUP160;NUP37;NUP210;NUP54;NUP133;NUP88;NUP205;NUP155
gsea,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.618987699991445,1.9892154269381344,0.0,0.0024186903612266647,0.204,20/28,32.07%,RAN;SSB;NDC1;AAAS;NUP93;NUP62;RANBP2;XPOT;NUP85;NUP107;NUP43;NUP35;NUP160;NUP37;NUP210;NUP54;NUP133;NUP88;NUP205;NUP155
gsea,apoptotic process (GO:0006915),0.4160396830366332,1.9880194736481502,0.0,0.0024310252589008984,0.205,50/126,30.89%,GZMB;PRF1;PPIA;IFNG;GAPDH;BAX;AKT1;GZMA;BAK1;PTK2B;PLK3;MCM2;PRKCE;CIT;DAPK2;CASP7;CD14;CASP1;IFIT2;BNIP3;IL2RA;BCL2L11;TNFRSF21;MDM2;HIP1;HSPD1;AIFM2;PAK4;DHCR24;CASP3;BID;ESPL1;RIPK1;BNIP1;AHCYL1;MTOR;JADE1;NLRP3;CHEK1;PIDD1;TNFSF12;NSG1;NDUFS1;TRAIP;RELT;APAF1;NCKAP1;BIK;FADD;IL1B
gsea,protein catabolic process (GO:0030163),0.5502241823807423,1.9855139540551878,0.0,0.0025035661206799934,0.213,16/32,24.81%,CTSD;HSP90AA1;UCHL3;DAB2IP;IDE;CEACAM1;RNF5;DENND3;PRSS16;NCCRP1;PRPF19;RIPK1;HSPA8;CLN5;MTOR;CHEK2
gsea,positive regulation of gene expression (GO:0010628),0.41888231290210953,1.9846081484552174,0.0,0.002545382958264316,0.219,87/227,31.24%,ID2;ACTB;ACTG1;SERPINB9;VIM;HILPDA;MT3;CCL3;IFNG;GAPDH;CSF1;RPS27L;AKT1;EGR1;HNRNPD;DNMT1;EZR;CAMK2N1;PKP3;GLMN;STAT3;DEK;ADAM19;FUBP1;RAB27A;E2F1;OLFM1;EIF4A3;ERN1;MIF;TFRC;EIF3D;EIF2AK3;EIF3C;CTCF;BRCA1;DDX58;FLOT1;MEF2C;TXK;PIK3CG;PLCG2;TESC;RDX;PARK7;POLR2F;POLR2L;OSR2;AGPAT2;HMGN5;HSPA1B;U2AF2;IL33;PDGFB;EIF6;HSPA1A;FAM98B;GABPA;WNT11;FMR1;SFRP4;VPS35;RIPK1;SLC11A1;BAZ1B;VSIR;MTOR;EIF2AK2;PIWIL2;MAZ;LARP4B;MOV10;IL10;ATF4;VEGFA;TADA3;TLR4;HGS;HCFC1;ITGAX;TYROBP;FGR;IL21;METTL14;CD36;IL1B;SMARCA5
gsea,homotypic cell-cell adhesion (GO:0034109),0.6538592048063787,1.9817886645044172,0.0,0.0026405608839568796,0.228,7/20,7.86%,ACTB;ACTG1;PPIA;PLEK;FLNA;MYH9;DSC2
gsea,recombinational repair (GO:0000725),0.5263926119533849,1.9813574663244502,0.0,0.0026396950695152916,0.229,28/56,26.06%,RPA2;NABP1;RPA3;RAD51;PSMD14;SMC6;RPA1;FEN1;NUCKS1;AUNIP;RAD51AP1;RAD50;MMS22L;BRCA2;BRCA1;SMC5;UBE2N;RBBP8;MCM8;SPIDR;HUS1;PALB2;GEN1;RAD51C;RECQL;RAD54B;TONSL;RFWD3
gsea,heterotypic cell-cell adhesion (GO:0034113),-0.6218089611899316,-1.9809007091507382,0.0,0.008947887101084172,0.311,7/17,14.70%,ITGB1;CD200;ITGB7;NINJ1;VCAM1;MADCAM1;ITGA7
gsea,ephrin receptor signaling pathway (GO:0048013),0.6294154370595422,1.9774737610653799,0.0,0.002757171103988912,0.239,6/28,6.43%,ACTB;ACTG1;SIPA1L1;ACTR2;LYN;HRAS
gsea,positive regulation of fibroblast proliferation (GO:0048146),0.6794041949231802,1.976473534791743,0.0,0.002773420731416573,0.241,5/18,7.48%,S100A6;CDKN1A;CDK6;E2F1;MIF
gsea,mRNA metabolic process (GO:0016071),0.5077155025129869,1.9742537848533712,0.007009345794392523,0.00284225854251381,0.245,32/59,27.55%,SRSF2;HNRNPA2B1;LSM2;SNRPD3;SLBP;SRSF7;ERN1;SNRPB;U2AF1;ZFP36;SSB;SNRPE;SRSF9;LSM3;PTBP1;TCERG1;NCBP2;NONO;HSPA1B;U2AF2;SF3A2;HSPA1A;SRSF1;SF3B2;USP39;PRPF3;GEMIN2;SNRPF;LSM11;DHX15;SF3B4;NCBP1
gsea,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.4787703399788424,-1.9705088699790507,0.0,0.009921521884286624,0.342,16/52,13.98%,CCR7;TRAF1;SEMA4C;MFHAS1;GADD45B;HIPK2;NCF1;ZC3H12A;SH3RF1;RASSF2;F2RL1;TRAF4;RASGRP1;PJA2;UNC5CL;MID1
gsea,regulation of protein kinase B signaling (GO:0051896),-0.4324213707229504,-1.9695690562150867,0.0,0.009862865637467468,0.346,33/84,28.84%,CCR7;ITGB1;NTRK3;RACK1;RAMP3;SH2B3;P2RX4;KIT;TRAT1;IRS2;ENG;MFHAS1;PIK3R2;PINK1;PIK3R1;PTPN11;SPRY2;PHLPP1;CX3CL1;AXL;FGF2;HBEGF;BANK1;RCN3;DAG1;RICTOR;GATA3;HSP90AB1;DDIT3;RET;ICOS;MET;F3
gsea,axon guidance (GO:0007411),-0.4448006695904558,-1.9680406204600365,0.0,0.009896211879479772,0.352,26/68,27.07%,EMB;EVL;PRKCA;PLXNC1;NRP1;SEMA4C;CXCR4;IRS2;SPTBN1;GRB10;PIK3R1;USP33;PTPN11;ALCAM;SEMA4B;SPTAN1;PALLD;PLCG1;KIF5C;KLF7;GPC1;DAG1;UNC5A;NRP2;PLXNB2;RET
gsea,ribosome biogenesis (GO:0042254),-0.5294889976802384,-1.965306843528364,0.003683241252302026,0.00994281884280542,0.359,27/134,12.71%,RPLP1;RPL13;RPLP0;RPL10A;RPL8;RPL41;RPL15;RPL10;RPL3;NPM1;RPL7;RPS25;RPS2;RPL4;RPL14;RPL5;RPS6;WDR12;RCL1;RPL7A;RPS17;UTP14A;RPS15;RPL31;RPL23A;MDN1;HEATR3
gsea,liver development (GO:0001889),0.6316865222100855,1.9646877999996268,0.0,0.003260397032351553,0.281,8/18,20.52%,CEBPB;ANXA1;E2F7;PCK2;XBP1;E2F8;AURKA;PRKCSH
gsea,cell-cell junction assembly (GO:0007043),0.6192482470025302,1.9636590839334704,0.0017761989342806395,0.0032682379642229894,0.283,6/21,7.21%,ACTB;ACTG1;PKP3;CTNND2;CTNNA1;RHOC
gsea,regulation of cell cycle process (GO:0010564),0.5011768608614471,1.9629800772805595,0.0,0.003281783059397389,0.285,38/64,31.57%,PRC1;MKI67;AURKB;FBXO5;KIF11;RACGAP1;PLK3;TIPIN;BUB1;PKMYT1;KNSTRN;PIN1;NEK2;PLK4;KIF20A;PLK1;CDKN2B;DCUN1D3;ECT2;SPAG5;CEP250;MAP9;AURKA;KIF20B;MAD1L1;DBF4;CCP110;PDXP;CHEK1;CDC25C;RAB11FIP4;TTL;RMI2;RPRD1B;CAV2;SIX3;CALM2;RCC1
gsea,cellular protein catabolic process (GO:0044257),0.5565727509898502,1.961361199068168,0.0019047619047619048,0.0033239555052541315,0.289,13/29,15.50%,GZMB;GZMA;CAPN2;CLTC;MALT1;BNIP3;DAB2IP;IDE;PSMA6;MDM2;RNF5;DENND3;AP2A2
gsea,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.5578892446603212,1.9610249641985804,0.0,0.003325667367749796,0.292,21/40,25.73%,ANXA1;AKT1;UBE2C;CDK1;FBXO5;ANAPC5;DLGAP5;CCND3;TFDP1;CCNB1;CDCA5;RDX;ADAM17;RB1;CDC7;ESPL1;DTL;EIF4G1;RAD51C;LSM11;CDC25C
gsea,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.5410139758765603,1.959815145901236,0.00186219739292365,0.0033615486198688535,0.297,8/37,9.67%,CEBPB;CDKN2A;CDKN1A;BAX;CDK1;MED30;RUNX2;CCNB1
gsea,epithelial cell differentiation (GO:0030855),0.5195160409556723,1.9590892961569104,0.0,0.0033970991692034032,0.303,17/44,15.31%,LGALS3;ANXA1;PGK1;AKT1;TAGLN2;CDK1;ANXA4;UPK1A;PCNA;E2F7;PIH1D1;HDAC1;PCK2;E2F4;ANXA7;ALDOC;E2F8
gsea,regulation of actin cytoskeleton organization (GO:0032956),0.5300636493402033,1.954949793139909,0.0,0.003567810023289822,0.317,13/45,12.12%,CORO1A;NEB;ARHGDIA;RHOQ;EZR;SH3BP1;ABI3;PTK2B;RHOF;RHOC;HIP1R;BAIAP2;IQGAP2
gsea,regulation of protein secretion (GO:0050708),0.508647679930281,1.9525584321346694,0.0,0.0036976254333621265,0.326,13/58,14.60%,CCL5;ADAM8;PPIA;IFNG;EZR;SLC2A1;EXPH5;RHBDF2;FRMD4A;HMGCR;UNC13B;ITPR3;PPID
gsea,cell cycle G1/S phase transition (GO:0044843),0.52509056533846,1.9520294878707283,0.0,0.0036920059418220626,0.327,20/44,23.80%,CDKN2A;CDKN1A;CDK6;CDKN3;CCNA2;PLK3;E2F1;CCNE1;CDKN2C;CDC34;RB1;NASP;CDC7;USP37;POLE;CCNE2;EIF4E;E2F3;DBF4;GSPT1
gsea,cellular response to topologically incorrect protein (GO:0035967),0.5911481416389428,1.9465833034320836,0.004132231404958678,0.003892476852690229,0.343,13/23,30.11%,BAX;BAK1;HSPA5;ERN1;DAB2IP;OPTN;STUB1;HSPA1B;HSPA1A;HSPA8;TM7SF3;HSPA14;BAG3
gsea,positive regulation of cell population proliferation (GO:0008284),0.4203004493257244,1.944109201021841,0.0,0.003963640012616779,0.349,78/205,28.57%,CCL5;S100A6;ID2;HILPDA;CDKN1A;IFNG;CSF1;CDK6;F2R;PRC1;LAMC1;BIRC5;AKT1;NAP1L1;LYN;IL12RB2;PTK2B;FBXO5;CALR;COX17;TIPIN;NME1;HRAS;HNRNPU;AREG;DERL2;SLC25A5;E2F1;LTF;MIF;HDAC1;SAPCD2;SLAMF1;HMOX1;PTPN6;TTK;MDM2;XBP1;CNBP;MEF2C;CD86;CLCF1;FOXM1;OSR2;HMGN5;FXN;ADAM17;DHX9;CDC7;PDGFB;DNAJA2;SAAL1;KIF20B;MATK;CDC123;KIF14;NCCRP1;FAM98B;SHC1;DHPS;ESM1;BST2;SINHCAF;LAMC2;HPSE;RARA;MAZ;STAT1;GRK5;UFL1;VEGFA;S1PR2;CDCA7L;TCIRG1;PRMT1;ITGAX;TSPAN31;RPRD1B
gsea,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.5968596648577184,-1.9434994708707574,0.0021691973969631237,0.012437881500652948,0.411,8/22,19.11%,MAP4K4;PACSIN1;DCLK1;KLK8;PAK1;LRRK2;TAOK1;SGK1
gsea,plasma membrane invagination (GO:0099024),0.6773784716160168,1.9411793003674171,0.0,0.004083833179294958,0.359,5/17,9.72%,SNX9;SH3BP1;MYH9;AURKB;ITGAM
gsea,nucleic acid metabolic process (GO:0090304),0.5311809433429748,1.9389632540307298,0.0,0.004213941305621313,0.365,25/49,25.66%,RAN;PCBP1;HNRNPA2B1;HNRNPD;HNRNPA3;LSM8;HNRNPF;KPNA2;HNRNPU;FEN1;TOPBP1;POLR2C;RAD50;HNRNPA1;POLR2F;POLR2L;PTBP1;NCBP2;ANKLE1;GTF2F1;HNRNPM;DNA2;HNRNPK;ENPP1;RBMX
gsea,morphogenesis of an epithelium (GO:0002009),0.7111232788173616,1.9385919116139487,0.003179650238473768,0.004233500146622632,0.37,2/15,0.22%,ACTB;ACTG1
gsea,cellular response to unfolded protein (GO:0034620),0.6141698244147515,1.9385044009751669,0.0041753653444676405,0.004214767845088903,0.37,14/20,30.23%,BAX;BAK1;HSPA5;ERN1;DAB2IP;OPTN;HSPD1;HSPA1B;HSPA1A;HSPA8;TM7SF3;HSPA14;BAG3;ABCB10
gsea,regulation of phosphorylation (GO:0042325),0.47905898402698555,1.9379140203853142,0.0,0.004223307824786177,0.373,31/74,24.42%,CCL5;CDKN2A;CDKN1A;LYN;GLMN;PTGES3;MCM7;MIF;BARD1;CDKN2C;PIN1;DSCAM;CCDC88C;NDC1;AAAS;CDKN2B;NUP93;NUP62;RANBP2;NUP85;NUP107;NUP43;CORO1C;EIF6;NUP35;KCTD20;NUP160;NUP37;PRKAG2;NUP210;NUP54
gsea,telomere maintenance (GO:0000723),0.531195541851821,1.937600443992675,0.0,0.0042155798838640806,0.374,16/40,19.22%,RPA2;TINF2;RPA3;PCNA;RAD51;PTGES3;SMC6;RPA1;SP100;POLD2;RAD50;POLD1;SMC5;RIF1;POLD3;HUS1
gsea,positive regulation of angiogenesis (GO:0045766),-0.4594838255736543,-1.9372580935027597,0.0,0.013163340297858284,0.43,19/60,22.74%,ITGB1;PRKCA;HIF1A;KLF4;NINJ1;PIK3R6;SERPINE1;HIPK2;ITGB8;ZC3H12A;PRKCB;ECM1;SMAD1;TWIST1;FGF2;PLCG1;DLL1;HK2;PRKD2
gsea,regulation of proteasomal protein catabolic process (GO:0061136),0.5768927864724276,1.9371561721544346,0.0019230769230769232,0.004202545336979407,0.375,12/28,16.03%,ALAD;PSME2;GLMN;USP14;PSMD14;UCHL5;RAD23A;DAB2IP;PSMC2;XPO1;PSMC5;PSME3
gsea,NIK/NF-kappaB signaling (GO:0038061),0.537358187038851,1.9353507827822185,0.002242152466367713,0.004264534399466933,0.38,26/42,23.91%,AKT1;PSMA3;PSMB6;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;MALT1;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;TRAF2;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4;PSMD11;ZFP91;BIRC2
gsea,regulation of G0 to G1 transition (GO:0070316),0.5716785539795768,1.9329178258872084,0.002232142857142857,0.004331314330016359,0.386,18/32,28.33%,RRM2;RAD51;CBX3;E2F1;TFDP1;DAB2IP;CBX5;EHMT2;BRCA1;CDKN2B;PCGF2;RBBP8;CDC7;RBBP4;CHEK1;APAF1;EED;RBBP7
gsea,regulation of cellular response to stress (GO:0080135),0.45979322886266016,1.9312242209506805,0.0,0.004376300146556324,0.391,46/87,31.10%,CEBPB;RPA2;MANF;YWHAE;RPA3;PTGES3;HSP90AA1;RPA1;MAPKAPK2;RSL1D1;NDC1;DNAJB1;AAAS;DNAJC2;NUP93;NUP62;RANBP2;HSPH1;VASH1;AIFM2;NUP85;CAMK2G;HSPA1B;NUP107;NUP43;HIKESHI;HSPA1A;DYRK3;NUP35;NEK6;HSPA8;NUP160;MLST8;EIF4G1;NUP37;MTOR;NUP210;NUP54;ATF4;ALOX5;CLN3;NUP133;NUP88;BAG3;NUP205;FKBP4
gsea,regulation of embryonic development (GO:0045995),0.6867398941289368,1.9310405188382753,0.003703703703703704,0.004357517742493851,0.391,3/15,5.40%,CFL1;CDK1;RACGAP1
gsea,heterochromatin assembly (GO:0031507),0.6668751391081826,1.9307704302715183,0.002105263157894737,0.004365192210416398,0.393,6/15,13.42%,CDKN2A;HELLS;HDAC1;SMCHD1;CENPV;POLE3
gsea,defense response to symbiont (GO:0140546),0.4918432291605883,1.930144514848764,0.0,0.004398985803022033,0.396,24/64,26.54%,PRF1;FLNA;LYST;ISG20;ISG15;ZBP1;IFITM3;MLKL;IFITM1;RIPK3;SERINC3;CGAS;IFIT2;BNIP3;DDX58;G3BP1;RNASEL;BST2;IFITM2;EIF2AK2;MOV10;STAT1;IFIT1;EXOSC4
gsea,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.5204471429654587,1.9267270904250255,0.0,0.004547216357724348,0.409,7/38,13.99%,HAVCR2;TMSB4X;CDKN2A;ANXA4;DAB2IP;FAF1;CACTIN
gsea,regulation of neurogenesis (GO:0050767),0.5921695047094577,1.9262908109471646,0.0,0.004564378653813774,0.411,4/26,3.14%,IFNG;HMGB2;NAP1L1;CX3CR1
gsea,positive regulation of JNK cascade (GO:0046330),-0.49536285369970834,-1.9262425720663627,0.002242152466367713,0.014425804159854259,0.457,13/39,13.84%,CCR7;TRAF1;MFHAS1;GADD45B;HIPK2;NCF1;SH3RF1;RASSF2;F2RL1;TRAF4;RASGRP1;PJA2;UNC5CL
gsea,mRNA transport (GO:0051028),0.4836090197114957,1.9261004498940135,0.002403846153846154,0.0045503714689123466,0.411,44/79,27.55%,ALYREF;MAGOHB;SRSF3;SRSF2;HNRNPA2B1;SLBP;SRSF7;UPF1;EIF4A3;RBM8A;U2AF1;DDX39B;ZFP36;NDC1;RNPS1;AAAS;NUP93;NUP62;RANBP2;HHEX;SRSF9;MAGOH;NUP85;NCBP2;NUP107;NUP43;U2AF2;SRSF6;CPSF2;SRSF1;SRRM1;NUP35;FMR1;EIF4E;SARNP;THOC6;NUP160;NUP37;NUP210;NUP54;RBM15B;GLE1;NUP133;NCBP1
gsea,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.5822500797149184,1.9258333599329986,0.0,0.004541630740149316,0.412,21/32,31.13%,ALYREF;PCNA;RAD51;TIPIN;NUCKS1;CENPS;FAM111A;POLD1;MMS22L;TIMELESS;EME1;POLE;GEN1;ETAA1;TONSL;RFWD3;TRAIP;RTEL1;FANCM;BLM;DONSON
gsea,cellular response to amino acid starvation (GO:0034198),-0.5142097272303953,-1.9255599731395627,0.0,0.0142752835239213,0.459,9/35,18.40%,DAPL1;SESN3;FAS;CASTOR1;SESN1;MAPK8;DAP;SESN2;RNF152
gsea,JNK cascade (GO:0007254),-0.6292305667216583,-1.921817940524319,0.002004008016032064,0.014528375408788803,0.47,3/18,3.17%,RPS27A;RIPK2;TRIB1
gsea,response to amino acid starvation (GO:1990928),-0.5108983265581936,-1.9217104874454398,0.0,0.014264223128629006,0.47,9/36,18.40%,DAPL1;SESN3;FAS;CASTOR1;SESN1;MAPK8;DAP;SESN2;RNF152
gsea,regulation of protein localization to plasma membrane (GO:1903076),0.5310724308614593,1.9213119285763562,0.0,0.004691924217732205,0.424,14/41,15.36%,ACTB;LGALS3;IFNG;RHOQ;AKT1;VAMP8;ATP2B4;ABI3;CLTC;PRKCE;ZDHHC2;KIF5B;PICALM;ITGA3
gsea,regulation of neuron apoptotic process (GO:0043523),0.5139388118654133,1.9211159216780214,0.0,0.004672455652513399,0.424,10/43,13.93%,ADAM8;MT3;CCL3;F2R;BAX;PTK2B;SET;MEF2C;CLCF1;PARK7
gsea,histone lysine demethylation (GO:0070076),-0.620376410416949,-1.9207263022590564,0.0,0.01417582774720567,0.475,9/20,17.99%,KDM5B;KDM2B;KDM4D;KDM7A;JMJD1C;KDM1B;KDM3A;KDM4B;KDM6B
gsea,regulation of T cell proliferation (GO:0042129),0.5378774398453213,1.919780737932874,0.0,0.004714172876128171,0.428,10/36,13.18%,CCL5;CEBPB;LGALS3;ANXA1;GLMN;RIPK3;SPN;TFRC;TNFRSF21;CD86
gsea,axonal transport (GO:0098930),-0.5998341830793094,-1.9177476216187237,0.00477326968973747,0.014367065400645078,0.489,8/20,14.86%,HIF1A;AP3B1;KIF1B;NEFL;TMEM108;BLOC1S2;KIF3B;AP3S1
gsea,actin filament organization (GO:0007015),0.4625838821841549,1.9171349151081294,0.0,0.004806191548407596,0.433,21/81,14.99%,ALDOA;NEDD9;TPM3;CORO1A;MYO1F;NEB;TPM4;LCP1;FLNA;ELMO2;SH3BP1;MYO1G;RHOF;CAPG;RHOC;ERMN;HIP1R;HIP1;BAIAP2;MYO5A;FLII
gsea,regulation of innate immune response (GO:0045088),0.5127914633753796,1.9169168553652727,0.0,0.004786494042061663,0.433,11/38,18.37%,CCL5;ADAM8;LRP8;PTPN6;LYAR;CACTIN;ERAP1;POLR3G;RNASEL;DHX9;TRAFD1
gsea,regulation of cytokinesis (GO:0032465),0.5196242721957021,1.9164786020228466,0.0022172949002217295,0.0048071424303723995,0.437,25/45,26.25%,PRC1;AURKB;RACGAP1;PLK3;E2F7;PRKCE;CIT;CDC6;PIN1;KIF23;PLK4;CENPV;KIF20A;PLK1;ECT2;E2F8;MAP9;AURKA;KIF20B;CDC14A;KIF14;GIPC1;CCP110;PDXP;RAB11FIP4
gsea,proteolysis (GO:0006508),0.4506720682063266,1.913329589244358,0.0,0.004897660998704335,0.44,35/104,22.58%,GZMB;CTSD;ST14;GZMA;CAPN2;NAPSA;TMPRSS6;ADAM19;PSMB5;MALT1;CASP7;CASP1;LRP8;METAP2;RNPEP;FAM111A;IDE;PSMA6;MDM2;VASH1;SPCS3;AFG3L2;ERAP1;CPNE1;DPP3;PSMD6;ADAM17;PRSS16;CASP3;ZMPSTE24;PSMC4;HTRA3;UBA3;ERMP1;NLN
gsea,sterol metabolic process (GO:0016125),0.5687773104393469,1.9125730148253868,0.0,0.004912709660778075,0.443,13/26,23.60%,LBR;MSMO1;SC5D;PMVK;FDX1;SQLE;HMGCR;DHCR7;OSBPL5;SOAT1;NSDHL;INSIG1;PRKAG2
gsea,regulation of interleukin-12 production (GO:0032655),-0.5544114411455601,-1.911699516922775,0.005141388174807198,0.015119941757507553,0.506,7/26,9.50%,CCR7;LTB;RIPK2;FOXP1;IL16;TNFSF4;IL23A
gsea,negative regulation of catalytic activity (GO:0043086),0.676442898760538,1.9108621779372652,0.001639344262295082,0.004942524083406954,0.447,2/15,2.86%,MT3;GZMA
gsea,positive regulation of translation (GO:0045727),0.5079722795946131,1.9086456068109932,0.0,0.0050116385876942055,0.454,19/52,24.45%,CCL5;VIM;PKM;RPS27L;HNRNPD;EIF5A;EIF4A3;EIF3D;EIF3C;CNBP;YBX3;EIF5A2;DHX9;CDC123;EIF6;FMR1;MTOR;PIWIL2;LARP4B
gsea,regulation of heart contraction (GO:0008016),-0.49248706493476624,-1.9032400159772522,0.0,0.016138741422291422,0.532,10/36,12.86%,CAMK2D;P2RX4;ATP2A3;TMEM65;CELF2;ATP1A1;ITPR1;ATP1B1;ATP2B2;ITPR2
gsea,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5975772635488041,1.9030473981128044,0.013761467889908258,0.005355869952936539,0.474,11/22,25.51%,CDKN1A;CDK1;CLSPN;TOPBP1;PLK1;BRCA1;FZR1;BRCC3;TICRR;DTL;CHEK1
gsea,regulation of cell cycle (GO:0051726),0.404980305143269,1.8996433493660965,0.0,0.005511042069864539,0.481,57/159,25.51%,ID2;CDKN2A;CDKN1A;IFNG;CDK6;PCLAF;CKS1B;BIRC5;CDKN3;RUNX3;CCNB2;CAMK2N1;CENPF;GMNN;FBXO5;CALR;STAT3;DLGAP5;HRAS;HNRNPU;ERN1;MIF;BARD1;CDKN2C;MASTL;FIGNL1;JUND;CCNB1;RAD23A;MLF1;DAB2IP;MYBL2;PLK1;MDM2;BRCA1;CDKN2B;DCUN1D3;FOXM1;DDIAS;PRR11;LIN54;RB1;DHCR24;KIF20B;CDC14A;CDC123;RBBP4;APBB1;TARDBP;NEK6;FBXL8;DTL;RARA;BIRC2;TTLL12;GRK5;CHEK1
gsea,DNA integrity checkpoint signaling (GO:0031570),0.5565174187297673,1.8976335432769516,0.002079002079002079,0.0056307974218529604,0.488,14/28,25.51%,CLSPN;TIPIN;E2F1;CDC6;BRIP1;CDC45;RAD9A;TIMELESS;HUS1;PRPF19;CDT1;DNA2;CHEK2;CHEK1
gsea,Fc receptor signaling pathway (GO:0038093),0.4510936945086298,1.8968491682772843,0.0,0.005642591426236618,0.489,30/64,22.25%,LAT2;FCER1G;PSMA3;PSMB6;PSMB2;LYN;PSME2;GRAP2;PSMA4;PSMD14;PSMA5;PSMB5;MALT1;PSMA6;PSMD1;PSMC1;PSMB7;PLCG2;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;TEC;PSMD3;PSMD2;PSMC4;SHC1;PSMD11;TAB1
gsea,cellular response to DNA damage stimulus (GO:0006974),0.3871808940425633,1.896212703103138,0.0,0.005654292564444025,0.492,118/245,36.09%,CDKN1A;PCLAF;LIG1;BAX;TOP2A;ZBTB38;CRIP1;CDK1;NABP1;BAK1;LYN;RFC2;RAD51;PLK3;CBX3;MCM7;FANCF;SMC1A;UPF1;SMC6;RPA1;CTLA4;E2F1;BARD1;FEN1;TOPBP1;CGAS;MAPKAPK2;POLA1;RFC5;HPF1;MASTL;RFC3;SFN;RFC4;RAD51AP1;CBX5;CENPS;RAD50;BCL2L11;FAM111A;RBBP5;POLD1;FBXO31;RAD54L;BRCA1;SMC5;CBX1;POLE3;RAD9A;PARK7;POLE2;RNF168;RBBP8;UBE2T;NSMCE4A;MCM8;WDHD1;RIF1;UBA1;MCM10;TIGAR;TIMELESS;SPIDR;BID;HUS1;APBB1;ZDHHC16;POLH;TICRR;FANCG;FMR1;WDR76;SLF1;BAZ1B;UBA6;DTL;ETAA1;FBXO45;FANCA;FANCL;SUV39H1;CSNK1E;RAD51C;RECQL;CHEK2;CHEK1;PIDD1;PWWP3A;UFL1;RFWD3;EXO1;MBD4;TRAIP;PDS5A;RMI2;RTEL1;BACH1;NUDT1;HIC1;BLM;XRCC2;HELB;RAD18;PSME4;DDB1;RAD51D;MMS19;SLF2;MTREX;HINFP;YAP1;POLK;ATR;RAD17;RECQL4;MUTYH;WNT1
gsea,defense response to virus (GO:0051607),0.46789449207894945,1.8950236178414928,0.0,0.005704511141481932,0.495,24/70,26.54%,PRF1;FLNA;LYST;ISG20;ISG15;ZBP1;IFITM3;MLKL;IFITM1;RIPK3;SERINC3;CGAS;IFIT2;BNIP3;DDX58;G3BP1;RNASEL;BST2;IFITM2;EIF2AK2;MOV10;STAT1;IFIT1;EXOSC4
gsea,platelet degranulation (GO:0002576),0.5021787653444951,1.8945514038475613,0.0014619883040935672,0.00573030088886966,0.498,17/57,21.91%,TMSB4X;ALDOA;PLEK;LGALS3BP;MANF;FLNA;TUBA4A;TAGLN2;LYN;ACTN4;FAM3C;PDGFB;SCCPDH;TOR4A;NHLRC2;ENDOD1;CYB5R1
gsea,positive regulation of phagocytosis (GO:0050766),0.6128826015590644,1.889845857131028,0.0,0.005980953853872576,0.508,7/27,14.96%,FCER1G;IFNG;CALR;LMAN2;RAB27A;LYAR;IL15RA
gsea,regulation of double-strand break repair via homologous recombination (GO:0010569),0.5407907672053683,1.8895985845690357,0.0,0.005981622029773729,0.51,18/33,33.32%,RPA2;ACTR2;RAD51;CGAS;SMCHD1;FIGNL1;RAD51AP1;PARPBP;RIF1;TIMELESS;SPIDR;CHEK1;RMI2;RTEL1;FANCB;HELB;WRAP53;MMS19
gsea,regulation of microtubule cytoskeleton organization (GO:0070507),0.6224457722669482,1.889312126800608,0.0017730496453900709,0.005996539895211639,0.513,6/18,19.44%,STMN1;TRIM36;SKA1;SKA2;SKA3;BICD2
gsea,positive regulation of intracellular transport (GO:0032388),0.6129607323206108,1.8850219555697727,0.004555808656036446,0.006262210078244345,0.529,6/18,17.89%,NEDD4;PLK3;PRR5L;PGAP1;SPAG5;KIF20B
gsea,RNA metabolic process (GO:0016070),0.46658786875104374,1.8848155069173242,0.002173913043478261,0.0062476473472723275,0.53,37/83,32.87%,PCBP1;ISG20;HNRNPA2B1;HNRNPD;HNRNPA3;LSM8;RNASEH2B;HNRNPF;HNRNPU;POLR2C;ATXN1;DDX39B;SYNCRIP;TFIP11;HNRNPA1;POLR2F;POLR2L;PPP1R8;PTBP1;NCBP2;DDX20;RNASEL;DHX9;GTF2F1;HNRNPM;HNRNPUL1;HNRNPK;RBMX;NCBP1;RNASEH1;SNRNP40;RNASEH2A;METTL14;BICD1;GTF2F2;MRPL44;TBRG4
gsea,response to endoplasmic reticulum stress (GO:0034976),0.45736350324178043,1.8842815009706293,0.0,0.006237892990762976,0.531,24/61,25.90%,CEBPB;HSP90B1;PDIA3;BAX;BAK1;HSPA5;EIF2S1;PDIA4;ERN1;CREB3L1;ATF6;ATP2A2;DAB2IP;P4HB;BCL2L11;EIF2AK3;FLOT1;RNF5;TRAF2;TMEM33;HYOU1;CHAC1;ATF4;UFL1
gsea,positive regulation of ATPase activity (GO:0032781),0.6150554443487262,1.8830934056571949,0.0,0.006345196523587727,0.535,8/19,16.89%,PFN1;DNAJB11;HNRNPU;UHRF1;DNAJC9;DNAJB1;AHSA1;DHX9
gsea,negative regulation of G0 to G1 transition (GO:0070317),0.5705739381827098,1.8826063840509508,0.002188183807439825,0.00634446980659069,0.535,17/29,28.33%,RRM2;RAD51;CBX3;E2F1;TFDP1;DAB2IP;CBX5;EHMT2;BRCA1;PCGF2;RBBP8;CDC7;RBBP4;CHEK1;APAF1;EED;RBBP7
gsea,regulation of peptide hormone secretion (GO:0090276),0.5922110171359743,1.8822326745990934,0.0,0.0063391045416190134,0.538,4/27,5.47%,CCL5;IFNG;SLC2A1;CHD7
gsea,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.5043974864125135,1.8797347348584725,0.002145922746781116,0.006532722293048562,0.547,23/39,27.74%,CDKN1A;BAX;CDK1;RBL2;PCNA;PLK3;E2F7;E2F1;TFDP1;E2F4;SFN;CCNB1;MDM2;CNOT9;E2F8;GTSE1;AURKA;PCBP4;CHEK2;PIDD1;CDC25C;ARID3A;PRMT1
gsea,negative regulation of immune response (GO:0050777),0.5001466036051289,1.8791604914263749,0.0,0.006540519889445077,0.549,18/58,18.37%,HAVCR2;LGALS3;CCR2;ADRB1;LYN;MYH9;CALCA;RHBDF2;ADORA2B;LYAR;PRKAR2A;CYSLTR2;PLCG2;CACTIN;VIPR2;ADAM17;ADRB2;TRAFD1
gsea,regulation of filopodium assembly (GO:0051489),-0.568588833076649,-1.8787790733306509,0.0,0.020311862934534044,0.604,4/18,7.55%,CCR7;NRP1;RIPOR2;PIK3R1
gsea,cellular protein-containing complex assembly (GO:0034622),0.44930050697979573,1.8768447367270267,0.0,0.006690612757754658,0.559,36/79,21.09%,SNX9;VAMP8;CENPW;HIGD1A;CLTB;CENPF;PTGES3;DLGAP5;CLTC;HSP90AA1;CENPE;MID1IP1;ANLN;CENPT;NDC1;CENPA;HIP1R;PFDN6;HIP1;NUP93;HSPD1;PICALM;TRAF2;NUP107;DHX9;SAMM50;ADRB2;EIF4H;HSPA1A;HSPA4;PSMG2;USH1C;VBP1;MIS12;PSMD11;ADRM1
gsea,negative regulation of neuron death (GO:1901215),0.4889803037192389,1.8759304423991696,0.0,0.006720640307975973,0.561,17/43,26.44%,ADAM8;MT3;CSF1;F2R;AKT1;CD200R1;PTK2B;SET;MEF2C;CLCF1;PARK7;TRAF2;KIF14;VPS35;EIF4G1;ATF4;CLN3
gsea,protein depolymerization (GO:0051261),0.6344111732020212,1.8737567849408414,0.0,0.006896302456761458,0.571,9/18,18.65%,CFL1;STMN1;MICAL2;KIF2C;KIF18A;CKAP5;KIF18B;KIF14;KATNB1
gsea,cellular response to organic cyclic compound (GO:0071407),0.4764384598690413,1.8730160520586934,0.0,0.006929890611587291,0.577,22/63,25.16%,CCL5;ACTB;HSP90B1;CCL3;SPP1;EGR1;EZR;DIAPH1;RAD51;CTNNA1;CASP7;TIPARP;BRCA1;MEF2C;PDGFB;CASP3;SPIDR;NR3C1;INSIG1;IMPACT;RUVBL2;PDXP
gsea,positive regulation of fat cell differentiation (GO:0045600),0.6024603681877286,1.8730020112661028,0.001610305958132045,0.006908937589659669,0.577,7/23,11.50%,ID2;CEBPB;METRNL;AKT1;HNRNPU;ZFP36;XBP1
gsea,lymphocyte chemotaxis (GO:0048247),0.611228230591591,1.8727277635591024,0.0014684287812041115,0.006897153957250007,0.578,4/23,0.73%,CCL5;ADAM8;CCL4;CCL3
gsea,regulation of GTPase activity (GO:0043087),0.4198380527323323,1.8716776474848982,0.0,0.006943845725130059,0.581,30/104,22.32%,CCL5;RGS1;CCL4;RGS16;CCL3;CHN2;SNX9;S100A10;ADAP1;F2R;TMED2;ADRB1;SIPA1L1;SH3BP1;PLXND1;RGS8;HRAS;DOCK8;PIN1;DAB2IP;ARHGAP11A;RDX;ECT2;PICALM;FGD3;ALS2;WNT11;ARHGEF5;RRP1B;TBC1D7
gsea,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5386683697376025,1.8690343340569688,0.003780718336483932,0.007079701090863639,0.587,10/32,17.76%,NEDD4;IFNG;RAN;FLNA;YWHAE;ECT2;NCBP2;GTSE1;DHX9;ANP32B
gsea,membrane organization (GO:0061024),0.4206868854656821,1.8656022398647576,0.0017953321364452424,0.007281456163037956,0.598,43/101,29.30%,ACTB;ACTG1;SNX9;VAMP8;M6PR;ACTR2;CLTB;REEP4;CLTC;PACSIN2;CEP55;AREG;TFRC;LDLR;KIF20A;HIP1R;HIP1;NUP93;TMEM43;PICALM;AP2A2;ITSN1;CORO1C;MYADM;SYNGR1;TMEM33;ADRB2;COX18;VAMP7;TIMM50;FZD4;GCA;STAM2;HSPA8;DNM3;NPC1;SYNGR2;CLN3;AP2B1;AP3D1;HGS;IGF2R;TRIP10
gsea,regulation of DNA repair (GO:0006282),0.5540123717097273,1.864000536891545,0.0,0.0073484691068275475,0.603,11/26,19.72%,PCNA;DEK;USP1;SMCHD1;BRCA1;UBE2N;RNF168;DHX9;TIGAR;BRCC3;POLH
gsea,regulation of smooth muscle cell proliferation (GO:0048660),0.5957753405935411,1.8630226169355437,0.00303951367781155,0.007441561136933917,0.61,4/27,2.61%,CCL5;ID2;IFNG;AKT1
gsea,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4602282015651377,1.8622834546369416,0.0,0.007503108849509353,0.614,27/54,27.91%,CDKN1A;RPS27L;BAX;CDK1;RBL2;PCNA;PLK3;E2F7;E2F1;TFDP1;E2F4;SFN;CCNB1;SP100;MDM2;CNOT9;FOXM1;E2F8;GTSE1;AURKA;PCBP4;CHEK2;PIDD1;CDC25C;ARID3A;PRMT1;PAXIP1
gsea,cellular response to hypoxia (GO:0071456),0.44409955834836917,1.8619754140077063,0.0,0.0074938930128650195,0.617,44/77,27.39%,ADAM8;HILPDA;MT3;EPAS1;PGK1;PSMA3;PSMB6;HIGD1A;ELOC;PSMB2;PSME2;LMNA;PLK3;PSMA4;PSMD14;PSMA5;PSMB5;EGLN1;HMOX1;BNIP3;P4HB;PSMA6;MDM2;PSMD1;PSMC1;PSMB7;PSMC2;STUB1;PSMD12;PSMD6;PSMC5;PSME3;SUV39H2;PSMD3;TIGAR;PSMD2;PSMC4;HYOU1;PSMD11;MTOR;SUV39H1;VEGFA;PSMC6;CPEB2
gsea,regulation of tumor necrosis factor production (GO:0032680),0.48995526325299277,1.8601098267869935,0.0,0.007624890088626584,0.62,32/65,30.64%,HAVCR2;CCL3;IFNG;CCR2;HMGB1;CX3CR1;STAT3;CD14;LTF;MIF;SPN;SLAMF1;MAPKAPK2;ZFP36;PTPN6;DDX58;PLCG2;FRMD8;CACTIN;DHX9;IL33;RIPK1;TMEM106A;VSIR;RARA;PTPRJ;IL10;TLR4;HSPB1;TYROBP;SYK;FADD
gsea,regulation of cellular response to heat (GO:1900034),0.4872752991198463,1.859255512720268,0.002331002331002331,0.007680768862419422,0.625,36/62,32.07%,RPA2;YWHAE;RPA3;PTGES3;HSP90AA1;RPA1;MAPKAPK2;NDC1;DNAJB1;AAAS;DNAJC2;NUP93;NUP62;RANBP2;HSPH1;NUP85;CAMK2G;HSPA1B;NUP107;NUP43;HIKESHI;HSPA1A;NUP35;HSPA8;NUP160;MLST8;NUP37;MTOR;NUP210;NUP54;NUP133;NUP88;BAG3;NUP205;FKBP4;NUP155
gsea,cellular protein modification process (GO:0006464),0.3379060385103323,1.8580679926857482,0.0,0.007731904080753389,0.63,201/480,36.88%,GLRX;LGALS1;HSP90B1;MT3;DUSP5;SPP1;CSF1;CDK6;STK39;EPAS1;ANXA1;LAMC1;BIRC5;AKT1;PSMA3;ASB2;DDOST;PSMB6;CDK1;RUNX3;PDIA6;UBE2M;DUSP2;CISH;ELOC;PSMB2;LYN;BMP2K;UBE2S;PSME2;PTK2B;AURKB;ISG15;RCN1;PTPN7;RPN1;RPN2;PSMA4;PRKCE;PSMD14;FAM20A;PSMA5;PSMB5;PTPRE;DAPK2;ERN1;RIPK3;ST3GAL6;CCNE1;UBE2L6;PPP2CB;MAPKAPK2;COPS4;CDK14;FUT7;METAP2;UCHL3;TIPARP;NEK2;KEAP1;MAPK6;BCR;PLK4;P4HB;PPM1J;PLK1;PTPN12;RBBP5;PTPN6;SEPHS1;FBXO31;PSMA6;EIF2AK3;RYK;PPM1G;STT3A;LMTK3;PSMD1;PSMC1;PSMB7;WDR5;TXK;COPS5;DCUN1D3;GAN;ANKRD9;PARK7;PSMC2;TYK2;GMFB;PAK4;PGAP1;NUS1;PSMD12;CDC34;PSMD6;PSMC5;PDP1;PSME3;RNASEL;TEC;CCNF;PDGFB;AURKA;LRR1;FBXW4;PSMD3;ST3GAL3;PTPN5;FUT4;BCKDK;MATK;PSMD2;PSMC4;B4GALT5;HASPIN;ASB1;B3GALT5;FBXO30;DYRK3;TIMM50;WNT11;CTDSP1;PRKCSH;KLHL25;ST3GAL4;PSMD11;NEK6;FBXL14;UBA3;PPP2R1B;GOLM1;FBXL8;ALG3;BRD2;TAB1;CAMKK2;DTL;MINK1;NPC1;MTOR;EIF2AK2;RARA;PRKAG2;SOCS2;PARP10;CSNK1E;KLHL20;PLOD2;TRIOBP;CHEK2;PTPRJ;COPS3;PDXP;GRK5;DCAF13;SRPK1;CHEK1;NAGPA;UFL1;PARP14;PSMC6;ALG10B;PEAK1;MGAT4A;RBBP7;CUL5;PPP5C;ZDHHC6;FGR;PTPN9;SPSB2;SYK;MAP4K1;PSME4;B3GALT4;ICMT;CDK4;DDB1;MPI;CDK2;EIF2AK4;VCAN;HUNK;CCL2;EVPL;CTSG;CHUK;FBXO15;UST;GPS1;PIGU;SKP2;PTAR1;ST3GAL5;PPP3CB;FBXO44;SERP2;DSP;FAM20B;AGA
gsea,negative regulation of lymphocyte proliferation (GO:0050672),0.5944516561093899,1.8577685507744364,0.0016233766233766235,0.007730679108228357,0.631,7/23,13.18%,CEBPB;LYN;GLMN;CTLA4;SPN;TNFRSF21;CD86
gsea,metal ion homeostasis (GO:0055065),0.6528368098992023,1.8573133220604514,0.0,0.007755371545628567,0.634,3/16,6.52%,MT3;SELENON;FAM20A
gsea,IRE1-mediated unfolded protein response (GO:0036498),0.5391892659129497,1.8561833633080913,0.002074688796680498,0.007831527755380133,0.638,17/26,27.82%,DNAJB11;PDIA6;HSPA5;EDEM1;LMNA;ERN1;HDGF;XBP1;MYDGF;DCTN1;HYOU1;SHC1;KDELR3;ADD1;SRPRB;EXTL3;GFPT1
gsea,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.6383000724934454,1.8539407135896968,0.013043478260869565,0.007988626097113243,0.642,8/15,27.91%,SUB1;MED30;PSMC2;PSMC5;PSMC4;MED14;PSMC6;PAXIP1
gsea,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.5053414605517087,-1.8539351534013497,0.004,0.02562840658233052,0.672,11/38,18.02%,RPS27A;NFKBIA;REL;RIPK2;PRDX4;RELB;BIRC3;TICAM2;TLR7;IRAK1BP1;MAP3K14
gsea,positive regulation of multicellular organismal process (GO:0051240),0.43985501034335994,1.8525772218744436,0.0,0.008050624067584219,0.65,38/149,23.57%,PLAC8;CEBPB;HILPDA;CFL1;IFNG;GAPDH;ACADL;ENO1;CCR2;F2R;EPAS1;VAMP8;ADRB1;GLMN;FBXO5;FABP5;OLFM1;MIF;GATM;TFRC;GLIPR2;XBP1;FLOT1;TXK;PIK3CG;AGPAT2;RIF1;IL33;PDGFB;ADRB2;B4GALT5;VAMP7;SLC27A1;HCAR2;TRPV2;SLC11A1;MTOR;EIF2AK2
gsea,regulation of T cell activation (GO:0050863),0.5668026104087024,1.8514553221339725,0.0034965034965034965,0.008116451355378146,0.654,8/24,16.76%,CCL5;LGALS3;PRELID1;CCR2;TBX21;PAG1;HSPD1;DUSP3
gsea,RNA transport (GO:0050658),0.4947207158584835,1.8496878739780327,0.00468384074941452,0.00819455571684874,0.658,29/53,22.75%,ALYREF;MAGOHB;SRSF3;SRSF2;HNRNPA2B1;SLBP;YBX1;SRSF7;EIF4A3;RBM8A;U2AF1;DDX39B;ZFP36;RNPS1;NUP62;FLOT1;SRSF9;MAGOH;HNRNPA1;CKAP5;NCBP2;U2AF2;SRSF6;SRSF1;SRRM1;FMR1;EIF4E;SARNP;THOC6
gsea,centromere complex assembly (GO:0034508),0.5823878619437303,1.8490278497752162,0.008968609865470852,0.008250977769180807,0.661,26/32,28.90%,CENPW;CENPF;HELLS;DLGAP5;KNL1;CENPE;CENPT;CENPV;CENPS;CENPH;CENPA;CENPK;CENPN;MIS18A;HJURP;CENPQ;MIS18BP1;NASP;OIP5;RBBP4;MIS12;CENPI;CENPM;CENPP;RBBP7;CENPO
gsea,cellular response to ionizing radiation (GO:0071479),0.4879050096806874,1.8453333470893047,0.0020833333333333333,0.008572534344367666,0.668,12/37,19.22%,CDKN1A;TMEM109;RAD51;HRAS;FIGNL1;NUCKS1;RAD51AP1;MDM2;ECT2;RAD9A;SPIDR;HUS1
gsea,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.4796250548540394,-1.8447849748042118,0.005698005698005698,0.027618679190724454,0.696,16/39,30.87%,RPS27A;SPRY1;BAMBI;HIPK2;SPRY2;PMEPA1;SMAD1;SMAD5;SPRED1;CIDEA;TRIM33;EID2;SPRED3;CRIM1;LEMD3;SMAD7
gsea,regulation of lipid metabolic process (GO:0019216),0.4872356722469379,1.8443429258394533,0.0,0.008618880765209183,0.669,18/45,24.13%,ID2;FDPS;NCOR2;HMGCS1;FDFT1;SREBF2;SC5D;PMVK;MID1IP1;SQLE;HMGCR;DHCR7;TBL1XR1;LSS;NFYB;MVK;PRKAG2;IDI1
gsea,regulation of autophagosome assembly (GO:2000785),-0.5825852328456493,-1.843814300904093,0.004310344827586207,0.027384992551360808,0.7,10/18,24.94%,PINK1;C9ORF72;LRRK2;IFT88;RAB3GAP1;MTMR3;TBC1D14;ADPRH;TMEM39A;PIKFYVE
gsea,negative regulation of Wnt signaling pathway (GO:0030178),0.4381701865512302,1.8437376154775713,0.0,0.00864398216537705,0.672,40/89,29.18%,TLE5;PSMA3;PSMB6;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;HDAC1;DKKL1;DAB2IP;CCDC88C;PSMA6;PSMD1;PSMC1;PSMB7;FRMD8;TAX1BP3;KREMEN2;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;NXN;PSMD3;PSMD2;PSMC4;FRZB;FZD4;WNT11;PSMD11;SFRP4;ALPK2;RUVBL2;JADE1;PSMC6;HMGXB4;HIC1
gsea,regulation of neuron death (GO:1901214),0.47884417878856905,1.843703269591706,0.0,0.008618852289044498,0.672,16/43,23.10%,CCL5;IFNG;CSF1;AKT1;EGR1;CD200R1;EIF2S1;ITGAM;MEF2C;PICALM;PARK7;TRAF2;DHCR24;KIF14;VPS35;EIF4G1
gsea,regulation of smoothened signaling pathway (GO:0008589),-0.5453035688320378,-1.84210900832997,0.006607929515418502,0.027371310006027192,0.703,9/21,21.82%,RACK1;RORA;PTCH1;MGRN1;FUZ;IFT81;CREBBP;TULP3;RAB34
gsea,adherens junction organization (GO:0034332),0.6552819284557501,1.8416134335647727,0.001564945226917058,0.008797617762269689,0.683,3/17,8.77%,ACTB;CTNNA1;CDH17
gsea,cellular response to BMP stimulus (GO:0071773),-0.5177131177967933,-1.8411807657914707,0.005698005698005698,0.027280890388263066,0.706,10/22,26.37%,PDCD4;ENG;HIVEP1;TGFBR3;SMAD1;SMAD5;USP9X;RGMB;BMP7;TGFB2
gsea,positive regulation of protein kinase B signaling (GO:0051897),-0.4153921908148436,-1.8410690151826157,0.0,0.026878399137355725,0.706,27/68,31.30%,CCR7;ITGB1;RAMP3;P2RX4;KIT;TRAT1;IRS2;ENG;MFHAS1;PIK3R2;PINK1;PIK3R1;PTPN11;SPRY2;CX3CL1;AXL;FGF2;HBEGF;RICTOR;GATA3;HSP90AB1;RET;ICOS;MET;F3;C1QBP;PIK3R5
gsea,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.6103531796261845,1.8409327632116335,0.006382978723404255,0.008809432808432889,0.684,12/22,21.17%,UBE2C;FBXO5;ANAPC5;DLGAP5;CENPE;CDC6;CCNB1;PLK1;ANAPC15;RB1;ESPL1;NEK6
gsea,positive regulation of hydrolase activity (GO:0051345),0.4271420257584377,1.840107641069421,0.0017761989342806395,0.008837687601229546,0.688,23/81,22.32%,CCL5;RGS1;CCL4;RGS16;CCL3;SNX9;S100A10;HMGB2;F2R;ADRB1;SH3BP1;RGS8;HRAS;RHOC;DOCK8;RIPK3;PIN1;ARHGAP11A;ECT2;PICALM;ALS2;WNT11;TBC1D7
gsea,intrinsic apoptotic signaling pathway (GO:0097193),0.44426103946520645,1.8377864780191242,0.0,0.009009811601614822,0.694,22/56,32.42%,CEBPB;CDKN1A;BAX;CRIP1;HINT1;BAK1;E2F1;ERN1;SFN;BNIP3;DAB2IP;BCL2L11;BRCA1;TRAF2;CHAC1;CHEK2;ATF4;APAF1;CUL5;HIC1;RRP8;TRIB3
gsea,B cell differentiation (GO:0030183),-0.5057699582314099,-1.836143529662987,0.0,0.027610745266770327,0.721,8/30,18.23%,ITGB1;IRF2BP2;KIT;TPD52;VCAM1;TCF3;HDAC9;HDAC5
gsea,regulation of calcium ion transport (GO:0051924),0.5898485138358333,1.835966974324337,0.006309148264984227,0.009147970278070223,0.701,4/23,1.78%,CCL5;CCL4;CCL3;F2R
gsea,organelle organization (GO:0006996),0.37040198848099015,1.8342262899090807,0.0,0.009232059154633685,0.704,67/211,28.84%,HILPDA;CFL1;CCL3;NEDD9;PPIA;ATP8B4;CYCS;CHCHD10;TMED2;CENPW;GEM;DIAPH1;CDCA8;PACSIN2;LMAN2;CEP55;DIAPH3;FAM174B;MTFR2;LMAN1;MICAL2;CENPT;PLEKHF1;EIF2AK3;OPTN;PI4K2B;SPRYD3;CFAP126;STOML2;ARL1;PARK7;ARHGAP10;LNPK;PAK4;PPID;ODF2;SMPD4;ATP8B2;PEX7;NRF1;MNS1;DPYSL2;PLD2;FGD3;PITPNB;DOP1B;FMNL3;DYRK3;GABPA;FANCG;ZW10;AGTPBP1;BNIP1;KLHL20;MYO18A;ARHGAP21;ESRRA;KIF3A;WDR81;MREG;MAST3;RHOT2;HCFC1;RAB32;LYSMD3;GORASP2;CAV2
gsea,response to growth factor (GO:0070848),-0.5751005647750662,-1.8330041193479696,0.004618937644341801,0.028121362263861065,0.73,8/18,14.13%,CPNE3;RACK1;KLF4;HTRA2;STAT5B;CTNNB1;URI1;MYC
gsea,regulation of transport (GO:0051049),0.5997909794914766,1.8328199459451462,0.0018315018315018315,0.009331891398203668,0.708,2/17,0.22%,ACTB;ACTG1
gsea,antigen receptor-mediated signaling pathway (GO:0050851),0.41854165362426793,1.8326137675492518,0.0,0.009325462752941096,0.709,37/90,20.94%,LAT2;THEMIS;PSMA3;PSMB6;CD38;PSMB2;PSME2;GRAP2;PSMA4;PSMD14;PSMA5;PSMB5;CTLA4;MALT1;PAG1;TNFRSF21;PSMA6;PSMD1;PSMC1;PSMB7;STOML2;MEF2C;TXK;UBE2N;PLCG2;PSMC2;PSMD12;PLEKHA1;PSMD6;PSMC5;PSME3;TEC;PSMD3;PSMD2;PSMC4;THEMIS2;PSMD11
gsea,cytoskeleton-dependent intracellular transport (GO:0030705),0.6068714199103075,1.8324815370218612,0.003883495145631068,0.009315028149268165,0.71,7/17,15.56%,MYO10;TUBA1C;TUBA1B;TUBA1A;CCDC88C;KIF5B;DYNC1I2
gsea,positive regulation of signaling receptor activity (GO:2000273),-0.5092975095487442,-1.831361982947432,0.008086253369272238,0.028139533549363428,0.734,6/27,7.04%,ITGB1;HIF1A;JAK2;ARC;NRP1;NCF1
gsea,positive regulation of signal transduction (GO:0009967),-0.3809339371387901,-1.830459954438307,0.0,0.02793201005207529,0.737,45/119,26.37%,TNFSF11;IL7R;CD74;FAS;NTRK3;PRKCA;HIF1A;JAK2;FGFBP3;NRP1;MGAT5;TNFAIP3;KLF2;CD226;GRB10;PIK3R1;TMEM108;PTPN11;IL6ST;C1QTNF12;PRKCB;MAML2;MACF1;SORBS1;ARNT;LRRK2;MAML3;ASXL1;CREBBP;HOMER1;AXL;TSPAN5;PRKCZ;POGLUT1;KAT2B;JCAD;DLL1;RAB34;PRKD2;WLS;GATA3;P2RY6;TRIM44;ITGB3;TGFB2
gsea,regulation of TORC1 signaling (GO:1903432),-0.5986148644262115,-1.8302478215708584,0.008016032064128256,0.027639512421536002,0.737,6/17,18.40%,SESN3;CASTOR1;C9ORF72;SESN1;SESN2;RNF152
gsea,cellular response to organonitrogen compound (GO:0071417),0.5191522455439198,1.8282646714572197,0.002936857562408223,0.009675880052993777,0.726,10/38,12.56%,ACTB;HSP90B1;EGR1;CAPN2;EZR;DIAPH1;CTNNA1;BRCA1;XBP1;MEF2C
gsea,interleukin-12-mediated signaling pathway (GO:0035722),0.5656307399115362,1.8281313279429006,0.01284796573875803,0.009644259529944778,0.726,19/27,16.66%,CFL1;ANXA2;PPIA;IFNG;LMNB1;LCP1;HNRNPA2B1;IL12RB1;IL12RB2;PSME2;SNRPA1;HNRNPF;GSTO1;MIF;RALA;P4HB;HNRNPDL;TYK2;MTAP
gsea,negative regulation of protein binding (GO:0032091),0.4747705304976091,1.8279957416724242,0.0017953321364452424,0.009624871081774997,0.726,16/43,19.13%,ACTB;CDKN1A;TLE5;BAX;AKT1;AURKB;PIN1;IFIT2;ATP2A2;TFIP11;PARK7;PDGFB;AURKA;GTF2F1;ADRB2;MAP2
gsea,lysosome organization (GO:0007040),0.563890458794198,1.8279404908101748,0.0,0.009605608532619306,0.727,9/21,28.58%,ARSB;CORO1A;GNPTAB;TFEB;CLN5;MTOR;NAGPA;CLN3;VPS33A
gsea,cellular response to interleukin-12 (GO:0071349),0.5652306657480535,1.8251599081750232,0.012195121951219513,0.009940935092543547,0.738,19/28,16.66%,CFL1;ANXA2;PPIA;IFNG;LMNB1;LCP1;HNRNPA2B1;IL12RB1;IL12RB2;PSME2;SNRPA1;HNRNPF;GSTO1;MIF;RALA;P4HB;HNRNPDL;TYK2;MTAP
gsea,Ras protein signal transduction (GO:0007265),0.424606143157268,1.8236745821507088,0.0,0.010075603312198275,0.74,22/75,20.90%,CDKN2A;CDKN1A;CFL1;ADGRG1;ARHGDIA;CCNA2;DNMT1;GRAP2;HRAS;NRAS;CYFIP1;RALA;GPSM2;G3BP1;TAX1BP3;PARK7;RB1;RAP2A;RTKN;SHC1;KPNB1;HACD3
gsea,chemokine-mediated signaling pathway (GO:0070098),0.5853479326704973,1.8216564009551648,0.0,0.010288548176567377,0.749,7/26,9.95%,CCL5;CCL4;CCL3;CCR2;STK39;PTK2B;CCR1
gsea,protein stabilization (GO:0050821),0.40685509754799287,1.8215157130994881,0.0,0.01027134986378702,0.749,32/99,30.11%,PFN1;MT3;CDKN1A;GAPDH;FLNA;CALR;PTGES3;HSP90AA1;PIN1;FLOT2;CCT7;HIP1R;HIP1;FLOT1;HSPD1;CRTAP;TESC;PARK7;CCT8;MCM8;HSPA1B;GTSE1;HSPA1A;NCLN;WNT10B;RABL3;CHEK2;TCP1;WDR81;HCFC1;TYROBP;BAG3
gsea,positive regulation of proteolysis (GO:0045862),0.506445936093718,1.8189686087212782,0.0,0.0105019679133192,0.762,7/32,14.79%,ADAM8;SNX9;IFNG;BAK1;PLK1;PERP;STUB1
gsea,Fc-epsilon receptor signaling pathway (GO:0038095),0.4369818592980455,1.8189150930260245,0.0022988505747126436,0.01046852215563347,0.762,30/64,22.25%,LAT2;FCER1G;PSMA3;PSMB6;PSMB2;LYN;PSME2;GRAP2;PSMA4;PSMD14;PSMA5;PSMB5;MALT1;PSMA6;PSMD1;PSMC1;PSMB7;PLCG2;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;TEC;PSMD3;PSMD2;PSMC4;SHC1;PSMD11;TAB1
gsea,mesenchymal cell differentiation (GO:0048762),0.5577358237680967,1.818808717139498,0.0052173913043478265,0.010439195636559314,0.762,4/22,12.56%,S100A4;HNRNPAB;FAM83D;MEF2C
gsea,positive regulation of cell-matrix adhesion (GO:0001954),-0.5645191173675047,-1.8147296317776986,0.002232142857142857,0.0314250750280514,0.774,7/21,14.58%,CCR7;MAP4K4;UTRN;NRP1;CX3CL1;PPM1F;ABL1
gsea,positive regulation of protein localization to membrane (GO:1905477),0.472641491344901,1.8142113284516141,0.00186219739292365,0.010865713689539615,0.768,16/47,18.67%,GZMB;LGALS3;IFNG;AKT1;ATP2B4;YWHAE;PRKCE;HRAS;E2F1;TFDP1;SFN;ITGAM;KIF5B;ITGA3;NMT1;BID
gsea,regulation of hematopoietic stem cell differentiation (GO:1902036),0.5020166701838156,1.8126242090782594,0.006224066390041493,0.011021666528741153,0.773,23/42,23.57%,PSMA3;PSMB6;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;LMO1;PSMD3;PSMD2;PSMC4;PSMD11;EIF2AK2
gsea,BMP signaling pathway (GO:0030509),-0.5254464802274414,-1.8122434015842896,0.005479452054794521,0.03186809642116984,0.782,10/21,26.37%,PDCD4;ENG;HIVEP1;TGFBR3;SMAD1;SMAD5;USP9X;RGMB;BMP7;TGFB2
gsea,positive regulation of interleukin-2 production (GO:0032743),0.5867060955507174,1.8118673737654418,0.009652509652509652,0.011079887852658874,0.774,8/18,14.97%,CCR2;ANXA1;GLMN;MALT1;STOML2;PLCG2;CD86;TRAF2
gsea,phospholipid transport (GO:0015914),0.5436536754488791,1.8066663207728537,0.0019646365422396855,0.011631554769690198,0.788,8/25,19.50%,PRELID1;ATP8B4;PRELID3B;LDLR;ATP8B2;OSBPL5;PITPNB;PLTP
gsea,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.5774399947035375,-1.8037219567869678,0.0025380710659898475,0.034022539850303936,0.803,4/18,7.55%,ZFP36L1;CD160;PIK3R2;PIK3R1
gsea,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.6234738479981146,-1.8028753530081763,0.0054249547920434,0.03384594021260629,0.804,1/16,0.12%,RPS27A
gsea,protein homooligomerization (GO:0051260),0.447162321875582,1.802283332798603,0.001949317738791423,0.012006710989967166,0.795,13/57,19.23%,PRF1;ALDOA;ALAD;TK1;MLKL;EHD4;MIF;TMEM120A;ECT2;ALDH9A1;SLC1A5;GLS;ALS2
gsea,epithelial to mesenchymal transition (GO:0001837),0.5404932874538088,1.7991441200631029,0.0035211267605633804,0.012348858918596951,0.799,5/23,12.11%,S100A4;HNRNPAB;FAM83D;OLFM1;EOMES
gsea,cytokine-mediated signaling pathway (GO:0019221),0.36869719414133445,1.7977990364965928,0.0,0.012478674327172914,0.803,134/311,30.89%,CCL5;TMSB4X;CCR5;VIM;HSP90B1;MT3;CDKN1A;IRF8;FCER1G;CFL1;CCL4;CCL3;ANXA2;TNFRSF9;PPIA;IFNG;LMNB1;CSF1;CCR2;IL1R2;PLP2;LCP1;ANXA1;BIRC5;AKT1;PSMA3;EGR1;ISG20;PSMB6;HNRNPA2B1;IL10RA;IL12RB1;CISH;PSMB2;IL12RB2;PSME2;PTK2B;ISG15;GRAP2;STAT3;SNRPA1;IFITM3;HNRNPF;PSMA4;PSMD14;CANX;HSP90AA1;PSMA5;PSMB5;GSTO1;IFI30;EIF5A;CASP1;IFITM1;MIF;LRP8;ACTN4;IL21R;HMOX1;IFIT2;RALA;ITGAM;SP100;TNFRSF1A;CCR1;IL2RA;P4HB;BCL2L11;PTPN6;PSMA6;PSMD1;PSMC1;PSMB7;EDARADD;UBE2N;CD86;CEACAM1;CLCF1;HNRNPDL;PSMC2;TYK2;PSMD12;IL15RA;TRAF2;PSMD6;PSMC5;CAMK2G;PSME3;ADAM17;RNASEL;TEC;MTAP;IL33;PDGFB;CASP3;PSMD3;PSMD2;PSMC4;TRAF5;SMARCA4;SLC27A1;SHC1;NCAM1;PSMD11;RIPK1;BST2;IFITM2;TAB1;HSPA8;CSF2RB;SOCS2;BIRC2;PTPRJ;STAT1;TCP1;IL10;IFIT1;ALOX5;TNFSF12;VEGFA;GPR35;TXLNA;PSMC6;TNFSF13B;GBP2;TRIM21;ITGAX;RAPGEF1;INPPL1;IL21;SYK;OSM;CD36;IL1B
gsea,regulation of translational initiation (GO:0006446),0.49817389555564984,1.7971553759759973,0.00234192037470726,0.012501002574941371,0.804,17/34,28.61%,CCL5;CEBPB;MIF4GD;EIF3B;EIF2AK3;NCBP2;CDC123;EIF5B;EIF4H;KLHL25;FMR1;EIF4G1;IMPACT;ATF4;GLE1;NCBP1;HSPB1
gsea,regulation of angiogenesis (GO:0045765),-0.38765457706387435,-1.796759726352814,0.0,0.03523890450630663,0.814,45/95,33.43%,ITGB1;CD160;PRKCA;HIF1A;KLF4;GTF2I;RGCC;TNFAIP3;NINJ1;PIK3R6;CXCL10;SERPINE1;HIPK2;ITGB8;ZC3H12A;SPRY2;PRKCB;ECM1;CTNNB1;CXCL13;NF1;TWIST1;FGF2;PLCG1;SERPINF1;SPRED1;HK2;GLUL;ATF2;PRKD2;ROCK1;FOXJ2;FLT1;TGFB2;PML;VASH2;F3;ROCK2;SPHK1;RHOB;FOXO4;STAB1;HIPK1;PTPRM;AGO1
gsea,regulation of protein export from nucleus (GO:0046825),0.6492844975198483,1.7961297323286274,0.0017543859649122807,0.01258016839435666,0.81,7/15,17.76%,YWHAE;BARD1;SP100;RANGAP1;PARK7;GTSE1;ANP32B
gsea,negative regulation of mitochondrion organization (GO:0010823),0.5776211212164452,1.7961103890287458,0.004132231404958678,0.012541460183912485,0.81,7/19,18.93%,PRELID1;AKT1;SLC25A5;TFRC;BNIP3;FXN;HSPA1A
gsea,ribosome assembly (GO:0042255),-0.5832789648641485,-1.7960243756207102,0.017408123791102514,0.03507900925957688,0.814,10/32,14.83%,RPLP0;RPSA;RPL10;RPL3;NPM1;RPL5;RPS15;RPL23A;MDN1;DDX3X
gsea,negative regulation of cell population proliferation (GO:0008285),0.38105221150888097,1.7956414813923012,0.0,0.012567165419555876,0.812,69/163,42.98%,S100A11;CDKN2A;CDKN1A;IFNG;CDK6;ADGRG1;F2R;CDKN3;TINF2;RUNX3;CAMK2N1;LYN;GLMN;PTK2B;KLF10;LMNA;E2F7;NME1;HRAS;E2F1;IFITM1;CDKN2C;TFDP1;CDC6;ITGA1;HMOX1;DAB2IP;PTPN6;CTCF;CDKN2B;NUP62;TESC;HSPA1B;THAP12;FRZB;HSPA1A;RBBP4;SFRP4;E2F3;SMYD2;EIF2AK2;PARP10;PTPRJ;IL10;EEF1E1;HGS;KLF11;ING5;OSM;IL1B;STRN;FOXP3;SULT2B1;SKI;TGFB3;CHERP;AIF1;NOTCH1;IFIT3;MFN2;PINX1;NUPR1;CTBP2;PPARG;GPNMB;NLRC3;ETS1;RAPGEF2;CD300A
gsea,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.40144712433577057,1.7952354246938989,0.0,0.012585186411267052,0.812,63/162,30.68%,ACTB;ACTG1;NEDD9;STMN1;CSF1;RHOQ;AKT1;MAPKAPK3;SIPA1L1;ELMO2;ACTR2;LYN;PTK2B;STAT3;ATP6V0A2;CD7;HNRNPF;HRAS;HSP90AA1;CYFIP1;STYK1;MAPKAPK2;GRB7;POLR2C;GALNT3;SHCBP1;IDE;EIF2AK3;RYK;CEP57;BAIAP2;HNRNPA1;POLR2F;POLR2L;MVP;NUS1;PTBP1;NCBP2;AP2A2;ITSN1;PDGFB;CASP3;GTF2F1;HNRNPM;ADRB2;NCF2;SHC1;SOCS2;SLC39A14;TNK2;PTPRJ;VEGFA;AP2B1;TCIRG1;NCBP1;NCKAP1;RAPGEF1;CAV2;BCAR1;FGR;SYK;SPRED2;PDGFA
gsea,histone modification (GO:0016570),0.4279223973727926,1.7950059701662577,0.0021598272138228943,0.012565577133294805,0.813,20/68,27.74%,MT3;PADI2;CCNA2;AURKB;INCENP;HDAC1;UHRF1;EHMT2;UBE2N;PARK7;NAA50;TBL1XR1;SGF29;RBM14;BAZ1B;TRERF1;RUVBL2;UFL1;MTA2;PRMT1
gsea,response to UV (GO:0009411),0.4259286653685545,1.7948537339003952,0.0021929824561403508,0.012534865158101045,0.813,18/65,25.32%,NEDD4;PCLAF;AKT1;BAK1;PCNA;AURKB;EIF2S1;SMPD1;USP1;FEN1;NOC2L;POLD1;DCUN1D3;POLH;FMR1;DTL;RUVBL2;ATF4
gsea,DNA synthesis involved in DNA repair (GO:0000731),0.5059376627487538,1.7946822309595645,0.010964912280701754,0.012522985810745946,0.814,20/35,26.53%,PCLAF;RPA2;RPA3;PCNA;RFC2;ISG15;RPA1;UBE2L6;POLA1;RFC5;RFC3;RFC4;POLD2;POLD1;POLD3;POLE;POLH;DTL;PARP10;RFC1
gsea,regulation of translation (GO:0006417),0.4082650092377612,1.7946536075359387,0.0,0.012485152016755778,0.814,52/115,33.13%,GZMB;VIM;GAPDH;RPS27L;HNRNPD;PKP3;CALR;TYMS;YBX1;UPF1;EIF4A3;CYFIP1;GRB7;SYNCRIP;MIF4GD;EIF3B;DHFR;EIF3D;EIF2AK3;EIF3C;MRPL13;CNOT9;NCBP2;DHX9;EIF5B;EIF4H;EIF6;KLHL25;FMR1;EIF4E;LTN1;EIF4G1;MTOR;EIF2AK2;GSPT1;PIWIL2;NANOS1;IMPACT;CAPRIN1;LARP4B;NCL;SHMT2;GLE1;NCBP1;ETF1;HSPB1;METTL14;MTG1;PUM3;LARP1;NEMF;EIF2AK4
gsea,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4599526472981093,1.7945244780615288,0.0018450184501845018,0.012458666637011999,0.814,14/41,17.91%,CCL5;HNRNPF;POLR2C;GALNT3;ZFP36;SHCBP1;CEP57;HNRNPA1;POLR2F;POLR2L;PTBP1;NCBP2;GTF2F1;HNRNPM
gsea,spindle assembly (GO:0051225),0.4946377197991442,1.7937642400575586,0.00684931506849315,0.012502558659843883,0.814,28/46,34.58%,FLNA;TPX2;KIF11;KIFC1;SMC1A;HAUS4;TUBGCP2;NEK2;SMC3;SAC3D1;AAAS;HAUS8;HAUS6;MAP9;KPNB1;STAG1;NEK6;HAUS5;CEP192;CHEK2;HAUS7;TUBGCP5;OFD1;RCC1;HAUS2;TUBGCP3;KIF2A;WRAP73
gsea,T cell receptor signaling pathway (GO:0050852),0.42072418789140503,1.792694985309951,0.0021413276231263384,0.012594088132882045,0.817,33/74,20.94%,THEMIS;PSMA3;PSMB6;PSMB2;PSME2;GRAP2;PSMA4;PSMD14;PSMA5;PSMB5;CTLA4;MALT1;PAG1;TNFRSF21;PSMA6;PSMD1;PSMC1;PSMB7;STOML2;TXK;UBE2N;PLCG2;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;TEC;PSMD3;PSMD2;PSMC4;THEMIS2;PSMD11
gsea,ribosomal large subunit assembly (GO:0000027),-0.6568575931432532,-1.7907528785945914,0.013779527559055118,0.036255109212954315,0.826,7/17,13.06%,RPLP0;RPL10;RPL3;RPL5;RPL23A;MDN1;FASTKD2
gsea,regulation of epithelial to mesenchymal transition (GO:0010717),-0.47189276343613895,-1.788999796048274,0.0,0.036294990495838744,0.828,17/37,27.27%,RGCC;SPRY1;LEF1;TIAM1;BAMBI;SPRY2;AXIN2;OVOL2;CTNNB1;TWIST1;SPRED1;EZH2;DAG1;GATA3;TGFB2;SPRED3;USF3
gsea,regulation of protein localization to nucleus (GO:1900180),0.5268599566997523,1.785575084402736,0.010101010101010102,0.013504292380236718,0.837,9/27,16.40%,AKT1;CDK1;CTNNA1;TFRC;PIN1;PLK1;EIF2AK3;PARK7;GTSE1
gsea,regulation of proteolysis (GO:0030162),0.562902515354803,1.7855150652326288,0.007905138339920948,0.013471426442481692,0.837,7/20,14.79%,SERPINE2;AKT1;BAK1;CAMK2N1;PLK1;PERP;STUB1
gsea,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5513336613765264,1.7852820953363864,0.010309278350515464,0.01346066656929389,0.838,5/20,9.02%,CEBPB;MT3;HSPA5;CREB3L1;ATF6
gsea,fibroblast growth factor receptor signaling pathway (GO:0008543),0.4998062685961428,1.7829749291664816,0.00392156862745098,0.01369027844304828,0.843,12/30,17.91%,HNRNPF;POLR2C;GALNT3;SHCBP1;CEP57;HNRNPA1;POLR2F;POLR2L;PTBP1;NCBP2;GTF2F1;HNRNPM
gsea,positive regulation of cellular catabolic process (GO:0031331),0.4173962488298733,1.7827895955123862,0.0,0.013660785013841123,0.844,24/73,27.29%,ADAM8;SNX9;IFNG;HMGB1;EZR;UPF1;HSP90AA1;PRR5L;ATF6;BNIP3;PLEKHF1;OPTN;FAF1;RDX;SVIP;MTDH;TRIM65;TFEB;ZC3H18;VPS35;ENTPD5;MOV10;UFL1;TRIM21
gsea,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5677981638968583,1.7824233266896228,0.005928853754940711,0.013660421984741631,0.844,4/19,3.45%,CCL5;F2R;OCIAD2;IL10RA
gsea,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.484262935163136,-1.7819775603016426,0.004914004914004914,0.0380623533826145,0.841,12/30,30.87%,RPS27A;SPRY1;BAMBI;SPRY2;PMEPA1;SPRED1;CIDEA;NRROS;EID2;SPRED3;LEMD3;SMAD7
gsea,positive regulation of T cell proliferation (GO:0042102),0.5331118422035221,1.7814118172672107,0.0016313213703099511,0.013764722054847847,0.845,7/30,13.18%,CCL5;CCR2;HMGB1;ANXA1;IL12RB1;TFRC;CD86
gsea,regulation of stem cell differentiation (GO:2000736),0.4801570333155806,1.781369681411838,0.010660980810234541,0.01373167122221539,0.845,26/48,24.33%,PSMA3;PSMB6;PSMB2;PSME2;PSMA4;PSMD14;HNRNPU;PSMA5;PSMB5;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;LMO1;PSMD3;PSMD2;PSMC4;NSUN2;PSMD11;EIF2AK2;HOXB4
gsea,regulation of RNA metabolic process (GO:0051252),0.4983870430536621,1.7799935128472493,0.002036659877800407,0.013878210867801494,0.845,9/28,20.95%,AHNAK;PCBP1;HNRNPF;MBNL3;PTBP1;SNRNP70;METTL4;PCBP4;RRP1B
gsea,positive regulation of protein localization to nucleus (GO:1900182),0.4875631914847873,1.7792143687773159,0.013043478260869565,0.013948770510818045,0.846,13/45,16.40%,IFNG;RAN;FLNA;AKT1;CDK1;TFRC;CCT7;PLK1;EIF2AK3;ECT2;PARK7;CCT8;GTSE1
gsea,negative regulation of peptidase activity (GO:0010466),0.6285214828445248,1.7791754464087273,0.005934718100890208,0.01392974222494218,0.846,4/18,2.61%,SERPINB9;GAPDH;SERPINE2;AKT1
gsea,negative regulation of growth (GO:0045926),0.45416717584062316,1.7789587718414839,0.005244755244755245,0.01392860815816493,0.846,24/55,29.64%,MT3;CDKN2A;CDKN1A;ENO1;OSGIN1;CDKN2C;DCUN1D3;DCBLD2;HSPA1B;RB1;FRZB;HSPA1A;SMARCA4;APBB1;WNT11;EI24;BST2;ENPP1;JADE1;PTPRJ;RBBP7;NME6;ING5;PSRC1
gsea,positive regulation of defense response (GO:0031349),0.45499926115958395,1.7788011465173246,0.007476635514018692,0.013899107863593337,0.847,19/52,31.87%,CCL5;ADAM8;CCL3;IFNG;CCR2;ZBP1;TNFRSF1A;OPTN;MEF2C;POLR3G;DHX9;IL33;RIPK1;TLR4;IL21;POLR3D;OSM;IL1B;TLR2
gsea,regulation of cell-cell adhesion (GO:0022407),0.6065276881862302,1.778687796074372,0.009416195856873822,0.013876849919262236,0.847,8/17,22.85%,ADAM8;FUT7;FLOT2;ZDHHC2;CEACAM1;FUT4;ADA;MINK1
gsea,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4943200942005946,1.7769643547226122,0.015217391304347827,0.014129768680879659,0.854,28/43,31.47%,PSMA3;PSMB6;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;LMO1;PSMD3;PSMD2;PSMC4;PSMD11;EIF2AK2;PSMC6;LMO2;METTL14;OSM;PSME4
gsea,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5222976386223839,1.7763384891723943,0.001579778830963665,0.014191367601136994,0.858,9/31,17.33%,TMSB4X;MAP2K3;HMGB1;ANXA1;AKT1;HMOX1;NUS1;ADAM17;PDGFB
gsea,positive regulation of cytokine production involved in immune response (GO:0002720),-0.5980120249198911,-1.7734093489038316,0.006097560975609756,0.04027256818034425,0.853,6/15,10.52%,XCL1;CD160;KIT;CD226;TNFSF4;F2RL1
gsea,regulation of T cell receptor signaling pathway (GO:0050856),-0.5487651720226128,-1.7731275663818173,0.006160164271047228,0.039886288250590575,0.853,8/20,6.44%,TESPA1;CD160;CD81;SH2D1A;TRAT1;KCNN4;PRNP;CD226
gsea,regulation of stress fiber assembly (GO:0051492),0.4825418892597758,1.7728675360000847,0.0,0.014673356948267172,0.863,8/41,20.53%,ACTG1;PFN1;STMN1;S100A10;RHOC;GPR65;WNT11;ARHGEF5
gsea,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.6015805325581561,1.7728278980526624,0.004746835443037975,0.014635167492866624,0.863,9/19,17.27%,NEDD9;S100A10;FLNA;CALR;ACTN4;P4HB;DOCK5;CORO1C;MYADM
gsea,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.49495487769485175,1.7717697014411682,0.013157894736842105,0.014764537453839882,0.868,25/41,20.94%,EPAS1;PSMA3;PSMB6;HIGD1A;ELOC;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;EGLN1;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4;PSMD11
gsea,regulation of kinase activity (GO:0043549),-0.4772447547992674,-1.7716262229478061,0.002932551319648094,0.03995818768150192,0.857,10/32,16.87%,CD74;NTRK3;EEF1A1;KIT;IRS2;TTN;TSPYL2;PRDX3;NBN;AXL
gsea,protein localization to nucleus (GO:0034504),0.43735964504638836,1.7699126589450462,0.006263048016701462,0.014945323487658237,0.868,31/69,32.32%,RAN;AKT1;CHCHD10;YWHAE;CALR;STAT3;LMNA;HNRNPU;NUTF2;PLK1;MDM2;NUP93;NUP62;HHEX;BANP;RRS1;NUP85;NUP107;HIKESHI;KPNB1;E2F3;RPF2;IPO7;GBP2;NUP133;TAF3;IPO9;NUP88;SYK;NUP155;RANBP6
gsea,regulation of axon extension (GO:0030516),0.5847801710768987,1.7694978981762688,0.0017301038062283738,0.014955224068563736,0.869,5/20,19.13%,MT3;L1CAM;OLFM1;TRIM46;MAP2
gsea,regulation of gene silencing by miRNA (GO:0060964),0.49109442993326197,1.768563985583284,0.008565310492505354,0.01504457851948466,0.869,25/43,32.07%,STAT3;POLR2C;ZFP36;NDC1;AAAS;NUP93;NUP62;RANBP2;POLR2F;POLR2L;NUP85;NUP107;NUP43;DHX9;NUP35;FMR1;NUP160;EIF4G1;NUP37;NUP210;NUP54;NUP133;NUP88;NUP205;NUP155
gsea,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.5295489097025018,-1.768199595447051,0.004962779156327543,0.040761901807398256,0.866,8/23,16.17%,CCR7;P2RX4;TBC1D1;RABGAP1;USP6NL;IFT88;IFT140;TBC1D14
gsea,positive regulation of cellular component biogenesis (GO:0044089),0.44494871719502455,1.7673443526681158,0.0,0.015178246649712923,0.87,23/50,30.50%,PFN1;LGALS3;IFNG;PLEK;BAX;BAK1;RHOC;PIH1D1;TFRC;SYNPO2;DAB2IP;BCL2L11;FLOT1;FAF1;PARK7;SPIDR;BID;CDT1;SLF1;VEGFA;HGS;SYK;BIK
gsea,protein sumoylation (GO:0016925),0.5121312142842916,1.7658653807482159,0.00663716814159292,0.015338669005968381,0.872,21/36,32.07%,SUMO2;SAE1;NDC1;AAAS;NUP93;NUP62;RANGAP1;RANBP2;UBA2;NUP85;NUP107;NUP43;NUP35;NUP160;NUP37;NUP210;NUP54;NUP133;NUP88;NUP205;NUP155
gsea,negative regulation of protein kinase activity (GO:0006469),0.45034199958668614,1.765827148422542,0.004098360655737705,0.015302799001201194,0.872,18/42,25.83%,CDKN1A;PPIA;IFNG;AKT1;CAMK2N1;SFN;DAB2IP;CEACAM1;PARK7;MVP;RB1;DUSP3;CORO1C;DUSP19;TAB1;YWHAG;PRKAG2;PRKRIP1
gsea,positive regulation of smooth muscle cell proliferation (GO:0048661),0.566055747642248,1.765686677974036,0.0028735632183908046,0.015267128274238269,0.872,6/26,9.24%,CCL5;ID2;AKT1;DNMT1;ERN1;HMOX1
gsea,chemical homeostasis (GO:0048878),-0.4952208234720733,-1.764585418750998,0.002531645569620253,0.04157199211251039,0.872,12/26,18.63%,ZBTB20;IRS2;THADA;PNPLA8;WNK1;KLHL3;TLCD1;SLC4A7;DDX3X;ABHD4;ABCB4;ADCK1
gsea,actin filament bundle organization (GO:0061572),0.6093088042543786,1.7579534175726146,0.006220839813374806,0.016400960836662922,0.886,6/19,20.61%,NEDD9;LCP1;EZR;BAIAP2;USH1C;ADD1
gsea,response to interleukin-1 (GO:0070555),0.4964547909180325,1.7561349973021139,0.003257328990228013,0.016651422746818106,0.887,10/39,13.99%,CCL5;CCL4;CCL3;TLE5;ANXA1;GBP3;UPF1;SMPD1;DAB2IP;CACTIN
gsea,regulation of mRNA catabolic process (GO:0061013),0.43555927763106755,1.7553177118640573,0.011013215859030838,0.016764893831322406,0.889,45/75,26.76%,VIM;AKT1;PSMA3;PSMB6;HNRNPD;EXOSC8;PSMB2;PSME2;PKP3;SET;PSMA4;UPF1;PSMD14;PSMA5;PSMB5;MAPKAPK2;PRR5L;ZFP36;SERBP1;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;XPO1;PSMD6;PSMC5;PSME3;PSMD3;EXOSC9;PSMD2;PSMC4;HSPA1A;PCBP4;PSMD11;FMR1;EXOSC3;HSPA8;EIF4G1;EXOSC1;MOV10;EXOSC4;PSMC6;EXOSC2
gsea,regulation of gene silencing by RNA (GO:0060966),0.4997414818673306,1.7550325817390595,0.011363636363636364,0.016720235128306494,0.889,22/38,32.07%,POLR2C;NDC1;AAAS;NUP93;NUP62;RANBP2;POLR2F;POLR2L;NUP85;NUP107;NUP43;NUP35;FMR1;NUP160;EIF4G1;NUP37;NUP210;NUP54;NUP133;NUP88;NUP205;NUP155
gsea,regulation of posttranscriptional gene silencing (GO:0060147),0.4997414818673306,1.7550325817390595,0.011363636363636364,0.016720235128306494,0.889,22/38,32.07%,POLR2C;NDC1;AAAS;NUP93;NUP62;RANBP2;POLR2F;POLR2L;NUP85;NUP107;NUP43;NUP35;FMR1;NUP160;EIF4G1;NUP37;NUP210;NUP54;NUP133;NUP88;NUP205;NUP155
gsea,regulated exocytosis (GO:0045055),0.4494608941282702,1.754588032498628,0.0014749262536873156,0.01674852604391229,0.89,21/70,21.91%,TMSB4X;ALDOA;PLEK;LGALS3BP;MANF;FLNA;TUBA4A;TAGLN2;LYN;MYH9;SYNGR3;ACTN4;FAM3C;PDGFB;SYNGR1;VAMP7;SCCPDH;TOR4A;NHLRC2;ENDOD1;CYB5R1
gsea,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.5541908484771192,-1.7543093232213829,0.019753086419753086,0.04509581808155235,0.891,7/18,17.53%,HIF1A;PDCD4;PER1;ZC3H12A;IL17RA;GBP5;PLD4
gsea,protein deubiquitination (GO:0016579),0.3682415581416234,1.7542168796400648,0.007444168734491315,0.016743129579943287,0.891,60/144,31.47%,ACTB;CCNA2;PSMA3;PSMB6;CDK1;CLSPN;PSMB2;PSME2;PSMA4;USP14;PSMD14;PSMA5;PSMB5;USP1;UCHL5;BARD1;UCHL3;KEAP1;RAD23A;ACTL6A;PSMA6;MDM2;BRCA1;PSMD1;PSMC1;DDX58;PSMB7;COPS5;PSMC2;PSMD12;TRAF2;PSMD6;PSMC5;PSME3;IL33;PSMD3;USP15;ADRB2;PSMD2;PSMC4;USP37;BRCC3;CDC20;PSMD11;ADRM1;RIPK1;STAM2;TAB1;BIRC2;CCP110;NLRP3;SHMT2;TADA3;PSMC6;HGS;HCFC1;INO80E;MINDY1;USP5;PSME4
gsea,DNA geometric change (GO:0032392),0.5755950787557184,1.7536822232863856,0.008421052631578947,0.016751139277705357,0.891,12/21,29.44%,HMGB2;HMGB1;ANXA1;HNRNPA2B1;RAD50;DHX9;PIF1;DNA2;HMGB3;RECQL;RTEL1;BLM
gsea,regulation of canonical Wnt signaling pathway (GO:0060828),0.4049210012716197,1.7530704295575614,0.0,0.016812467888640485,0.891,43/108,24.87%,TLE5;LRRK1;PSMA3;PSMB6;PSMB2;PSME2;CTNND2;PSMA4;PSMD14;PSMA5;PSMB5;HDAC1;CDK14;PIN1;DKKL1;DAB2IP;CCDC88C;PSMA6;PSMD1;PSMC1;HHEX;PSMB7;FRMD8;KREMEN2;PSMC2;PSMD12;ZEB2;PSMD6;PSMC5;PSME3;TBL1XR1;PSMD3;PSMD2;PSMC4;NRARP;FRZB;FZD4;WNT11;PSMD11;SFRP4;CSNK1E;RUVBL2;JADE1
gsea,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.39968480839572795,-1.7518067724308062,0.002967359050445104,0.045359825272522664,0.892,23/69,27.28%,CCR7;XCL1;TNFSF11;CD74;NTRK3;PRKCA;GPR183;NRP1;RAMP3;MFHAS1;CD44;PTPN11;SPRY2;CX3CL1;F2RL1;RASGRP1;FGF2;PRKCZ;CCL25;CCL1;PRKD2;P2RY6;FBXW7
gsea,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4530578483011317,1.751761196187738,0.010917030567685589,0.016900074045403515,0.892,35/53,28.60%,EPAS1;PSMA3;PSMB6;HIGD1A;ELOC;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;EGLN1;HMOX1;DNAJB1;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4;HSPA1A;PSMD11;IMPACT;ATF4;CHEK1;VEGFA;PSMC6;MAPK7;BACH1
gsea,activation of protein kinase B activity (GO:0032148),0.5947279334258916,1.7497064741165187,0.003257328990228013,0.017153066240037634,0.893,8/16,23.51%,MT3;PPIA;AKT1;PRR5;PARK7;PDGFB;MLST8;MTOR
gsea,regulation of osteoclast differentiation (GO:0045670),0.6192927079234345,1.7496941732817695,0.013409961685823755,0.017106955846919254,0.893,5/15,9.95%,CEBPB;CCL3;IFNG;CSF1;CCR1
gsea,protein polyubiquitination (GO:0000209),0.372433370913319,1.7470219592844045,0.0,0.017493311441948683,0.9,58/139,27.29%,NEDD4;PSMA3;UBE2C;PSMB6;PSMB2;UBE2S;PSME2;ANAPC5;PSMA4;PSMD14;TRIM36;PSMA5;PSMB5;BARD1;UBE2L6;FBXO31;PSMA6;MDM2;BRCA1;PSMD1;PSMC1;RNF126;PSMB7;DCAF15;UBE2N;RNF5;PSMC2;RNF168;FZR1;STUB1;UNKL;PSMD12;TRAF2;CDC34;UBE2T;PSMD6;PSMC5;PSME3;CCNF;HERC6;FBXW4;PSMD3;PSMD2;PSMC4;TRAF5;FBXO30;PRPF19;PSMD11;FBXL14;FBXL8;DTL;ZFP91;UBE2E3;BIRC2;KLHL20;PSMC6;TMEM129;TRIM21
gsea,regulation of mitotic spindle organization (GO:0060236),0.5633377575177347,1.746715942856647,0.008733624454148471,0.017499186808030063,0.901,11/21,18.93%,TACC3;TPX2;CLTC;HNRNPU;PLK1;NUP62;GPSM2;HSPA1B;MAP9;DCTN1;HSPA1A
gsea,postreplication repair (GO:0006301),0.49768206457309017,1.7465905078913768,0.017391304347826087,0.017465649442112905,0.901,20/35,26.53%,PCLAF;RPA2;RPA3;PCNA;RFC2;ISG15;RPA1;UBE2L6;RFC5;RFC3;RFC4;POLD2;POLD1;BRCA1;UBE2N;POLD3;POLH;DTL;PARP10;RFC1
gsea,chromatin remodeling at centromere (GO:0031055),0.5508982729921776,1.7461356134747126,0.0196078431372549,0.01750757072943813,0.902,24/28,31.93%,CENPW;HELLS;KNL1;CENPT;CENPV;CENPS;CENPH;CENPA;CENPK;CENPN;MIS18A;HJURP;CENPQ;MIS18BP1;NASP;OIP5;RBBP4;CENPI;CENPM;CENPP;RBBP7;CENPO;SMARCA5;CENPU
gsea,termination of RNA polymerase II transcription (GO:0006369),0.5576967134366746,1.7435882809670753,0.01160092807424594,0.01783327007972938,0.907,14/21,33.76%,SNRPD3;SLBP;SNRPB;SNRPE;NCBP2;CPSF2;MAZ;SNRPF;LSM11;NCBP1;CPSF1;TTF2;CPSF4;CPSF3
gsea,mismatch repair (GO:0006298),0.5494966406662132,1.7435076302709815,0.0043859649122807015,0.017789347853717594,0.907,13/24,30.09%,RPA2;LIG1;RPA3;PCNA;RPA1;POLD2;POLD1;POLD3;EXO1;MLH1;PMS2;RNASEH2A;MSH5
gsea,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.48264755277265453,1.7413570523353616,0.005964214711729622,0.018096349264533292,0.91,11/31,17.82%,RPS27L;BAX;CRIP1;BAK1;TMEM109;E2F1;PHLDA3;SFN;BCL2L11;BRCA1;AEN
gsea,regulation of cellular protein metabolic process (GO:0032268),-0.47362261745191864,-1.740909541587093,0.005263157894736842,0.049159463042615266,0.91,7/33,9.51%,RPL10;NFKBIA;NFKB1;KLF4;ATXN2;SSH1;METAP1
gsea,polyol metabolic process (GO:0019751),-0.5357104516017437,-1.740847842330281,0.018,0.048655410727195675,0.91,9/21,23.86%,INPP4B;ITPKB;SLC5A3;NUDT4;PLD4;PLCG1;PLCB4;PPIP5K2;SYNJ1
gsea,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.42738760620346067,-1.7407236770848498,0.0,0.04817848108163827,0.91,19/46,30.87%,RPS27A;SPRY1;BAMBI;ENG;HIPK2;SPRY2;TGFBR3;PMEPA1;CREBBP;SPRED1;DKK3;CIDEA;TRIM33;HSP90AB1;EID2;SPRED3;MEN1;LEMD3;SMAD7
gsea,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.44431960557743855,1.740067318163722,0.005847953216374269,0.01825275920009574,0.913,28/59,20.97%,LRRK1;PSMA3;PSMB6;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;PIN1;PSMA6;PSMD1;PSMC1;HHEX;PSMB7;PSMC2;PSMD12;ZEB2;PSMD6;PSMC5;PSME3;TBL1XR1;PSMD3;PSMD2;PSMC4;NRARP;PSMD11;SFRP4
gsea,response to unfolded protein (GO:0006986),0.5020664588901247,1.7384540375962778,0.0099601593625498,0.018421268491873338,0.914,19/35,30.11%,BAX;BAK1;HSPA5;HSP90AA1;ERN1;DAB2IP;DNAJB1;OPTN;HSPH1;HSPD1;HSPA1B;HSPA1A;HSPA4;DNAJB4;HSPA8;TM7SF3;HSPB1;HSPA14;BAG3
gsea,positive regulation of interleukin-12 production (GO:0032735),-0.5780093183877818,-1.7358888855537442,0.009174311926605505,0.0493181810655353,0.913,6/17,9.50%,CCR7;LTB;RIPK2;IL16;TNFSF4;IL23A
gsea,regulation of cytoskeleton organization (GO:0051493),0.4634096016368961,1.7346384776212753,0.0015267175572519084,0.018985157953889543,0.92,20/52,26.44%,CORO1A;RHOQ;CAPN2;EZR;DIAPH1;SH3BP1;RHOF;TRIM36;RHOC;HIP1R;BAIAP2;IQGAP2;CLIC4;BICD2;ARHGEF5;BST2;MLST8;MTOR;IQGAP3;CLN3
gsea,positive regulation of neuron death (GO:1901216),0.5287305264765984,1.7344537889625857,0.008818342151675485,0.018958080989338703,0.92,7/28,13.76%,CCL3;IFNG;BAX;EGR1;EIF2S1;ITGAM;PICALM
gsea,protein modification by small protein removal (GO:0070646),0.3639671212487911,1.7326347272569476,0.005154639175257732,0.01917471488708455,0.921,57/152,28.18%,ACTB;CCNA2;PSMA3;PSMB6;CDK1;CLSPN;PSMB2;PSME2;PSMA4;USP14;PSMD14;PSMA5;PSMB5;USP1;UCHL5;BARD1;COPS4;UCHL3;KEAP1;RAD23A;ACTL6A;PSMA6;MDM2;BRCA1;PSMD1;PSMC1;DDX58;PSMB7;COPS5;PSMC2;PSMD12;TRAF2;PSMD6;PSMC5;PSME3;IL33;PSMD3;USP15;ADRB2;PSMD2;PSMC4;USP37;BRCC3;CDC20;PSMD11;ADRM1;RIPK1;STAM2;TAB1;BIRC2;CCP110;NLRP3;COPS3;TADA3;PSMC6;HGS;HCFC1
gsea,modification-dependent protein catabolic process (GO:0019941),0.3869531432683938,1.7324580608078932,0.004728132387706856,0.019156875852242097,0.922,41/99,26.28%,NEDD4;ASB2;UBE2C;ELOC;UBE2S;AURKB;ISG15;ANAPC5;MAD2L1;PSMD14;BUB3;UBE2L6;UHRF1;KEAP1;PLK1;ANAPC15;MDM2;XBP1;RNF130;RNF126;RNF5;PSMC2;RNF168;FZR1;STUB1;CDC34;BUB1B;UBA1;AURKA;FBXW4;PSMD3;CDC20;KLHL25;PSMD11;ADRM1;FBXL14;UBA6;DTL;FBXO45;COPS3;WDR81
gsea,phosphatidylinositol-mediated signaling (GO:0048015),-0.47475934856221136,-1.7294083102626803,0.015345268542199489,0.05149223131782038,0.922,11/30,26.92%,ZFP36L1;CD160;IRS2;PIK3R2;PIK3R1;INPP5F;NF1;PLCB4;PITPNM2;GATA3;PLCH1
gsea,nucleobase-containing compound catabolic process (GO:0034655),0.5388916982202867,1.7291608231966542,0.008130081300813009,0.019671568791918934,0.925,11/23,29.81%,ENTPD1;ISG20;HNRNPD;RNASEH2B;NUDT5;PPP1R8;ENTPD5;NCBP1;RNASEH1;NUDT1;RNASEH2A
gsea,positive regulation of cell migration (GO:0030335),0.40182371488430974,1.7290177770609818,0.00273224043715847,0.019639817998874296,0.925,48/134,30.89%,CCL5;S100A11;ACTG1;PFN1;CCL3;NEDD9;IFNG;CSF1;CCR2;SEMA4A;F2R;PTK2B;HSPA5;FBXO5;STAT3;PRKCE;HRAS;RHOC;ACTN4;GRB7;CCR1;DAB2IP;DOCK5;GLIPR2;XBP1;PLCG2;RDX;ADAM17;GTSE1;MYADM;PDGFB;KIF20B;ARHGEF39;WNT11;FAM110C;VSIR;LAMC2;MTOR;MAZ;VEGFA;CD151;ITGAX;SYNE2;BCAR1;FGR;PDGFA;SEMA7A;IL1B
gsea,branched-chain amino acid metabolic process (GO:0009081),-0.5944377545566932,-1.7289910431865114,0.017509727626459144,0.05054909189156433,0.922,9/15,20.72%,HIBADH;BCKDHA;HIBCH;IVD;BCAT1;MCCC2;ACADSB;MCCC1;ACAD8
gsea,branched-chain amino acid catabolic process (GO:0009083),-0.5944377545566932,-1.7289910431865114,0.017509727626459144,0.05054909189156433,0.922,9/15,20.72%,HIBADH;BCKDHA;HIBCH;IVD;BCAT1;MCCC2;ACADSB;MCCC1;ACAD8
gsea,telomere organization (GO:0032200),0.4885309124427122,1.7259938095681673,0.020964360587002098,0.02011889492180184,0.93,22/35,35.82%,RPA2;TINF2;RPA3;PCNA;PTGES3;RPA1;SP100;POLD2;RAD50;POLD1;RIF1;POLD3;HUS1;DNA2;RTEL1;BLM;CTC1;DCLRE1B;RAD51D;LTO1;ATR;RECQL4
gsea,myeloid leukocyte differentiation (GO:0002573),-0.46840069659010014,-1.725669362630423,0.005012531328320802,0.051087927046703285,0.925,12/39,20.96%,CCR7;TNFSF11;GPR183;FOXP1;LEF1;KIT;CSF2;BATF;F2RL1;FARP2;CBFA2T3;BATF3
gsea,positive regulation of macromolecule metabolic process (GO:0010604),0.3792827856600076,1.7256658457405467,0.0,0.02013677619511348,0.93,57/164,28.41%,ID2;ACTG1;SERPINB9;MT3;CCL3;ANXA2;IFNG;CSF1;AKT1;EGR1;DNMT1;EZR;CAMK2N1;PKP3;STAT3;ADAM19;FUBP1;RAB27A;E2F1;OLFM1;TFRC;EIF2AK3;CTCF;BRCA1;DDX58;MEF2C;PLCG2;TESC;RDX;PARK7;OSR2;HMGN5;HSPA1B;PPHLN1;IL33;PDGFB;HSPA1A;FAM98B;GABPA;WNT11;FMR1;SFRP4;VPS35;SLC11A1;VSIR;RESF1;MTOR;MAZ;MOV10;ATF4;VEGFA;TADA3;MAPK7;TLR4;HGS;HCFC1;ITGAX
gsea,negative regulation of neuron apoptotic process (GO:0043524),0.483212084776677,1.7244655655989458,0.005338078291814947,0.020321810483191524,0.931,11/32,18.29%,ADAM8;MT3;F2R;CX3CR1;PTK2B;SET;MEF2C;CLCF1;PARK7;NONO;KIF14
gsea,carbohydrate derivative biosynthetic process (GO:1901137),0.5841351230629646,1.72391401515997,0.02696629213483146,0.020389441168903087,0.933,10/15,21.03%,TPI1;RRM2;RRM1;TKT;GCNT1;ALG6;ALG8;B4GALT5;ST3GAL4;SCCPDH
gsea,negative regulation of cell growth (GO:0030308),0.43535118169178305,1.7225677085666136,0.0017793594306049821,0.020563468468481727,0.935,25/58,29.64%,MT3;CDKN2A;CDKN1A;ENO1;OSGIN1;CDKN2C;DCUN1D3;DCBLD2;HSPA1B;RB1;TRIM46;FRZB;HSPA1A;MAP2;SMARCA4;APBB1;WNT11;EI24;BST2;ENPP1;JADE1;PTPRJ;RBBP7;NME6;PSRC1
gsea,regulation of p38MAPK cascade (GO:1900744),-0.5271001889268752,-1.722528849723493,0.017582417582417582,0.05179465342653817,0.931,10/23,12.64%,DUSP1;MFHAS1;GADD45B;PER1;NCF1;ZC3H12A;DUSP10;PHLPP1;RASGRP1;PJA2
gsea,ribosomal large subunit biogenesis (GO:0042273),-0.5444852968536275,-1.7223878267159978,0.034026465028355386,0.051327164323743,0.932,14/43,15.19%,RPLP0;RPL10A;RPL10;RPL3;NPM1;RPL7;RPL14;RPL5;WDR12;RPL7A;RPL23A;MDN1;HEATR3;LAS1L
gsea,Rho protein signal transduction (GO:0007266),0.5179307760937942,1.722372491364113,0.006644518272425249,0.020542458845082892,0.935,5/24,18.18%,CFL1;ADGRG1;ARHGDIA;TAX1BP3;RTKN
gsea,regulation of intracellular signal transduction (GO:1902531),0.337225178476433,1.7223354748112611,0.0,0.020496567673634836,0.935,104/234,30.89%,TMSB4X;CHN2;ARHGDIA;RPA2;PRDM1;CCNG1;RHOQ;PREX1;AKT1;PRR5;CDK1;ABR;EZR;LYN;RPA3;RFC2;AURKB;TPX2;RHOF;RACGAP1;FAM83D;PLK3;RASD2;RPA1;DAPK2;RHOC;BARD1;TOPBP1;HDAC1;PIN1;RFC5;RFC3;BRIP1;KMT5A;BCR;TAF15;RFC4;DAB2IP;RAD50;EHMT2;NOC2L;AKAP12;MDM2;OPTN;BRCA1;ARHGAP11A;PRKAR2A;SRGAP3;BANP;PLCG2;CEACAM1;ECT2;RAD9A;ARHGAP10;PAK4;RBBP8;RRS1;TRAF2;CPNE1;ITSN1;FGD3;AURKA;WDR54;TRAF5;RBBP4;PTPMT1;HUS1;ARHGEF5;WWC1;ENTPD5;BRPF1;DNA2;MINK1;MLST8;ARHGAP19;SMYD2;MTOR;PRKAG2;BIRC2;RPF2;ARHGAP21;CHEK2;MYO9B;PIP4K2B;CHEK1;PIDD1;UFL1;VEGFA;EXO1;DEPDC1B;MTA2;RHOT2;RMI2;TAF3;RBBP7;RRAGB;HSPB1;TRIP10;ING5;SSRP1;BLM;TAF2;BOP1;IL1B
gsea,cellular defense response (GO:0006968),0.5299228712522757,1.721988716820158,0.010291595197255575,0.020500758731805208,0.935,8/25,10.79%,PRF1;CCR5;LGALS3BP;KLRG1;CX3CR1;PTK2B;SPN;ADORA2B
gsea,positive regulation of mRNA catabolic process (GO:0061014),-0.5149724212607519,-1.7215441297278196,0.013461538461538462,0.051125097182160524,0.933,8/27,9.91%,ZFP36L1;CELF1;EIF4ENIF1;ZC3H12A;PABPC1;BTG2;TOB1;RIDA
gsea,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.39213165159005536,-1.719775919945598,0.004395604395604396,0.0511948830096,0.933,30/77,34.09%,RPS27A;TNFSF11;NFKBIA;NFKB1;RIPK2;TRAF1;NPM1;IL18R1;AR;NFKBIB;NFKB2;CX3CL1;PRKCB;PRDX3;SLCO3A1;TRIM25;CD40LG;PRKCZ;TERF2IP;PRKD2;TAB3;DHX33;TRIM5;SPHK1;RELA;CLOCK;APP;ARHGEF2;CARD11;TRIM14
gsea,lymphocyte migration (GO:0072676),0.5707490924926669,1.7174724468504785,0.008223684210526315,0.02133780538430158,0.94,6/21,4.42%,CCL5;ADAM8;CCL4;CCL3;TBX21;MYO1G
gsea,regulation of gene expression (GO:0010468),0.32897778898450875,1.7157655980337716,0.0,0.02158475010319649,0.941,168/453,33.59%,HAVCR2;ID2;ACTG1;SERPINB9;CEBPB;MT3;CCL3;IFNG;CSF1;CDK6;TLE5;TBX21;PRDM1;HNRNPAB;AHNAK;PCBP1;AKT1;ZBTB38;PTP4A3;CRIP1;EGR1;HNRNPD;HINT1;ATP2B4;RUNX3;DNMT1;EZR;ARNT2;RBL2;CAMK2N1;LYN;PKP3;GLMN;NAB1;CALR;STAT3;CHD7;ADAM19;YBX1;HNRNPF;FUBP1;HRAS;RAB27A;E2F1;OLFM1;LTF;MIF;HDAC1;CREB3L1;TFRC;PIN1;TIPARP;CREM;ATXN1;NSD2;NFIL3;MBNL3;RBL1;FLOT2;MLF1;CCR1;MYBL2;ANXA7;EIF2AK3;CTCF;BRCA2;SLC7A5;BRCA1;DDX58;CNBP;MEF2C;TXK;PLCG2;TESC;RDX;PICALM;PARK7;CACTIN;HNRNPDL;OSR2;PTBP1;CPNE1;TCF19;YBX3;NONO;TFEB;HMGN5;HSPA1B;LIN54;NUP107;SNRNP70;RB1;METTL4;MYADM;IL33;PDGFB;AURKA;COQ7;NFYB;MYCBP;SNAI3;NR3C1;HSPA1A;FAM98B;SRSF10;APBB1;TARDBP;GABPA;NPAT;WNT11;NUP35;PCBP4;RRP1B;SFRP4;VPS35;ZNHIT3;WWC1;MYBL1;SLC11A1;SAP30;VSIR;ALPK2;HNRNPK;SBNO2;MTOR;PARP10;MSC;NANOS1;MAZ;MOV10;CHEK2;ESRRA;IL10;ATF4;VEGFA;PARP14;TADA3;TRIM21;TLR4;HGS;HCFC1;ITGAX;UTY;UTP4;DIP2A;BACH1;MAFA;SRRT;HIC1;TYROBP;HMG20B;NFYC;PEG3;NAB2;CD36;IL1B;CDH1;GCFC2;TLR2;KHSRP;CDK4;SP1;CPSF4;LARP1;CDK2;FOXP3;UBAP2;PTRH2
gsea,negative regulation of catabolic process (GO:0009895),0.5407996024870725,1.7143980610767102,0.009900990099009901,0.02176861124826409,0.943,10/23,30.89%,FLNA;MAD2L1;PIN1;HMGCR;BANP;TIGAR;HCAR2;AZIN1;PDE3B;IL1B
gsea,calcium ion transport (GO:0006816),0.47370413997454563,1.7135429263659938,0.001594896331738437,0.02181583795029862,0.944,8/41,13.01%,CCL5;CCR5;CCL3;ATP2B4;SLC3A2;ATP2A2;CCR1;TRPC1
gsea,cellular response to organic substance (GO:0071310),-0.41769059974648304,-1.713247587199752,0.0028089887640449437,0.05338401789249142,0.939,20/56,14.44%,CCR7;CPNE3;RACK1;KLF4;IL18R1;LEF1;RAMP3;HTRA2;NFAT5;CXCR4;SIGIRR;PTPN11;STAT5B;RAMP1;CTNNB1;MAPK8;NCOA2;LRRK2;URI1;PTPN13
gsea,regulation of actin filament polymerization (GO:0030833),-0.46658494806643047,-1.7122539224754372,0.0,0.05325980648976954,0.94,11/30,25.86%,CCR7;EVL;SSH2;SSH1;NCK2;PFN2;CDC42EP3;HCK;FCHSD2;PLEKHG2;ARFGEF1
gsea,cellular response to tumor necrosis factor (GO:0071356),0.38856880308264236,1.7115244867216803,0.003883495145631068,0.022142805636077824,0.947,52/104,27.02%,CCL5;TMSB4X;CCL4;CCL3;TNFRSF9;GBP3;AKT1;PSMA3;PSMB6;PSMB2;PSME2;PTK2B;NPNT;PSMA4;PSMD14;PSMA5;PSMB5;EIF5A;ACTN4;ZFP36;TNFRSF1A;DAB2IP;TNFRSF21;PSMA6;BRCA1;PSMD1;PSMC1;PSMB7;EDARADD;CACTIN;PSMC2;PSMD12;TRAF2;SMPD4;YBX3;PSMD6;PSMC5;PSME3;ADAM17;DHX9;PSMD3;PSMD2;PSMC4;TRAF5;PSMD11;RIPK1;BIRC2;STAT1;TNFSF12;PSMC6;TNFSF13B;GBP2
gsea,regulation of interferon-gamma production (GO:0032649),-0.4357436217359963,-1.7109230395393473,0.005025125628140704,0.053250417715081995,0.941,20/46,16.87%,CCR7;XCL1;SLAMF6;CRTAM;IL18R1;ZFPM1;PRNP;PDE4B;CD226;TNFSF4;ZC3H12A;IL23A;F2RL1;RASGRP1;EBI3;TLR7;LGALS7;PDCD1LG2;SCRIB;AXL
gsea,cellular response to cytokine stimulus (GO:0071345),-0.3443850435507333,-1.7107068364851206,0.0,0.0528168953483389,0.941,236/236,99.99%,CCR7;TCF7;XCL1;RPS27A;ITGB1;TNFSF11;ZFP36L1;JUNB;SLA;STAT4;NFKB1;HIF1A;JAK2;IFNAR2;BCL6;RORA;IL18R1;BCL2;LEF1;DUSP1;FOS;HTRA2;SH2B3;KIT;RIPOR2;NFAT5;SOCS5;SOCS3;CXCR4;LRCH1;CSF2;CXCL10;IL16;SOCS1;NFE2L2;ZEB1;STAT5A;BATF;S1PR1;GRB10;PIK3R1;SIGIRR;ZC3H12A;WNK1;LIF;PTPN11;IL6ST;IFNGR2;STAT5B;CX3CL1;IL23A;VCAM1;IL3;EBI3;MAPK8;MAOA;STAT6;MYC;FOXO1;PTPN13;CSF2RA;GBP5;TWIST1;AXL;FGF2;IRF5;ERBIN;SLC12A2;IRF4;CCL25;SDC1;CCL1;HCK;CBL;BCL2L1;STAT2;TIMP1;GATA3;FN1;F3;SOS1;RELA;FOXO3;IL2;SOCS6;PTGS2;TANK;POU2F1;ARHGEF2;CD80;BAG4;PIK3CA;F13A1;MAPK13;PHB;IL13;HYAL2;IRF1;CXCL2;SIRPA;PIK3CB;PF4;TNF;GSK3B;PNPT1;SMAD3;CD40;UBB;CCL17;PTPN23;IRAK3;CCL8;LIFR;DAPK1;CCL22;GSDME;RO60;MMP9;CEBPD;GAS6;USP10;HAX1;NOS2;CCL7;IL13RA1;ACOD1;PIM1;FSCN1;IL22RA2;FLT3;CSF1R;SHMT1;SIRT1;MUC1;CCND1;PIK3CD;OXSR1;ZFP36L2;PID1;AIF1;IL1RN;PTAFR;OSMR;CHUK;CD4;CTSG;CCL2;ICAM1;KHSRP;TLR2;IL1B;CD36;OSM;SYK;PTPN9;INPPL1;RAPGEF1;ITGAX;TLR4;GBP2;TXLNA;VEGFA;ALOX5;RBMX;IFIT1;IL10;STAT1;PTPRJ;SOCS2;CSF2RB;SBNO2;HSPA8;IFITM2;RIPK1;SHC1;PTPN5;CASP3;DHX9;TEC;YBX3;SMPD4;CDC34;TYK2;CACTIN;CLCF1;CD86;XBP1;BRCA1;TNFRSF21;PTPN6;PTPN12;BCL2L11;IL2RA;DAB2IP;CCR1;TNFRSF1A;ITGAM;ZFP36;HMOX1;SYNCRIP;ST3GAL6;LRP8;DOCK8;CASP1;HSP90AA1;HNRNPU;UPF1;PTPN7;NPNT;STAT3;GRAP2;IL12RB2;GBP6;IL12RB1;IL10RA;EGR1;AKT1;GBP4;BIRC5;GBP3;ANXA1;PLP2;STK39;IL1R2;CCR2;GBP7;CSF1;GAPDH;CCL3;CCL4;IRF8;CDKN1A;HSP90B1;VIM;CCR5;CCL5
gsea,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.558469313899795,-1.7104033352072288,0.012875536480686695,0.052446822860062296,0.941,4/17,12.13%,RPS27A;BIRC3;TICAM2;IKBKE
gsea,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.5753057420179077,-1.710110093609316,0.02364066193853428,0.05206332886218015,0.941,4/16,10.52%,XCL1;TNFRSF4;TNFSF4;F2RL1
gsea,regulation of protein binding (GO:0043393),0.41761141214232955,1.7090251437286825,0.0,0.022563281533063844,0.95,23/64,27.29%,ACTB;CDKN1A;TLE5;RAN;BAX;AKT1;AURKB;PIN1;IFIT2;PLK1;IDE;HIP1R;TFIP11;FLOT1;PARK7;PDGFB;AURKA;GTF2F1;ADD1;CSNK1E;IFIT1;TMC8;TRIM21
gsea,monocyte chemotaxis (GO:0002548),0.5862709351589078,1.7084655589986393,0.009708737864077669,0.022614301734858688,0.952,6/19,6.37%,CCL5;CCL4;CCL3;LGALS3;ANXA1;CALCA
gsea,ribosomal small subunit biogenesis (GO:0042274),-0.5766544988630988,-1.7084170303543473,0.016791044776119403,0.05236298364574731,0.941,7/25,8.27%,RPSA;NPM1;RPS25;SRFBP1;RPS6;RPS17;RPS15
gsea,regulation of cell motility (GO:2000145),0.43516933255598844,1.7061224452227675,0.003125,0.023049843547454863,0.956,17/54,19.10%,TMSB4X;CDK6;OSGIN1;SERPINE2;FLNA;AKT1;DIAPH1;ABI3;PLXND1;LMNA;PIN1;DDX58;MEMO1;ADGRG3;CEACAM1;KIF14;SLK
gsea,translesion synthesis (GO:0019985),0.4903824611841418,1.7061002742066815,0.015350877192982455,0.022998881898314002,0.956,19/33,26.53%,PCLAF;RPA2;RPA3;PCNA;RFC2;ISG15;RPA1;UBE2L6;RFC5;RFC3;RFC4;POLD2;POLD1;POLE2;POLD3;POLH;DTL;PARP10;RFC1
gsea,regulation of apoptotic process (GO:0042981),0.3235496782773368,1.7058958537765134,0.0,0.022984636167853567,0.957,141/379,30.64%,CTSD;LGALS1;SERPINB9;HSP90B1;MT3;CFL1;PTMA;PPIA;PRELID1;IKZF3;OSGIN1;ARHGDIA;HMGB1;ANXA1;FLNA;BIRC5;BAX;PREX1;AKT1;TOP2A;GZMA;ASNS;CDK1;HIGD1A;ABR;ANXA4;CD38;BAK1;PTK2B;HSPA5;CALR;MAD2L1;ZBP1;PLK3;SMPD1;NME1;HSP90AA1;CTLA4;MALT1;DAPK2;E2F1;OLFM1;LTF;CASP1;MIF;BARD1;LRP8;RIPK3;ACTN4;HDAC1;ARL6IP1;ANGPTL4;TFRC;PHLDA3;ATF6;IFIT2;FIGNL1;RSL1D1;BNIP3;PA2G4;STIL;DKKL1;DAB2IP;PHLDA1;BCL2L11;PLK1;UNC13B;PTPN6;RNPS1;XBP1;HIP1R;HIP1;NUP62;HSPD1;MEF2C;FAF1;COPS5;DCUN1D3;ECT2;PERP;PARK7;MTDH;ARHGAP10;AIFM2;PPID;TRAF2;ANP32E;API5;HMGN5;FXN;HSPA1B;MYDGF;DDX20;ITSN1;DHCR24;FGD3;CASP3;ANP32B;RTKN;MTCH2;KIF14;BID;FRZB;HSPA1A;SLK;APBB1;TARDBP;SHC1;WNT11;ARHGEF5;RRP1B;SFRP4;RIPK1;WNT10B;TNFSF10;THOC6;ALPK2;HNRNPK;BNIP1;SOCS2;BIRC2;KLHL20;MYO18A;STAT1;GRK5;IL10;ATF4;UTP11;PIDD1;VEGFA;CLN3;EEF1E1;APAF1;TCTN3;HSPB1;KLF11;BCAR1;ING5;DDAH2;BAG3;FADD
gsea,positive regulation of cytokinesis (GO:0032467),0.575827745084783,1.7045368439205288,0.015151515151515152,0.02307125744152526,0.959,12/19,22.93%,AURKB;RACGAP1;PRKCE;CIT;CDC6;KIF23;CENPV;ECT2;KIF20B;CDC14A;KIF14;GIPC1
gsea,positive regulation of cell division (GO:0051781),0.575827745084783,1.7045368439205288,0.015151515151515152,0.02307125744152526,0.959,12/19,22.93%,AURKB;RACGAP1;PRKCE;CIT;CDC6;KIF23;CENPV;ECT2;KIF20B;CDC14A;KIF14;GIPC1
gsea,positive regulation of DNA repair (GO:0045739),0.49121248699320086,1.70404653532311,0.014583333333333334,0.023093135204730157,0.959,14/31,25.92%,HMGB1;PCNA;SMCHD1;BRCA1;UBE2N;FOXM1;RNF168;DHX9;TIGAR;TIMELESS;SPIDR;BRCC3;SLF1;SPIRE2
gsea,positive regulation of neurogenesis (GO:0050769),0.5200234647114365,1.7032617497978262,0.004746835443037975,0.02320216611034224,0.96,6/28,5.46%,IFNG;ARHGDIA;NAP1L1;CX3CR1;PLXND1;METRN
gsea,regulation of cell migration (GO:0030334),0.37183881142005915,1.7003558211909933,0.0,0.023694873906295415,0.965,73/185,34.82%,CCL5;TMSB4X;ACTG1;ARSB;CCL3;NEDD9;CSF1;SEMA4A;OSGIN1;SERPINE2;F2R;ANXA1;FLNA;AKT1;ABI3;PTK2B;PLXND1;HSPA5;STAT3;LMNA;HRAS;RHOC;IFITM1;MIF;ACTN4;GRB7;PRR5L;CCR1;XBP1;DDX58;SRGAP3;ADGRG3;RDX;CEACAM1;CLIC4;ADAM17;GTSE1;DUSP3;RAP2A;CORO1C;MYADM;PDGFB;KIF14;SLK;ARHGEF39;WNT11;FAM110C;BST2;SINHCAF;VSIR;MINK1;LAMC2;MAZ;PTPRJ;VEGFA;CLN3;RAP2C;CD151;ITGAX;SYNE2;BCAR1;FGR;PDGFA;SEMA7A;IL1B;CDH1;TMSB15A;IGSF10;PLAU;DUSP22;KIF2A;SEMA6D;CASS4
gsea,regulation of blood vessel endothelial cell migration (GO:0043535),0.4922202823393108,1.7003165506909328,0.009375,0.023649199455401986,0.965,11/35,17.33%,TMSB4X;MAP2K3;HMGB1;AKT1;ATP2B4;SH3BP1;VASH1;MEF2C;NUS1;ADAM17;PDGFB
gsea,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.5099693706553867,-1.6999624870687926,0.007772020725388601,0.055147934902115545,0.944,11/25,29.59%,JUN;HIF1A;KLF4;FOS;GNL3;FGF2;GATA3;TGFB2;FOSL1;RELA;FOXO3
gsea,RNA-dependent DNA biosynthetic process (GO:0006278),0.5463746238228698,1.6995800574621673,0.01991150442477876,0.02372621617790667,0.967,7/24,10.43%,PPIA;TINF2;PTGES3;HSP90AA1;RPA1;NHP2;RAD50
gsea,cellular response to growth factor stimulus (GO:0071363),-0.3803431718815145,-1.6987486680054185,0.0051813471502590676,0.05514812090103256,0.944,27/73,30.87%,XCL1;ZFP36L1;CPNE3;NTRK3;EEF1A1;RACK1;KLF4;NRP1;HTRA2;NR4A1;CD44;PTPN11;STAT5B;SPRY2;WNT10A;OVOL2;CTNNB1;EGR3;URI1;NDNF;PLCG1;PRKD2;BMP7;FLT1;SPHK1;RELA;SMAD7
gsea,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.503369220880942,-1.6969458080668738,0.007662835249042145,0.05529291167266973,0.945,7/23,16.08%,RGCC;LEF1;TIAM1;BAMBI;AXIN2;CTNNB1;TWIST1
gsea,cellular response to hormone stimulus (GO:0032870),-0.45042224173901935,-1.6963064692009457,0.0047169811320754715,0.055005189187795414,0.945,14/39,13.31%,ZFP36L1;NR4A3;CTSS;RAMP3;CTSL;ATP1A1;AR;TFPI;TRIM24;STAT5B;KLF9;RAMP1;NCOA2;URI1
gsea,regulation of B cell proliferation (GO:0030888),-0.4795285921391471,-1.6959089200450213,0.011961722488038277,0.0547097415615967,0.945,12/31,14.57%,CD74;CD81;GPR183;TNFRSF4;BCL2;IRS2;TNFRSF13C;VAV3;BST1;CD320;TNFRSF13B;AHR
gsea,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5748140690240934,1.6954246877335246,0.02012072434607646,0.0245418570918858,0.973,11/18,32.99%,EXOSC8;LSM2;LSM3;EXOSC9;EXOSC3;EXOSC1;EXOSC4;EXOSC2;PATL1;LSM7;TTC37
gsea,response to estrogen (GO:0043627),0.5453092539863095,1.694333244400368,0.006666666666666667,0.024705524462546827,0.973,3/17,11.48%,SERPINB9;RBBP5;BRCA1
gsea,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.5127888867346526,-1.693810315715348,0.010309278350515464,0.055212802024427854,0.946,11/24,29.59%,JUN;HIF1A;KLF4;FOS;GNL3;FGF2;GATA3;TGFB2;FOSL1;RELA;FOXO3
gsea,positive regulation of developmental process (GO:0051094),0.4069130640914276,1.6920111193370937,0.0016666666666666668,0.025141226003829276,0.977,24/73,29.46%,CEBPB;CFL1;FBXO5;LMNA;LRP8;TFRC;RALA;BNIP3;PA2G4;DAB2IP;XBP1;RIF1;CORO1C;PDGFB;AURKA;B4GALT5;FZD4;CDC20;FMR1;VPS35;LLPH;VEGFA;PAXIP1;ZDHHC6
gsea,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4879370299716287,1.6914445119919572,0.0014970059880239522,0.02519912388817334,0.977,9/36,17.33%,CCL5;NEDD4;F2R;PIK3AP1;LYN;PTPN6;PIK3CG;MYDGF;PDGFB
gsea,regulation of macrophage activation (GO:0043030),-0.5489569437734491,-1.6904639367667051,0.013888888888888888,0.056188830930012236,0.948,5/16,12.64%,CD74;CD200;MFHAS1;ZC3H12A;PJA2
gsea,small GTPase mediated signal transduction (GO:0007264),0.4172612249322489,1.688856577046911,0.0067226890756302525,0.025687625673556543,0.979,17/56,20.90%,CDKN2A;CDKN1A;CCNA2;ABR;DNMT1;GRAP2;HRAS;NRAS;BCR;RALA;CCDC88C;G3BP1;PARK7;RB1;PLD2;SHC1;HACD3
gsea,negative regulation of secretion by cell (GO:1903531),0.6039441737358379,1.6879549820173645,0.007987220447284345,0.025799878842254174,0.979,5/16,10.21%,ANXA1;VAMP8;RHBDF2;TNFRSF1A;HMGCR
gsea,myeloid cell differentiation (GO:0030099),-0.47624772576578056,-1.6878098827564816,0.014251781472684086,0.05676436338522587,0.948,12/26,26.70%,JAK2;ZFPM1;KIT;MFHAS1;CSF2;HIPK2;PRDX3;TET2;KAT8;FLVCR1;IKZF1;HSPA9
gsea,positive regulation of cell motility (GO:2000147),-0.3627514886476022,-1.6867570971426749,0.007633587786259542,0.05680655355788097,0.951,104/104,99.99%,CCR7;ITGB1;MAP4K4;CPNE3;NTRK3;PRKCA;RACK1;MGAT5;CCN1;LEF1;PECAM1;KIT;SEMA4C;TIAM1;ITGA6;SPOCK2;SPRY2;SOD2;SEMA4B;F2RL1;PAK1;PPM1F;TWIST1;HBEGF;ELP3;ATM;FLT1;RET;ADRA2A;F3;ROCK2;SPHK1;CCAR1;CAVIN1;MYO1C;DAB2;VIL1;EDN1;GRN;CARMIL2;SUN2;CXCL16;RUFY3;PLET1;ACVR1;ELP5;CTSH;ELP6;IGF1;MMP9;ADAM9;CCL7;THBS1;COL1A1;SMIM22;CSF1R;MMP14;GPNMB;TJP1;LGR6;PIK3CD;GCNT2;NOTCH1;RIPOR1;AIF1;CASS4;SEMA6D;PLAU;IL1B;SEMA7A;PDGFA;FGR;BCAR1;SYNE2;ITGAX;CD151;VEGFA;MAZ;LAMC2;VSIR;FAM110C;WNT11;ARHGEF39;PDGFB;MYADM;GTSE1;ADAM17;RDX;XBP1;CCR1;GRB7;ACTN4;RHOC;HRAS;STAT3;HSPA5;PTK2B;F2R;SEMA4A;CSF1;NEDD9;CCL3;ACTG1;CCL5
gsea,positive regulation of immunoglobulin production (GO:0002639),-0.5423654658567761,-1.6862142960355817,0.01284796573875803,0.056483605952780465,0.951,5/18,16.26%,XCL1;TNFRSF4;TNFSF4;KMT5B;SHLD1
gsea,mRNA destabilization (GO:0061157),-0.5233049226884374,-1.6850095282652293,0.01893939393939394,0.05646011433889685,0.954,12/22,30.90%,ZFP36L1;ZC3H12D;CELF1;ZC3H12A;RIDA;FTO;RC3H2;ROCK1;CNOT1;ROCK2;PLEKHN1;GIGYF2
gsea,regulation of insulin secretion (GO:0050796),0.4866496088350366,1.6849574076198697,0.0015220700152207,0.02641678714458841,0.98,5/38,13.90%,CCL5;IFNG;SLC2A1;ACSL4;ITPR3
gsea,regulation of epithelial cell migration (GO:0010632),0.49185350336284017,1.6847381334512632,0.00684931506849315,0.02640956313781131,0.98,10/28,17.11%,PFN1;ARSB;IFNG;PRKCE;DAB2IP;DOCK5;GLIPR2;PLCG2;CEACAM1;CORO1C
gsea,positive regulation of transcription by RNA polymerase I (GO:0045943),0.5536788750345766,1.6846084942242192,0.014799154334038054,0.026378987821854546,0.981,11/20,34.73%,PIH1D1;EIF2AK3;LYAR;SMARCA4;MTOR;ATF4;NCL;SMARCB1;UBTF;PWP1;WDR75
gsea,regulation of response to DNA damage stimulus (GO:2001020),0.510332801828349,1.683276275402875,0.017316017316017316,0.02662851994848124,0.982,13/24,26.06%,RPA2;FBXO5;USP1;KMT5A;UBE2N;NSMCE4A;ANKLE1;POLH;FMR1;WDR76;ETAA1;SMYD2;RFWD3
gsea,regulation of protein polymerization (GO:0032271),0.5469990011321126,1.6830414295026166,0.014925373134328358,0.02661211847899638,0.982,2/18,6.50%,PFN1;HSP90AA1
gsea,glucose homeostasis (GO:0042593),-0.46737769839045423,-1.6819822438120748,0.01,0.05724456513520072,0.956,11/29,21.84%,HIF1A;BACE2;RPS6;LRRC8D;PIK3R2;PIK3R1;PDK2;SOX4;FOXO1;KLF7;HK2
gsea,regulation of interleukin-2 production (GO:0032663),0.4923657810617047,1.681795725364252,0.011881188118811881,0.026787360720971553,0.983,12/27,14.97%,HAVCR2;CCR2;TBX21;ANXA1;EZR;GLMN;MALT1;ZFP36;STOML2;PLCG2;CD86;TRAF2
gsea,cellular response to interleukin-1 (GO:0071347),0.41295051634395974,1.6812040312899093,0.0056179775280898875,0.026840159274312703,0.983,32/75,22.25%,CCL5;CCL4;CCL3;IL1R2;GBP3;PSMA3;EGR1;PSMB6;PSMB2;PSME2;PSMA4;UPF1;PSMD14;PSMA5;PSMB5;DAB2IP;PSMA6;PSMD1;PSMC1;PSMB7;UBE2N;CACTIN;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4;PSMD11;TAB1
gsea,regulation of cation channel activity (GO:2001257),-0.4545756043117555,-1.680350457109976,0.006191950464396285,0.05752815210216614,0.958,8/29,16.75%,ITGB1;CTSS;CAMK2D;NEFL;NETO1;FGF13;HOMER1;PRRT1
gsea,ubiquitin-dependent ERAD pathway (GO:0030433),0.44507009278264187,1.6760290270448273,0.012219959266802444,0.02787493375011039,0.986,12/37,30.39%,HSP90B1;HSPA5;EDEM1;DERL2;RNF5;STUB1;FOXRED2;NCCRP1;PSMC6;TMEM129;TMUB1;NPLOC4
gsea,response to reactive oxygen species (GO:0000302),-0.5003165614002343,-1.6759780244890319,0.0163265306122449,0.05916233092836503,0.959,11/24,17.84%,JUN;HIF1A;FOS;PTPRK;NCF1;SOD2;PDK2;MAPK8;PRDX3;GPX1;TXNRD2
gsea,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.4115452773314534,-1.6753637079270818,0.0025974025974025974,0.058957604687322133,0.96,21/47,28.64%,NTRK3;RACK1;RIPK2;RAMP3;PINK1;CD44;LIF;DDIT4;SPRY2;RASSF2;NCK2;PAK1;PFN2;TNKS1BP1;PPM1F;TERF2IP;PRKD2;FNIP1;HSP90AB1;AXIN1;CNKSR3
gsea,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5409521551479125,-1.6743220270677606,0.023060796645702306,0.05894416060193663,0.961,4/18,12.13%,RPS27A;BIRC3;TICAM2;IKBKE
gsea,regulation of protein modification process (GO:0031399),0.4820600685869413,1.6735612475317498,0.006802721088435374,0.028363021446893767,0.987,8/31,17.20%,MT3;IFNG;LYN;PIN1;HPF1;CCDC88C;CORO1C;ABCA2
gsea,negative regulation of cellular catabolic process (GO:0031330),-0.4426190727878448,-1.6729624141303467,0.01405152224824356,0.05917558267071919,0.961,16/35,29.01%,DAPL1;BCL2;TIMP2;PTPN3;CST3;ZKSCAN3;DAP;TBC1D14;ROCK1;TIMP1;TAB3;KDM4A;MFSD2A;TLK2;MET;RASIP1
gsea,actomyosin structure organization (GO:0031032),-0.48411253028113277,-1.671602288648643,0.012371134020618556,0.0592125992356787,0.963,7/27,17.38%,ITGB1;PDLIM1;TTN;CSRP1;SORBS1;EPB41;TNNT1
gsea,regulation of protein-containing complex assembly (GO:0043254),0.4006079066714906,1.6708196863954612,0.005253940455341506,0.02889195927058262,0.987,33/67,30.84%,LGALS3;IFNG;BAX;BAK1;HSPA5;HSP90AA1;RHOC;PIH1D1;TFRC;DAB2IP;BCL2L11;TFIP11;FAF1;SVIP;PARK7;TRAF2;HJURP;RB1;SPIDR;BID;NCLN;AIDA;CDT1;HSPA8;SLF1;EIF2AK2;IMPACT;VEGFA;TMC8;HCFC1;SYK;BIK;CD36
gsea,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.35987384889121155,-1.6698673205987768,0.006329113924050633,0.059495488468561106,0.965,97/97,99.99%,CCR7;XCL1;DUSP4;CD74;NTRK3;PRKCA;GPR183;NRP1;DUSP6;SPRY1;CCN1;RAMP3;MFHAS1;TNIP1;CD44;DUSP10;PTPN11;SPRY2;CX3CL1;F2RL1;TGFBR3;RASGRP1;FGF2;SPRED1;PRKCZ;CCL25;FBLN1;CCL1;PRKD2;P2RY6;SPRED3;FBXW7;FN1;CNKSR3;APP;RPS6KA6;PHB;GPR55;SIRPA;APOE;TNF;GAREM1;CCL17;CCL8;C5AR1;CCL22;APIP;GAS6;FFAR4;HTR2A;CCL7;RAPGEF2;CSF1R;GPNMB;PHB2;NOTCH2;GCNT2;ABCA7;NOTCH1;ARRB1;CD4;CCL2;ICAM1;MTURN;IL1B;CD36;SEMA7A;PDGFA;SPRED2;SYK;TLR4;SCIMP;ARHGEF5;SHC1;PDGFB;DUSP3;CEACAM1;GLIPR2;PTPN6;DAB2IP;CCR1;PIN1;SLAMF1;MIF;HRAS;FAM83D;NPNT;PTK2B;LYN;CAMK2N1;EZR;HMGB1;F2R;CCL3;CCL4;MT3;CCL5
gsea,actin cytoskeleton reorganization (GO:0031532),0.533458671218734,1.6698400027847635,0.004366812227074236,0.029045501290558183,0.987,9/31,11.84%,NEDD9;PLEK;ANXA1;FLNA;SIPA1L1;EZR;MYH9;RALA;GPR65
gsea,supramolecular fiber organization (GO:0097435),0.367642728110691,1.6696475931657822,0.0,0.029012297854457556,0.987,64/149,34.56%,VIM;ALDOA;STMN1;TPM3;CORO1A;MYO1F;TPM4;ELMO2;SH3BP1;ADAMTS14;MYO1G;RHOF;PLK3;CALCA;LTF;RHOC;TUBGCP2;RIPK3;UBE2L6;PIN1;FIGNL1;ERMN;P4HB;CCDC88C;KIF2C;COLGALT1;MDM2;HIP1R;HIP1;KIF18A;CENPJ;CRTAP;CKAP5;MYO5A;FLII;KIF18B;CORO1C;LTBP3;DCTN1;KIF14;KATNB1;SLK;RIPK1;LAMC2;CLIP2;PLOD2;TRIOBP;PLEC;KIF24;TUBGCP5;COL6A3;CD151;TCHH;BCAR1;INPPL1;CD36;CLIP1;PPP1R9B;PLOD3;MYO6;DST;TUBGCP3;P4HA1;KIF2A
gsea,protein localization to chromosome (GO:0034502),0.5142673490453559,1.6685694183611741,0.028761061946902654,0.029250509565371393,0.988,11/22,22.30%,RPA2;TINF2;RPA1;RAD21;PLK1;CENPA;CTCF;MCM8;RB1;HASPIN;SLF1
gsea,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.4490289530894984,1.6678029828860192,0.017467248908296942,0.029382213953667247,0.988,18/46,26.53%,RPA2;ISG20;RPA3;PCNA;RFC2;RPA1;FEN1;RFC5;RFC3;RFC4;POLD2;RAD50;POLD1;ANKLE1;POLD3;DNA2;ENPP1;RFC1
gsea,cellular response to interleukin-6 (GO:0071354),-0.5594162493377902,-1.667470194224098,0.02823529411764706,0.060126435057742775,0.966,5/16,8.61%,NFKB1;JAK2;SOCS3;PTPN11;IL6ST
gsea,regulation of programmed cell death (GO:0043067),0.36494792280790367,1.666585373611139,0.0,0.029592891352002552,0.989,41/101,29.16%,LGALS1;PRELID1;IKZF3;OSGIN1;BIRC5;BAX;AKT1;CALR;NME1;HSP90AA1;MALT1;DAPK2;CASP1;LRP8;RIPK3;ACTN4;RSL1D1;BNIP3;BCL2L11;PTPN6;HIP1;NUP62;PERP;AIFM2;TRAF2;ANP32E;PSMC5;TIGAR;ANP32B;RTKN;BID;SLK;TARDBP;RIPK1;ALPK2;BIRC2;STAT1;PIDD1;TM7SF3;APAF1;BCAR1
gsea,regulation of axonogenesis (GO:0050770),0.5836258903272529,1.665732602159111,0.01386481802426343,0.029723199909507572,0.989,5/15,5.46%,ARHGDIA;SIPA1L1;PLXND1;KIF13B;METRN
gsea,spliceosomal snRNP assembly (GO:0000387),0.5258666653590923,1.6650110629664658,0.010917030567685589,0.02983876373057264,0.989,14/27,29.92%,SNRPD1;LSM2;SNRPD3;SNRPB;SNRPE;DDX20;SRSF10;PRPF19;PRPF3;STRAP;GEMIN2;SNRPF;PRPF8;CLNS1A
gsea,proteolysis involved in cellular protein catabolic process (GO:0051603),0.4423351199891708,1.6649178232491797,0.009708737864077669,0.029790084640665175,0.989,9/39,14.79%,GZMB;GZMA;CAPN2;ISG15;MALT1;IDE;PSMA6;MDM2;STUB1
gsea,regulation of DNA metabolic process (GO:0051052),0.4811794347841982,1.6635211026143428,0.02207505518763797,0.030127444367362644,0.989,12/28,22.36%,SUB1;ALYREF;HNRNPD;KPNA2;UPF1;USP1;NUCKS1;UBE2N;POLH;TICRR;CDT1;PIF1
gsea,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5758174801978789,1.6631458794677816,0.024291497975708502,0.03013452338359332,0.989,11/17,32.99%,EXOSC8;LSM2;LSM3;EXOSC9;EXOSC3;EXOSC1;EXOSC4;EXOSC2;PATL1;LSM7;TTC37
gsea,cellular response to amino acid stimulus (GO:0071230),-0.5437407981695636,-1.6623930423452826,0.017094017094017096,0.06178547760947016,0.968,4/15,16.27%,SESN3;CASTOR1;SESN1;SESN2
gsea,steroid metabolic process (GO:0008202),0.546398475970092,1.6601165778488525,0.0196078431372549,0.03085922658130392,0.992,9/19,23.21%,HSD11B1;MSMO1;FDFT1;HSD17B7;FDX1;DHCR24;LSS;DHRS11;NPC1
gsea,cellular response to virus (GO:0098586),0.5176437016452898,1.6576137598778597,0.019736842105263157,0.031429599066859486,0.992,7/19,20.96%,CCL5;BAX;HSP90AA1;EIF5A;DDX58;RRP1B;FMR1
gsea,ERAD pathway (GO:0036503),0.41991736239487754,1.656232244794783,0.006329113924050633,0.031662509006737054,0.992,16/45,36.37%,HSP90B1;HSPA5;EDEM1;DERL2;GET4;RNF5;STUB1;FOXRED2;NCCRP1;PSMC6;TMEM129;TMUB1;NPLOC4;CCDC47;UGGT1;FBXO44
gsea,negative regulation of phosphorylation (GO:0042326),0.4293407634856115,1.6556816934214265,0.006349206349206349,0.03169110982640929,0.993,18/52,25.83%,CDKN2A;CDKN1A;PPIA;LYN;HNRNPU;CDKN2C;PRR5L;DAB2IP;CDKN2B;PARK7;CACTIN;CORO1C;MYADM;TIGAR;TARDBP;PAQR3;IMPACT;PRKRIP1
gsea,type I interferon signaling pathway (GO:0060337),0.5081198173955426,1.6540339476807888,0.0288659793814433,0.03197243884303115,0.993,15/31,27.02%,IRF8;EGR1;ISG20;ISG15;IFITM3;IFITM1;IFIT2;SP100;TYK2;RNASEL;BST2;IFITM2;STAT1;IFIT1;GBP2
gsea,cellular response to type I interferon (GO:0071357),0.5081198173955426,1.6540339476807888,0.0288659793814433,0.03197243884303115,0.993,15/31,27.02%,IRF8;EGR1;ISG20;ISG15;IFITM3;IFITM1;IFIT2;SP100;TYK2;RNASEL;BST2;IFITM2;STAT1;IFIT1;GBP2
gsea,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5133055470674324,1.653699021745765,0.010830324909747292,0.0319697293539049,0.993,7/21,16.77%,MT3;AKT1;YWHAE;LTF;ARL6IP1;SFN;DHCR24
gsea,inositol phosphate metabolic process (GO:0043647),-0.5035930119260448,-1.6516631625781408,0.023305084745762712,0.06624528710047685,0.975,9/21,23.86%,INPP4B;ITPKB;NUDT4;PLD4;FGF2;PLCG1;PLCB4;PPIP5K2;SYNJ1
gsea,gene expression (GO:0010467),-0.3936944413285221,-1.6515535514228639,0.022727272727272728,0.06577063584232316,0.975,69/203,35.00%,RPLP1;RPS27A;RPL13;RPLP0;RPL10A;RPL8;RPSA;RPS18;RPL41;RPL15;RPL10;RPS8;MRPS6;RPS26;EEF1A1;RPL3;TSPAN32;RPL7;RPS25;RPS2;RPL4;RPL14;RPL5;CELF2;RPS6;TNIP1;RPL7A;RPS17;SMG6;RPS15;RPL31;POLR2A;NFKBIB;FUBP3;RPL23A;PABPC4;ADARB2;FASTKD2;TASP1;POLR2E;YARS2;UPF3B;UPF2;TSPAN5;HBS1L;MRPL37;BAZ2A;APOBEC1;FARSB;LMF1;DHX38;FYTTD1;POM121;NOL9;HNRNPH3;ADAR;BCL3;RBM6;MRPL11;DTX1;POLR2H;TSPAN33;DDX54;THRB;NUP98;THOC5;CASC3;NUP188;AGO2
gsea,DNA repair (GO:0006281),0.35525208201254044,1.6501796682402141,0.007125890736342043,0.03284726362589674,0.993,115/218,38.95%,RPA2;LIG1;CDK1;NABP1;RPA3;PCNA;RFC2;RAD51;FANCF;KPNA2;SMC1A;UPF1;RPA1;USP1;BARD1;FEN1;TOPBP1;POLA1;RFC5;HPF1;RAD21;FAAP100;RFC3;BRIP1;TRIP13;NSD2;RFC4;NUCKS1;RAD23A;RAD51AP1;POLD2;CENPS;RAD50;FAM111A;POLD1;NEIL3;RAD54L;BRCA2;BRCA1;UBE2N;CDCA5;RAD9A;PARK7;POLE2;RNF168;RBBP8;UBE2T;NSMCE4A;WDHD1;FANCD2;POLD3;TIMELESS;EME1;BRCC3;HUS1;POLE;APBB1;POLH;TICRR;FANCG;BAZ1B;FANCI;DNA2;FANCA;FANCL;CSNK1E;RAD51C;RECQL;APEX2;CHEK2;CHEK1;PWWP3A;RFWD3;EXO1;MBD4;TRAIP;PDS5A;MLH1;PMS2;RMI2;FANCM;FANCB;BACH1;TDP2;NUDT1;PPP5C;BLM;RNASEH2A;WRNIP1;XRCC2;RAD18;SMARCA5;PSME4;DDB1;DCLRE1B;RAD51D;MMS19;GTF2H2;LIG4;HINFP;POLK;ATR;DCLRE1A;RAD17;PRIMPOL;RECQL4;MUTYH;FAAP24;XRCC5;WDR48;ERCC8;GTF2H4;PIAS4;ASCC2;ABRAXAS1
gsea,regulation of type I interferon production (GO:0032479),0.4104586470889461,1.6497725313969314,0.008583690987124463,0.032900425805200334,0.993,16/54,19.36%,IRF8;GAPDH;ISG15;ZBP1;CD14;UBE2L6;CGAS;POLA1;PIN1;DDX58;G3BP1;POLR2F;POLR2L;POLR3G;DHX9;POLR3K
gsea,negative regulation of cellular process (GO:0048523),0.3300138401647699,1.647896430875912,0.0,0.03331595837977528,0.993,103/250,37.06%,S100A11;MT3;CDKN2A;CDKN1A;ENO1;CDK6;OSGIN1;ADGRG1;ARHGDIA;F2R;CDKN3;VAMP8;RUNX3;CAMK2N1;ORC6;LYN;GLMN;MYH9;PTK2B;PLXND1;GMNN;FBXO5;TMEM109;KLF10;LMNA;E2F7;NME1;HRAS;JAM2;LPXN;IFITM1;MIF;SPN;CDKN2C;CDC6;ITGA1;DSCAM;BNIP3;SP100;DAB2IP;PTPN6;TNFRSF21;EIF2AK3;CTCF;CDKN2B;NUP62;DCUN1D3;TESC;PARK7;DCBLD2;FOXM1;HSPA1B;RB1;ANP32B;SRSF6;THAP12;FRZB;HSPA1A;RBBP4;SMARCA4;APBB1;WNT11;SFRP4;EI24;VPS35;BST2;MYBL1;SINHCAF;SMYD2;EIF2AK2;PIWIL2;ENPP1;IMPACT;JADE1;PTPRJ;IL10;ALOX5;NOS1;EEF1E1;PDE3B;HGS;RBBP7;NME6;KLF11;ING5;BLM;PSRC1;OSM;IL1B;RAD18;SUZ12;PPP1R9B;TLR2;STRN;FOXP3;SULT2B1;SKI;TAF6;TGFB3;WNT1;SPHK2;CHERP;SRGAP2
gsea,regulation of protein catabolic process (GO:0042176),0.4194754676386402,1.6470499731550619,0.012474012474012475,0.03347199447775132,0.993,22/45,32.70%,NEDD4;FLNA;MAD2L1;FAM83D;BARD1;PIN1;TIPARP;DAB2IP;HMGCR;IDE;ZDHHC2;MDM2;FAF1;BANP;FZR1;AZIN1;DTL;CHEK2;TNFSF12;HGS;HECW2;DDB1
gsea,ncRNA export from nucleus (GO:0097064),0.5072574920505643,1.6465849636955863,0.03044496487119438,0.03353708804782515,0.993,21/31,32.07%,RAN;SSB;NDC1;AAAS;NUP93;NUP62;RANBP2;XPOT;NUP85;NCBP2;NUP107;NUP43;NUP35;NUP160;NUP37;NUP210;NUP54;NUP133;NUP88;NUP205;NUP155
gsea,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5300707346346141,1.6462954992215626,0.024429967426710098,0.03353367407173047,0.993,9/21,24.32%,NEDD9;S100A10;FLNA;CALR;P4HB;DOCK5;MYADM;CAPRIN1;TRIOBP
gsea,nucleic acid-templated transcription (GO:0097659),0.49212104156961967,1.645593533770142,0.01867219917012448,0.033671856550526146,0.993,7/25,14.35%,PTMA;E2F1;POLR2C;MLF1;RNPS1;POLR2F;POLR2L
gsea,regulation of BMP signaling pathway (GO:0030510),-0.4568183967456556,-1.644983689487307,0.010958904109589041,0.06836756470028349,0.977,13/26,33.48%,CCN1;BAMBI;ENG;HIPK2;SMAD1;SMAD5;NUMA1;TRIM33;CRIM1;LEMD3;SMAD7;TWSG1;RBPMS2
gsea,response to amyloid-beta (GO:1904645),-0.4913978806377848,-1.6438700821762826,0.015625,0.06850745052115013,0.978,7/22,20.59%,RAMP3;PRNP;VCAM1;ABCC1;CASP4;CACNA2D1;CACNA1A
gsea,organic substance transport (GO:0071702),0.4157215858262089,1.64380989483234,0.005703422053231939,0.03406208278040104,0.993,19/50,41.52%,HSP90B1;ABCB9;TAP2;MYH9;CENPF;NDC1;ABCA2;HIKESHI;PLTP;RUFY1;KIF3A;SLCO2A1;ARRDC3;SCAMP4;ABCA7;CEP290;SLC19A2;CMTM6;VPS33B
gsea,regulation of protein dephosphorylation (GO:0035304),0.5134898484645394,1.6433385607643236,0.011185682326621925,0.03410903874151763,0.993,7/21,15.03%,HSP90B1;PPIA;SMPD1;CDCA2;PIN1;PPP1R8;PTBP1
gsea,negative regulation of supramolecular fiber organization (GO:1902904),0.4484339253068494,1.642918502574778,0.01556420233463035,0.034139559705258664,0.994,14/34,22.29%,PFN1;STMN1;CORO1A;TPX2;MID1IP1;LDLR;HIP1R;PFDN6;PFDN4;MYADM;KATNB1;MAP2;VBP1;HSPA8
gsea,cellular transition metal ion homeostasis (GO:0046916),0.44937931372129303,1.6427553930172105,0.010526315789473684,0.03410517477105658,0.994,15/36,24.14%,MT3;TMPRSS6;ATP6V0A2;TFRC;HMOX1;SLC39A6;ANKRD9;NUBP1;SLC31A1;FXN;CYB561A3;SLC39A4;TMEM199;SLC11A1;SLC39A14
gsea,positive regulation of protein import into nucleus (GO:0042307),0.5260673396602547,1.6408298907225616,0.02074688796680498,0.03452335242462352,0.994,4/18,13.62%,IFNG;RAN;FLNA;ECT2
gsea,positive regulation of cytoskeleton organization (GO:0051495),-0.418467232176176,-1.6407007507390476,0.008241758241758242,0.06952451828561984,0.978,14/41,21.42%,CCR7;EVL;NTRK3;SYNPO;NRP1;CX3CL1;NCK2;F2RL1;PFN2;ABL1;CDC42EP3;NUMA1;HCK;FCHSD2
gsea,negative regulation of nucleic acid-templated transcription (GO:1903507),0.32932390867488687,1.6400331989507326,0.0018148820326678765,0.03464144148614995,0.994,92/228,46.34%,ID2;MT3;CDKN2A;IFNG;ENO1;TLE5;TBX21;HMGB2;BIRC5;ZBTB38;CD38;NCOR2;TMPRSS6;CENPF;NAB1;GMNN;CALR;SET;KLF10;CBX3;CALCA;E2F1;HDAC1;CREB3L1;ATXN1;KMT5A;RUNX2;NFIL3;PA2G4;DAB2IP;CBX5;MDM2;CTCF;BRCA1;HHEX;FOXM1;SMARCC2;NONO;RB1;PDGFB;SUV39H2;TIMELESS;NR3C1;SMARCA4;SHC1;WNT11;HSPA8;TRERF1;SBNO2;RARA;SUV39H1;RBM15B;ELK3;SFMBT1;SAMD1;EED;KDM8;SIX3;GCFC2;TRIB3;PAX9;FOXP3;SETDB2;HINFP;ZBTB14;WWP1;XRCC5;ZC3H8;NOTCH1;PIAS4;ZBTB16;DMAP1;PHB2;SIRT1;HDAC2;CTBP2;SPI1;PPARG;FOXE1;RBM15;PRMT2;SFPQ;CCAR2;NKRF;BASP1;PRDM5;CIITA;GAS6;KAT7;FOXK2;CBY1;USP47
gsea,cellular response to epidermal growth factor stimulus (GO:0071364),-0.5209588777317258,-1.6392559362348933,0.028925619834710745,0.06953508818579926,0.978,4/17,8.73%,ZFP36L1;EEF1A1;PTPN11;STAT5B
gsea,sodium ion transport (GO:0006814),-0.4926698624870418,-1.6379200954068236,0.019662921348314606,0.06962570194885422,0.978,7/18,19.11%,SLC9B2;ATP1B1;SLC6A6;FGF13;SLC12A2;SLC6A11;SGK1
gsea,cellular response to chemical stress (GO:0062197),0.4045908156798007,1.637893875503668,0.0038535645472061657,0.03513170214647385,0.994,19/60,27.39%,MT3;PPIA;SRXN1;PRDX1;CYCS;GSR;TXNRD1;EIF2S1;PRR5L;KEAP1;PARK7;HSPA1B;HSPA1A;NCF2;SLC25A24;ERMP1;ATF4;PYCR1;CPEB2
gsea,blood vessel morphogenesis (GO:0048514),-0.4923746694380425,-1.6369684351078595,0.011764705882352941,0.06956637255101503,0.978,7/19,18.21%,NRP1;ENG;ITGB8;CUL7;TGFBR3;NF1;ADM
gsea,inflammatory response (GO:0006954),0.4283026500744565,1.6359803799120103,0.0042796005706134095,0.035582376105966255,0.995,23/95,13.36%,CCL5;CCR5;ADAM8;CEBPB;CCL4;CCL3;CCRL2;IFNG;CCR2;F2R;HMGB1;ANXA1;KLRG1;STAT3;GPR68;CD14;MAPKAPK2;FUT7;TNFRSF1A;CCR1;IL2RA;PIK3CG;ABCF1
gsea,negative regulation of cell migration (GO:0030336),-0.3908687952355312,-1.633791558403647,0.012012012012012012,0.07068798030282648,0.98,27/60,32.02%,EVL;CD74;ZMYND8;TRIB1;ENG;PTPRK;SERPINE1;MCTP1;VCL;DUSP10;CX3CL1;FUZ;PFN2;DLC1;RAP2B;NF1;FGF2;MIA3;MITF;DAG1;TIMP1;SCAI;FOXO3;RHOB;ARID2;SMAD7;CLASP1
gsea,positive regulation of Wnt signaling pathway (GO:0030177),0.4026918171041772,1.6337266323832977,0.012048192771084338,0.03608181656519668,0.995,36/67,32.33%,LRRK1;PSMA3;PSMB6;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;PIN1;PSMA6;PSMD1;PSMC1;HHEX;PSMB7;PSMC2;PSMD12;ZEB2;PSMD6;PSMC5;PSME3;TBL1XR1;PSMD3;PSMD2;PSMC4;NRARP;SMARCA4;PSMD11;SFRP4;CSNK1E;DEPDC1B;PSMC6;JUP;PSME4;TLR2;SULF2
gsea,regulation of cell differentiation (GO:0045595),0.39965982217789486,1.6335621238290419,0.0035335689045936395,0.03606764823396156,0.995,18/63,25.76%,ID2;CEBPB;LGALS3;CSF1;CDK6;RUNX3;RUNX2;FLOT2;PA2G4;PTBP1;ANP32B;NSUN2;SINHCAF;YWHAG;EIF2AK2;BIRC2;ATF4;ALOX5
gsea,activation of protein kinase activity (GO:0032147),0.41181397035933875,1.6324113540037128,0.011111111111111112,0.03630339607876582,0.995,25/54,25.94%,MT3;PPIA;AKT1;PRR5;CLSPN;PTK2B;TPX2;CALCA;MALT1;RIPK3;PRKAR2A;CD86;ECT2;PARK7;PAK4;TRAF2;PDGFB;ADRB2;KIF14;SLC11A1;MINK1;ZFP91;MLST8;MTOR;VEGFA
gsea,cellular response to chemokine (GO:1990869),0.4963516140927991,1.631288398135495,0.01818181818181818,0.036583216922091745,0.996,8/31,9.95%,CCL5;CCL4;CCL3;CCR2;STK39;PTK2B;DOCK8;CCR1
gsea,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.49286046128587524,1.6307874184408986,0.035794183445190156,0.036660692692558575,0.996,11/29,17.53%,RPA2;RPA3;PCNA;RFC2;RPA1;RFC5;RFC3;RFC4;POLD2;POLD1;POLD3
gsea,positive regulation of cellular protein metabolic process (GO:0032270),0.4224181350231711,1.6289446024251237,0.013565891472868217,0.03701249161275838,0.996,24/56,24.45%,VIM;CSF1;RPS27L;AKT1;HNRNPD;EZR;BAK1;HSP90AA1;EIF4A3;UHRF1;PLK1;EIF3D;EIF3C;FAF1;RDX;PERP;STUB1;EIF6;FMR1;VPS35;EIF4G1;MTOR;PIWIL2;LARP4B
gsea,cellular protein localization (GO:0034613),-0.33279871575497016,-1.6284479422976934,0.0,0.0730065028041286,0.982,55/131,34.69%,TBC1D4;CD74;PACSIN1;ARL5C;NPM1;AP3B1;ARL4D;PTPRK;NAPB;STX11;VCL;TBC1D1;TBC1D30;DNAJC27;SNX13;GRTP1;AXIN2;TICAM2;CTNNB1;NSF;RAB6B;LRRK2;RABGAP1;AHI1;UNC93B1;USP6NL;TBC1D14;ADPRH;PRRT1;ARMCX3;SH3PXD2B;COG3;BBS4;SGSM2;SCG5;AP4M1;GGA2;WLS;REEP1;CPE;RPGR;STX16;SGSM3;FBLN5;RAB23;SNX27;RAB38;HERC2;TM9SF4;TBC1D5;CEP68;CD63;ARHGEF2;COG7;CTTN
gsea,positive regulation of MAPK cascade (GO:0043410),-0.33918329985955054,-1.6281813122397937,0.0035460992907801418,0.07261764866327422,0.982,110/110,99.99%,CCR7;XCL1;TNFSF11;CD74;NTRK3;PRKCA;GPR183;NRP1;RAMP3;KIT;SEMA4C;PIK3R6;MFHAS1;CD44;LIF;PTPN11;SPRY2;CX3CL1;F2RL1;RASGRP1;LRRK2;MID1;TAOK1;FGF2;PRKCZ;CCL25;CCL1;JCAD;PRKD2;EZH2;ROCK1;KSR1;P2RY6;FLT1;TGFB2;DHX33;RET;FBXW7;TRIM5;ADRA2A;ROCK2;PIK3R5;APP;EDN1;PHB;GPR55;APOE;TNF;CD40;GAREM1;CCL17;CCL8;C5AR1;CCL22;TAOK2;GSDME;IGF1;GAS6;FFAR4;HTR2A;CCL7;RAPGEF2;BCAR3;FLT3;CSF1R;GPNMB;PHB2;NOTCH2;GCNT2;ABCA7;NOTCH1;ARRB1;CD4;CCL2;ICAM1;MTURN;CD36;SEMA7A;PDGFA;OSM;CAV2;VEGFA;PTPRJ;EIF2AK2;TMEM106A;SCIMP;WWC1;SHC1;ADRB2;DUSP19;PDGFB;MYDGF;PLCG2;PIK3CG;GLIPR2;RYK;DAB2IP;CCR1;SLAMF1;MIF;HRAS;NPNT;PTK2B;HMGB1;F2R;CCL3;CCL4;MT3;ADAM8;CCL5
gsea,protein polymerization (GO:0051258),0.5007448451977847,1.6269691426130783,0.01680672268907563,0.03754725243331959,0.996,9/24,13.07%,PREX1;UBE2C;DIAPH1;UBE2S;DIAPH3;MID1IP1;PIN1;CENPJ;CKAP5
gsea,positive regulation of interleukin-1 production (GO:0032732),0.5290398106602614,1.6266873153078505,0.017045454545454544,0.03756169008047461,0.996,7/21,7.23%,CCL3;IFNG;HMGB1;EGR1;STAT3;MALT1;CASP1
gsea,receptor metabolic process (GO:0043112),-0.4649576091324496,-1.626405844708479,0.016867469879518072,0.07298178404325874,0.982,9/28,20.14%,ITGB1;CD81;CD9;EHD3;RAMP3;RAMP1;GRK2;ADM;PIK3R4
gsea,embryonic limb morphogenesis (GO:0030326),-0.5159805120292916,-1.6261619478020708,0.014634146341463415,0.07260377915148261,0.982,5/16,16.08%,AFF3;PTCH1;CTNNB1;CREBBP;TWIST1
gsea,extracellular matrix disassembly (GO:0022617),0.5351381907713577,1.6260249536926494,0.00794912559618442,0.03768365126546314,0.996,7/22,12.26%,ADAM8;LCP1;LAMC1;CAPN2;TMPRSS6;CAPG;FLOT1
gsea,CENP-A containing nucleosome assembly (GO:0034080),0.5224315525074709,1.624176055980036,0.04054054054054054,0.03810369614266889,0.996,22/26,31.93%,CENPW;KNL1;CENPT;CENPS;CENPH;CENPA;CENPK;CENPN;MIS18A;HJURP;CENPQ;MIS18BP1;NASP;OIP5;RBBP4;CENPI;CENPM;CENPP;RBBP7;CENPO;SMARCA5;CENPU
gsea,CENP-A containing chromatin organization (GO:0061641),0.5224315525074709,1.624176055980036,0.04054054054054054,0.03810369614266889,0.996,22/26,31.93%,CENPW;KNL1;CENPT;CENPS;CENPH;CENPA;CENPK;CENPN;MIS18A;HJURP;CENPQ;MIS18BP1;NASP;OIP5;RBBP4;CENPI;CENPM;CENPP;RBBP7;CENPO;SMARCA5;CENPU
gsea,ncRNA catabolic process (GO:0034661),0.5131496101255104,1.6240362886038544,0.028513238289205704,0.03808815169359935,0.996,13/19,42.70%,EXOSC8;EXOSC9;EXOSC3;POP1;EXOSC4;EXOSC2;DIS3L;MTREX;SND1;EXOSC10;ZCCHC8;EXOSC5;DIS3
gsea,positive regulation of intracellular signal transduction (GO:1902533),0.3352646639623058,1.6228359649272028,0.0,0.038343263963799674,0.996,86/233,32.68%,S100A4;CCL5;LGALS1;ADAM8;CCL4;CCL3;LITAF;NEDD4;GAPDH;F2R;HMGB1;FLNA;PIK3AP1;BAX;PTP4A3;CX3CR1;LYN;RASD2;HRAS;HSP90AA1;AREG;MALT1;CD14;LTF;RHOC;CASP1;MIF;ACTN4;SLC20A1;CGAS;TFRC;HMOX1;TNFRSF1A;DAB2IP;BCL2L11;PTPN6;RYK;HIP1;NUP62;UBE2N;PIK3CG;PLCG2;CD86;ECT2;PARK7;MTDH;TRAF2;CPNE1;MYDGF;PDGFB;DUSP19;USP15;ADRB2;BID;TRAF5;SHC1;WNT11;FAM110C;NEK6;WWC1;RIPK1;BST2;TMEM106A;TNFSF10;MLST8;HPSE;EIF2AK2;BIRC2;MAZ;PTPRJ;VEGFA;THEM4;TRIM21;TLR4;RRAGB;CAV2;PPP5C;FGR;OSM;FADD;TMEM101;PDGFA;IL1B;TLR2;TRIB3;STRN
gsea,regulation of cellular protein localization (GO:1903827),0.47588488266760737,1.6227253539102138,0.008016032064128256,0.038285738128064795,0.996,9/27,24.15%,LCP1;HSP90AA1;PIN1;ABCA2;TRIM46;SPIDR;MAP2;KCNAB2;CSNK1E
gsea,MAPK cascade (GO:0000165),0.34256164848005993,1.6224038972345123,0.0,0.03831913535406899,0.996,62/142,39.05%,CCL5;CCR5;MT3;DUSP5;CCL3;PSMA3;PSMB6;CDK1;PSMB2;YWHAE;PSME2;PTPN7;PSMA4;PSMD14;HRAS;PSMA5;PSMB5;AREG;NRAS;MAPKAPK2;ZFP36;DAB2IP;IL2RA;PSMA6;PSMD1;PSMC1;PSMB7;MEF2C;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;RASAL2;PDGFB;PSMD3;PSMD2;PSMC4;SHC1;NCAM1;PSMD11;CAMKK2;MINK1;CSF2RB;PAQR3;PSMC6;DLG2;PPP5C;PDGFA;IL1B;PSME4;ICMT;CCL2;CHUK;GFRA2;ACTN2;RALGDS;MRAS;SPTA1;ZFP36L2;MAP3K7;SHOC2
gsea,regulation of interleukin-8 production (GO:0032677),0.4683416081053292,1.6210854840089421,0.01639344262295082,0.03865488854074346,0.996,19/36,31.87%,TMSB4X;F2R;HMGB1;ANXA1;ANXA4;STAT3;CD14;DDX58;PARK7;CACTIN;HSPA1B;HSPA1A;RIPK1;IL10;TLR4;SYK;FADD;IL1B;TLR2
gsea,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3917936333797355,1.6204382544395206,0.007326007326007326,0.038759612343810514,0.996,37/70,43.17%,HAVCR2;TMSB4X;ID2;CDKN2A;FLNA;ANXA4;KEAP1;EGLN1;SP100;DAB2IP;EOMES;ADGRG3;CACTIN;RB1;SFRP4;PARP10;NLRP3;UFL1;TRIM21;PAXIP1;TAF3;FOXP3;EIF2AK4;LRRC14;MTURN;CHUK;ARRB1;PHB2;SIRT1;HDAC2;NUPR1;SPI1;NLRC3;TAF1;PRMT2;PIM1;ACOD1
gsea,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5387692448917569,1.6200395740580766,0.02529182879377432,0.03879438321574257,0.996,2/17,3.43%,SUB1;MED30
gsea,regulation of postsynapse organization (GO:0099175),0.5663651224277476,1.619151082770664,0.016891891891891893,0.03897802515197112,0.996,3/15,4.25%,CFL1;SIPA1L1;ABI3
gsea,positive regulation of cellular biosynthetic process (GO:0031328),0.3798574810530557,1.6187324238176686,0.005110732538330494,0.03902501558366223,0.996,42/95,32.70%,CCL5;VIM;IFNG;RPS27L;AKT1;EGR1;HNRNPD;PCNA;HSP90AA1;EIF4A3;MID1IP1;LDLR;STARD4;EIF3D;EIF3C;FAF1;ATAD5;PAOX;PARK7;ZEB2;LPGAT1;DHX9;PDGFB;EIF6;SLC27A1;FMR1;CDT1;DNA2;GIPC1;MTOR;PIWIL2;LARP4B;PRMT1;TLR4;DDAH2;ABCB10;METTL14;CD36;IL1B;SP1;CTC1;DDB1
gsea,embryonic heart tube morphogenesis (GO:0003143),0.5415279421674237,1.618147262519053,0.014732965009208104,0.03909483769302918,0.996,5/16,12.56%,TBX21;MICAL2;STIL;EOMES;MEF2C
gsea,positive regulation of response to external stimulus (GO:0032103),0.40977896606651787,1.6180844315284868,0.015202702702702704,0.03903415410689882,0.996,21/66,31.87%,CCL5;ADAM8;CCL3;IFNG;CCR2;ZBP1;TNFRSF1A;OPTN;POLR3G;DHX9;IL33;PDGFB;USP15;RIPK1;SCIMP;TLR4;IL21;POLR3D;OSM;IL1B;TLR2
gsea,plasma membrane bounded cell projection assembly (GO:0120031),-0.34108012075787764,-1.6178665512206236,0.004728132387706856,0.07642323502705343,0.986,49/119,31.87%,ITGB1;MAP4K4;ASAP1;CCDC28B;NRP1;EHD3;IFT80;CD2AP;KIT;RILPL2;RAB3IP;VCL;S1PR1;PDE6D;DYNC2H1;NEK1;FUZ;KIF3B;CPLANE1;RAP2B;AHI1;B9D1;IFT81;IFT88;MTSS1;IFT140;CCDC88A;ABLIM2;SSX2IP;GSN;IFT74;TMEM216;CEP41;BBS4;TNIK;LZTFL1;CLUAP1;PTPDC1;EXOC2;RPGR;RAB23;ARL13B;KIF27;PIBF1;SPATA13;IQCB1;POC1B;FNBP1L;CEP162
gsea,"nucleotide-excision repair, DNA incision (GO:0033683)",0.48862161014046984,1.6171446269339378,0.03225806451612903,0.039243806429222504,0.997,11/30,17.53%,RPA2;RPA3;PCNA;RFC2;RPA1;RFC5;RFC3;RFC4;POLD2;POLD1;POLD3
gsea,inorganic cation transmembrane transport (GO:0098662),-0.3587616316531074,-1.6170256338979434,0.0,0.076313914818498,0.986,30/71,35.89%,ORAI1;P2RX4;TRPM1;ATP2A3;KCNN4;MCOLN2;ATP1A1;KCNK10;ATP1B1;SLC6A6;SLC41A1;SLC9A9;HVCN1;TRPA1;SLC12A2;SLC6A11;CACNA1A;CACNA2D4;KCNC1;SLC39A1;SLC6A12;SLC39A13;SLC6A9;KCNQ3;KCNG2;DMAC2L;SCN4B;ATP1A3;SLC12A3;SLC39A11
gsea,"RNA splicing, via transesterification reactions (GO:0000375)",0.5442767856978298,1.6168830040890294,0.03036876355748373,0.03922629177995108,0.997,15/18,40.99%,SRSF10;SRRM1;PRPF3;GEMIN2;SF3B4;PRPF8;SNRNP40;KHSRP;DBR1;PRPF4;TXNL4A;SRSF4;SCAF11;SF3A3;PRPF6
gsea,regulation of double-strand break repair (GO:2000779),0.4804829645302837,1.615573623448192,0.028985507246376812,0.03955140660837147,0.997,13/28,28.27%,RPA2;ACTR2;DEK;RAD51;FIGNL1;RAD51AP1;FOXM1;TIMELESS;SPIDR;SLF1;CHEK1;SPIRE2;RTEL1
gsea,protein localization to organelle (GO:0033365),0.39323033693699866,1.6152114399330635,0.008016032064128256,0.039604233834085775,0.997,26/61,24.11%,RPA2;SNX10;YWHAE;ISG15;CALR;LMNA;YBX1;PACSIN2;RPA1;GET4;HMOX1;SSB;MDM2;OPTN;HHEX;BANP;ARL1;CEP250;DHX9;MTCH2;BICD2;VPS35;CNTLN;ALDH3A2;GCC2;PAQR3
gsea,cellular response to oxygen-containing compound (GO:1901701),0.3780486108075857,1.6150249864505908,0.002789400278940028,0.03959872218230782,0.997,51/137,35.51%,ACTB;CCR5;VIM;HSP90B1;MT3;HMGB2;HMGB1;AKT1;EGR1;CX3CR1;CAPN2;ATP2B4;EZR;LYN;PTK2B;UPF1;CD14;CASP1;ZFP36;DAB2IP;XBP1;MEF2C;CD86;TESC;CACTIN;PDGFB;FZD4;WNT11;CAMKK2;WNT10B;INSIG1;SBNO2;MTOR;IMPACT;RUVBL2;NLRP3;PDXP;IL10;TLR4;RRAGB;RAPGEF1;IL1B;TLR2;CD274;CDK2;CCL2;CTSG;CHUK;FES;IPO5;CIB2
gsea,positive regulation of kinase activity (GO:0033674),-0.39990629508741304,-1.6141448690604943,0.018518518518518517,0.07725326885153869,0.986,19/41,35.56%,CCR7;CD74;NTRK3;CCN1;KIT;RASSF2;TRAF4;XRCC6;LCP2;NBN;AXL;MMD;FLT1;RET;MET;EPHA3;MRNIP;LMO4;DAXX
gsea,cellular component disassembly (GO:0022411),0.5229102195847443,1.614082156284903,0.011326860841423949,0.03976724159603286,0.997,9/23,20.42%,ADAM8;LCP1;LAMC1;CAPN2;TMPRSS6;CAPG;FLOT1;DYRK3;EXOC8
gsea,positive regulation of p38MAPK cascade (GO:1900745),-0.5376015577917719,-1.6131510892045662,0.04128440366972477,0.07715960473955369,0.986,5/16,12.64%,MFHAS1;GADD45B;NCF1;ZC3H12A;PJA2
gsea,cellular response to light stimulus (GO:0071482),0.44892516361594914,1.6123325403370758,0.023679417122040074,0.040201842477618016,0.997,15/36,36.46%,NEDD4;BAK1;PCNA;AURKB;EIF2S1;SMPD1;NOC2L;POLD1;FMR1;RUVBL2;ATF4;EIF2AK4;POLK;ATR;CDC25A
gsea,negative regulation of cell motility (GO:2000146),-0.4004543881954326,-1.6120173125719741,0.012853470437017995,0.07715617338022236,0.986,24/48,30.87%,CD74;ZMYND8;ENG;PTPRK;SERPINE1;MCTP1;VCL;DUSP10;CX3CL1;FUZ;DLC1;RAP2B;NF1;FBLN1;MIA3;CCDC125;MITF;DAG1;GATA3;SCAI;FOXO3;RHOB;ARID2;SMAD7
gsea,ribonucleoprotein complex biogenesis (GO:0022613),-0.49798849150783564,-1.6113027001689542,0.04734848484848485,0.07697121841177225,0.986,10/40,12.71%,NPM1;RPL7;RPS25;RPL14;RPL5;RPS6;WDR12;RPS17;RPS15;HEATR3
gsea,"regulation of gene expression, epigenetic (GO:0040029)",0.40905578398951364,1.6112795509578313,0.013729977116704805,0.040451324965296694,0.997,17/52,36.49%,ACTB;DNMT1;GLMN;DEK;CTCF;POLR2F;POLR2L;PPHLN1;RBBP4;BAZ1B;EED;RBBP7;SMARCA5;SUZ12;TAF1A;SPHK2;TBP
gsea,regulation of anatomical structure morphogenesis (GO:0022603),0.411251590736654,1.6112290786017331,0.007961783439490446,0.04037896518856309,0.997,14/59,16.86%,CFL1;NEDD4;SIPA1L1;ABI3;PLXND1;KIF13B;LZTS1;EGLN1;HMOX1;SP100;VASH1;MEF2C;CEACAM1;RAP2A
gsea,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.5281987178912294,-1.6088828629120022,0.03571428571428571,0.07768070917482,0.987,8/18,20.56%,RORA;TNFAIP3;TNIP1;PER1;ZC3H12A;TRIM59;TNIP3;OTUD7B
gsea,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.36970251903956797,1.6081146998109914,0.01440329218106996,0.04128493094158073,0.997,30/76,30.67%,S100A4;LGALS1;LITAF;GAPDH;F2R;FLNA;MALT1;LTF;RHOC;CASP1;SLC20A1;TFRC;HMOX1;TNFRSF1A;NUP62;UBE2N;ECT2;MTDH;TRAF2;TRAF5;NEK6;RIPK1;BST2;TMEM106A;TNFSF10;BIRC2;TRIM21;PPP5C;FADD;TMEM101
gsea,regulation of stress-activated MAPK cascade (GO:0032872),-0.4888864259579571,-1.6060118252362903,0.018329938900203666,0.078617821168033,0.988,12/22,17.25%,MAP4K4;FAS;SEMA4C;PER1;PHLPP1;F2RL1;TGFBR3;RASGRP1;MID1;MYC;FOXO1;TAOK1
gsea,cytoskeleton organization (GO:0007010),0.405804540839945,1.6034095807548443,0.007739938080495356,0.04269147100543672,0.998,16/60,19.43%,CFL1;CCL3;NEDD9;DIAPH1;RHOF;PACSIN2;RHOC;DIAPH3;MICAL2;SPRYD3;ARHGAP10;PAK4;DPYSL2;PLD2;FGD3;FMNL3
gsea,negative regulation of signal transduction (GO:0009968),0.3756637163768313,1.6028917230013493,0.001443001443001443,0.042784419733368495,0.998,39/108,34.65%,CCL5;NEDD4;PLEK;SMPDL3B;RGS2;AKT1;CX3CR1;LYN;CALR;SMPD1;PTPRE;LTF;SLAMF1;CREB3L1;GRB7;DAB2IP;PTPN12;HHEX;TAX1BP3;CACTIN;RB1;NXN;NRARP;FRZB;SFRP4;ENPP1;CHAC1;MAZ;PTPRJ;IL10;PIP4K2B;HGS;HMGXB4;HIC1;IL1B;SULF2;LRRC14;NR4A2;ARRB1
gsea,regulation of protein import into nucleus (GO:0042306),0.5049008396152683,1.6024310459313447,0.019230769230769232,0.04287450671159695,0.998,8/20,35.28%,IFNG;RAN;FLNA;ECT2;JUP;BAG3;CDH1;IPO5
gsea,positive regulation of protein import (GO:1904591),0.505696066114899,1.600028875270421,0.020366598778004074,0.04353242221052963,0.998,9/19,35.28%,IFNG;RAN;FLNA;ECT2;ARHGEF5;JUP;BAG3;CDH1;IPO5
gsea,neuron migration (GO:0001764),-0.4989166119194556,-1.5987885606210368,0.03524229074889868,0.08193218340767387,0.992,10/18,19.69%,NRP1;SH3RF1;CEP85L;DDIT4;TUBB2B;FGF13;TUBB2A;NDNF;USP9X;ELP3
gsea,telomere maintenance via telomere lengthening (GO:0010833),0.4880603021632778,1.5978646851756066,0.045454545454545456,0.044105975744959475,0.998,15/27,32.96%,TINF2;RAD51;PTGES3;HSP90AA1;RPA1;NHP2;RAD50;PIF1;RFC1;PPP6R3;RTEL1;CTC1;DCLRE1B;CDK2;WRAP53
gsea,fat cell differentiation (GO:0045444),-0.46657799674066314,-1.5974596398349599,0.02694610778443114,0.082069001514677,0.993,10/27,25.50%,NR4A3;KLF4;SDF4;NR4A1;FOXO1;CLIP3;TMEM120B;BBS4;EGR2;MAFB
gsea,regulation of cell population proliferation (GO:0042127),0.3189237505029384,1.5969841682688368,0.0,0.04431642741278116,0.998,152/339,42.02%,S100A11;ID2;HILPDA;CDKN2A;CDKN1A;TNFRSF9;IFNG;CSF1;CDK6;OSGIN1;ADGRG1;HMGB2;F2R;PRC1;BIRC5;CDKN3;AKT1;NAP1L1;CAMK2N1;LYN;IL12RB2;GLMN;PTK2B;FBXO5;CALR;STAT3;KLF10;LMNA;COX17;TIPIN;E2F7;NME1;HRAS;AREG;DERL2;SLC25A5;IFITM1;HDAC1;SAPCD2;CDKN2C;SLAMF1;UHRF1;TFRC;CDC6;ITGA1;JUND;SQLE;DAB2IP;SHCBP1;PTPN6;TTK;MDM2;CTCF;XBP1;CDKN2B;NUP62;CNBP;HHEX;RNF126;CD86;TESC;CLCF1;FOXM1;OSR2;HMGN5;FXN;HSPA1B;ADAM17;CDC7;JAG2;PDGFB;DNAJA2;TIMELESS;KIF20B;MATK;CDC123;KIF14;THAP12;FRZB;NCCRP1;HSPA1A;RBBP4;FAM98B;SHC1;SFRP4;DHPS;ESM1;SINHCAF;LAMC2;SMYD2;EIF2AK2;RARA;BIRC2;MAZ;PTPRJ;STAT1;GRK5;IL10;UFL1;VEGFA;S1PR2;CDCA7L;TCIRG1;EEF1E1;PRMT1;HGS;ITGAX;TSPAN31;RPRD1B;KLF11;ING5;JUP;SIX3;IL21;OSM;PDGFA;IL1B;CDCA7;PPP1R9B;CDK4;STRN;TBRG4;CDK2;FOXP3;SULT2B1;DUSP22;SKI;FES;YAP1;TGFB3;OSMR;CIAO1;WNT1;CHERP;ACER3;AIF1;XRCC5;NOTCH1;IFIT3;MVD;GCNT2;CXCL9;SIRT1;HDAC2;PINX1;TJP1;NUPR1;CTBP2;GPNMB;CSF1R;FLT3;ETS1
gsea,nucleotide-excision repair (GO:0006289),0.39445293018245814,1.596719640486133,0.020833333333333332,0.04431886892087005,0.998,39/72,41.04%,RPA2;LIG1;RPA3;PCNA;RFC2;RPA1;COPS4;POLA1;RFC5;POLR2C;RFC3;BRIP1;RFC4;RAD23A;POLD2;POLD1;BRCA2;COPS5;POLR2F;POLR2L;POLD3;HUS1;POLE;PRPF19;COPS3;AQR;RFC1;DDB1;MMS19;GTF2H2;LIG4;GPS1;POLK;POLR2B;ERCC8;GTF2H4;SIRT1;COPS7B;OGG1
gsea,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5023973092232095,1.5962452590895335,0.03885480572597137,0.04440252479364667,0.998,10/21,25.22%,ANXA1;AKT1;FAM83D;CCND3;TFDP1;PLCG2;RDX;ADAM17;EIF4G1;LSM11
gsea,heart looping (GO:0001947),0.5466369892069511,1.5959255052371277,0.016453382084095063,0.04431878048888396,0.998,5/15,12.56%,TBX21;MICAL2;STIL;EOMES;MEF2C
gsea,determination of heart left/right asymmetry (GO:0061371),0.5466369892069511,1.5959255052371277,0.016453382084095063,0.04431878048888396,0.998,5/15,12.56%,TBX21;MICAL2;STIL;EOMES;MEF2C
gsea,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.5473339625702283,1.5944106359218246,0.05982905982905983,0.04475914956904759,0.998,13/20,19.25%,RPA2;LIG1;RPA3;PCNA;RFC2;RPA1;RFC5;RFC3;RFC4;POLD2;POLD1;POLD3;POLE
gsea,RNA catabolic process (GO:0006401),0.45609401106181746,1.5940346014841562,0.03036876355748373,0.04478754827043668,0.998,19/31,38.90%,ISG20;HNRNPD;LSM2;RNASEH2B;ERN1;FEN1;ZFP36;PPP1R8;HSPA1B;HSPA1A;DNA2;NCBP1;RNASEH1;RNASEH2A;MTREX;SND1;CNOT10;ZFP36L2;DXO
gsea,bone development (GO:0060348),-0.528645678655173,-1.5936671630820627,0.02358490566037736,0.0834945985164151,0.994,5/16,24.83%,RPL13;VKORC1;SH3PXD2B;PTGER4;P3H1
gsea,protein dephosphorylation (GO:0006470),-0.3790974853632877,-1.5936022751151218,0.013282732447817837,0.08301128240510514,0.994,31/63,33.18%,DUSP4;SSH2;DUSP6;PPP1R15A;DUSP1;PTPRK;PPP1CB;SSH1;PPP2R3A;PTPN3;UBLCP1;CTDSP2;DUSP10;PTPN11;PPM1L;LHPP;PPTC7;CTDNEP1;PPP4R2;PPM1F;PTPN13;MTMR3;RPRD1A;DUSP18;DUSP12;BTRC;DUSP7;PTPRS;PPM1M;DUSP16;PTPRM
gsea,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5170976854876533,1.5931144664354318,0.023547880690737835,0.044988859202625145,0.998,5/21,12.92%,GLRX;NEDD4;STK39;PRKCE;SCN1B
gsea,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5144410916291371,1.5927243383545384,0.045275590551181105,0.04503614889638941,0.998,10/18,25.22%,ANXA1;AKT1;CCND3;TFDP1;CDC6;RDX;MTBP;ADAM17;EIF4G1;LSM11
gsea,regulation of cytosolic calcium ion concentration (GO:0051480),0.42659952588249683,1.5922240456570385,0.010043041606886656,0.04510995294071086,0.998,20/52,33.24%,CXCR6;CCR5;CCRL2;CCR2;F2R;HMGB1;CX3CR1;ATP2B4;YWHAE;CD55;CALCA;CCR1;TRPC1;ITPR3;S1PR4;GPR35;CLN3;CAV2;CD36;RYR1
gsea,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.39218945498599744,1.5921948540103126,0.005859375,0.04502115382074883,0.998,35/65,38.87%,TMED2;CD55;KDELR2;SEC24D;LMAN2;CAPZA2;AREG;LMAN1;ACTR1A;MIA2;BCAP29;PGAP1;DYNC1LI2;DYNC1I2;COPB2;COPG1;DCTN1;CNIH2;VAMP7;HYOU1;KDELR3;ZW10;ARCN1;DYNLL2;SEC24A;ATL2;TMED1;USO1;COPA;ARFGAP3;COPZ2;STX17;DYNC1H1;SPTA1;GOLGA2
gsea,regulation of interferon-alpha production (GO:0032647),0.5220035150537268,1.5907801891766746,0.03386454183266932,0.045326807721897976,0.998,7/18,27.90%,HAVCR2;DDX58;HSPD1;DHX9;STAT1;IL10;TLR4
gsea,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.4853133302097503,1.5902450620465138,0.03112033195020747,0.0454092600086324,0.998,13/25,32.99%,EXOSC8;LSM2;ZFP36;CNOT9;LSM3;EXOSC9;EXOSC3;EXOSC1;EXOSC4;EXOSC2;PATL1;LSM7;TTC37
gsea,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.33389246725501903,-1.5896289339487153,0.0026109660574412533,0.08467900484033132,0.994,52/126,37.45%,RPS27A;TNFSF11;NFKBIA;CD200;NFKB1;RIPK2;TRAF1;NPM1;IL18R1;RGCC;KIT;AR;HIPK2;NFKBIB;NFKB2;CX3CL1;JMY;PRKCB;MAVS;IKBKE;CTNNB1;TCF3;PRDX3;SLCO3A1;TRIM25;CD40LG;HDAC5;PRKCZ;TERF2IP;BEX1;HSF1;CAMK1D;ATF2;ARID5B;PRKD2;DVL2;TAB3;DDIT3;DHX33;TRIM5;SPHK1;RELA;CLOCK;APP;ARHGEF2;CARD11;TRIM14;HDAC4;PRKCI;LRP6;EDN1;MAP3K13
gsea,regulation of chemotaxis (GO:0050920),-0.5113914084630075,-1.5885884462896853,0.04580152671755725,0.08470603734603664,0.995,5/15,14.37%,GPR183;P2RX4;CXCR4;F2RL1;PPM1F
gsea,positive regulation of endothelial cell migration (GO:0010595),0.4249437178761796,1.5877519410582281,0.00303951367781155,0.04617536198470607,0.998,15/47,32.27%,TMSB4X;MAP2K3;HMGB1;AKT1;PTK2B;CALR;PIK3CG;NUS1;ADAM17;PDGFB;ANXA3;VEGFA;HSPB1;BCAR1;SP1
gsea,histone exchange (GO:0043486),0.4809755894665187,1.5871977881354906,0.05405405405405406,0.04627746770696626,0.998,23/32,31.93%,CENPW;KNL1;CENPT;CENPS;CENPH;CENPA;CENPK;CENPN;MIS18A;ANP32E;HJURP;CENPQ;MIS18BP1;NASP;OIP5;RBBP4;CENPI;CENPM;CENPP;RBBP7;CENPO;SMARCA5;CENPU
gsea,neuron development (GO:0048666),0.3875350909068633,1.5866562513983784,0.013986013986013986,0.046395968105808115,0.998,21/60,31.71%,NEDD4;STMN1;HMGB1;MANF;RUNX3;LYN;L1CAM;RYK;XBP1;MEF2C;RB1;MAP4;B4GALT5;MAP2;CLN5;PBX3;PRMT1;TDP2;GBA2;PPP1R9B;NPY
gsea,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.5338419406793548,1.5841758148967635,0.030107526881720432,0.047167650488907024,0.998,3/16,12.74%,TINF2;HNRNPU;HNRNPA1
gsea,protein ubiquitination (GO:0016567),0.31753529005976344,1.5840340896806637,0.002197802197802198,0.0471190764795129,0.998,81/216,31.47%,NEDD4;BSPRY;EPAS1;PSMA3;ASB2;UBE2C;PSMB6;ELOC;PSMB2;UBE2S;PCNA;PSME2;ISG15;PSMA4;PSMD14;TRIM36;PSMA5;PSMB5;BARD1;UBE2L6;UHRF1;UCHL3;KEAP1;PLK1;FBXO31;PSMA6;MDM2;BRCA1;PSMD1;PSMC1;RNF126;PSMB7;DCAF15;UBE2N;GAN;ANKRD9;PSMC2;RNF168;STUB1;UNKL;PSMD12;TRAF2;CDC34;UBE2T;PSMD6;PSMC5;PSME3;CCNF;UBA1;HERC6;FBXW4;PSMD3;PSMD2;PSMC4;ASB1;FBXO30;KLHL25;PRPF19;PSMD11;FBXL14;FBXL8;UBA6;LEO1;DTL;UBE2E3;FBXO45;FANCL;BIRC2;KLHL20;KCTD13;RFWD3;TRAIP;PSMC6;TMEM129;TRIM21;CUL5;SPSB2;RAD18;USP5;HECW2;PSME4
gsea,second-messenger-mediated signaling (GO:0019932),-0.38413419260218284,-1.5822665941768719,0.016339869281045753,0.08773264117823433,0.995,48/48,99.83%,CCR7;TNFSF11;CCR6;GUCY1A1;CXCR3;CCR8;P2RX4;CXCR4;CXCR5;MCTP1;DGKD;NUDT4;KSR2;LRRK2;NDNF;GUCY1B1;PLCG1;SPHK1;CCR4;EDN1;EDNRB;PDPK1;APOE;PLA2G4B;RCAN1;CCR9;BTK;CCR3;NOS2;MCU;PPP1R9B;CD36;DDAH2;MAFA;NOS1;CAMKK2;RCAN3;PLCG2;EIF2AK3;CCR1;MCTP2;CX3CR1;CCR2;CCRL2;CCL3;LAT2;CCR5;CXCR6
gsea,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.49278858605434694,1.5819407514047255,0.02336448598130841,0.04768125503159346,0.998,6/27,13.63%,CCL5;IFNG;LYN;STAT3;TNFRSF1A;CLCF1
gsea,epidermal cell differentiation (GO:0009913),0.5255391695957223,1.5813183846979852,0.030035335689045935,0.04777469971139187,0.998,6/18,17.35%,ANXA1;ST14;HDAC1;BCR;CLIC4;CASP3
gsea,ATP-dependent chromatin remodeling (GO:0043044),0.46414666096972157,1.5803422923006563,0.03508771929824561,0.04801033209288304,0.998,12/30,31.24%,ACTB;HDAC1;ACTL6A;SMARCC2;ANP32E;NASP;RBBP4;SMARCA4;SMARCB1;MTA2;SMARCC1;SMARCA5
gsea,negative regulation of programmed cell death (GO:0043069),0.3299964090486249,1.5753070138051923,0.0034423407917383822,0.049622741390180025,0.999,73/188,30.11%,SERPINB9;HSP90B1;MT3;CFL1;PTMA;PRELID1;ARHGDIA;ANXA1;FLNA;BIRC5;AKT1;ASNS;CDK1;HIGD1A;ANXA4;CD38;PTK2B;HSPA5;MAD2L1;PLK3;MALT1;LTF;MIF;BARD1;RIPK3;HDAC1;ARL6IP1;ANGPTL4;TFRC;FIGNL1;BNIP3;PA2G4;STIL;PLK1;XBP1;NUP62;HSPD1;COPS5;PARK7;MTDH;ARHGAP10;AIFM2;API5;HMGN5;PSMC5;FXN;HSPA1B;MYDGF;DHCR24;CASP3;TIGAR;KIF14;BID;HSPA1A;SHC1;WNT11;RIPK1;THOC6;HNRNPK;BNIP1;SOCS2;BIRC2;KLHL20;MYO18A;GRK5;IL10;PIDD1;VEGFA;CLN3;TM7SF3;HSPB1;DDAH2;BAG3
gsea,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.49778096082261303,1.5748430529949846,0.030737704918032786,0.049697713315590704,0.999,13/23,25.99%,HNRNPU;RBM8A;MBNL3;RNPS1;CELF4;MAGOH;HNRNPA1;SMU1;PTBP1;SRSF6;FMR1;RBMX;RBM15B
gsea,negative regulation of endothelial cell migration (GO:0010596),0.5692057644891401,1.5724956201356732,0.030855539971949508,0.05048103581745317,0.999,6/19,12.56%,HMGB1;ATP2B4;SP100;DAB2IP;VASH1;MEF2C
gsea,external encapsulating structure organization (GO:0045229),-0.34650583168374127,-1.5721250551868597,0.00966183574879227,0.09336586207121209,0.995,35/68,35.78%,ITGB1;ITGB7;PECAM1;COLQ;SERPINE1;ITGA6;ITGB8;SPOCK2;ICAM2;CD44;ADAMTS6;VCAM1;FURIN;MADCAM1;COL27A1;NID1;ITGA7;ADAMTS20;NF1;NDNF;FGF2;SH3PXD2A;GFOD2;DAG1;ST7;ITGB3;MMP24;FBLN5;FN1;ITGA10;SMOC1;APP;ITGB4;COL11A1;COL7A1
gsea,negative regulation of mitotic cell cycle (GO:0045930),-0.48050298849084133,-1.5710907511330108,0.024553571428571428,0.09335073819944695,0.995,8/24,16.51%,ZFP36L1;BCL6;RGCC;PLK2;PTPN3;BTG2;CTNNB1;SCRIB
gsea,regulation of inflammatory response (GO:0050727),-0.3453933813984465,-1.5709273405832551,0.009345794392523364,0.09288687972473274,0.995,101/101,99.99%,XCL1;NFKBIA;CD200;JAK2;BCL6;KLF4;RORA;PDCD4;MGST2;FOXP1;CCN4;TNFAIP3;NINJ1;NFKBIZ;DNASE1L3;MFHAS1;CELF1;SERPINE1;IL16;TNFAIP8L2;BST1;TNIP1;TNFSF4;AREL1;BIRC3;CX3CL1;IL23A;TLR7;ABCC1;SELENOS;IL17RA;CASP4;CCL1;HCK;GATA3;PTGER4;LPL;SPHK1;RELA;IL2;NR1H3;PTGS2;APP;MAPK13;IL13;HYAL2;SIRPA;FEM1A;APOE;USP18;GRN;TNF;SPATA2;PLA2G7;MEFV;MMP9;SETD6;FFAR4;ACOD1;ETS1;NLRC3;PPARG;CASP12;LACC1;GHSR;TLR2;IL1B;SEMA7A;OSM;IL21;AKNA;TLR4;MAPK7;UFL1;ALOX5;IL10;NLRP3;BIRC2;SBNO2;RIPK1;VPS35;MVK;IL33;DHX9;RB1;PARK7;PSMA6;TNFRSF1A;CASP1;ZBP1;CD200R1;AOAH;PIK3AP1;SMPDL3B;ANXA1;METRNL;CCR2;IFNG;CCL3;TMSB4X;CCL5
gsea,cellular response to oxidative stress (GO:0034599),0.37236397969748825,1.5709193686623768,0.013307984790874524,0.050943080709381305,0.999,22/70,27.39%,MT3;PPIA;SRXN1;PRDX1;CYCS;GSR;AKT1;TXNRD1;EIF2S1;PRR5L;KEAP1;HMOX1;PARK7;HSPA1B;HSPA1A;NCF2;SLC25A24;CAMKK2;ERMP1;ATF4;PYCR1;CPEB2
gsea,receptor-mediated endocytosis (GO:0006898),0.39337944433660055,1.5699543124786952,0.014173228346456693,0.05113745897238819,0.999,30/68,32.08%,HSP90B1;FCER1G;NEDD4;SNX9;M6PR;CLTB;CALR;CLTC;CANX;HSP90AA1;TFRC;LDLR;ITGAM;HIP1R;HSPH1;PICALM;AP2A2;ADRB2;PDLIM7;AP1G2;HYOU1;RABEPK;DNM3;CLN3;AP2B1;IGF2R;CAV2;SYK;CD36;AP1G1
gsea,cellular response to molecule of bacterial origin (GO:0071219),0.43014677445747584,1.5693043320282232,0.016975308641975308,0.051258288600678444,0.999,23/57,34.17%,CCR5;VIM;HMGB2;HMGB1;CX3CR1;UPF1;CD14;CASP1;ZFP36;DAB2IP;XBP1;MEF2C;CD86;CACTIN;SBNO2;NLRP3;IL10;TLR4;IL1B;TLR2;CD274;CCL2;CTSG
gsea,negative regulation of type I interferon production (GO:0032480),0.49332087098443633,1.5692684595588078,0.03302752293577982,0.05117237441903214,0.999,6/22,13.99%,HAVCR2;ISG15;UBE2L6;PIN1;DDX58;CACTIN
gsea,regulation of keratinocyte differentiation (GO:0045616),-0.516079438988135,-1.5667654687157522,0.025522041763341066,0.09473146638996134,0.995,8/16,29.11%,ZFP36L1;CTSL;AQP3;NME2;NUMA1;ROCK1;NCOA3;ROCK2
gsea,regulation of DNA recombination (GO:0000018),0.48714121468335914,1.5665702224618645,0.045951859956236324,0.05198990116174148,0.999,12/24,29.44%,ALYREF;RPA2;RAD51;KPNA2;FIGNL1;RAD51AP1;RAD50;SPIDR;IL10;CHEK1;RTEL1;BLM
gsea,positive regulation of cytokine production (GO:0001819),-0.31734970101673005,-1.5656673029390624,0.0,0.09477973784663747,0.995,179/179,99.95%,CCR7;XCL1;SLAMF6;CRTAM;CD74;LTB;CD200;NFKB1;HIF1A;RIPK2;RORA;IL18R1;FOXP1;RGCC;MBP;POU2F2;ZFPM1;PDE4B;SPTBN1;CSF2;SERPINE1;IL16;BATF;CD226;LY9;POU2AF1;TNFSF4;AIRE;PTPN11;IL6ST;NFKB2;IL23A;F2RL1;RASGRP1;C1QTNF4;EBI3;MAVS;CTNNB1;TLR7;XRCC6;ARNT;POLR1C;STAT6;CREBBP;IL17RA;GBP5;RFTN1;TWIST1;POLR2E;SCRIB;CD40LG;IRF5;IRF4;PRKCZ;CCL1;POLR3B;PRKD2;IRF7;GATA3;PTGER4;DDIT3;IFIH1;DHX33;LPL;ADRA2A;PRKDC;DHX58;F3;ROCK2;SPHK1;RELA;IL2;PIBF1;POLR2H;AGPAT1;PTGS2;APP;CADM1;ARHGEF2;CARD11;CD80;RUNX1;MAPK13;PHB;IL13;HYAL2;IRF1;POLR3GL;RAB7B;POLR3A;TNF;POLR3E;DDX41;KAT2A;CD40;EP300;C3;NOS2;CSF1R;NFAM1;CCDC88B;LACC1;PIK3CD;MAP3K7;POLR3F;XRCC5;AIF1;SPHK2;CD4;POLR3H;SULF2;CD274;TLR2;IL1B;FADD;OSM;POLR3D;SYK;IL21;FGR;TYROBP;TLR4;ATF4;IL10;NLRP3;RARA;EIF2AK2;HPSE;TMEM106A;SLC11A1;SCIMP;RIPK1;POLR3K;HSPA1A;IL33;DHX9;ADAM17;POLR3G;HSPA1B;AGPAT2;TRAF2;POLR2L;POLR2F;PARK7;G3BP1;CD86;PLCG2;PIK3CG;TXK;HSPD1;STOML2;FLOT1;DDX58;XBP1;BRCA1;SLC7A5;EIF2AK3;HMOX1;CGAS;MIF;CD14;MALT1;ZBP1;STAT3;ISG15;GLMN;IL12RB2;IL12RB1;EGR1;ANXA1;HMGB1;F2R;CCR2;GAPDH;IFNG;FCER1G;HILPDA;CEBPB;HAVCR2
gsea,negative regulation of B cell activation (GO:0050869),0.5751247298673795,1.5655950965056336,0.02593192868719611,0.05223219285308923,0.999,4/15,10.80%,ID2;LYN;CTLA4;TNFRSF21
gsea,cellular response to starvation (GO:0009267),-0.3658276293863096,-1.565491726216423,0.012170385395537525,0.09428004603745074,0.995,30/71,34.87%,DAPL1;SESN3;FAS;CASTOR1;USP33;ZC3H12A;SESN1;ATG7;MAPK8;LRRK2;FOXO1;PMAIP1;DAP;MTMR3;SESN2;RNF152;MYBBP1A;PIK3R4;SIK2;ATF2;FNIP1;MFSD2A;ATP6V1G3;MAP3K5;NPRL3;FOXO3;BHLHA15;ATG14;XPR1;FADS1
gsea,protein K63-linked ubiquitination (GO:0070534),0.47655191509174133,1.5654547191405679,0.04319654427645788,0.052207854224035594,0.999,14/23,27.29%,NEDD4;UBE2S;RNF126;UBE2N;RNF5;RNF168;STUB1;TRAF2;UBE2T;TRAF5;PRPF19;ZFP91;UBE2E3;TRIM21
gsea,fatty acid oxidation (GO:0019395),-0.4683574674118517,-1.5647082268038948,0.029069767441860465,0.09424205527728481,0.995,13/26,22.85%,BDH2;ADH4;DECR1;ADH5;ACADM;ABCD3;PECR;HACL1;MTLN;SLC25A17;MECR;ECI1;ACAD11
gsea,protein homotetramerization (GO:0051289),0.48151953512626144,1.564675970973359,0.02,0.052367393667558056,0.999,11/23,40.46%,ALDOA;TK1;ALDH9A1;GLS;SHMT2;HSD17B10;RYR1;ALDH1A3;CRYZ;GOLGA2;SHMT1
gsea,negative regulation of autophagy (GO:0010507),-0.4208045102009263,-1.5644240508376825,0.020642201834862386,0.0938440989931513,0.995,16/35,33.24%,DAPL1;BCL2;PINK1;ATG7;LRRK2;ZKSCAN3;DAP;TBC1D14;TAB3;KDM4A;TLK2;MET;RASIP1;WDR6;EIF4G2;CPTP
gsea,innate immune response (GO:0045087),0.36723291633008315,1.563941561918527,0.019138755980861243,0.052526331075444584,0.999,43/107,37.58%,PGLYRP1;FCER1G;CORO1A;HMGB1;PGLYRP2;CX3CR1;LYN;PTK2B;ISG15;IFITM3;SMPD1;CAPZA2;MALT1;LTF;IFITM1;SERINC3;STYK1;SP100;DDX58;PIK3CG;PLCG2;PPP1R14B;NCF2;BST2;IFITM2;SLC11A1;TNK2;SRPK1;IFIT1;SHMT2;TRIM21;TLR4;TYROBP;FGR;SYK;TLR2;TKFC;CLPB;CHUK;FES;SKP2;CLEC4E;CFB
gsea,extracellular structure organization (GO:0043062),-0.3442945667586597,-1.5631233376319367,0.01,0.09401892764961224,0.995,35/69,35.78%,ITGB1;ITGB7;PECAM1;COLQ;SERPINE1;ITGA6;ITGB8;SPOCK2;ICAM2;CD44;ADAMTS6;VCAM1;FURIN;MADCAM1;COL27A1;NID1;ITGA7;ADAMTS20;NF1;NDNF;FGF2;SH3PXD2A;GFOD2;DAG1;ST7;ITGB3;MMP24;FBLN5;FN1;ITGA10;SMOC1;APP;ITGB4;COL11A1;COL7A1
gsea,positive regulation of cellular protein localization (GO:1903829),0.41524298242453656,1.5624479959077981,0.029880478087649404,0.05300913992552054,0.999,18/39,38.73%,AKT1;CDK1;TFRC;PLK1;NDC80;EIF2AK3;NUP62;PARK7;CEP250;GTSE1;CENPQ;CDT1;TYROBP;BICD1;MAP1A;YAP1;ABCA7;GPR137B
gsea,apoptotic mitochondrial changes (GO:0008637),0.49007599906129745,1.5592274831604285,0.03639846743295019,0.054126287610747253,0.999,13/21,26.46%,BAX;BAK1;GGCT;SFN;IFIT2;BNIP3;HSPD1;AIFM2;BID;TIMM50;VPS35;THEM4;NDUFS1
gsea,regulation of neuron differentiation (GO:0045664),0.4506363221192975,1.5590138374499325,0.02394106813996317,0.05410785943755986,0.999,8/28,24.24%,ID2;CALR;MEF2C;ECT2;CPNE1;KCTD11;YWHAG;IMPACT
gsea,regulation of phosphoprotein phosphatase activity (GO:0043666),0.5138221487708717,1.558145298710579,0.028282828282828285,0.054296916347895005,0.999,3/16,8.66%,HSP90B1;ITGA1;MASTL
gsea,positive regulation of leukocyte chemotaxis (GO:0002690),-0.44296286789514777,-1.5566846139844417,0.03856749311294766,0.09738317567907541,0.995,7/27,20.06%,CCR7;XCL1;CCR6;CXCL10;SERPINE1;F2RL1;CCL1
gsea,positive regulation of mononuclear cell migration (GO:0071677),0.468057929811799,1.5566232934863482,0.03783783783783784,0.05484411567907889,0.999,7/21,9.95%,CCL5;LGALS3;CCR2;HMGB1;CALR;JAM2;CCR1
gsea,regulation of cell growth (GO:0001558),0.34681801640380655,1.5562718898054666,0.02154398563734291,0.054884148030668274,0.999,43/104,29.64%,MT3;CDKN2A;CDKN1A;ENO1;OSGIN1;AKT1;CISH;DERL2;CDKN2C;TFRC;DCUN1D3;NUBP1;CEACAM1;DCBLD2;PAK4;FXN;HSPA1B;ADAM17;RB1;EXOSC9;KIF14;FRZB;HSPA1A;SMARCA4;APBB1;WNT11;TMEM97;EI24;BST2;EIF4G1;MTOR;SOCS2;ENPP1;JADE1;PTPRJ;TMC8;EXOSC4;EXOSC2;NCBP1;RBBP7;NME6;BCAR1;PSRC1
gsea,regulation of actin filament-based process (GO:0032970),0.44903918516849883,1.5560783067746782,0.015479876160990712,0.05488965506677854,0.999,14/36,25.77%,CORO1A;RHOQ;EZR;SH3BP1;RHOF;RHOC;HIP1R;BAIAP2;IQGAP2;ARHGEF5;BST2;MLST8;MTOR;IQGAP3
gsea,cellular glucose homeostasis (GO:0001678),-0.4721165559273629,-1.555929104910679,0.03205128205128205,0.09716771217040968,0.995,8/21,14.40%,HIF1A;RACK1;ZBTB20;LRRC8D;PIK3R2;PIK3R1;SOX4;FOXO1
gsea,neuron differentiation (GO:0030182),0.4427879594784531,1.5555735676902553,0.009888751545117428,0.054988928646505925,0.999,17/54,28.67%,ID2;MANF;RUNX3;PIN1;RUNX2;RYK;ACSL4;XBP1;MEF2C;CASP3;FZD4;WNT11;WNT10B;EPOP;VEGFA;PBX3;TDP2
gsea,cellular response to decreased oxygen levels (GO:0036294),0.3936716773271881,1.5537566284185937,0.026262626262626262,0.055583297865006986,0.999,19/45,27.39%,ADAM8;HILPDA;MT3;EPAS1;PGK1;LMNA;EGLN1;HMOX1;BNIP3;P4HB;MDM2;STUB1;SUV39H2;TIGAR;HYOU1;MTOR;SUV39H1;VEGFA;CPEB2
gsea,regulation of MAPK cascade (GO:0043408),-0.35385581099459945,-1.5533813310295388,0.0111731843575419,0.09816038271438898,0.995,33/70,29.11%,MAP4K4;CD74;FAS;NTRK3;CCN1;DUSP1;KIT;PEBP1;PIK3R2;LIF;PHLPP1;CX3CL1;TGFBR3;RASGRP1;PAK1;NF1;TAOK1;FGF2;SPRED1;JCAD;TNIK;PAK6;DAG1;ROCK1;LBH;KSR1;FLT1;DHX33;RET;TRIM5;FN1;ADRA2A;ROCK2
gsea,lymphocyte proliferation (GO:0046651),-0.5030356017486312,-1.5531520308238993,0.0446927374301676,0.09769550602677121,0.995,6/16,16.72%,TNFRSF4;BCL2;CD70;TNFSF14;RASGRP1;CD40LG
gsea,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.48364652371805483,-1.5521174162119906,0.023411371237458192,0.09782541502862008,0.995,6/17,30.13%,TNFAIP3;SERPINE1;NFE2L2;NDNF;GATA3;TNIP2
gsea,skin development (GO:0043588),0.48006346919380366,1.5519185600111158,0.011204481792717087,0.05625751029251705,0.999,10/31,19.17%,STMN1;ANXA1;ST14;BCR;SFN;ITGA3;CLIC4;DHCR24;CASP3;ERRFI1
gsea,organophosphate biosynthetic process (GO:0090407),0.4865331013780291,1.551320843100174,0.04085603112840467,0.056383277433149505,0.999,6/19,32.13%,TPI1;AGPAT4;TKT;PCYT2;GK;PPIP5K1
gsea,DNA replication-independent nucleosome assembly (GO:0006336),0.4765760384073335,1.5502177708887894,0.061946902654867256,0.05672428809261917,0.999,25/32,31.93%,CENPW;ASF1B;KNL1;CENPT;CENPS;CENPH;CENPA;CENPK;CENPN;MIS18A;HAT1;HJURP;CENPQ;MIS18BP1;NASP;OIP5;RBBP4;CENPI;HIRA;CENPM;CENPP;RBBP7;CENPO;SMARCA5;CENPU
gsea,positive regulation of GTPase activity (GO:0043547),-0.32720948695025037,-1.5488931886756514,0.007772020725388601,0.09925186681362731,0.995,110/110,99.99%,CCR7;XCL1;ITGB1;MAP4K4;RGS10;TBC1D4;NTRK3;RACK1;TIAM1;NET1;PKP4;ITGA6;TBC1D1;ARHGAP24;TBC1D30;SYDE2;CX3CL1;SNX13;GRTP1;F2RL1;RASGRP1;RABGAP1;USP6NL;RAB3GAP1;CXCL13;NF1;MMUT;TBC1D14;ADPRH;SCRIB;CCL25;CCDC125;CCL1;SGSM2;EZH2;RSU1;DOCK9;DOCK11;SGSM3;ARHGAP25;TBC1D5;DVL3;ARHGEF19;RGP1;DOCK7;TSC1;TGM2;GSK3B;BCAS3;CD40;EVI5;EVI5L;CCL17;ARAP1;ARHGAP27;RAP1GDS1;TBC1D8;TBCK;CCL8;RASGRF1;ARHGEF26;AFDN;CCL22;ARHGAP22;TBC1D9;CCL7;RAPGEF2;BCAR3;TBC1D25;RASGRP2;GNB5;TBC1D22B;SRGAP2;RALGAPA2;TBC1D13;CCL2;RALGAPB;TBC1D10B;ASAP3;CAV2;RAPGEF1;TBC1D7;ARHGEF5;WNT11;TBC1D8B;ALS2;CORO1C;PICALM;TAX1BP3;ECT2;RANGAP1;GPR65;ARHGAP11A;BCR;PIN1;DOCK8;HRAS;RGS8;SH3BP1;ABR;SIPA1L1;ADRB1;F2R;S100A10;SNX9;CCL3;RGS16;CCL4;RGS1;CCL5
gsea,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.41151218344515633,1.5487047264573526,0.0061068702290076335,0.0571433675943276,0.999,17/49,30.68%,CCL5;NEDD4;F2R;PIK3AP1;LYN;DAB2IP;PTPN6;PIK3CG;CEACAM1;MYDGF;PDGFB;ENTPD5;MAZ;PIP4K2B;FGR;OSM;PDGFA
gsea,protein import into nucleus (GO:0006606),0.4152255774830981,1.5486757706326721,0.026607538802660754,0.05704963593190488,0.999,25/47,32.32%,RAN;AKT1;STAT3;KPNA2;NUTF2;NUP93;NUP62;RANBP2;NUP85;NUP107;CBLB;HIKESHI;KPNB1;NUP35;KPNA3;E2F3;NUP54;KPNA6;IPO7;NUP133;IPO9;NUP88;SYK;NUP155;RANBP6
gsea,negative regulation of protein-containing complex assembly (GO:0031333),0.4542524764854229,1.5484417127203327,0.023985239852398525,0.05703979822044361,0.999,9/26,26.34%,HMGB1;HSPA5;TFIP11;SVIP;PARK7;KIF14;AIDA;IMPACT;TMC8
gsea,regulation of viral transcription (GO:0046782),0.4803744886341269,1.5480566716262256,0.031315240083507306,0.05709310775723617,0.999,10/22,27.29%,NELFE;IFITM3;POLR2C;ZFP36;POLR2F;POLR2L;DHX9;GTF2F1;LARP7;TRIM21
gsea,regulation of myeloid cell differentiation (GO:0045637),0.4105569479649853,1.5470723169514295,0.02434782608695652,0.05734420929016498,0.999,13/42,27.74%,LGALS3;CDK6;DPY30;LYN;PTK2B;HDAC1;RBBP5;MEF2C;WDR5;EIF6;LEO1;MOV10;PRMT1
gsea,positive regulation of Ras protein signal transduction (GO:0046579),-0.42941091339816206,-1.5466154345103336,0.01904761904761905,0.10016304038140017,0.995,11/32,19.18%,MAP4K4;JAK2;ARHGEF3;GPR18;IRS2;RASGEF1A;NET1;F2RL1;RASGRP1;ERBIN;EPOR
gsea,positive regulation of lymphocyte proliferation (GO:0050671),-0.42301273772782777,-1.5465378501805125,0.01707317073170732,0.0996431797828204,0.995,19/37,16.72%,CD74;CD81;GPR183;TNFRSF4;BCL2;CD70;IRS2;TNFRSF13C;VAV3;BST1;CD320;TNFSF4;SLC7A1;IL6ST;IL23A;VCAM1;NCK2;PDCD1LG2;CD40LG
gsea,T cell differentiation (GO:0030217),-0.48466973902304133,-1.5463875169869545,0.0364963503649635,0.09916246059362901,0.995,4/21,11.72%,TCF7;ZFP36L1;KIT;SOX4
gsea,DNA recombination (GO:0006310),0.45064337638584173,1.5451316604825354,0.03171247357293869,0.05804354353548238,0.999,19/32,35.82%,HMGB1;RAD51;RPA1;RAD21;RAD50;RAD54L;TSN;GEN1;HMGB3;RAD51C;RECQL;RAD54B;EXO1;RTEL1;BLM;XRCC2;RAD51D;LIG4;RECQL4
gsea,stem cell differentiation (GO:0048863),-0.5108239211223131,-1.5450302309636839,0.04439746300211417,0.09943255815912103,0.995,5/17,10.40%,KIT;JARID2;MLLT3;BATF;EPCAM
gsea,positive regulation of cellular process (GO:0048522),0.3179161186856181,1.5435826138017734,0.002936857562408223,0.05856323936253878,0.999,110/277,32.94%,CCL5;ADAM8;HILPDA;MT3;FCER1G;IFNG;CSF1;ADGRG1;F2R;PRC1;BIRC5;AKT1;NAP1L1;LYN;IL12RB2;PTK2B;FBXO5;CALR;LMNA;COX17;TIPIN;SMC6;LMAN2;HRAS;AREG;DERL2;SLC25A5;RAB27A;ACTN4;HDAC1;SAPCD2;SLAMF1;CDC6;FUT7;ZFP36;RAD23A;PA2G4;P4HB;PTPN6;TTK;LYAR;MDM2;XBP1;SMC5;CNBP;FLOT1;FAF1;CD86;CLCF1;FOXM1;OSR2;IL15RA;SPAG5;NSMCE4A;HMGN5;FXN;ADAM17;ANKLE1;CDC7;PDGFB;DNAJA2;EXOSC9;KIF20B;MATK;CDC123;KIF14;NCCRP1;FAM98B;SHC1;FMR1;DHPS;ESM1;SINHCAF;SLC11A1;LAMC2;ACLY;EIF4G1;RARA;MAZ;PTPRJ;GRK5;CHEK1;UFL1;VEGFA;S1PR2;CDCA7L;EXOSC4;EXOSC2;TRIM21;TCIRG1;NCBP1;PRMT1;TLR4;HCFC1;ITGAX;TSPAN31;RPRD1B;IL21;OSM;PDGFA;NCMAP;CD36;IL1B;RAD18;MAP1A;TLR2;CDK4;HDGFL2;TBRG4;CDK2
gsea,glycoprotein metabolic process (GO:0009100),-0.4547227202238238,-1.5435636111488016,0.03877551020408163,0.09974050991405763,0.995,9/25,29.12%,HIF1A;ST6GALNAC3;ST8SIA1;ST8SIA4;TNIP1;MAN1C1;GANC;ST6GALNAC6;MAN2A1
gsea,positive regulation of neuron apoptotic process (GO:0043525),0.5384467680533267,1.5434736745688298,0.044326241134751775,0.058492562015254865,0.999,3/15,9.72%,CCL3;BAX;ITGAM
gsea,neurogenesis (GO:0022008),0.5095397396894625,1.542994721474112,0.04900181488203267,0.05855168527820047,0.999,7/19,25.12%,CDK6;ANXA1;CIT;RYK;CLN5;CHAC1;WDR62
gsea,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.28473327476334714,-1.5420277301676104,0.0,0.10011416649611107,0.995,217/442,38.83%,RPS27A;TNFSF11;NFKBIA;JUNB;REL;NFKB1;NR4A3;JUN;HIF1A;CD81;RIPK2;TCF12;MYB;KLF4;RORA;NPM1;RGCC;CCN1;LEF1;POU2F2;ZFPM1;FOS;PCGF5;NFAT5;IER5;NRIP1;PLAGL1;CALCOCO1;ENG;CSRNP1;ELK4;AR;SSBP2;CXCL10;HIVEP1;SERPINE1;SENP1;NR4A1;NFE2L2;PIK3R2;KLF2;TBL1X;ITGA6;TNIP1;PER1;PTOV1;HIPK2;POU2AF1;NFATC1;PIK3R1;ZC3H12A;HSF2;AIRE;LIF;STAT5B;ERG;ATRX;CREBRF;FOSL2;NFKB2;CX3CL1;FUBP3;KDM1B;DCAF6;EPCAM;NCK2;F2RL1;GNL3;HMGA1;KMT2C;KAT6B;MAML2;TFDP2;SOX4;MAVS;CTNNB1;SMAD1;NCOA2;APEX1;XRCC6;TCF3;ARNT;SMAD5;ARNTL;TFE3;NCOA7;STAT6;AHI1;MAML3;ASXL1;MYC;PFKM;FOXO1;RFX5;CREBBP;AHR;ABL1;KMT2A;DDX3X;PLSCR1;NR5A2;TET2;GLYR1;BPTF;MEPCE;TWIST1;MRTFB;IRF2;TOX2;TFCP2;PRDM2;NME2;MED12;TAF9;FGF2;IRF5;KDM6B;HDAC5;PHF10;INO80;IRF4;CREB1;TET1;DOT1L;KMT2D;TCF20;TET3;ZBTB17;TNIP3;BEX1;KAT2B;HSF1;KLF7;MITF;DLL1;LMO7;CEBPZ;E2F5;RARG;ATF2;EGR2;ATF3;PRKD2;EGR4;CCDC62;DVL2;SMARCA2;ATM;IRF7;GATA3;KAT8;MED13;SSBP3;DDIT3;SIN3A;FOXJ2;DVL1;NAMPT;NFIX;TGFB2;CDK12;NCOA1;NCOA3;PAX3;ZSCAN21;RPS6KA3;FOSL1;MET;E4F1;PRKDC;SOX30;THRAP3;MED24;MEN1;RELA;FOXO3;SOX15;GRIN1;MED4;TNIP2;SPIB;TAF6L;CLOCK;ZBED3;SMAD7;FOXO4;BCLAF1;NR1H3;DVL3;APP;THRB;IL4I1;POU2F1;AGO1;REST;ARHGEF2;DAB2;AGO2;RORB;PAXBP1;ZBED4;HDAC4;LRP6;RXRA;PELP1;RUNX1;PHIP;GCN1;EDN1;SETX;MED16;HELZ2;HYAL2;INHBA;IRF1;ATF5;PBX2
gsea,protein export from nucleus (GO:0006611),0.5040982554317347,1.5408216835480204,0.04819277108433735,0.05923261706662353,0.999,8/17,29.97%,RAN;CALR;NUTF2;XPO1;ANKLE1;CCHCR1;RANBP3;XPO7
gsea,posttranscriptional regulation of gene expression (GO:0010608),-0.43450149561507057,-1.5405699415670204,0.028735632183908046,0.10045121824318634,0.995,17/32,35.95%,RPL10;LARP4;ATXN2;PER1;METAP1;GEMIN5;EIF2A;EIF2B4;RBM4B;FOXO3;PUM2;APP;TCOF1;ATG14;SPOUT1;NANOS3;METTL16
gsea,negative regulation of cell projection organization (GO:0031345),0.4985974349792026,1.5396400409410935,0.05330882352941176,0.05960842625178056,0.999,5/18,31.10%,MT3;CRMP1;PAQR3;PTPN9;FKBP4
gsea,positive regulation of cellular component organization (GO:0051130),0.37883808218918563,1.5387443156051888,0.016574585635359115,0.059862921853321864,0.999,27/59,30.50%,LGALS3;IFNG;BAX;BAK1;SMPD1;RHOC;PIH1D1;TFRC;LMAN1;BNIP3;DAB2IP;BCL2L11;FLOT1;FAF1;PARK7;RB1;DCTN1;SPIDR;BID;ADD1;CDC20;CDT1;SLF1;VEGFA;CD151;SYK;BIK
gsea,regulation of cell development (GO:0060284),0.5080962690837002,1.5374863993328909,0.020123839009287926,0.060218501718956007,0.999,3/21,3.14%,HMGB2;AKT1;CX3CR1
gsea,intraciliary transport involved in cilium assembly (GO:0035735),-0.47724780809839773,-1.5370567086087075,0.04319654427645788,0.10211276594459193,0.995,10/22,24.28%,IFT80;KIFAP3;DYNC2H1;KIF3B;IFT81;IFT88;IFT140;SSX2IP;IFT74;CLUAP1
gsea,negative regulation of cell-cell adhesion (GO:0022408),-0.45132968450271943,-1.5367763742517426,0.03431372549019608,0.10169840549410127,0.995,8/22,19.57%,KLF4;RGCC;MBP;ASS1;WNK1;EPCAM;PPM1F;MIA3
gsea,interstrand cross-link repair (GO:0036297),0.42779372431984136,1.5367570231844643,0.045871559633027525,0.06041122192455009,0.999,23/41,28.55%,RPA2;RPA3;RAD51;FANCF;RPA1;USP1;FAAP100;NUCKS1;RAD51AP1;CENPS;NEIL3;RNF168;UBE2T;MCM8;FANCD2;EME1;FANCG;FANCI;FANCA;FANCL;RFWD3;FANCM;FANCB
gsea,positive regulation of protein dephosphorylation (GO:0035307),0.5237848902360944,1.5360261641984678,0.052,0.06062534472630496,0.999,6/15,15.03%,PPIA;SMPD1;CDCA2;PIN1;ITGA1;PTBP1
gsea,regulation of ion transport (GO:0043269),-0.47950771199014736,-1.5355217596579902,0.04487179487179487,0.10194939160145415,0.995,7/16,15.42%,P2RX4;CLDN10;ATP1A1;PER1;WNK1;NKAIN1;SYT11
gsea,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.534116748843038,1.5347227593062214,0.03925619834710744,0.061065866497711625,1.0,6/15,22.73%,NELFE;HNRNPU;RNF168;TCERG1;LARP7;LEO1
gsea,DNA damage checkpoint signaling (GO:0000077),0.4590749216638166,1.5334606668377468,0.045081967213114756,0.061493804392948034,1.0,12/22,35.73%,CLSPN;E2F1;BRIP1;RAD9A;HUS1;PRPF19;CHEK2;CHEK1;DONSON;HINFP;ATR;RAD17
gsea,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.4180631280818927,1.5323361141042304,0.020202020202020204,0.06188285435462349,1.0,20/38,28.07%,AKT1;AREG;RHBDF2;ITGA1;DAB2IP;PTPN12;HIP1R;HIP1;NUP62;RNF126;CNOT9;CEACAM1;MVP;DUSP3;WDR54;MVB12B;ERRFI1;STAM2;PTPRJ;HGS
gsea,negative regulation of apoptotic process (GO:0043066),0.3127441040366486,1.5312786205654632,0.005067567567567568,0.062198125055544236,1.0,112/228,43.39%,SERPINB9;ADAM8;HSP90B1;MT3;CFL1;PTMA;PRELID1;ARHGDIA;F2R;ANXA1;FLNA;BIRC5;AKT1;CX3CR1;ASNS;CDK1;HIGD1A;ANXA4;CD38;YWHAE;PTK2B;HSPA5;MAD2L1;SET;PLK3;MALT1;LTF;MIF;BARD1;HDAC1;ARL6IP1;ANGPTL4;TFRC;SFN;FIGNL1;BNIP3;PA2G4;STIL;PLK1;XBP1;NUP62;HSPD1;MEF2C;COPS5;CLCF1;PARK7;MTDH;ARHGAP10;API5;HMGN5;FXN;HSPA1B;MYDGF;RB1;DHCR24;CASP3;KIF14;BID;HSPA1A;SHC1;WNT11;RIPK1;THOC6;HNRNPK;BNIP1;SOCS2;BIRC2;KLHL20;MAZ;MYO18A;GRK5;IL10;PIDD1;VEGFA;CLN3;HSPB1;DDAH2;BAG3;FOXQ1;PTRH2;LIG4;CCL2;CTSG;NR4A2;NAA15;PCID2;YAP1;TGFB3;NAA35;WNT1;DFFA;NAA16;ANKLE2;TXNDC5;NOTCH1;BHLHB9;ANXA5;IFIT3;NOTCH2;YME1L1;CSNK2A2;PHB2;SIRT1;HDAC2;TJP1;NUPR1;MPO;ERC1;PIM1;SFPQ;FZD3;THBS1
gsea,transcription-coupled nucleotide-excision repair (GO:0006283),0.39876169700625924,1.5312091105801353,0.053738317757009345,0.06210716045193199,1.0,28/53,38.52%,RPA2;LIG1;RPA3;PCNA;RFC2;RPA1;COPS4;RFC5;POLR2C;RFC3;RFC4;POLD2;POLD1;COPS5;POLR2F;POLR2L;POLD3;PRPF19;COPS3;AQR;RFC1;DDB1;GTF2H2;GPS1;POLK;POLR2B;ERCC8;GTF2H4
gsea,lytic vacuole organization (GO:0080171),0.48769310164885715,1.530548109545274,0.031496062992125984,0.062272270734533404,1.0,7/19,26.44%,ARSB;GNPTAB;TFEB;CLN5;MTOR;NAGPA;CLN3
gsea,mononuclear cell differentiation (GO:1903131),0.5882506685214444,1.5302408517606978,0.036211699164345405,0.062299327213334345,1.0,3/15,4.53%,IRF8;LYN;MYH9
gsea,positive regulation of actin filament polymerization (GO:0030838),-0.4536293463247931,-1.5301977307002423,0.019444444444444445,0.10465972034436943,0.995,9/23,21.42%,CCR7;EVL;SCIN;NCK2;PFN2;GSN;CDC42EP3;HCK;FCHSD2
gsea,positive regulation of mitotic nuclear division (GO:0045840),0.5115199177174024,1.5259417439067509,0.03636363636363636,0.0640535803723666,1.0,8/21,20.13%,ANAPC5;DLGAP5;NUSAP1;NUP62;RB1;PDGFB;AURKA;ESPL1
gsea,regulation of cell-matrix adhesion (GO:0001952),-0.40384852268420635,-1.5255664218011213,0.037383177570093455,0.10709225716050626,0.995,14/36,34.05%,CCR7;MAP4K4;UTRN;GPM6B;VCL;BST1;CX3CL1;MACF1;NF1;CCL25;ROCK1;ROCK2;CLASP1;EPHA3
gsea,positive regulation of programmed cell death (GO:0043068),0.3105522861171973,1.525255769750247,0.008865248226950355,0.06422524823883398,1.0,58/154,30.64%,PRF1;CTSD;IFNG;HMGB1;BAX;PREX1;TOP2A;GZMA;ABR;BAK1;ZBP1;SMPD1;CTLA4;DAPK2;E2F1;OLFM1;BARD1;PHLDA3;ATF6;IFIT2;BNIP3;DKKL1;DAB2IP;PHLDA1;BCL2L11;UNC13B;RNPS1;HIP1R;HSPD1;FAF1;DCUN1D3;ECT2;AIFM2;PPID;DDX20;ITSN1;FGD3;CASP3;MTCH2;BID;FRZB;APBB1;ARHGEF5;RRP1B;SFRP4;RIPK1;WNT10B;TNFSF10;ATF4;UTP11;PIDD1;EEF1E1;APAF1;TCTN3;KLF11;ING5;SYK;FADD
gsea,"negative regulation of transcription, DNA-templated (GO:0045892)",0.28885156798355893,1.5247900057007966,0.0017123287671232876,0.06431600239157634,1.0,178/427,45.55%,ID2;CEBPB;MT3;CDKN2A;IRF8;IFNG;ENO1;TLE5;TBX21;MXD1;HMGB2;HMGB1;PRDM1;FLNA;BIRC5;MXI1;ZBTB38;RUNX3;CD38;EZR;NCOR2;TMPRSS6;CENPF;AURKB;NAB1;GMNN;CALR;STAT3;SET;KLF10;PLK3;CBX3;E2F7;CALCA;HNRNPU;E2F1;SREBF2;HDAC1;CREB3L1;UHRF1;GLIS1;CREM;ATXN1;KMT5A;RUNX2;NFIL3;ZFP36;SP100;PA2G4;HDGF;DAB2IP;CBX5;EHMT2;NOC2L;PLK1;ZBTB32;DNAJB1;LYAR;MDM2;CTCF;BRCA1;IRF2BPL;CNBP;PCGF2;EOMES;HHEX;MEF2C;RIPPLY3;MTDH;FOXM1;SMARCC2;PPID;OSR2;ZEB2;TCERG1;E2F8;NONO;RIF1;DDX20;ETS2;RB1;TBL1XR1;IL33;PDGFB;SUV39H2;TIMELESS;NR3C1;SMARCA4;APBB1;SHC1;WNT11;DCAF1;WWC1;HSPA8;LARP7;SAP30;TRERF1;SBNO2;SMYD2;RARA;SUV39H1;ZFP90;IMPACT;CBX6;MAZ;SKIL;STAT1;ATF4;VEGFA;RBM15B;ELK3;NFIC;SFMBT1;SAMD1;MTA2;EED;ZBTB2;TAF3;HCFC1;BACH1;KLF11;HIC1;SP2;KDM8;SIX3;PEG3;NAB2;GCFC2;TRIB3;HOXB13;PAX9;FOXP3;DUSP22;SKI;NR4A2;SETDB2;HINFP;YAP1;E2F6;ZBTB14;WWP1;HCFC2;XRCC5;ZC3H8;NOTCH1;CTR9;PIAS4;ZBTB16;FST;DMAP1;CCND1;MUC1;PHB2;SIRT1;HDAC2;JDP2;CTBP2;SPI1;PPARG;WWOX;FOXE1;RBM15;THAP1;TRPS1;TAF1;PRMT2;MAFK;SFPQ;CCAR2;NKRF;BASP1;PRDM5;CIITA;GAS6;DNMT3B;KAT7;FOXK2;DICER1
gsea,positive regulation of apoptotic signaling pathway (GO:2001235),-0.4360343456894237,-1.5230896791413278,0.02528735632183908,0.10819055720991776,0.995,11/27,38.46%,FAS;RACK1;BCL2;PMAIP1;BCL2L1;DDIT3;PML;BCLAF1;BOK;LTBR;HYAL2
gsea,regulation of protein localization (GO:0032880),0.41616052799749975,1.5230663108344207,0.03138075313807531,0.06493293783478016,1.0,9/30,27.29%,CTSD;HSP90AA1;RSL1D1;PICALM;TRIM46;MAP2;CSNK1E;UFL1;TRIM21
gsea,regulation of endothelial cell proliferation (GO:0001936),-0.38111561948328404,-1.5230326552856843,0.01718213058419244,0.10766097275456864,0.995,16/39,28.84%,PRKCA;HIF1A;NRP1;RGCC;NR4A1;STAT5A;ECM1;EGR3;ARNT;NF1;FGF2;PRKD2;NRP2;ITGB3;VASH2;F3
gsea,cellular macromolecule biosynthetic process (GO:0034645),-0.38073280364976525,-1.5222489462100697,0.06810035842293907,0.10765219581319278,0.995,64/183,35.00%,RPLP1;RPS27A;RPL13;RPLP0;RPL10A;EEF1B2;RPL8;RPSA;RPS18;RPL41;RPL15;RPL10;RPS8;MRPS6;RPS26;EEF1A1;RPL3;RPL7;RPS25;RPS2;RPL4;RPL14;RPL5;RPS6;EEF2;EEF1G;TNIP1;RPL7A;RPS17;RPS15;TBRG1;RPL31;POLR2A;NFKBIB;TOP1MT;FUBP3;RPL23A;EEF1D;ALAS1;PABPC4;EEFSEC;NBN;ORC5;POLR2E;YARS2;TUFM;HBS1L;MRPL37;BAZ2A;FARSB;RECQL5;ATM;MCM9;BCL3;MRPL11;DTX1;REV1;POLR2H;RHNO1;EIF4G2;THRB;GRWD1;TSFM;AGO2
gsea,protein secretion (GO:0009306),0.4607377002169348,1.5220167687940775,0.038461538461538464,0.0652989756236379,1.0,12/21,35.64%,ANXA1;CANX;PDIA4;MIA2;PARK7;CAMK2G;COPG1;RAB3D;NAGPA;MAFA;SNX19;ARFGAP3
gsea,negative regulation of binding (GO:0051100),0.38470034007923726,1.5217606656723714,0.012681159420289856,0.06528805127178793,1.0,20/50,26.34%,ACTB;CDKN1A;TLE5;BAX;AKT1;GZMA;AURKB;E2F1;PIN1;IFIT2;SP100;TFIP11;PARK7;CPNE1;PDGFB;AURKA;GTF2F1;CSNK1E;IFIT1;TMC8
gsea,'de novo' posttranslational protein folding (GO:0051084),0.47077331286342966,1.5187577378517498,0.0498960498960499,0.06648412567856694,1.0,14/24,36.27%,SDF2L1;HSPA5;PTGES3;DNAJB1;HSPA1B;HSPA1A;DNAJB4;ENTPD5;HSPA8;DNAJB13;HSPA14;HSPA13;HSPA2;UGGT1
gsea,positive regulation of interferon-gamma production (GO:0032729),-0.4482227589157096,-1.5186534078871219,0.034934497816593885,0.10950401841477192,0.995,13/26,16.51%,SLAMF6;CRTAM;IL18R1;ZFPM1;PDE4B;CD226;TNFSF4;IL23A;F2RL1;RASGRP1;EBI3;TLR7;SCRIB
gsea,cell chemotaxis (GO:0060326),-0.42188074764610467,-1.5174309541983035,0.03937007874015748,0.1097460132410554,0.995,16/30,24.42%,CCR7;CCR6;CXCR3;CCR8;NRP1;LEF1;KIT;CXCR4;CXCR5;NR4A1;CX3CL1;EGR3;ABCC1;HBEGF;CCL25;RAB13
gsea,Golgi organization (GO:0007030),0.3694226463396949,1.515845657150472,0.012219959266802444,0.06769538167452761,1.0,20/58,31.98%,ATP8B4;TMED2;CDK1;PLK3;LMAN2;FAM174B;LMAN1;OPTN;PI4K2B;ARL1;ATP8B2;ZW10;GCC2;MYO18A;ARHGAP21;LYSMD3;GORASP2;NPLOC4;ATL2;TMED1
gsea,negative regulation of angiogenesis (GO:0016525),-0.3744365674305478,-1.5157696524412345,0.02425876010781671,0.11017598360864934,0.995,22/42,33.43%,CD160;KLF4;GTF2I;RGCC;CXCL10;SERPINE1;KLF2;SPRY2;CTNNB1;SLC12A2;SERPINF1;SPRED1;ATF2;ROCK1;FOXJ2;TGFB2;PML;ROCK2;FOXO4;STAB1;PTPRM;AGO1
gsea,B cell receptor signaling pathway (GO:0050853),0.5074063449498163,1.5154316714863665,0.04265402843601896,0.06776194733245264,1.0,8/22,16.53%,LAT2;BAX;CD38;CTLA4;MEF2C;PLCG2;PLEKHA1;TEC
gsea,cell morphogenesis involved in differentiation (GO:0000904),-0.44147450285501394,-1.5152454311508428,0.031331592689295036,0.1099721254035129,0.995,6/26,12.26%,ACTN1;NRP1;ITGB7;RILPL2;PIK3R1;ATRNL1
gsea,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.40232136443754407,1.51278031252778,0.03684210526315789,0.06884669152023708,1.0,17/45,37.27%,CDKN2A;RGS2;AKT1;LYN;SMPD1;DAB2IP;PLK1;PRKAR2A;HHEX;RB1;PAQR3;PTPRJ;IPO7;IL1B;UCHL1;IPO5;PKIB
gsea,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.508775191489067,1.5125263431988205,0.03380281690140845,0.06884681456845813,1.0,8/24,20.48%,F2R;GNA15;CX3CR1;CALCA;F2RL2;GPR65;GNA11;F2RL3
gsea,positive regulation of interleukin-1 beta production (GO:0032731),0.5152661422420604,1.512513147549793,0.03962264150943396,0.06873369858125912,1.0,12/19,30.84%,CCL3;IFNG;EGR1;STAT3;MALT1;CASP1;TMEM106A;NLRP3;TLR4;HSPB1;TYROBP;CD36
gsea,cilium assembly (GO:0060271),0.3261914237456358,1.511907476482334,0.012371134020618556,0.06891531137273985,1.0,66/145,39.28%,TTC39C;FLNA;TUBB4B;SNX10;TUBA4A;CDK1;ACTR2;YWHAE;TUBA1A;HSP90AA1;CNTRL;EHD4;HAUS4;TUBG1;IFT27;NEK2;E2F4;PLK4;ACTR1A;PLK1;CEP57;CENPJ;EXOC4;CKAP5;TMEM107;HAUS8;ODF2;DYNC1I2;CEP250;HAUS6;NEDD1;DCTN1;CDC14A;EXOC8;HAUS5;CEP192;YWHAG;DYNLL2;TMEM80;CSNK1E;CCP110;TMEM237;KIF3A;KIF24;HAUS7;NDE1;EHD2;OFD1;TCTN3;CEP83;CEP76;HAUS2;SDCCAG8;SCLT1;CEP70;CCNO;PCNT;CEP89;RP2;CEP78;ALMS1;NOTCH1;DYNC1H1;CEP152;CEP72;CEP290
gsea,regulation of toll-like receptor signaling pathway (GO:0034121),0.5149350080217044,1.5118406858576419,0.05263157894736842,0.06883014768240013,1.0,8/15,33.53%,SMPDL3B;FLOT2;FLOT1;CACTIN;BIRC2;CD36;TLR2;LRRC14
gsea,positive regulation of protein polymerization (GO:0032273),-0.3985829543306587,-1.5117353666489532,0.028277634961439587,0.1119009621428196,0.997,15/32,34.69%,CCR7;EVL;PINK1;NCK2;PAK1;PFN2;TOGARAM1;CDC42EP3;NUMA1;HCK;FCHSD2;MET;ARL2;CLASP1;CTTN
gsea,positive regulation of wound healing (GO:0090303),0.5196036008000526,1.5110135770054225,0.043343653250773995,0.06902371960548627,1.0,10/18,23.51%,ACTG1;F2R;ANXA1;PRKCE;HRAS;ENPP4;XBP1;ST3GAL4;HPSE;MTOR
gsea,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.41098434712134824,-1.5100047019019427,0.021406727828746176,0.11255296958377314,0.997,13/32,34.31%,JAK2;CCN1;ENG;HIPK2;CREBBP;NUMA1;HSP90AB1;BMP7;TGFB2;MEN1;TWSG1;HFE;DAB2
gsea,regulation of interleukin-1 beta production (GO:0032651),-0.41865466018568986,-1.5090467494606847,0.02849002849002849,0.11250783867508111,0.997,10/33,15.03%,CCR7;JAK2;RIPK2;FOXP1;TNFAIP3;CD33;ZC3H12A;CX3CL1;F2RL1;GBP5
gsea,gonad development (GO:0008406),-0.474450378088766,-1.507479175500387,0.03896103896103896,0.11296804396575112,0.997,7/16,33.38%,KIT;AR;NCOA4;GATA3;TGFB2;SOX15;WNT2B
gsea,chromatin assembly (GO:0031497),0.4769776908854341,1.5068490322837453,0.050997782705099776,0.0709331946178802,1.0,13/25,22.24%,HMGB2;NAP1L1;CHAF1B;CHAF1A;NOC2L;CTCF;POLE3;NAP1L3;LIN54;ANP32B;RBBP4;NAP1L4;BRD2
gsea,regulation of mitochondrion organization (GO:0010821),-0.4527739805007257,-1.5047362848346646,0.03636363636363636,0.11426553922698292,0.997,10/24,27.28%,HTRA2;PINK1;PISD;VDAC1;PLSCR3;LRRK2;INF2;STAT2;MGARP;FBXW7
gsea,clathrin-dependent endocytosis (GO:0072583),0.5290495681913687,1.5041261417261649,0.05457746478873239,0.0721286209586488,1.0,6/15,16.59%,CLTB;CLTC;CANX;PICALM;AP2A2;ITSN1
gsea,potassium ion transport (GO:0006813),-0.4160066402818411,-1.5038279108634574,0.025179856115107913,0.11428212991737835,0.997,8/23,32.55%,KCNN4;KCNMB4;KCNK10;SLC9A9;KCNC1;KCNQ3;KCNMB1;KCNG2
gsea,chaperone cofactor-dependent protein refolding (GO:0051085),0.48492784800546407,1.503699463751993,0.05443548387096774,0.07222248736708622,1.0,10/20,29.20%,SDF2L1;HSPA5;PTGES3;DNAJB1;HSPA1B;HSPA1A;DNAJB4;HSPA8;DNAJB13;HSPA14
gsea,regulation of phagocytosis (GO:0050764),0.49020677644351995,1.5012250218334053,0.06003159557661927,0.07319417611591664,1.0,7/28,14.96%,FCER1G;IFNG;CALR;LMAN2;RAB27A;LYAR;IL15RA
gsea,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4901737450605705,1.5010944795255043,0.04538799414348463,0.07312995559306566,1.0,9/25,27.90%,HAVCR2;LTF;SLAMF1;PTPN6;CACTIN;VSIR;RARA;IL10;TLR4
gsea,regulation of protein kinase activity (GO:0045859),0.35821777874150273,1.500916458342504,0.020080321285140562,0.07308488799136198,1.0,27/59,34.30%,CDKN1A;MAP2K3;SNX9;PPIA;CSF1;AKT1;CAMK2N1;PTK2B;CENPE;SFN;CEACAM1;ECT2;PARK7;RB1;DUSP19;ALS2;TAB1;CAMKK2;YWHAG;PRKAG2;PRKRIP1;RAP2C;HSPB1;FGR;TRIB3;CEP85;CD4
gsea,hemopoiesis (GO:0030097),-0.3733422206824641,-1.5001904080147201,0.013745704467353952,0.11623959425822411,0.997,23/46,35.20%,ZFPM1;SH2B3;KIT;ETV6;CSF2;PRRC2C;TOX;IL3;TGFBR3;TNFRSF13B;PRDX3;KMT2A;TET2;PLD4;DLL1;KAT8;FLT1;TGFB2;BMI1;HIPK1;WNT2B;GLRX5;LYL1
gsea,positive regulation of protein phosphorylation (GO:0001934),-0.29359838041553843,-1.4992188300112284,0.006211180124223602,0.11626054350141896,0.997,159/159,99.56%,CCR7;CD74;FAS;NTRK3;JAK2;RACK1;CD81;RIPK2;NRP1;CCN1;RAMP3;PLAUR;PECAM1;PRNP;ENG;PINK1;CD44;LIF;PTPN11;SPRY2;ENPP2;CX3CL1;RASSF2;IL3;TRAF4;AXIN2;RASGRP1;PAK1;MAVS;PFN2;XRCC6;LCP2;LRRK2;TNKS1BP1;ABL1;DDX3X;NBN;SLCO3A1;FGF2;CLIP3;TERF2IP;BANK1;CCND2;TNIK;PRKD2;AKTIP;DVL2;MMD;FNIP1;HSP90AB1;BMP7;ITGB3;TGFB2;BRAT1;AXIN1;KNDC1;ROCK2;SPHK1;WDFY2;FBH1;DVL3;TWSG1;HFE;APP;ATG14;ARHGEF2;DAB2;MRNIP;CD80;DAXX;INHBA;DOCK7;ACVRL1;ITGA5;PGF;TNF;RBPMS;CD40;RPTOR;FXR2;ACVR1;HDAC6;RPS6KA5;C3;INHA;RALB;CDK2AP1;TAOK2;LATS1;IGF1;MMP9;GAS6;HAX1;RAPGEF2;BCAR3;GDF11;CSF1R;GPNMB;LIMCH1;CAMK1;SIRT1;CCND1;VEGFB;XRCC5;TMEM119;TGFB3;ARRB1;CD4;CALM2;IL1B;PDGFA;OSM;RAP2C;S1PR2;NOS1;VEGFA;PTPRJ;TNK2;PRKAG2;EIF4G1;CAMKK2;RIPK1;FMR1;ALS2;DUSP19;PDGFB;SH2D3C;RAP2A;TEC;ADAM17;MYDGF;PARK7;PLCG2;CNOT9;FLOT1;TTK;PLK1;RAD50;PIN1;TFRC;LRP8;MIF;CCND3;CENPE;FAM20A;HSP90AA1;HRAS;PTK2B;LYN;ATP2B4;CX3CR1;AKT1;CSF1;IFNG;PPIA;SNX9;MAP2K3;CDKN1A;MT3
gsea,negative regulation of transcription by RNA polymerase II (GO:0000122),0.2964128263447945,1.4981222335327402,0.0033003300330033004,0.07423494085979879,1.0,127/295,43.00%,ID2;CEBPB;IRF8;NEDD4;IFNG;ENO1;TLE5;TBX21;MXD1;HMGB1;PRDM1;MXI1;RUNX3;EZR;NCOR2;TMPRSS6;AURKB;CALR;STAT3;KLF10;PLK3;E2F7;HNRNPU;E2F1;SREBF2;HDAC1;UHRF1;GLIS1;CREM;ATXN1;KMT5A;NFIL3;ZFP36;SP100;HDGF;DAB2IP;CBX5;EHMT2;NOC2L;PLK1;ZBTB32;DNAJB1;LYAR;MDM2;CTCF;IRF2BPL;CNBP;PCGF2;EOMES;HHEX;MEF2C;RIPPLY3;MTDH;FOXM1;PPID;OSR2;ZEB2;TCERG1;E2F8;RIF1;DDX20;ETS2;RB1;TBL1XR1;IL33;PDGFB;SUV39H2;NR3C1;HSPA1A;SMARCA4;APBB1;DCAF1;WWC1;LARP7;SAP30;SMYD2;RARA;SUV39H1;ZFP90;IMPACT;CBX6;MAZ;SKIL;STAT1;ATF4;VEGFA;NFIC;MTA2;EED;ZBTB2;TAF3;HCFC1;BACH1;KLF11;HIC1;SP2;BAG3;PEG3;TRIB3;HOXB13;FOXP3;DUSP22;SKI;NR4A2;YAP1;E2F6;HCFC2;NOTCH1;CTR9;ZBTB16;CC2D1A;FST;DMAP1;CCND1;SIRT1;HDAC2;JDP2;CTBP2;SPI1;PPARG;WWOX;FOXE1;THAP1;TRPS1;TAF1;MAFK;SFPQ
gsea,positive regulation of establishment of protein localization (GO:1904951),0.5293595277015352,1.4954240330058137,0.07912087912087912,0.07539155801699113,1.0,4/16,14.22%,PTP4A3;CCT7;CENPJ;CCT8
gsea,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.46241476835943585,-1.4937334070411639,0.05179282868525897,0.11968631258308804,0.997,8/23,17.89%,ITPKB;SOCS5;SOCS3;SOCS1;PIK3R2;PIK3R1;TTC7B;SOCS7
gsea,regulation of interleukin-17 production (GO:0032660),-0.47294451234927404,-1.4934391683039367,0.07494145199063232,0.11924328882361855,0.997,10/18,29.97%,SLAMF6;PRNP;LY9;TNFSF4;IL23A;RFTN1;CCL1;DDIT3;SPHK1;IL2
gsea,neuron projection morphogenesis (GO:0048812),0.3727827311956273,1.491857127682408,0.025925925925925925,0.07699004454077357,1.0,20/53,33.13%,S100A6;ACTB;CTNND2;DAB2IP;RYK;BAIAP2;AFG3L2;CPNE1;KIF20B;MAP2;ALS2;APBB1;NEFH;MINK1;IMPACT;NCKAP1;DIP2A;LLGL1;MAP1A;EIF2AK4
gsea,microtubule polymerization or depolymerization (GO:0031109),0.5216139065078718,1.4917363369515417,0.07114624505928854,0.076901119801223,1.0,9/16,18.65%,STMN1;PIN1;KIF2C;KIF18A;CENPJ;CKAP5;KIF18B;KIF14;KATNB1
gsea,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.39488196864777975,1.49170085764561,0.04639175257731959,0.07678955183177255,1.0,21/47,31.08%,ADAM8;IFNG;AKT1;ATP2B4;HRAS;INCENP;LTF;CCND3;PIH1D1;DAB2IP;PIK3CG;ADAM17;PDGFB;ADRB2;SLC27A1;ETAA1;VEGFA;PSRC1;PDGFA;IL1B;CALM2
gsea,positive regulation of phosphorylation (GO:0042327),0.34512154227344577,1.4908997135518178,0.012413793103448275,0.07708650195167002,1.0,48/107,49.73%,CCL5;MT3;PPIA;IFNG;AKT1;LYN;GLMN;PTGES3;HRAS;HSP90AA1;FAM20A;CCND3;MIF;TFRC;PIN1;DSCAM;RAD50;RYK;FLOT1;MYDGF;ADAM17;RAP2A;FMR1;KCTD20;RIPK1;ENTPD5;CAMKK2;VEGFA;IL1B;VAC14;CD4;ARRB1;TMEM119;VEGFB;CCND1;SIRT1;LIMCH1;GPNMB;CSF1R;FLT3;THBS1;GAS6;MMP9;IGF1;CDK2AP1;RALB;DRD4;C3
gsea,regulation of mitochondrial membrane potential (GO:0051881),0.45481177708976056,1.4907335615459902,0.04945054945054945,0.07705399337813996,1.0,8/23,27.38%,PRELID1;BAX;AKT1;BAK1;STOML2;PARK7;NDUFS1;PYCR1
gsea,vesicle organization (GO:0016050),0.43762814612518997,1.4906933376542095,0.052104208416833664,0.07695310866934349,1.0,6/26,20.42%,CORO1A;SNX10;PLEKHF1;PI4K2B;ALS2;EXOC8
gsea,receptor internalization (GO:0031623),-0.4359372449340534,-1.4899542121324165,0.040380047505938245,0.1210257455697175,0.997,9/24,18.21%,ITGB1;CD81;CD9;RAMP3;SCYL2;RAMP1;GRK2;SAG;ADM
gsea,skeletal system development (GO:0001501),-0.364784112611195,-1.4882774653013295,0.02,0.12154645014867048,0.997,15/40,27.01%,RPL13;CREB3L2;ITGB8;CD44;VKORC1;SOX4;RFLNB;SH3PXD2B;ALPL;HAPLN4;PTGER4;P3H1;BMP7;TGFB2;RPS6KA3
gsea,cellular response to peptide hormone stimulus (GO:0071375),-0.3744216574810652,-1.4881769348519671,0.03414634146341464,0.12099084436461231,0.997,21/49,29.56%,ZFP36L1;TBC1D4;NFKB1;NR4A3;IRS2;NR4A1;PIK3R2;PIK3R1;SORBS1;SELENOS;HDAC9;FOXO1;C2CD5;HDAC5;SLC25A33;KAT2B;MGARP;ADCY6;RAB13;PRKDC;RELA
gsea,error-free translesion synthesis (GO:0070987),0.5090763963694475,1.4864443962572782,0.08225108225108226,0.07895340203757305,1.0,9/18,10.95%,RPA2;RPA3;PCNA;RFC2;RPA1;RFC5;RFC3;RFC4;POLD1
gsea,regulation of DNA binding (GO:0051101),-0.43837160480597315,-1.4839309265903708,0.06352941176470588,0.12350423014016382,0.997,9/24,29.63%,NFKBIA;JUN;JAK2;LEF1;PLAUR;MAPK8;DOT1L;SUMO3;BCL3
gsea,natural killer cell activation (GO:0030101),0.5093865048133557,1.4836753387642032,0.0625,0.08017340858090016,1.0,7/15,26.81%,PRDX1;ULBP1;IL21R;NFIL3;ELF4;RABL3;SLAMF7
gsea,chromosome organization (GO:0051276),0.3651168326368828,1.4814546354950744,0.026785714285714284,0.08119315751587547,1.0,35/70,41.14%,HMGB2;PADI2;HMGN2;TOP2A;CENPW;GEM;CDCA8;NUF2;HDAC1;COPS4;NUCKS1;CENPT;CENPV;CENPH;NDC80;HHEX;COPS5;POLE3;SMARCA4;CDT1;SUV39H1;COPS3;PWWP3A;RFWD3;NUP133;NUP155;LRWD1;DDB1;LIG4;GPS1;PHF19;SIRT1;HDAC2;COPS7B;CDAN1
gsea,positive regulation of nucleic acid-templated transcription (GO:1903508),0.30098530760863174,1.4776552583800087,0.004878048780487805,0.08306910298023654,1.0,112/258,42.66%,ID2;CEBPB;MT3;SPP1;MAP2K3;TBX21;HMGB2;F2R;HNRNPAB;AKT1;EGR1;HNRNPD;RUNX3;MED30;CD38;ARNT2;STAT3;E2F1;HDAC1;RUNX2;TAF15;NFIL3;ATAD2;SP100;SNX5;MRPL12;CTCF;BRCA2;BRCA1;DNAJC2;NUP62;CNBP;EOMES;HHEX;MEF2C;CD86;TESC;PICALM;FOXM1;SMARCC2;OSR2;NUP85;KLF6;TFEB;HMGN5;PSMC5;ZMIZ1;ETS2;TBL1XR1;PDGFB;ELF4;SMARCA4;APBB1;SHC1;FZD4;NPAT;WNT11;MYBL1;BRPF1;CAMKK2;TRERF1;MED14;RARA;ZFP90;MAZ;CHEK2;ILF2;STAT1;IL10;ATF4;NOS1;TADA3;JMJD6;BICRAL;HCFC1;ING5;BLM;PSRC1;KDM8;IL1B;SMARCC1;FOXF1;PHF5A;CDH1;SP1;FOXP3;MMS19;CD4;CHUK;ATXN7L3;NAA15;PCID2;HINFP;YAP1;TGFB3;WNT1;MLLT11;PPP3CB;NAA16;NOTCH1;NFYA;NCOA6;ZBTB16;CEP290;HDAC2;TRIP4;PPARG;ELF1;FOXE1;ETS1;DTX3L;PRMT2
gsea,regulation of mRNA stability (GO:0043488),0.3533762999419887,1.475652561018964,0.0472972972972973,0.08397975834332938,1.0,52/94,32.87%,VIM;AKT1;PSMA3;PSMB6;HNRNPD;EXOSC8;PSMB2;PSME2;SET;YBX1;PSMA4;PSMD14;HNRNPU;PSMA5;PSMB5;E2F1;MAPKAPK2;TAF15;ZFP36;SERBP1;PSMA6;PSMD1;PSMC1;PSMB7;PSMC2;PSMD12;XPO1;PSMD6;PSMC5;PSME3;PSMD3;EXOSC9;PSMD2;PSMC4;HSPA1A;PCBP4;PSMD11;FMR1;EXOSC3;SLC11A1;HSPA8;EIF4G1;EXOSC1;EXOSC4;PSMC6;EXOSC2;HSPB1;METTL14;PSME4;KHSRP;LARP1;TBRG4
gsea,cellular respiration (GO:0045333),0.459286738642828,1.4754814762535193,0.05894736842105263,0.08392379449724409,1.0,5/18,11.92%,ETFB;CYCS;MDH2;MTFR2;NDUFA5
gsea,B cell activation (GO:0042113),-0.37541391130518986,-1.4723297426582833,0.022435897435897436,0.13125760857840385,0.998,16/45,28.40%,ITGB1;GPR183;BCL2;CD70;KIT;TPD52;VCAM1;PRKCB;RASGRP1;TCF3;HDAC9;CD40LG;HDAC5;BANK1;CD79B;BLNK
gsea,regulation of macroautophagy (GO:0016241),0.37725261950186395,1.469276126396745,0.04121475054229935,0.08727696935026144,1.0,18/45,28.40%,NEDD4;GAPDH;AKT1;ATP6V0A2;ERN1;LZTS1;SCOC;BNIP3;SNX5;EXOC4;CASP3;EXOC8;VPS35;MLST8;MTOR;PRKAG2;CLN3;RRAGB
gsea,regulation of mitotic nuclear division (GO:0007088),0.44359659322902156,1.4680926879503424,0.06927175843694494,0.08778496657011194,1.0,19/31,31.57%,MKI67;FBXO5;NUSAP1;PKMYT1;PIN1;NEK2;CCNB1;ANAPC15;NUP62;PDGFB;AURKA;KIF20B;PDXP;CHEK1;CDC25C;NME6;CAV2;IL1B;RCC1
gsea,negative regulation of cell cycle (GO:0045786),0.39979138187689933,1.467943051842059,0.056261343012704176,0.08772296066972676,1.0,11/39,25.50%,CDKN2A;CDK6;RUNX3;CAMK2N1;GMNN;MAD2L1;PLK1;HHEX;RB1;IL10;IPO7
gsea,very long-chain fatty acid metabolic process (GO:0000038),-0.45699896222389297,-1.4666036237099531,0.04804804804804805,0.1350629230619122,0.998,9/16,36.78%,ACSL6;HACD1;ABCD3;ELOVL6;ACSL1;PEX2;ACOT1;ACOT4;ACOX1
gsea,positive regulation of stress fiber assembly (GO:0051496),-0.43348504272748045,-1.4664609320216622,0.05365853658536585,0.13452900777517113,0.998,8/22,15.52%,EVL;NRP1;RGCC;PAK1;PFN2;PPM1F;ABL1;CCDC88A
gsea,protein phosphorylation (GO:0006468),0.2894823606520489,1.4645037356723984,0.009025270758122744,0.08958573842801518,1.0,103/229,42.91%,CDK6;STK39;BIRC5;CCNA2;AKT1;MAPKAPK3;CDK1;RUNX3;CLSPN;STK32C;LYN;ABI3;BMP2K;PTK2B;AURKB;PRKCE;CIT;FAM20A;DAPK2;INCENP;ERN1;RIPK3;CCNE1;MAPKAPK2;CDK14;MASTL;NEK2;MAPK6;BCR;PLK4;DAB2IP;PLK1;PTPN6;TTK;EIF2AK3;RYK;LMTK3;TXK;TYK2;GMFB;PAK4;RNASEL;TEC;CDC7;PDGFB;AURKA;USP15;BCKDK;MATK;HASPIN;SLK;DYRK3;WNT11;NEK6;RIPK1;BRD2;CAMKK2;BAZ1B;MINK1;MTOR;EIF2AK2;RARA;PRKAG2;CSNK1E;CHEK2;GRK5;SRPK1;CHEK1;CAD;PEAK1;MAST3;TLR4;FGR;SYK;RIOK2;MAP4K1;TLR2;CDK4;CDK2;EIF2AK4;HUNK;CCL2;CTSG;CHUK;FES;ATR;PPP3CB;FAM20B;MAP2K6;GTF2H4;PPP4R1;MAP3K7;OXSR1;PIK3CD;CSNK2A2;CAMK1;CSF1R;FLT3;CDKL3;TAF1;CDK8;ERC1;PIM1
gsea,regulation of reactive oxygen species metabolic process (GO:2000377),0.4597920306305885,1.4642306775480485,0.04363001745200698,0.0895861574227552,1.0,10/25,25.76%,MT3;CDKN1A;BRCA1;FOXM1;PDGFB;COQ7;EIF6;RIPK1;DCXR;ALOX5
gsea,regulation of organelle organization (GO:0033043),0.3970909192355152,1.4636539850207098,0.040160642570281124,0.08976354721802973,1.0,16/34,27.80%,CAPN2;EZR;DIAPH1;ARL6IP1;LMAN1;CENPV;RDX;MYO5A;ZEB2;CLIC4;TMEM33;ARHGEF5;VPS35;CDT1;CLN3;RHOT2
gsea,peptidyl-proline modification (GO:0018208),0.4957986429236188,1.463332407530963,0.0847457627118644,0.08981241076847124,1.0,9/18,31.10%,PPIA;PPIG;PIN1;PPIL1;PPID;FKBP5;PPIH;PPWD1;FKBP4
gsea,peptidyl-lysine trimethylation (GO:0018023),-0.4995975789674049,-1.4610137654820707,0.06818181818181818,0.1382471401019279,0.998,11/17,23.47%,SMYD5;KMT5B;SETD1B;KMT2A;TET2;KMT2D;TET3;ETFBKMT;BEND3;SETD2;EEF2KMT
gsea,dephosphorylation (GO:0016311),-0.3494051733744071,-1.4601572413719202,0.021526418786692758,0.13821284429659791,0.998,31/65,33.18%,DUSP4;SSH2;DUSP6;DUSP1;PTPRK;PPP1CB;SSH1;PPP2R3A;PLPP1;PTPN3;UBLCP1;CTDSP2;DUSP10;PPM1L;ACP6;LHPP;CTDNEP1;PPP4R2;PPM1F;PTPN13;MTMR3;ALPL;ACP2;DUSP18;DUSP12;BTRC;DUSP7;PTPRS;PPM1M;DUSP16;PTPRM
gsea,protein modification by small protein conjugation (GO:0032446),0.30141968159116167,1.4598669238364037,0.017429193899782137,0.09156823523143967,1.0,69/180,32.70%,NEDD4;BSPRY;EPAS1;ASB2;UBE2C;UBE2M;ELOC;UBE2S;PCNA;ISG15;SUMO2;BARD1;SAE1;UHRF1;UCHL3;KEAP1;NDC1;PLK1;AAAS;MDM2;BRCA1;NUP93;NUP62;RANGAP1;RANBP2;DCAF15;UBE2N;DCUN1D3;GAN;ANKRD9;UBA2;RNF168;NUP85;STUB1;CDC34;UBE2T;NUP107;NUP43;CCNF;UBA1;ASB1;NUP35;KLHL25;UBA3;UBA6;LEO1;NUP160;NUP37;UBE2E3;FBXO45;NUP210;KLHL20;NUP54;KCTD13;UFL1;RFWD3;TRAIP;TMEM129;NUP133;TRIM21;CUL5;SPSB2;NUP88;NUP205;RAD18;USP5;HECW2;NUP155;DDB1
gsea,regulation of cytokine production (GO:0001817),0.3784732213081905,1.4595541569156334,0.02463768115942029,0.09164433170062264,1.0,29/70,30.03%,HILPDA;IRF8;IFNG;GAPDH;CCR2;ANXA1;LYN;GLMN;ISG15;ZBP1;LTF;MIF;RIPK3;MAPKAPK2;POLA1;DDX58;FLOT1;TXK;PIK3CG;AGPAT2;IL33;ASB1;SLC11A1;EIF2AK2;IL10;ALOX5;TRIM21;FGR;IL21
gsea,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3930695811755606,1.4593142056570603,0.03429355281207133,0.09163732536606736,1.0,20/53,38.41%,CXCR6;CCR5;CCRL2;CCR2;F2R;HMGB1;GNA15;CX3CR1;CD55;CALCA;F2RL2;CCR1;GPR65;ITPR3;S1PR4;F2RL3;GPR35;CD36;CIB2;C3AR1
gsea,negative regulation of intracellular signal transduction (GO:1902532),-0.31162833831760184,-1.4577900889147495,0.02032520325203252,0.1393512785817758,0.998,54/102,39.09%,RACK1;RORA;BCL2;RNF157;DUSP1;PLAUR;CD2AP;SH2B3;TNFAIP3;PEBP1;AJUBA;PIK3R2;ITPR1;PIK3IP1;PINK1;TNIP1;PER1;PDE10A;MGRN1;ZC3H12A;DDIT4;DGKD;PHLPP1;ARNTL;URI1;HDAC7;DDX3X;TRIM59;NF1;TSPAN6;TWIST1;HERPUD1;SPRED1;TNIP3;BANK1;OTUD7B;STAMBP;BCL2L1;DAG1;FNIP1;DDIT3;BMP7;ARHGAP25;TNFAIP8L1;TMEM127;NPRL3;RELA;AKT1S1;SH3BP4;UBR1;TANK;DLG5;HYAL2;TSC1
gsea,negative regulation of kinase activity (GO:0033673),0.4124834660352166,1.4564733744303908,0.049523809523809526,0.09319994890077159,1.0,16/31,34.20%,PPIA;AKT1;CAMK2N1;HNRNPU;SFN;CEACAM1;PARK7;RB1;DUSP19;TAB1;YWHAG;PRKAG2;PRKRIP1;HSPB1;TRIB3;CEP85
gsea,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3567594023191244,1.4562100679485614,0.0378657487091222,0.09318639110659996,1.0,23/59,30.64%,CTSD;RPS27L;F2R;HMGB1;CYCS;BAX;MALT1;CASP1;CASP8AP2;EIF2AK3;HIP1R;HIP1;HSPD1;TRAF2;ANP32B;BID;RIPK1;TNFSF10;NLRP3;PIDD1;APAF1;SYK;FADD
gsea,positive regulation of protein transport (GO:0051222),0.3959323863104032,1.4551065851398663,0.03697478991596639,0.09367962353252866,1.0,14/39,26.44%,ADAM8;PPIA;EZR;PLK3;EXPH5;PRR5L;FRMD4A;UNC13B;PPID;KIF20B;APBB1;ARHGEF5;MYO18A;CLN3
gsea,positive regulation of organelle organization (GO:0010638),0.46650790482327703,1.4539912300049789,0.06192660550458716,0.09421742188673703,1.0,5/17,18.17%,ANXA2;ANXA1;LMAN1;LNPK;ADRB2
gsea,cellular response to calcium ion (GO:0071277),-0.42395048950583003,-1.4537877164826938,0.07395498392282958,0.1418503947642768,0.998,25/25,93.74%,CPNE3;CAMK2D;ITPKB;SYT11;SYT4;CPNE9;LGMN;PPIF;RASA4;PRKAA1;DMTN;RASGRP2;ALOX5AP;SYT7;CPNE7;RYR1;ADD1;SLC25A24;CPNE2;CLIC4;CPNE1;ECT2;PLCG2;MEF2C;SMPD1
gsea,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.44363428988996617,1.4536578410933305,0.061855670103092786,0.09424236014035373,1.0,8/21,25.32%,CEBPB;BAX;BAK1;ERN1;DAB2IP;TRAF2;CHAC1;ATF4
gsea,transcription elongation from RNA polymerase II promoter (GO:0006368),0.38438786613658027,1.453466684848832,0.05324074074074074,0.09418717380470507,1.0,23/40,38.52%,ELOC;NELFE;POLR2C;ELOF1;POLR2F;POLR2L;NCBP2;GTF2F1;ADRM1;LEO1;ELP2;NCBP1;SSRP1;IWS1;ELOA;GTF2F2;GTF2H2;PCID2;NELFCD;POLR2B;ELL;CTR9;GTF2H4
gsea,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.3495271258841819,-1.4532452393118882,0.03581267217630854,0.1415754011204665,0.998,55/55,99.99%,CD74;JAK2;CD81;RIPK2;NRP1;PECAM1;KIT;SOCS3;PRNP;CSF2;CD44;TNFRSF18;LIF;PTPN11;IL6ST;ENPP2;IL23A;IL3;ABL1;BANK1;ITGB3;IL2;PIBF1;ARHGEF2;CD80;ITGA5;PARP9;TNF;CD40;ACVR1;IGF1;GAS6;HAX1;FLT3;CSF1R;CASS4;OSM;IL21;PARP14;VEGFA;PTPRJ;TNK2;PDGFB;TEC;CLCF1;PLCG2;TNFRSF1A;LRP8;MIF;STAT3;PTK2B;LYN;IFNG;NEDD9;CCL5
gsea,"phagocytosis, engulfment (GO:0006911)",0.5593980709446101,1.4528347483664716,0.04704097116843703,0.09438189648460925,1.0,5/15,20.57%,SH3BP1;MYH9;ITGAM;VAMP7;XKR8
gsea,positive regulation of secretion by cell (GO:1903532),0.4202786466822236,1.4525453512629865,0.0449438202247191,0.09441442531396399,1.0,13/35,31.26%,ADAM8;PPIA;EZR;EXPH5;RAB27A;BAIAP3;FRMD4A;UNC13B;PPID;APBB1;MYO18A;IL1B;STXBP5
gsea,potassium ion transmembrane transport (GO:0071805),-0.3738880868605462,-1.4521051290921847,0.048507462686567165,0.14184035262759873,0.999,14/31,35.67%,KCNN4;ATP1A1;KCNK10;ATP1B1;SLC9A9;SLC12A7;SLC12A2;SLC12A6;KCNC1;FXYD2;KCNQ3;KCNG2;ATP1A3;SLC12A3
gsea,telomere maintenance via telomerase (GO:0007004),0.4687693250429804,1.4520608732624352,0.082039911308204,0.09451455556135854,1.0,12/23,32.96%,TINF2;PTGES3;HSP90AA1;RPA1;NHP2;RAD50;PIF1;RFC1;PPP6R3;RTEL1;CDK2;WRAP53
gsea,regulation of organelle assembly (GO:1902115),-0.39310142184093605,-1.4515713301091524,0.040983606557377046,0.14159489781971013,0.999,21/36,31.21%,NPM1;PLK2;ATXN2;C9ORF72;TBC1D1;RABGAP1;USP6NL;IFT88;MTMR3;IFT140;TBC1D14;ADPRH;VPS11;GSN;HCK;TRAPPC12;PIKFYVE;SGSM3;NPRL3;SPICE1;TBC1D5
gsea,cellular response to radiation (GO:0071478),0.42420531879086065,1.4507355930717856,0.07756813417190776,0.09511935394431499,1.0,8/24,19.22%,CDKN1A;RAD51;FIGNL1;RAD51AP1;ECT2;RAD9A;SPIDR;HUS1
gsea,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.44095270009589493,-1.450672349185778,0.06741573033707865,0.14169323099364584,0.999,8/21,20.11%,TNFSF11;ZFP36L1;CD74;PRKCA;LEF1;LIF;IL23A;HSF1
gsea,nucleosome organization (GO:0034728),0.4133952517154045,1.4495621753895356,0.07939914163090128,0.09567059267953751,1.0,19/39,31.24%,HMGB2;NAP1L1;CHAF1B;SET;CHAF1A;CTCF;POLE3;NAP1L3;SMARCC2;ANP32E;LIN54;NASP;ANP32B;SMARCA4;NAP1L4;BRD2;SMARCB1;SMARCC1;SMARCA5
gsea,protein modification process (GO:0036211),0.41075261242477545,1.4491451861480102,0.05765765765765766,0.09579596093490965,1.0,12/34,25.60%,UBE2M;UBE2S;RPN1;RPN2;RIPK3;ST3GAL6;UBE2L6;SEPHS1;CDC34;UBA3;PLOD2;NAGPA
gsea,positive regulation of cell projection organization (GO:0031346),0.3912250340340854,1.4490171279690658,0.059422750424448216,0.09574285505078757,1.0,19/44,42.95%,ARSB;ARHGDIA;LYN;PTK2B;PLXND1;METRN;DAB2IP;SCN1B;FZD4;CAPRIN1;RAPGEF1;FES;ARHGAP35;MAP6;KIDINS220;CAMK1;SS18L2;CDKL3;RAPGEF2
gsea,negative regulation of cellular biosynthetic process (GO:0031327),0.40531175552383847,1.4486188015941779,0.0718232044198895,0.09577881224996497,1.0,8/28,19.56%,ACADL;PLEK;ATP2B4;DKKL1;BRCA1;CEACAM1;ABCA2;SLC27A1
gsea,response to tumor necrosis factor (GO:0034612),0.36505407931196604,1.4481331152047872,0.032362459546925564,0.09591720992231527,1.0,17/52,21.71%,CCL5;CCL4;CCL3;GBP3;AKT1;NPNT;SMPD1;ZFP36;DAB2IP;TNFRSF21;BRCA1;CACTIN;SMPD4;YBX3;DHX9;CASP3;RIPK1
gsea,regulation of fat cell differentiation (GO:0045598),0.4062798857282865,1.4477756496577794,0.04669887278582931,0.09598624727786671,1.0,19/38,41.36%,ID2;CEBPB;AKT1;E2F1;ZFP36;XBP1;ZADH2;FRZB;WNT10B;ENPP1;ALOX5;ANKRD26;TRIB3;YAP1;WNT1;ZFP36L2;ZBTB16;SIRT1;PPARG
gsea,regulation of epidermal cell differentiation (GO:0045604),-0.4717076170635344,-1.4472931519363745,0.05121951219512195,0.14366679542818292,0.999,6/16,23.72%,ZFP36L1;CTSL;AQP3;KLF7;DLL1;ROCK1
gsea,organonitrogen compound biosynthetic process (GO:1901566),-0.3290402945498592,-1.4467034934099137,0.022988505747126436,0.1434793165941937,0.999,31/70,36.11%,MGST2;GCH1;PCSK1;ASS1;PLPP1;TNIP1;HACD1;CHKA;PPM1L;SGMS1;FURIN;ALAS1;SLC44A1;GSTK1;ELOVL6;STARD10;PRKD2;GPHN;SAMD8;MFSD2A;LPCAT1;GSTZ1;FA2H;SPHK1;GSTM1;GPAT4;SGPL1;PCTP;NMRAL1;GSTA4;LPCAT2
gsea,post-Golgi vesicle-mediated transport (GO:0006892),0.38438518464156735,1.4459739307293038,0.04435483870967742,0.09688665006965745,1.0,18/36,37.63%,VAMP8;CLTC;EXOC4;MYO5A;AP1M1;OSBPL5;DOP1B;VAMP7;AP1G2;EXOC8;HSPA8;KLHL20;HGS;LLGL1;AP1G1;ARRB1;RP2;TXNDC5
gsea,neuron projection development (GO:0031175),-0.3205580774856451,-1.4459454645260765,0.027472527472527472,0.1433496944917733,0.999,34/75,34.69%,MAP4K4;PACSIN1;DCLK1;GPM6B;ARC;HDGFL3;KLK8;CAMSAP2;TMEM108;BTG2;BICDL1;GPRIN3;BLOC1S2;PAK1;LRRK2;IFT88;TAOK1;SGK1;ULK1;TNIK;MICALL1;ROCK1;UNC5A;RAB13;TBC1D23;BMP7;CAMSAP1;VASH2;SHANK1;FRY;CDK16;APP;PTPRM;CTTN
gsea,positive regulation of T cell activation (GO:0050870),-0.39944958154120375,-1.443559491698003,0.06588235294117648,0.14458846624628102,0.999,15/33,24.20%,CCR7;TNFSF11;CD81;CD70;TNFRSF13C;TNFSF4;SLC7A1;IL6ST;IL23A;VCAM1;NCK2;PDCD1LG2;CD40LG;ZBTB1;GATA3
gsea,response to gamma radiation (GO:0010332),0.4585314804006126,1.4431168087388702,0.076,0.09849471034905526,1.0,9/19,37.40%,TMEM109;HRAS;MDM2;DCUN1D3;FANCD2;LIG4;YAP1;ATR;XRCC5
gsea,positive regulation of cell junction assembly (GO:1901890),-0.4692629814788311,-1.442573221452313,0.07809110629067245,0.1446414412250037,0.999,6/15,23.72%,MAP4K4;NRP1;PPM1F;ABL1;CLSTN1;ROCK1
gsea,negative regulation of protein catabolic process (GO:0042177),0.4648491456335365,1.442105275272871,0.07606679035250463,0.09895320596194536,1.0,9/19,25.26%,FLNA;MAD2L1;PIN1;DAB2IP;HMGCR;BANP;SNRNP70;AZIN1;IL10
gsea,positive regulation of telomere maintenance (GO:0032206),0.4715642422891958,1.4415964126468002,0.0782608695652174,0.0991363270091055,1.0,5/19,10.43%,HNRNPA2B1;HNRNPD;AURKB;NEK2;RAD50
gsea,negative regulation of cell death (GO:0060548),0.38812561411809854,1.4415931748252664,0.052901023890784986,0.09898287464447922,1.0,19/38,27.35%,MT3;CSF1;AKT1;CD200R1;TMEM109;BNIP3;NUP62;PARK7;TRAF2;PSMC5;HSPA1B;TIGAR;SRSF6;HSPA1A;WNT11;VPS35;EIF4G1;IMPACT;TM7SF3
gsea,ion transport (GO:0006811),-0.37135459085431305,-1.4407739314164263,0.05014749262536873,0.14539086240970625,1.0,18/39,30.01%,SLC1A2;KCNN4;SLC15A1;SLC26A11;SLC26A2;WNK1;SLC9A9;PIEZO1;TRPA1;VDAC1;SLC15A2;ANO10;SLC12A7;SLC12A2;SLC12A6;SLC39A1;SLC25A22;GRIN1
gsea,long-chain fatty acid metabolic process (GO:0001676),-0.3888834518894791,-1.439746176371065,0.028070175438596492,0.1455661627241117,1.0,17/29,36.89%,EPHX1;ACSL3;ACSL6;PNPLA8;HACL1;GPX1;ELOVL6;AIG1;FADS2;ACSL1;PTGS2;ACOT1;ACAD9;FADS1;ACOT4;ACOX1;SLC27A3
gsea,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4441594236058415,1.439611258378053,0.05178571428571429,0.1000469248798977,1.0,8/24,16.77%,MT3;AKT1;YWHAE;PIH1D1;ARL6IP1;SFN;PARK7;DHCR24
gsea,positive regulation of biomineral tissue development (GO:0070169),0.486710141199702,1.438807938078768,0.06212121212121212,0.10030533653438622,1.0,5/17,14.66%,CEBPB;ISG15;FBXO5;MEF2C;OSR2
gsea,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4524850881800613,1.4384550461531378,0.08582834331337326,0.10036462492610865,1.0,8/20,20.75%,UBE2C;UBE2S;PIN1;PLK1;UBE2N;DCUN1D3;FZR1;CDC20
gsea,negative regulation of protein metabolic process (GO:0051248),0.44960254471859673,1.4378723230160513,0.05695142378559464,0.10052466441069356,1.0,11/24,22.37%,FLNA;MAD2L1;PIN1;LDLR;FLOT2;HMGCR;PFDN6;BANP;PFDN4;VBP1;AZIN1
gsea,positive regulation of supramolecular fiber organization (GO:1902905),-0.359706944685492,-1.4377008977532932,0.03303303303303303,0.14658544488719455,1.0,21/45,37.38%,CCR7;EVL;SYNPO;CX3CL1;NCK2;F2RL1;PAK1;PFN2;GPX1;TOGARAM1;CDC42EP3;NUMA1;HCK;FCHSD2;MET;ARL2;CLASP1;APP;CTTN;VIL1;EDN1
gsea,positive regulation of cell-substrate adhesion (GO:0010811),-0.38952061664087817,-1.4371343369191876,0.04788732394366197,0.14646787157006635,1.0,33/33,99.22%,CCR7;UTRN;JAK2;NRP1;CX3CL1;PPM1F;ABL1;NDNF;CCL25;RSU1;FN1;ARL2;C1QBP;DOCK1;GSK3B;DMTN;FBLN2;CASS4;CD36;JUP;TRIOBP;PDGFB;MYADM;DOCK5;P4HB;NPNT;CALR;PTK2B;FLNA;S100A10;CDK6;CSF1;NEDD9
gsea,negative regulation of tumor necrosis factor production (GO:0032720),0.4843850789948101,1.4364159248583195,0.06744868035190615,0.10125980390987879,1.0,8/23,27.90%,HAVCR2;SLAMF1;PTPN6;CACTIN;VSIR;RARA;IL10;TLR4
gsea,microtubule polymerization (GO:0046785),0.47509305796625206,1.4359959335957868,0.09791666666666667,0.10129215672775656,1.0,8/18,27.09%,TPX2;TUBGCP2;TUBG1;PIN1;CENPJ;CKAP5;NDE1;TUBGCP5
gsea,positive regulation of inflammatory response (GO:0050729),-0.3634065671942051,-1.4329801815549938,0.04834605597964377,0.14912126381548346,1.0,24/49,33.07%,NFKBIA;CD81;C2CD4B;PDCD4;MGST2;CCN4;NINJ1;NFKBIZ;SERPINE1;IL16;TNIP1;TNFSF4;IL6ST;CX3CL1;IL23A;TLR7;ABCC1;IL17RA;C2CD4A;CCL1;PTGER4;LPL;IL2;APP
gsea,regulation of microtubule polymerization or depolymerization (GO:0031110),0.4814043586627133,1.43259326257172,0.0847457627118644,0.10315785309449976,1.0,8/16,31.70%,STMN1;SKA1;SKA2;SKA3;MAP2;GBA2;FKBP4;MAP1A
gsea,nucleosome assembly (GO:0006334),0.4679172116871897,1.4310517461438625,0.1111111111111111,0.10392205857662677,1.0,13/23,23.55%,HMGB2;NAP1L1;ASF1B;CHAF1B;CHAF1A;NAP1L3;HAT1;NASP;ANP32B;RBBP4;NAP1L4;BRD2;HIRA
gsea,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4407298832137561,1.4304956710496686,0.05683563748079877,0.10410224161361917,1.0,10/32,30.52%,CCL5;IFNG;LYN;STAT3;TNFRSF1A;CLCF1;VEGFA;PARP14;IL21;OSM
gsea,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3161507841686705,1.430182375824932,0.0457516339869281,0.10413379675699583,1.0,48/105,42.00%,S100A4;LGALS1;LITAF;GAPDH;F2R;FLNA;MALT1;LTF;RHOC;CASP1;SLC20A1;TFRC;HMOX1;TNFRSF1A;DAB2IP;OPTN;NUP62;UBE2N;PLCG2;ECT2;MTDH;CACTIN;TRAF2;CPNE1;TRAF5;NEK6;RIPK1;BST2;TMEM106A;TNFSF10;BIRC2;STAT1;PIDD1;UFL1;TRIM21;HSPB1;PPP5C;FADD;TMEM101;IL1B;CD4;CHUK;SPHK2;MAP3K7;CC2D1A;SIRT1;IKBKG;NLRC3
gsea,protein tetramerization (GO:0051262),0.4119489212245705,1.4294251672925316,0.06104129263913824,0.10442828246884328,1.0,11/30,40.46%,ALDOA;TK1;ALDH9A1;GLS;SHMT2;HSD17B10;RYR1;ALDH1A3;CRYZ;GOLGA2;SHMT1
gsea,"DNA-templated transcription, elongation (GO:0006354)",0.374210428799931,1.4285074714652206,0.06004618937644342,0.10479277716593287,1.0,23/41,38.52%,ELOC;NELFE;POLR2C;ELOF1;POLR2F;POLR2L;NCBP2;GTF2F1;ADRM1;LEO1;ELP2;NCBP1;SSRP1;IWS1;ELOA;GTF2F2;GTF2H2;PCID2;NELFCD;POLR2B;ELL;CTR9;GTF2H4
gsea,regulation of secretion by cell (GO:1903530),0.4599514737947219,1.4281038460960627,0.07588532883642496,0.10483076694944428,1.0,10/20,31.26%,ANXA1;VAMP8;MCTP2;RHBDF2;RALA;MEF2C;FMR1;RAB3D;LLGL1;STXBP5
gsea,negative regulation of blood vessel morphogenesis (GO:2000181),-0.36259918086850274,-1.4264621309646446,0.047619047619047616,0.15389092093280993,1.0,19/35,33.43%,CD160;KLF4;GTF2I;RGCC;CXCL10;SPRY2;CTNNB1;SERPINF1;SPRED1;ATF2;ROCK1;FOXJ2;TGFB2;PML;ROCK2;FOXO4;STAB1;PTPRM;AGO1
gsea,interleukin-1-mediated signaling pathway (GO:0070498),0.3792588303462812,1.4263385324723379,0.07306889352818371,0.10586425733181087,1.0,25/48,22.25%,IL1R2;PSMA3;EGR1;PSMB6;PSMB2;PSME2;PSMA4;PSMD14;PSMA5;PSMB5;PSMA6;PSMD1;PSMC1;PSMB7;UBE2N;PSMC2;PSMD12;PSMD6;PSMC5;PSME3;PSMD3;PSMD2;PSMC4;PSMD11;TAB1
gsea,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.4481815932803196,-1.4241231634172684,0.08292682926829269,0.15521356140450232,1.0,6/16,19.18%,JAK2;IRS2;RASGEF1A;RASGRP1;ERBIN;EPOR
gsea,peptidyl-lysine modification (GO:0018205),0.3543819531827946,1.423939104563831,0.04633204633204633,0.10726851372053559,1.0,34/65,42.21%,SUMO2;SAE1;NDUFAB1;NDC1;AAAS;NUP93;NUP62;RANGAP1;RANBP2;UBA2;PARK7;GCSH;NUP85;NUP107;NUP43;NUP35;NUP160;NUP37;NUP210;PLOD2;NUP54;NUP133;NUP88;NUP205;PLOD3;NUP155;NUP214;PIAS4;SEH1L;SIRT1;ATPSCKMT;VPS33B;SIRT3;PIAS3
gsea,protein complex oligomerization (GO:0051259),0.3777508034929793,1.4239265103095942,0.04790419161676647,0.10710817856917536,1.0,13/43,31.30%,PRF1;ALAD;EHD4;TMEM120A;STOML2;ECT2;ALS2;RBMX;SHMT2;JMJD6;PRMT1;BLM;ATL2
gsea,positive regulation of RNA splicing (GO:0033120),0.44348501145734387,1.4233394287594314,0.10416666666666667,0.10730974096539593,1.0,10/20,27.55%,DAZAP1;ERN1;CELF4;U2AF2;HSPA1A;RBMXL1;RBMX;NCL;SF3B4;NCBP1
gsea,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4546011077312164,1.4227060357347343,0.056856187290969896,0.10752777387555634,1.0,6/22,14.75%,MAP2K3;ANXA1;ERN1;MAPKAPK2;DAB2IP;NUS1
gsea,positive regulation of response to DNA damage stimulus (GO:2001022),0.392043506227968,1.4217582844545358,0.07045009784735812,0.10800112913018776,1.0,20/34,40.36%,PCNA;SMCHD1;BRCA1;UBE2N;RNF168;NSMCE4A;ANKLE1;DHX9;TIGAR;BRCC3;FMR1;EEF1E1;HIC1;SPRED2;WRAP53;ATR;ERCC8;ABRAXAS1;RNF8;SIRT1
gsea,regulation of chemokine production (GO:0032642),-0.43607921481539647,-1.4210610599385245,0.07242990654205607,0.15702639176063884,1.0,8/21,12.74%,CD74;HIF1A;FOXP1;TNFSF4;SIGIRR;AIRE;F2RL1;TLR7
gsea,response to peptide (GO:1901652),-0.44298844225368517,-1.4207960357717342,0.0794392523364486,0.15653879329246165,1.0,11/20,25.06%,STAT4;RAMP3;PRNP;STAT5A;STAT5B;STAT6;IRF5;ERBIN;CACNA1A;STAT2;EIF2B4
gsea,regulation of cell death (GO:0010941),0.3765898214530093,1.4198819922469217,0.06181818181818182,0.10902966880295657,1.0,18/41,31.17%,CCL5;MT3;TMEM109;BNIP3;FAF1;PARK7;HSPA1B;DHCR24;SRSF6;HSPA1A;SLC25A24;WNT11;VPS35;EIF4G1;IMPACT;RRAS2;CD36;RAD18
gsea,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.4523332215515007,-1.4177260439932768,0.08719851576994433,0.15840196368114173,1.0,9/21,41.49%,RPS27A;GTF2H3;CUL4B;ERCC5;XPC;CUL4A;CDK7;GTF2H1;PARP1
gsea,negative regulation of cold-induced thermogenesis (GO:0120163),-0.4122090048902919,-1.417134625193056,0.06172839506172839,0.1581649457308537,1.0,9/21,34.22%,IL18R1;TLE3;ABHD6;ARNTL;TFE3;CIDEA;DDIT3;NR1H3;PCTP
gsea,positive regulation of apoptotic process (GO:0043065),-0.28102261761130787,-1.4168787601385007,0.01327433628318584,0.1577221731978783,1.0,160/160,99.85%,RPS27A;ITGB1;FAM162A;FAS;JUN;RACK1;BCL6;ARHGEF3;DUSP6;TNFAIP8;HTRA2;TIAM1;PRNP;RPS6;GADD45B;NET1;VAV3;ITGA6;ARHGEF9;VAV2;ZC3H12A;RASSF2;JMY;SCIN;PSEN2;ITGB3BP;SOX4;DLC1;ATG7;CTNNB1;MAPK8;FOXO1;ABL1;PMAIP1;DDX3X;NF1;TNFRSF10B;SCRIB;DNAJA1;IRF5;CLIP3;MYBBP1A;PRR7;RARG;PLEKHG2;ATM;ARHGEF18;DDIT3;ARHGEF11;TGFB2;MAP3K5;SOS1;FOXO3;PLEKHN1;RHOB;BCLAF1;GADD45A;C1QBP;CCAR1;LATS2;IP6K2;REST;ARHGEF2;PAWR;BOK;PXT1;ARHGEF19;SOS2;AIFM1;QRICH1;PNMA1;SHQ1;TFAP4;GADD45G;TRIM35;TGM2;GRN;MAP3K20;TNF;OMA1;STK3;TRIM39;FOXA1;UBB;ARHGEF12;DAPK1;MAP3K11;ERCC3;ARHGEF26;LATS1;MELK;CCAR2;PRMT2;NUPR1;FGD2;SIRT1;HTT;ANO6;KALRN;MLLT11;SPHK2;TGFB3;PTRH2;FADD;ING5;KLF11;TCTN3;APAF1;EEF1E1;PIDD1;UTP11;ATF4;TNFSF10;WNT10B;RIPK1;SFRP4;RRP1B;ARHGEF5;APBB1;FRZB;BID;MTCH2;CASP3;FGD3;ITSN1;DDX20;PPID;AIFM2;ECT2;DCUN1D3;FAF1;HSPD1;HIP1R;RNPS1;UNC13B;BCL2L11;PHLDA1;DAB2IP;DKKL1;BNIP3;IFIT2;ATF6;PHLDA3;BARD1;OLFM1;E2F1;DAPK2;CTLA4;SMPD1;ZBP1;BAK1;ABR;GZMA;TOP2A;PREX1;BAX;HMGB1;TLE5;CCL3;CTSD
gsea,negative regulation of interferon-gamma production (GO:0032689),0.4516497705263222,1.41528776733385,0.07516339869281045,0.11194358620119572,1.0,7/19,33.03%,HAVCR2;HMGB1;VSIR;RARA;TLR4;CD274;FOXP3
gsea,peptidyl-serine modification (GO:0018209),0.3167792279897829,1.4146100354095108,0.03619047619047619,0.1122154628053494,1.0,29/89,35.67%,STK39;AKT1;MAPKAPK3;CDK1;CLSPN;STK32C;PRKCE;MAPKAPK2;HPF1;MASTL;GALNT3;PLK1;TTK;EIF2AK3;CDC7;PDGFB;AURKA;DYRK3;NEK6;MTOR;CSNK1E;MAST3;GALNT1;MBOAT4;POGLUT3;MAP4K1;CDK2;CHUK;ATR
gsea,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.4425960013581225,1.4128843770935795,0.08541666666666667,0.1131498993032736,1.0,5/20,17.82%,RPS27L;HINT1;TMEM109;PHLDA3;AEN
gsea,negative regulation of double-strand break repair (GO:2000780),0.4570562657447206,1.4125428464115457,0.07520325203252033,0.11321587028018572,1.0,9/20,30.53%,CGAS;SMCHD1;AUNIP;TFIP11;PARPBP;RIF1;RMI2;FANCB;HELB
gsea,regulation of cardiac conduction (GO:1903779),-0.4002325651085031,-1.4124282590614976,0.08152173913043478,0.16080379234342695,1.0,7/23,12.86%,ATP2A3;TMEM65;ATP1A1;ITPR1;ATP1B1;ATP2B2;ITPR2
gsea,positive regulation of protein localization to plasma membrane (GO:1903078),-0.39989242008232084,-1.4113120354981414,0.07407407407407407,0.1610545878933859,1.0,12/31,35.64%,ITGB1;RACK1;ACSL3;RAMP3;SPTBN1;RANGRF;PIK3R1;SORBS1;CLIP3;EPHA3;NKD2;PRKCI
gsea,cell-cell junction organization (GO:0045216),0.4427933612129216,1.4093026124450372,0.062409288824383166,0.1151492499493674,1.0,14/30,37.50%,F2R;PKP3;CTNND2;CTNNA1;CDH17;MARVELD2;MYADM;DSG2;JUP;CDH1;TGFB3;NLGN2;DSP;LIM2
gsea,regulation of wound healing (GO:0061041),0.48777539552258414,1.408221112788094,0.07436708860759493,0.11567534876664044,1.0,5/18,6.43%,ACTG1;F2R;ANXA1;PRKCE;HRAS
gsea,positive regulation of protein secretion (GO:0050714),0.40157454279676147,1.4080283330094905,0.059654631083202514,0.11562478476451063,1.0,18/38,38.33%,ADAM8;PPIA;EZR;EXPH5;FRMD4A;UNC13B;ACSL4;PPID;APBB1;HCAR2;MYO18A;TM7SF3;TLR4;TLR2;TGFB3;NLGN2;MYH10;MCU
gsea,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.48562303393179973,1.4060516050492342,0.08366533864541832,0.11672836009881293,1.0,6/16,18.93%,CREB3L1;BCL2L11;EIF2AK3;XBP1;PARK7;HSPA1A
gsea,positive regulation of binding (GO:0051099),0.37632425165816696,1.4050783758164063,0.04723127035830619,0.11720298073280357,1.0,17/49,27.55%,STMN1;HMGB2;HMGB1;RAN;GMNN;NME1;PIN1;IDE;HIP1R;FLOT1;DHX9;ADD1;CDT1;CLN5;RARA;TRIM21;NCBP1
gsea,organelle disassembly (GO:1903008),0.4249147704186338,1.404648526896844,0.09409190371991247,0.11729950393040428,1.0,9/21,25.90%,CDK1;PLK3;PELO;DENR;KIF5B;KLC1;DYRK3;EIF2D;UFL1
gsea,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.3651080416473904,-1.403388780718471,0.0702576112412178,0.16730442341138838,1.0,16/41,37.07%,FAS;BCL2;TNFAIP3;CSF2;AR;SERPINE1;ITGA6;BIRC6;SH3RF1;DDX3X;TNFRSF10B;GPX1;BCL2L1;RELA;ARHGEF2;PHIP
gsea,positive regulation of cell adhesion (GO:0045785),0.40505095358748283,1.4030442815627113,0.0685805422647528,0.11827079447720863,1.0,10/35,30.25%,CCL5;ADAM8;ADGRG1;NPNT;FUT7;P4HB;PDGFB;PTPRJ;VEGFA;SYK
gsea,glycosaminoglycan catabolic process (GO:0006027),0.4515570294213441,1.4017011369264067,0.07782101167315175,0.11898632442412946,1.0,9/19,37.74%,ARSB;HMMR;HPSE;GALNS;VCAN;CEMIP2;GNS;GUSB;SDC3
gsea,regulation of histone acetylation (GO:0035065),0.44677012276973527,1.4016805724238228,0.09533468559837728,0.11882727620496791,1.0,12/21,34.65%,SET;NOC2L;BRCA1;PARK7;RUVBL2;CHEK1;NOS1;PAXIP1;IWS1;IL1B;FOXP3;ARRB1
gsea,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.4677489673156505,1.401101328101937,0.11324786324786325,0.11903753695756214,1.0,8/19,26.76%,EXOSC8;ERI1;RRS1;ERI2;EXOSC9;NOP9;EXOSC3;EXOSC2
gsea,muscle organ development (GO:0007517),-0.42882081376267905,-1.4004437204561635,0.0521978021978022,0.1693577506323587,1.0,8/18,18.51%,UTRN;TCF12;CXCL10;CHD2;EGR3;ITGA7;COPRS;HBEGF
gsea,response to lipopolysaccharide (GO:0032496),0.3623040052134321,1.3985917167837703,0.03571428571428571,0.12059997554421972,1.0,28/76,34.17%,CCR5;VIM;HMGB2;F2R;HMGB1;MAPKAPK3;CX3CR1;UPF1;CD14;CASP1;MAPKAPK2;ZFP36;DAB2IP;XBP1;MEF2C;CD86;CACTIN;ADAM17;SLC11A1;SBNO2;NLRP3;IL10;NOS1;TLR4;IL1B;CD274;CCL2;CTSG
gsea,cell-substrate junction assembly (GO:0007044),-0.425158879734344,-1.3984220096049347,0.07555555555555556,0.17049809198971191,1.0,5/19,12.40%,ACTN1;PTPRK;ITGA6;DLC1;SORBS1
gsea,snRNA 3'-end processing (GO:0034472),0.44455507552725104,1.3978570963824126,0.10144927536231885,0.12098988040377447,1.0,11/17,41.74%,EXOSC8;EXOSC9;EXOSC3;INTS5;TOE1;EXOSC4;EXOSC2;INTS2;INTS1;INTS8;EXOSC5
gsea,cellular response to metal ion (GO:0071248),-0.3496900265796246,-1.397407536630261,0.05806451612903226,0.17068258898842711,1.0,19/48,35.56%,CPNE3;JUN;CAMK2D;ITPKB;FOS;P2RX4;PRNP;NCF1;SLC41A1;HVCN1;MAPK8;LRRK2;SYT11;SLC12A2;HSF1;SYT4;HFE;ATP13A2;DAXX
gsea,protein N-linked glycosylation (GO:0006487),0.3749309495195262,1.397329755929351,0.07802874743326489,0.12117196712507762,1.0,22/36,31.04%,DDOST;RPN1;RPN2;MAGT1;LMAN1;STT3A;MGAT4B;ALG6;ALG8;DPAGT1;MPDU1;ENTPD5;ALG13;ALG3;ALG10B;ALG9;MGAT4A;GFPT1;DOLPP1;ALG2;B4GALNT2;PMM1
gsea,peptidyl-serine phosphorylation (GO:0018105),0.3185378916722138,1.3960923682426163,0.04790419161676647,0.12183066912512534,1.0,26/81,35.67%,STK39;AKT1;MAPKAPK3;CDK1;CLSPN;STK32C;PRKCE;ERN1;MAPKAPK2;MASTL;PLK1;TTK;EIF2AK3;CDC7;PDGFB;AURKA;DYRK3;NEK6;RIPK1;MTOR;CSNK1E;MAST3;MAP4K1;CDK2;CHUK;ATR
gsea,spliceosomal complex assembly (GO:0000245),0.42674576918922985,1.396035535188642,0.09750566893424037,0.12168167266253313,1.0,22/29,41.88%,SNRPD1;DDX39B;SNRPE;SRSF9;CELF4;LUC7L;SF3A2;SRSF6;SRSF1;SRSF10;USP39;PRPF19;SRPK1;NCBP1;GCFC2;SMN1;TXNL4A;SNRNP200;SCAF11;SF3A3;PRPF6;LUC7L3
gsea,DNA duplex unwinding (GO:0032508),0.3861592275066635,1.3949547654625198,0.10042735042735043,0.12225682760285307,1.0,17/38,38.52%,ANXA1;MCM4;RAD51;MCM2;MCM6;MCM7;RPA1;RAD50;DHX9;PIF1;RECQL;RTEL1;BLM;DDB1;GTF2H2;RECQL4;GTF2H4
gsea,negative regulation of apoptotic signaling pathway (GO:2001234),0.3655081542237096,1.391554754155385,0.06457242582897033,0.12447543927450559,1.0,14/43,24.37%,LGALS3;PRELID1;AKT1;CX3CR1;SLC25A5;PIH1D1;NOC2L;PARK7;FXN;PSME3;RB1;HSPA1A;RIPK1;MAZ
gsea,calcium ion transmembrane transport (GO:0070588),-0.3724308548437827,-1.3905331773589564,0.10263157894736842,0.1762902205784904,1.0,13/33,30.31%,ORAI1;P2RX4;TRPM1;ATP2A3;MCOLN2;TRPA1;MICU3;PMPCB;CACNA2D1;CACNA1A;CACNA2D4;GRIN1;LETM1
gsea,positive regulation of axonogenesis (GO:0050772),0.4805181254169369,1.3902541939603401,0.11307420494699646,0.12517108835198223,1.0,4/16,5.92%,ARHGDIA;PLXND1;METRN;L1CAM
gsea,regulation of cellular component organization (GO:0051128),0.32429565305146874,1.38952005073265,0.058931860036832415,0.12546785719972123,1.0,34/75,31.31%,NEDD4;CISH;MKI67;PACSIN2;HNRNPU;HSP90AA1;TFRC;ERMN;DAB2IP;HIP1R;HIP1;NUBP1;CEACAM1;PICALM;PARK7;PAK4;TRAF2;HJURP;METTL4;AURKA;KIF14;NCLN;TMEM97;RUFY1;HSPA8;MTOR;SOCS2;TMC8;HCFC1;RAPGEF1;BCAR1;SSRP1;CD36;RAB4A
gsea,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3541301646896079,-1.3889944904486555,0.04491725768321513,0.1768926092760082,1.0,41/41,99.73%,CCR7;NRP1;RIPOR2;PIK3R1;F2RL1;FUZ;EPS8L1;CCDC88A;CDC42EP3;BBS4;DOCK11;FNBP1L;PIK3CA;ABI2;EPS8;CARMIL2;BCAS3;ARAP1;FAM98A;PLEKHM1;CEP120;CDC42EP1;PALM;FSCN1;HTT;ARHGAP35;CDC42EP2;WNT1;TGFB3;DEF8;NCKAP1;CCP110;FMR1;ANLN;RALA;KCTD17;CYFIP1;HRAS;ACTR2;RHOQ;PFN1
gsea,negative regulation of cellular protein localization (GO:1903828),-0.4300135960365785,-1.3886575898395146,0.09236947791164658,0.1764421438687096,1.0,10/21,35.12%,GPM6B;RIPOR2;MFHAS1;DNAJA1;OTUD7B;LZTFL1;SIN3A;ROCK2;LATS2;TTBK2
gsea,nervous system development (GO:0007399),-0.27977447539603056,-1.3861465900204661,0.01171875,0.17806752496429276,1.0,137/137,96.25%,EVL;MARCKSL1;DCLK1;GPM6B;MBP;NINJ1;ST8SIA4;CXCR4;JARID2;PAFAH1B3;NRGN;ARHGAP26;SPOCK2;ADORA2A;B3GNT5;SDHA;IL3;SCIN;PRPS1;FGF13;AHI1;ROGDI;NF1;TMEM223;AXL;FGF2;GSN;ELP3;EGR2;HAPLN4;DVL1;MARCKS;TRAK1;RPS6KA3;RBM45;FN1;MET;GSS;BTBD6;CRIM1;DPYSL4;ATXN3;BTD;RITA1;DYRK1A;FEZ1;HDAC4;HPCAL4;RPS6KA6;HAP1;IGF2BP2;FKTN;INHBA;SOX10;NRCAM;EDNRB;SOX8;ERCC6;WWTR1;EFNB3;RAPGEF5;DHX30;ATN1;GDA;RBFOX2;EP300;PPP2R5D;FLRT3;CDK5RAP2;BPNT1;MTR;DPYSL5;IGSF8;GFRA4;NAGLU;IGF2BP3;NAV1;ADGRA2;PMP22;LIMK1;NPTX1;ACHE;GDF11;PCDH1;SPG7;NOTCH2;ZBTB16;FARP1;KALRN;ANKLE2;CHERP;WWP1;NLGN2;GFRA2;YAP1;LIG4;VCAN;LRCH4;CDH1;NAB2;GBA2;NCKAP1;APAF1;VEGFA;UTP11;WDR62;CHAC1;ALDH3A2;DNM3;THOC6;CLN5;CRMP1;APLP1;DCTN1;DPYSL2;SDCBP2;ZEB2;GMFB;ECT2;MEF2C;IRF2BPL;RYK;ACTL6A;HMGCR;STIL;ATXN1;DSCAM;SREBF2;SMPD1;L1CAM;CAPG;CHD7;STAT3;NAB1;PLXND1;SLC2A1;ARNT2
gsea,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.34432067642134956,1.3860341327179067,0.0815450643776824,0.1276553963455024,1.0,37/67,27.01%,TMSB4X;TNFRSF9;PSMA3;PSMB6;PSMB2;PSME2;PTK2B;PSMA4;PSMD14;PSMA5;PSMB5;EIF5A;ACTN4;TNFRSF1A;PSMA6;PSMD1;PSMC1;PSMB7;EDARADD;PSMC2;PSMD12;TRAF2;PSMD6;PSMC5;PSME3;ADAM17;PSMD3;PSMD2;PSMC4;TRAF5;PSMD11;RIPK1;BIRC2;STAT1;TNFSF12;PSMC6;TNFSF13B
gsea,calcium-mediated signaling (GO:0019722),0.378289722070895,1.3858423886898095,0.06114130434782609,0.12757020037001962,1.0,29/52,55.40%,CXCR6;CCR5;LAT2;CCL3;CCRL2;CCR2;CX3CR1;MCTP2;ATP2A2;CCR1;EIF2AK3;PLCG2;RCAN3;STIMATE;CAMKK2;PTPRJ;PPP1R9B;PPP3CB;MCU;DMTN;CCR3;SLC9A1;BTK;CCR9;SLC8A1;RCAN1;TNNI3;PRKAA1;PLA2G4B
gsea,cellular macromolecule catabolic process (GO:0044265),0.4130295179024216,1.3850954363035788,0.10505050505050505,0.12792400074948357,1.0,17/26,36.37%,ISG20;HNRNPD;RNASEH2B;DAB2IP;IDE;RNF5;DENND3;PPP1R8;NCCRP1;RIPK1;CHEK2;NCBP1;RNASEH1;RNASEH2A;MTREX;SND1;FBXO44
gsea,response to steroid hormone (GO:0048545),-0.4339611897416096,-1.3850231247403506,0.07213114754098361,0.17841825293144425,1.0,8/17,31.14%,ATP1A1;AR;TFPI;URI1;MGARP;TGFB2;SOX30;NR1H3
gsea,negative regulation of BMP signaling pathway (GO:0030514),-0.44230370374179484,-1.3845084699386834,0.09947643979057591,0.1781233371022137,1.0,9/16,33.48%,BAMBI;HIPK2;SMAD1;SMAD5;TRIM33;CRIM1;LEMD3;SMAD7;RBPMS2
gsea,negative regulation of response to external stimulus (GO:0032102),-0.3406785046711829,-1.3831343209340035,0.04745762711864407,0.17849445226016358,1.0,47/47,98.43%,KLF4;RORA;TRIB1;TNFAIP3;KLK8;MFHAS1;SERPINE1;TNFAIP8L2;SIGIRR;SELENOS;INPP5F;FGF2;GATA3;PTGER4;DHX58;PTPRS;NR1H3;C1QBP;TRAF3IP1;IL13;SIRPA;FEM1A;APOE;IRAK3;MEFV;FFAR4;ACOD1;NLRC3;PPARG;GHSR;MAPK7;TRIM21;ALOX5;IL10;NLRP3;VPS35;MVK;TRAFD1;DUSP3;RB1;CACTIN;LYAR;TNFRSF1A;LTF;AOAH;SMPDL3B;METRNL
gsea,regulation of Wnt signaling pathway (GO:0030111),-0.34132182830539015,-1.3812525901704718,0.05912596401028278,0.17940354422600793,1.0,19/45,34.36%,RACK1;FAM53B;TNFAIP3;TIAM1;GRB10;NFATC1;MACF1;CTNNB1;LRRK2;MDFIC;NLK;WLS;FZD7;BTRC;AXIN1;SOX30;SHISA2;APP;NKD2
gsea,negative regulation of epithelial cell proliferation (GO:0050680),0.3947607629079705,1.3807651130645429,0.10492845786963434,0.13085443412905925,1.0,11/34,28.84%,CDK6;TINF2;RUNX3;DAB2IP;BRCA2;CDKN2B;VASH1;CEACAM1;STAT1;ALOX5;CAV2
gsea,heart morphogenesis (GO:0003007),-0.44872403644485065,-1.3796192170389645,0.10511363636363637,0.1802120461331539,1.0,5/15,12.25%,ZFPM1;ENG;TTN;TGFBR3;DLC1
gsea,negative regulation of fat cell differentiation (GO:0045599),-0.42746039363630806,-1.3788279666551158,0.07511737089201878,0.18022211597162918,1.0,7/20,24.20%,RORA;ZFPM1;TRIB2;ARNTL;ASXL1;FOXO1;GATA3
gsea,protein-containing complex assembly (GO:0065003),-0.2869561400889567,-1.3785304732402506,0.012755102040816327,0.17977564525945622,1.0,134/134,99.05%,TCF7;CD74;FAS;CTSZ;TRAF1;LEF1;CD2AP;TIAM1;WIPF1;HGSNAT;TLE3;TLE4;ZC3H12A;KIFAP3;CX3CL1;ST13;AXIN2;MDN1;CTNNB1;NSF;LRRK2;ZNHIT6;MYC;CREBBP;FARP2;KMT2A;PPP6R1;CAND1;KMT2D;MCFD2;SH3PXD2B;HSF1;MITF;GEMIN5;FANCC;TRAPPC9;PYGO2;ANKRD28;TRRAP;PML;FN1;AXIN1;SHANK1;MEN1;SEC16A;TSPAN33;TUBGCP4;HFE;CUL1;BOK;VIL1;NDUFAF1;COL7A1;RUVBL1;SEC23A;LIN7A;PDE4DIP;DNAJB14;TFAP4;TCF7L2;BCL9L;MDM4;TNF;GSK3B;SEC31A;OPA1;CDC73;CD40;EP300;CUL3;ASH2L;PLEKHA7;TLE1;TGFA;SEC23IP;MATN1;AFDN;WDCP;MEFV;SLC9A1;DNAJB12;REPS2;COL16A1;DMTN;IKBKG;SPG7;NIFK;GOLGA2;ANO6;MCU;YAP1;USO1;FADD;LLGL1;BLM;PPP6R3;SEC24A;FANCA;LEO1;RIPK1;PPIH;KPNA3;ZW10;USH1C;SMARCA4;CNIH2;CDC123;TSPAN4;SAMM50;DHX9;TRAF2;PPID;PICALM;AFG3L2;KNTC1;STOML2;PDZD11;MDM2;RBBP5;TNFRSF1A;LMAN1;HDAC1;TUBGCP2;LPXN;AREG;CAPZA2;SEC24D;CAPG;PTK2B;SLC2A1;TMED2;CHCHD10;LAMC1;SNX9
gsea,axonogenesis (GO:0007409),0.32665643848259585,1.3776703267180443,0.046801872074883,0.1330610558363855,1.0,38/84,41.18%,S100A6;ACTB;SEMA4A;EZR;DOK2;L1CAM;HSP90AA1;CYFIP1;GRB7;DSCAM;RYK;BAIAP2;SCN1B;AFG3L2;KIF5B;B4GALT5;PDLIM7;APBB1;SHC1;NCAM1;NEFH;MAPK7;LLGL1;SEMA7A;MAP1A;SEMA6D;GFRA2;ENAH;PPP3CB;NOTCH1;SPTA1;ARHGAP35;PIK3CD;SPG11;NOTCH2;SHTN1;LGR6;BSG
gsea,heme biosynthetic process (GO:0006783),0.4693351187929217,1.3774974802949949,0.08176100628930817,0.13278914704086683,1.0,7/15,34.23%,ALAD;HMBS;FXN;PGRMC1;CPOX;ABCB10;COX15
gsea,porphyrin-containing compound biosynthetic process (GO:0006779),0.4693351187929217,1.3774974802949949,0.08176100628930817,0.13278914704086683,1.0,7/15,34.23%,ALAD;HMBS;FXN;PGRMC1;CPOX;ABCB10;COX15
gsea,lipid transport (GO:0006869),0.36581532278594364,1.3767439583698025,0.07861060329067641,0.1331561790559349,1.0,17/43,38.67%,PRELID1;PRELID3B;FABP5;LDLR;CEACAM1;ABCA2;OSBPL5;PITPNB;PLTP;SLC27A1;GOT2;CLN3;SLCO2A1;CD36;OSBP;PRELID3A;ABCA7
gsea,regulation of RNA splicing (GO:0043484),0.36627894036566305,1.3761842290279367,0.07142857142857142,0.1333723612737099,1.0,16/37,26.87%,SRSF3;AHNAK;HNRNPF;ERN1;MBNL3;PTBP1;SNRNP70;U2AF2;METTL4;HSPA1A;SRSF10;RRP1B;LARP7;HNRNPK;SRPK1;JMJD6
gsea,import into nucleus (GO:0051170),0.36998675231872397,1.375926670568599,0.10176991150442478,0.1333536689840454,1.0,29/54,35.99%,RAN;AKT1;SNRPD1;SNRPD3;STAT3;SNRPB;NUTF2;SNRPE;NUP93;NUP62;HNRNPA1;NUP85;NUP107;DDX20;HIKESHI;KPNB1;E2F3;GEMIN2;SNRPF;IPO7;NUP133;IPO9;NUP88;SYK;NUP155;RANBP6;IPO5;NXT1;SMN1
gsea,negative regulation of metabolic process (GO:0009892),-0.3948319870886803,-1.3758731790613699,0.07197943444730077,0.1816576843736056,1.0,9/22,34.22%,IL18R1;TLE3;ABHD6;ARNTL;TFE3;CIDEA;DDIT3;NR1H3;PCTP
gsea,vesicle cytoskeletal trafficking (GO:0099518),0.47346314693194497,1.3736298197189563,0.08605341246290801,0.1350298995749532,1.0,8/20,31.92%,MYO1F;MYO1G;ACTN4;KIF5B;MYO5A;CLN3;NDE1;MYO6
gsea,carboxylic acid metabolic process (GO:0019752),0.47879026351522214,1.3733223256911071,0.09339774557165861,0.13506812978403052,1.0,5/17,9.82%,SLC2A3;SLC2A1;GSTO1;MIF;PON3
gsea,cellular response to reactive oxygen species (GO:0034614),-0.3684104545357062,-1.3716313924895314,0.0863157894736842,0.18473119899783141,1.0,16/36,31.36%,JUN;FOS;TNFAIP3;PTPRK;NET1;NFE2L2;NCF1;PDK2;MAPK8;PRDX3;ABL1;ANKZF1;MAP3K5;RELA;RHOB;ERCC6L2
gsea,regulation of response to external stimulus (GO:0032101),0.3443792893122692,1.3712511782802046,0.0528,0.13632794729394662,1.0,29/64,41.25%,TMSB4X;CCR2;F2R;ANXA1;PIK3AP1;CD55;ZBP1;USP14;CASP1;LRP8;METAP2;PSMA6;PARK7;ERAP1;NMT1;ZMPSTE24;SBNO2;BIRC2;ALOX5;UFL1;AKNA;FGR;SEMA7A;CD36;TKFC;LACC1;FCGR2B;CASP12;FNTB
gsea,peptidyl-asparagine modification (GO:0018196),0.4772177554719418,1.3711870795953387,0.10638297872340426,0.1359763641857983,1.0,7/15,15.39%,DDOST;RPN1;RPN2;MAGT1;LMAN1;STT3A;ALG8
gsea,protein N-linked glycosylation via asparagine (GO:0018279),0.4772177554719418,1.3711870795953387,0.10638297872340426,0.1359763641857983,1.0,7/15,15.39%,DDOST;RPN1;RPN2;MAGT1;LMAN1;STT3A;ALG8
gsea,regulation of cell adhesion (GO:0030155),0.3422061612681613,1.3711830208378013,0.05565217391304348,0.13577901097217598,1.0,23/60,34.38%,CCL5;ADAM8;ADGRG1;ARHGDIA;LYN;PTK2B;PLXND1;LPXN;SPN;FUT7;DSCAM;P4HB;ZDHHC2;PIK3CG;TESC;MYADM;KIF14;MINK1;PTPRJ;VEGFA;PDE3B;PLAU;FES
gsea,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3679206254250132,-1.3709478607938133,0.08471074380165289,0.18462034344172415,1.0,19/36,34.36%,RACK1;TRIB1;SOCS5;RNF19A;BAG2;RNF19B;DNAJB2;TRIB2;LRRK2;NUB1;ZER1;CBFA2T3;DVL1;FBXW7;VCP;AXIN1;SMAD7;DAB2;NKD2
gsea,nucleus organization (GO:0006997),0.4255807006476107,1.3706006451472241,0.11320754716981132,0.1360227735010231,1.0,10/21,32.07%,REEP4;CEP55;NDC1;NUP93;PITPNB;NUP35;NUP54;NUP133;NUP205;NUP155
gsea,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.41619091673551106,-1.3682740096801513,0.10263157894736842,0.1864863404722652,1.0,10/21,28.64%,DUSP4;DUSP6;SPRY1;TNIP1;DUSP10;SPRY2;SPRED1;FBLN1;SPRED3;CNKSR3
gsea,regulation of protein metabolic process (GO:0051246),-0.40424595212050685,-1.3670449624518228,0.10059171597633136,0.18694429732247672,1.0,11/25,35.54%,KLF4;PLAUR;ODC1;SSH1;KLF2;FURIN;MAPK8;HSP90AB1;ROCK2;APP;PARL
gsea,phosphatidylinositol biosynthetic process (GO:0006661),-0.3284905606862644,-1.3668823104801238,0.0724907063197026,0.18637189904186052,1.0,27/65,35.79%,INPP4B;ITPKB;SOCS5;SOCS3;PIK3R6;SOCS1;PIK3R2;PIK3R1;TTC7B;SYNJ2;PTPN13;INPP5F;MTMR3;PIGL;FGF2;SOCS7;PIK3R4;PITPNM2;PIGH;SYNJ1;PIKFYVE;PLEKHA8;SOCS6;PIK3R5;IP6K2;FAM126B;PIK3CA
gsea,positive regulation of DNA recombination (GO:0045911),0.4282948420246291,1.3666114584836562,0.09603340292275574,0.13883046559139972,1.0,9/21,33.32%,ACTR2;TFRC;RAD51AP1;RIF1;TIMELESS;PAXIP1;FANCB;WRAP53;MMS19
gsea,positive regulation of immune response (GO:0050778),0.37939950293774377,1.3662344959800947,0.08159722222222222,0.13891616961830683,1.0,18/35,43.16%,CCL5;ADAM8;IFNG;IL12RB1;ITGAM;XBP1;POLR3G;DHX9;NLRP3;IL10;POLR3D;FADD;EIF2AK4;SPHK2;POLR3F;FCGR2B;SIRT1;AKIRIN2
gsea,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.44837320310891726,-1.3659867433716826,0.10021786492374728,0.18650640959911055,1.0,7/17,30.71%,ACSL3;ACSL6;HACD1;FASN;ELOVL6;CBR4;ACSL1
gsea,positive regulation of cellular amide metabolic process (GO:0034250),0.3609122260251513,1.3658879176076557,0.07428571428571429,0.13898031602353844,1.0,17/47,25.61%,VIM;IFNG;RPS27L;HNRNPD;EIF4A3;TNFRSF1A;EIF3D;EIF3C;PICALM;ABCA2;CASP3;EIF6;FMR1;MTOR;PIWIL2;LARP4B;GSAP
gsea,positive regulation of chemotaxis (GO:0050921),-0.4212455523913608,-1.3652118437212017,0.09451219512195122,0.18645235622817358,1.0,10/20,28.84%,XCL1;NTRK3;NRP1;P2RX4;F2RL1;PPM1F;FGF2;PRKD2;MET;F3
gsea,RNA biosynthetic process (GO:0032774),0.45479137192839286,1.365060548032938,0.13588110403397027,0.1394042570146291,1.0,11/17,38.75%,PRIM1;POLA1;PRIM2;POLA2;HELB;TTF2;SMARCA5;TAF6;SMN1;TBP;NCOA6
gsea,lymphocyte differentiation (GO:0030098),-0.3527043193097217,-1.3626796113959518,0.0703125,0.18821358948375944,1.0,17/42,29.97%,ITGB1;KIT;TPD52;RELB;TOX;VCAM1;SOX4;TCF3;HDAC9;AXL;HDAC5;GATA3;LY6D;IKZF1;CD79B;BLNK;IL2
gsea,negative regulation of transport (GO:0051051),-0.4201722427574659,-1.3623608349588938,0.0943952802359882,0.18778399621236846,1.0,7/19,15.42%,RACK1;TRAT1;MCTP1;CRYAA;PPM1F;PLSCR1;SYT11
gsea,positive regulation of DNA biosynthetic process (GO:2000573),0.39230675629120904,1.3603761803532484,0.12863070539419086,0.14284432965028487,1.0,24/42,37.55%,PCNA;RFC2;AURKB;PTGES3;HSP90AA1;RFC5;NEK2;RFC3;RFC4;CCT7;DSCC1;HNRNPA1;CCT8;CHTF18;PDGFB;TCP1;MAP3K4;WRAP53;CHTF8;CCT6A;ATR;PKIB;XRCC5;CCT5
gsea,regulation of cellular component biogenesis (GO:0044087),0.40315394451415815,1.3596855216696297,0.12092130518234165,0.14310943529759035,1.0,13/26,30.84%,EZR;HSP90AA1;DAB2IP;RDX;TRAF2;HJURP;NCLN;FAM110C;HSPA8;PARP10;HCFC1;RAPGEF1;CD36
gsea,epidermis development (GO:0008544),0.44125751709095096,1.3589574807622702,0.11627906976744186,0.14341615620492446,1.0,13/22,41.37%,YBX1;FABP5;HDAC1;ATP2A2;FLOT2;LAMC2;ALDH3A2;EMP1;HOXB13;EVPL;DSP;HDAC2;SPRR1A
gsea,lipid homeostasis (GO:0055088),-0.3839965564446454,-1.3565117166179512,0.08638743455497382,0.19252790702507958,1.0,17/27,33.92%,ZBTB20;IRS2;THADA;PNPLA8;TLCD1;ABCG1;DDX3X;ABHD4;ABCB4;ADCK1;RCN3;TLCD2;LIPG;FBXW7;NR1H3;ATP13A2;ABCA1
gsea,response to metal ion (GO:0010038),0.39333445953592516,1.3559727436232465,0.0831889081455806,0.14546926563322402,1.0,12/29,31.08%,MT3;NEDD4;CRIP1;PPP2CB;TRPC1;ITPR3;FXN;SLC30A4;AHCYL1;PPP5C;ALG2;CALM2
gsea,positive regulation of histone modification (GO:0031058),0.45319845691804794,1.3548975693576748,0.11886792452830189,0.14615906784277555,1.0,9/17,34.65%,BRCA1;UBE2N;FMR1;RUVBL2;NOS1;PAXIP1;IL1B;FOXP3;ARRB1
gsea,regulation of hydrolase activity (GO:0051336),0.4192212591886534,1.3544820501489367,0.09206349206349207,0.1462561782381797,1.0,9/27,25.98%,CHN2;ADAP1;SIPA1L1;PLXND1;DAB2IP;RDX;FGD3;ARHGEF5;NOS1
gsea,regulation of ion transmembrane transporter activity (GO:0032412),0.4481848808489439,1.3542734667596383,0.09523809523809523,0.1462020308240883,1.0,6/20,23.36%,NEDD4;STK39;YWHAE;SCN1B;RIPK1;AHCYL1
gsea,regulation of chromosome organization (GO:0033044),0.46369217333526913,1.353235590655594,0.12875536480686695,0.14687556971120336,1.0,8/15,27.97%,HNRNPD;UPF1;BUB1;CENPV;RB1;CDT1;PIF1;RMI2
gsea,endomembrane system organization (GO:0010256),0.2973630226584152,1.3523395546810035,0.07184466019417475,0.1473668810756392,1.0,44/97,43.76%,ATP8B4;SNX10;TMED2;REEP4;LMAN2;FAM174B;LMAN1;PLEKHF1;EIF2AK3;OPTN;PI4K2B;NUP93;ARL1;LNPK;SMPD4;ATP8B2;SYNGR1;DOP1B;ALS2;EXOC8;ZW10;BNIP1;MYO18A;ARHGAP21;SYNGR2;AP3D1;LYSMD3;GORASP2;CAV2;NPLOC4;ATL2;TMED1;NUP155;RAB30;STX17;GOLGA2;HTT;NSFL1C;ARFGEF2;VPS33B;GAK;SEC61A1;CLASP2;SYNE1
gsea,circulatory system development (GO:0072359),0.3684802457190295,1.3496985643909543,0.085383502170767,0.14933045244990903,1.0,16/52,38.75%,ID2;CDKN1A;CRIP1;MICAL2;MEF2C;NXN;MTHFD1;PDGFB;PDLIM7;ZDHHC16;CACYBP;UTY;FOXF1;SMYD4;NOTCH1;NCOA6
gsea,glycosphingolipid metabolic process (GO:0006687),-0.4399162590070608,-1.3493521612897752,0.10305343511450382,0.19845056587890433,1.0,7/17,26.34%,ST6GALNAC3;ST8SIA1;CERK;GLA;HEXA;GM2A;ST6GALNAC6
gsea,regulation of signal transduction (GO:0009966),-0.3005926307095977,-1.3470270347733486,0.05080213903743316,0.19999883744130864,1.0,39/72,40.24%,RORA;CASTOR1;IGFBP2;SOCS5;PRNP;PTCH1;BST1;USP33;TMEM108;IGFBP7;DHRS3;TSPYL2;CX3CL1;GNG4;IL3;NCK2;FUZ;OVOL2;GRK2;LRRK2;IFT81;CREBBP;PLSCR1;HOMER1;MDFIC;TULP3;DLL1;SIK2;TIMP1;GATA3;TRIM5;AXIN1;DTX1;APP;CD63;CD80;RUNX1;WDR11;WWTR1
gsea,positive regulation of cell-cell adhesion (GO:0022409),0.4494096506873499,1.3468398839932643,0.12140575079872204,0.151443814415468,1.0,4/22,12.26%,CCL5;ADAM19;FUT7;FLOT1
gsea,nitrogen compound transport (GO:0071705),0.3293518327730215,1.3467373688381852,0.06563039723661486,0.15129380156211628,1.0,22/59,41.52%,HSP90B1;SLC52A3;SLC3A2;MYH9;CENPF;SLC16A10;NDC1;SLC7A5;SLC1A5;SLC6A13;HIKESHI;RUFY1;SLC11A1;KIF3A;SLC7A3;SLC52A2;ARRDC3;SCAMP4;CEP290;SLC19A2;CMTM6;VPS33B
gsea,organelle assembly (GO:0070925),0.28128967271018157,1.3463834208231027,0.050980392156862744,0.1513635401589247,1.0,73/166,39.90%,CORO1A;TTC39C;FLNA;SNX10;CENPW;ACTR2;CENPF;EIF2S1;DLGAP5;CENPE;EHD4;HAUS4;TUBGCP2;GRB7;NEK2;E2F4;ATP2A2;SAC3D1;ANLN;CENPT;PLK4;SQLE;CENPA;NUP62;CENPJ;EXOC4;LSM3;G3BP1;TMEM107;ATG9B;HAUS8;FLII;CEP250;HAUS6;CDC14A;RBM14;EXOC8;MIS12;NEK6;HAUS5;PACS2;STAM2;DYNLL2;UBAP2L;TMEM237;KIF3A;KIF24;HAUS7;TUBGCP5;VPS37C;EHD2;HGS;OFD1;TCTN3;RAB32;CEP83;GORASP2;ATXN2L;PATL1;BICD1;RCC1;HAUS2;SCLT1;CCNO;PCNT;CEP89;TUBGCP3;RP2;NOTCH1;DYNC1H1;GOLGA2;CEP290;NSFL1C
gsea,regulation of activated T cell proliferation (GO:0046006),-0.4190890805297812,-1.3458850187120477,0.12373737373737374,0.2004469153440965,1.0,7/16,16.51%,CRTAM;IGFBP2;PRNP;TNFSF9;IL23A;PDCD1LG2;SCRIB
gsea,central nervous system development (GO:0007417),-0.29058389811924873,-1.3446407414216208,0.03488372093023256,0.20095969111724138,1.0,50/93,39.72%,MARCKSL1;DCLK1;MBP;SCYL2;CXCR4;PTCH1;JARID2;PAFAH1B3;ADORA2A;B3GNT5;PTPN11;DDIT4;SCIN;LSR;SOX4;CDK5RAP1;AHI1;SYNJ2;ROGDI;RAB3GAP1;NF1;PBX4;BPTF;SMG9;GSN;ELP3;DLL1;EGR2;HAPLN4;SYNJ1;TBC1D23;PLXNB2;MARCKS;MFSD2A;RPS6KA3;POMK;ABCB6;GRIN1;BTD;PHF8;EML1;DHX37;HPCAL4;RPS6KA6;HAP1;C1QA;PBX2;SOX10;NRCAM;SOX8
gsea,regulation of interferon-beta production (GO:0032648),-0.3746532356026846,-1.3438212469604442,0.12040816326530612,0.20108049548506643,1.0,15/32,30.57%,REL;RIPK2;RELB;PTPN11;TRIM56;MAVS;TLR7;OAS3;DDX3X;IRF5;POLR3B;IRF7;IFIH1;DHX58;PTPRS
gsea,regulation of MAP kinase activity (GO:0043405),-0.33300830392018366,-1.3420891187441721,0.07932011331444759,0.20195741073293058,1.0,24/48,38.46%,TNFSF11;SPRY1;DUSP1;SH2B3;KIT;TRIB1;PIK3R6;SPRY2;RASGRP1;TRIB2;LRRK2;NF1;FGF2;SPRY4;EZH2;KSR1;BMP7;FLT1;CDK12;ADRA2A;DUSP7;PIK3R5;EDN1;HYAL2
gsea,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.4138819584370481,-1.3416191716838302,0.1070559610705596,0.20165067834358724,1.0,5/18,18.58%,XCL1;CAMK2D;CXCL10;CX3CL1;PLCG1
gsea,protein processing (GO:0016485),-0.3366779690410987,-1.3401643043001197,0.07228915662650602,0.20243033721807782,1.0,20/43,38.23%,CTSS;HTRA2;PCSK1;CPM;PTCH1;CTSL;PSEN2;FURIN;CASP4;PITRM1;CPD;XPNPEP3;CPE;DDI2;F3;CPXM1;ECE1;PARL;AEBP1;SPRTN
gsea,positive regulation of macroautophagy (GO:0016239),-0.39663681413970103,-1.3401026954678783,0.10404624277456648,0.2017445082118083,1.0,7/26,16.27%,SESN3;PINK1;C9ORF72;SESN1;VDAC1;RAB3GAP1;SESN2
gsea,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.3621451184522765,-1.3371455792325242,0.087248322147651,0.20410277381591999,1.0,15/32,40.48%,FAS;TRAF1;AR;ITGA6;BIRC6;SH3RF1;TNFRSF10B;FEM1B;PML;MADD;RELA;LTBR;PHIP;HYAL2;TCF7L2
gsea,protein-containing complex subunit organization (GO:0043933),0.34186037340033504,1.336856081875129,0.08243727598566308,0.15905696972995662,1.0,26/58,30.82%,SNX9;LAMC1;CHCHD10;SLC2A1;PTK2B;CAPG;CAPZA2;LPXN;TUBGCP2;NDC1;MDM2;KNTC1;AFG3L2;PICALM;PPID;TRAF2;TSPAN4;NUP35;ZW10;KPNA3;PPIH;FANCA;NUP54;NUP133;LLGL1;NUP205
gsea,"DNA-templated transcription, termination (GO:0006353)",0.3525393449398533,1.3358029242375298,0.10492505353319058,0.1597022560805269,1.0,24/47,39.42%,SNRPD3;SLBP;SNRPB;SNRPE;POLR2F;POLR2L;NCBP2;CPSF2;POLR3K;MAZ;SNRPF;LSM11;NCBP1;CPSF1;TTF2;UBTF;CPSF4;GTF2H2;CPSF3;TAF1A;SMN1;TBP;GTF2H4;CSTF1
gsea,negative regulation of response to stimulus (GO:0048585),0.4063183968319142,1.3352918144176391,0.10471204188481675,0.15996092410377888,1.0,11/26,40.36%,CDK6;TLE5;LYN;FBXO5;YBX1;RBL1;ALOX5;MAPK7;FOXP3;FCGR2B;SIRT1
gsea,neural tube closure (GO:0001843),-0.4172935851842047,-1.3352207142909727,0.1192214111922141,0.20527333999957542,1.0,11/20,26.37%,KDM2B;SEMA4C;FUZ;DLC1;SCRIB;PHACTR4;BBS4;DVL2;DVL1;PLXNB2;TGFB2
gsea,regulation of epithelial cell proliferation (GO:0050678),0.38129536737757597,1.3351155962377104,0.09785932721712538,0.15985364498129065,1.0,13/37,25.94%,CDK6;LAMC1;TINF2;RUNX3;NME1;HRAS;UHRF1;ZFP36;DAB2IP;CDKN2B;OSR2;SRSF6;VEGFA
gsea,cellular response to mechanical stimulus (GO:0071260),-0.38755706773282167,-1.3343833616069898,0.13443396226415094,0.2053565998867519,1.0,10/25,24.22%,NFKB1;FAS;TNFSF14;PIEZO1;MAPK8;TLR7;MAP3K1;TNFRSF10B;MAP3K14;PTGER4
gsea,negative regulation of cytokine production (GO:0001818),0.3221244717828894,1.3329972163079835,0.054411764705882354,0.16135068476739126,1.0,43/89,51.64%,HAVCR2;TMSB4X;IFNG;TBX21;HMGB1;ANXA1;ANXA4;CD200R1;EZR;ISG15;UBE2L6;SLAMF1;PIN1;ZFP36;PTPN6;TNFRSF21;DDX58;CEACAM1;CACTIN;ASB1;SLC11A1;VSIR;RARA;IL10;TLR4;TYROBP;NPLOC4;CD274;FOXP3;ARRB1;GHSR;FCGR2B;GPNMB;NLRC3;ACOD1;THBS1;FFAR4;GAS6;MEFV;INHA;RPS6KA5;ABCD1;IRAK3
gsea,cellular response to alcohol (GO:0097306),-0.401929544763758,-1.3328310580520717,0.10995850622406639,0.2061794220533403,1.0,9/21,24.22%,GRAMD1B;PTGER2;PTCH1;TNFSF4;KLF9;CTNNB1;AHR;ADCY6;PTGER4
gsea,mRNA catabolic process (GO:0006402),0.38338989735876144,1.332814732878351,0.11016949152542373,0.16127110012538692,1.0,13/25,39.40%,LSM2;UPF1;ERN1;ZFP36;HSPA1B;EXOSC9;HSPA1A;EXOSC4;MRTO4;CNOT10;ZFP36L2;DXO;EXOSC10
gsea,regulation of cell division (GO:0051302),0.3597091287930995,1.332585264316642,0.09977827050997783,0.1612641306829197,1.0,16/38,31.08%,PRC1;ORC6;AURKB;PLK3;PIN1;SFN;PLK4;KIF20A;PLK1;KIF18B;AURKA;CCP110;PDXP;RAB11FIP4;BLM;CALM2
gsea,negative regulation of protein modification process (GO:0031400),0.3510336529576158,1.3316583522690704,0.0912280701754386,0.16177526641767545,1.0,16/46,24.24%,PPIA;TINF2;ATP2B4;LYN;PRR5L;DAB2IP;CRTAP;CDYL;PARK7;CACTIN;PPP1R8;CORO1C;MYADM;TARDBP;PAQR3;IMPACT
gsea,positive regulation of ossification (GO:0045778),-0.4199476901066741,-1.3306540426680444,0.12195121951219512,0.2076916886528487,1.0,5/16,26.37%,GPM6B;CCN1;PTPN11;BMP7;TGFB2
gsea,cellular response to lipid (GO:0071396),0.3322409629103352,1.3303065220917885,0.0638002773925104,0.16273874049239045,1.0,38/100,39.14%,CCR5;VIM;SPP1;HMGB2;HMGB1;CX3CR1;LYN;PTK2B;UPF1;CD14;CASP1;ZFP36;DAB2IP;XBP1;MEF2C;CD86;TESC;CACTIN;NR3C1;FZD4;WNT11;WNT10B;INSIG1;SBNO2;RUVBL2;NLRP3;IL10;TLR4;MAP4K1;IL1B;CD274;CCL2;CTSG;FES;SPHK2;PID1;CTR9;CXCL9
gsea,"transcription, DNA-templated (GO:0006351)",0.28835456902328144,1.3297163042417084,0.07954545454545454,0.16303527493719686,1.0,56/124,39.30%,PTMA;ELOC;DEK;NELFE;PMF1;E2F1;TFDP1;POLR2C;TRIP13;TAF15;MLF1;RNPS1;MRPL12;XBP1;POLR2F;POLR2L;NCBP2;POLR3G;GTF2F1;GTF3A;POLR3K;LEO1;ATF4;RBMX;NFIC;NCBP1;DRG1;TAF3;PPP5C;SSRP1;IWS1;TAF2;ELOA;TTF2;SMARCA5;GTF2F2;UBTF;POLR3H;MMS19;GTF2H2;TAF6;NR4A2;PWP1;TAF1A;SMN1;TBP;NELFCD;MAF;POLR2B;GTF3C4;ELL;CTR9;NFYA;GTF2H4;NCOA6;GTF3C2
gsea,sodium ion transmembrane transport (GO:0035725),-0.37821066233614253,-1.3289421539795707,0.10355987055016182,0.20866994759223031,1.0,12/21,35.67%,ATP1A1;ATP1B1;SLC6A6;SLC9A9;SLC12A2;SLC6A11;FXYD2;SLC6A12;SLC6A9;SCN4B;ATP1A3;SLC12A3
gsea,regulation of bone mineralization (GO:0030500),0.4099439349485546,1.3289019178604027,0.10902896081771721,0.1634852454674699,1.0,9/23,25.76%,CCL3;BMP2K;PTK2B;ISG15;CCR1;MEF2C;OSR2;ENPP1;ALOX5
gsea,negative regulation of MAPK cascade (GO:0043409),-0.3377453566360562,-1.3284390877930623,0.08587257617728532,0.20839574056854376,1.0,25/46,39.14%,DUSP4;DUSP6;SPRY1;DUSP1;SH2B3;PEBP1;PIK3R2;TNIP1;DUSP10;SPRY2;MYC;FOXO1;NF1;SPRED1;FBLN1;SPRY4;DAG1;BMP7;SPRED3;CNKSR3;DUSP7;RPS6KA6;PHB;HYAL2;SIRPA
gsea,positive regulation of T cell differentiation (GO:0045582),-0.43544413116326064,-1.3262870087575185,0.1510204081632653,0.2099588203880132,1.0,11/18,24.20%,TESPA1;BCL6;LEF1;SOCS1;TNFSF9;TNFSF4;DUSP10;IL23A;SOX4;ZBTB1;GATA3
gsea,positive regulation of protein tyrosine kinase activity (GO:0061098),0.4908005539759348,1.325967035972314,0.14857142857142858,0.16578424641031966,1.0,5/15,17.33%,NEDD9;AREG;LRP8;ADAM17;PDGFB
gsea,regulation of microtubule-based process (GO:0032886),0.42901520452541264,1.3258378984633092,0.1280701754385965,0.16568218516328528,1.0,5/21,19.44%,DIAPH1;TRIM36;MEMO1;AURKA;BICD2
gsea,histone lysine methylation (GO:0034968),0.40451050639049285,1.3253245937642275,0.13174946004319654,0.16587911300885422,1.0,8/22,27.91%,DPY30;EHMT2;RBBP5;WDR5;SUV39H2;SMYD2;SUV39H1;PAXIP1
gsea,actin polymerization or depolymerization (GO:0008154),0.4010029474838171,1.3248845062241696,0.11578947368421053,0.1660141323682833,1.0,15/29,42.46%,CFL1;PREX1;DIAPH1;CAPG;DIAPH3;MICAL2;FLII;SPIRE2;DSTN;VILL;GHSR;ENAH;AIF1;SPIRE1;PSTPIP2
gsea,positive regulation of cell differentiation (GO:0045597),0.3291707908995039,1.3233414860281008,0.058898847631242,0.16714114312832357,1.0,44/96,47.87%,ID2;CEBPB;CSF1;AKT1;FBXO5;NPNT;CTNNA1;OLFM1;LTF;IFITM1;RUNX2;ZFP36;PA2G4;GLIPR2;XBP1;MEF2C;CEACAM1;ECT2;CPNE1;FRZB;KCTD11;XKR8;MTOR;IMPACT;HOXB4;CD36;IL1B;FES;YAP1;TGFB3;TMEM119;ZBTB16;GCNT2;CAMK1;PPARG;RAPGEF2;COL1A1;ASB4;BOC;FFAR4;TCF15;IGF1;WNT4;MSR1
gsea,error-prone translesion synthesis (GO:0042276),0.4577108604595579,1.3228228877508212,0.1721132897603486,0.16739813312644417,1.0,10/18,19.72%,RPA2;RPA3;PCNA;RFC2;RPA1;RFC5;RFC3;RFC4;POLE2;POLH
gsea,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4428801628501098,-1.322637265636434,0.13810741687979539,0.21300562672431986,1.0,5/15,27.07%,BCL2;HTRA2;CSF2;BCL2L1;RET
gsea,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.265349096560385,1.3217452448464044,0.061386138613861385,0.1681280094315899,1.0,93/208,46.33%,CEBPB;TBX21;CCNA2;ZBTB38;PTP4A3;HNRNPD;HINT1;RUNX3;ARNT2;PKP3;NAB1;GMNN;FBXO5;CALR;STAT3;CHD7;YBX1;E2F1;CYFIP1;CREM;ATXN1;SMC3;NSD2;NFIL3;NUCKS1;ESCO2;MLF1;EHMT2;MYBL2;BRCA2;CNBP;DSCC1;MEF2C;NONO;TFEB;HMGN5;LIN54;NUP107;RB1;NFYB;USP37;MYCBP;SNAI3;NR3C1;SRSF10;APBB1;NUP35;EIF4E;ZNHIT3;WWC1;MYBL1;SAP30;SBNO2;MSC;RABL3;CHEK2;ESRRA;ATF4;HCFC1;UTP4;BACH1;MAFA;SRRT;HIC1;NFYC;NAB2;PDGFA;GCFC2;SP1;PUM3;FOXP3;NOLC1;HINFP;FOXN2;HCFC2;NOTCH1;CTR9;NFYA;PHF19;ASCC2;OGG1;TRIP4;SPI1;THAP1;DENND4A;ERC1;SFPQ;CCAR2;ANKRD17;KAT7;FOXK2;HP1BP3;DDX25
gsea,regulation of viral entry into host cell (GO:0046596),0.4621668449492798,1.320841116677205,0.15355086372360843,0.16872534959561936,1.0,6/16,27.29%,LGALS1;IFITM3;IFITM1;P4HB;IFITM2;TRIM21
gsea,regulation of T cell differentiation (GO:0045580),0.40022486691779136,1.3197763239092493,0.12681912681912683,0.16947001322681812,1.0,11/23,23.72%,IFNG;PRELID1;CCR2;TBX21;PRDM1;CTLA4;IL2RA;XBP1;CLPTM1;ZMIZ1;FANCA
gsea,brain development (GO:0007420),0.33198109792611596,1.3196767728151029,0.08732876712328767,0.16934203443959858,1.0,21/54,54.87%,ADGRG1;CX3CR1;PHGDH;ARNT2;CENPF;TUBGCP2;ATXN1;EOMES;CLN5;UTP3;PBX3;SIX3;NCOA6;SPATA5;RAPGEF2;SCT;MAST1;MEIS1;CDK5RAP2;SETD1A;SPEF2
gsea,negative regulation of protein ubiquitination (GO:0031397),0.377898528967772,1.3194681966902944,0.12035010940919037,0.1693055674007017,1.0,9/28,25.90%,AKT1;ISG15;FBXO5;PARK7;HSPA1B;U2AF2;NXN;HSPA1A;UFL1
gsea,negative regulation of cellular component organization (GO:0051129),0.3531299027026852,1.3176802896167847,0.09523809523809523,0.17065328103781824,1.0,15/40,28.27%,LGALS3;HSPA5;DNAJB1;TFIP11;RDX;SVIP;HSPA1B;HSPA1A;AIDA;HSPA8;SACS;IMPACT;VEGFA;TMC8;RTEL1
gsea,protein localization to lysosome (GO:0061462),0.45645073162134375,1.3169402946742905,0.13682092555331993,0.17102758760502496,1.0,6/15,28.07%,NEDD4;M6PR;GCC2;NAGPA;AP3M1;HGS
gsea,translational termination (GO:0006415),0.37319134840485485,1.31161734749915,0.13501144164759726,0.175427444441476,1.0,30/55,33.08%,MRPL18;MRPL42;MRPL53;MRPL40;MRPL20;MRPL51;MRPL12;MRPS25;MRPL13;MRPL49;MRPL28;MRPL55;GSPT2;CHCHD1;MRPL39;MRPL19;MRPL17;MRPL15;GSPT1;MRPL16;MRPS12;ETF1;MRPS7;MRPS18A;MRPL35;MRPS31;MRPL44;MRPS2;MRPS10;ABCE1
gsea,protein ADP-ribosylation (GO:0006471),-0.43541654016139897,-1.3116116085258265,0.15090543259557343,0.22349672689566347,1.0,5/16,14.54%,PARP3;PARP8;ART3;SIRT5;SIRT4
gsea,regulation of telomere maintenance via telomerase (GO:0032210),0.38182621204420814,1.3102900252951908,0.1468682505399568,0.17638184821196762,1.0,21/34,41.83%,TINF2;AURKB;HNRNPU;NEK2;CCT7;HNRNPA1;CCT8;PIF1;TCP1;CTC1;MAP3K4;CCT6A;ATR;PKIB;XRCC5;CCT5;EXOSC10;HNRNPC;NAT10;PINX1;CCT2
gsea,negative regulation of interleukin-6 production (GO:0032715),-0.40803150020784906,-1.3086936492521548,0.12373737373737374,0.22566682205888355,1.0,6/18,15.42%,CD200;TNFAIP3;ZC3H12A;CX3CL1;SELENOS;SYT11
gsea,purinergic nucleotide receptor signaling pathway (GO:0035590),0.4833347791530739,1.3080340739886536,0.14790996784565916,0.17817365822870349,1.0,8/15,38.69%,ENTPD1;CASP1;ENTPD5;NLRP3;IL1B;CTSG;C3AR1;ANO6
gsea,protein methylation (GO:0006479),0.40352264264657756,1.306921652078834,0.13664596273291926,0.17888898994028452,1.0,9/23,32.03%,SNRPD3;SNRPB;EHMT2;FAM98B;GSPT1;PRMT1;ETF1;METTL22;ICMT
gsea,cellular iron ion homeostasis (GO:0006879),0.38787551395531294,1.3061440712921528,0.12016293279022404,0.17935657850706602,1.0,11/24,29.80%,TMPRSS6;ATP6V0A2;TFRC;HMOX1;NUBP1;FXN;CYB561A3;TMEM199;SLC11A1;SLC39A14;GLRX3
gsea,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4312922470839986,1.3056283234959523,0.14533622559652928,0.17955906419270387,1.0,14/23,37.55%,HNRNPA2B1;AURKB;NEK2;CCT7;HNRNPA1;CCT8;TCP1;RTEL1;MAP3K4;CCT6A;ATR;PKIB;XRCC5;CCT5
gsea,negative regulation of T cell proliferation (GO:0042130),0.43185978815478354,1.3052458559438784,0.15294117647058825,0.1796726197839287,1.0,8/18,33.03%,CEBPB;GLMN;SPN;TNFRSF21;CD86;IL10;CD274;FOXP3
gsea,cellular response to amyloid-beta (GO:1904646),-0.416797500219259,-1.3047533339016357,0.13310580204778158,0.22912385270181182,1.0,9/19,35.42%,PRNP;VCAM1;ABCC1;CASP4;CACNA2D1;CACNA1A;GRIN1;APP;ATP1A3
gsea,protein autophosphorylation (GO:0046777),0.30195356443375787,1.3037575143122875,0.09523809523809523,0.1807833924367702,1.0,32/76,35.67%,STK39;AKT1;MAPKAPK3;LYN;PTK2B;AURKB;DAPK2;ERN1;RIPK3;MAPKAPK2;NEK2;EIF2AK3;TXK;TEC;AURKA;SLK;NEK6;RIPK1;CAMKK2;MINK1;MTOR;EIF2AK2;CHEK2;GRK5;CAD;PEAK1;FGR;RIOK2;MAP4K1;EIF2AK4;FES;ATR
gsea,regulation of NIK/NF-kappaB signaling (GO:1901222),0.35420432098940247,1.3034321463377354,0.11069418386491557,0.18087336676875032,1.0,13/38,31.87%,TMSB4X;PTP4A3;EZR;CD14;ACTN4;ADGRG3;CD86;CPNE1;EIF2AK2;NLRP3;TLR4;IL1B;TLR2
gsea,hexose metabolic process (GO:0019318),0.4247344663327604,1.3025751021271759,0.14313725490196078,0.18138328606577278,1.0,9/18,36.79%,ALDOA;GALK1;SORD;ALDOC;HK1;DCXR;PMM1;PGM1;FUOM
gsea,modulation of chemical synaptic transmission (GO:0050804),-0.3419860131909122,-1.3009636943613345,0.11014492753623188,0.23252568165354287,1.0,15/35,38.73%,ITGB1;ARC;KCNMB4;MCTP1;TMEM108;LRRK2;HOMER1;SLC12A2;DGKI;CACNA1A;CLSTN1;APP;SYN1;DLGAP4;CACNA1B
gsea,glycerophospholipid biosynthetic process (GO:0046474),-0.2854097423421958,-1.296631961345913,0.06941431670281996,0.23653346934121167,1.0,38/90,36.11%,INPP4B;CPNE3;DGKA;PIK3R6;PIK3R2;PIK3R1;ETNK2;LCLAT1;PISD;CHKA;DGKD;ACP6;SLC44A1;SYNJ2;PTPN13;PLSCR1;INPP5F;MTMR3;ABHD4;FGF2;GNPAT;PIK3R4;STARD10;PITPNM2;SYNJ1;PIKFYVE;MFSD2A;LPCAT1;DGKE;PTDSS2;PLEKHA8;PIK3R5;GPAT4;AGPAT1;PCTP;PLA2G12A;PIK3CA;LPCAT2
gsea,unsaturated fatty acid metabolic process (GO:0033559),-0.4244470234648625,-1.2964502456922582,0.125,0.23590779216953048,1.0,7/16,30.71%,EPHX1;PNPLA8;GPX1;DECR2;FADS3;FADS2;ACSL1
gsea,positive regulation of response to stimulus (GO:0048584),0.3855346708616704,1.2962147038602223,0.12365591397849462,0.1871711008691014,1.0,10/28,27.45%,CDKN2A;ABI3;SELENON;CGAS;DDX58;NSMCE4A;ANKLE1;DHX9;FMR1;EEF1E1
gsea,positive regulation of transferase activity (GO:0051347),-0.3182920527349675,-1.2959642128750342,0.12555066079295155,0.2356447550893039,1.0,68/68,96.76%,CD74;CD200;NTRK3;KLF4;RPS2;KIT;NEK7;POLG2;PINK1;CTNNB1;MYC;ARRDC4;NBN;AXL;DCUN1D2;HSP90AB1;FLT1;RET;FBXW7;DBI;MET;AXIN1;PARN;CCT4;NAF1;BMI1;EPHA3;LMO4;NVL;EPM2AIP1;LMTK2;MAPKAPK5;DRD4;DCUN1D1;DKC1;DTX3L;FLT3;CSF1R;CCT2;XRCC5;PKIB;ARRDC3;CD4;CHTF8;VAC14;WRAP53;MAP3K4;TRIB3;TCP1;CHTF18;DCUN1D3;UBE2N;DSCC1;RYK;PLK1;RAD50;RFC4;RFC3;NEK2;RFC5;PIN1;HSP90AA1;PTGES3;AURKB;RFC2;PCNA;HNRNPD;HNRNPA2B1
gsea,endoplasmic reticulum organization (GO:0007029),0.3602996224647315,1.2955001409778935,0.12686567164179105,0.1876628897274553,1.0,15/33,33.05%,REEP4;LMAN2;GET4;LMAN1;HMOX1;EIF2AK3;LNPK;SMPD4;TMEM33;DOP1B;BNIP1;ALDH3A2;CAV2;ATL2;CCDC47
gsea,regulation of autophagy (GO:0010506),0.2786050998044121,1.295069754706378,0.06954887218045112,0.18786057653166374,1.0,58/112,51.72%,MT3;NEDD4;IFNG;GAPDH;HMGB1;AKT1;IL10RA;STAT3;ATP6V0A2;DAPK2;SREBF2;ERN1;KEAP1;ATF6;BNIP3;PLEKHF1;SNX5;OPTN;EXOC4;SVIP;MTDH;TRIM65;TFEB;CASP3;EXOC8;EIF4E;VPS35;MLST8;EIF4G1;MTOR;PRKAG2;IL10;PIP4K2B;UFL1;TRIM21;RRAGB;HSPB1;TRIB3;DRAM1;UCHL1;EIF4G3;GPR137B;GOLGA2;CSNK2A2;DEPDC5;NUPR1;RAB39B;UBQLN1;HAX1;USP10;FOXK2;MEFV;SLC38A9;DAPK1;PIK3C2A;HDAC6;ATP6V0E2;TRIM8
gsea,translational elongation (GO:0006414),-0.35888322491925057,-1.294784172416336,0.1615798922800718,0.23608243425626935,1.0,23/62,34.61%,EEF1B2;MRPS6;EEF1A1;RACK1;DAP3;EEF2;EEF1G;EEF1D;EEFSEC;MRPL45;TUFM;GFM2;MRPL37;MRPS35;MRPS27;GADD45GIP1;MRPL1;MRPL38;MRPS30;MRPL11;MRPL50;PTCD3;TSFM
gsea,carbohydrate homeostasis (GO:0033500),-0.3800557637676127,-1.2946730687103296,0.1489971346704871,0.2354022688709186,1.0,8/20,29.31%,BACE2;RPS6;PDK2;SOX4;KLF7;VGF;ADRA2A;CRY2
gsea,"retrograde transport, endosome to Golgi (GO:0042147)",0.3537097779860763,1.2939096130252072,0.12139917695473251,0.18867224100456684,1.0,14/35,33.52%,CLTC;LMAN1;BAIAP3;SNX5;RNF126;ARL1;DCTN1;VPS35;CLN5;GCC2;VPS52;VPS50;HEATR5B;TBC1D10B
gsea,mitochondrial translational termination (GO:0070126),0.36798856037176464,1.293151990276495,0.16441441441441443,0.18911714797077642,1.0,26/50,32.88%,MRPL18;MRPL42;MRPL53;MRPL40;MRPL20;MRPL51;MRPL12;MRPS25;MRPL13;MRPL49;MRPL28;MRPL55;CHCHD1;MRPL39;MRPL19;MRPL17;MRPL15;MRPL16;MRPS12;MRPS7;MRPS18A;MRPL35;MRPS31;MRPL44;MRPS2;MRPS10
gsea,regulation of actin cytoskeleton reorganization (GO:2000249),0.4461575203286469,1.2930838319068192,0.15412186379928317,0.1889348208005783,1.0,6/17,12.12%,ARHGDIA;ABI3;PTK2B;HRAS;BAIAP2;IQGAP2
gsea,heart development (GO:0007507),0.34860727865990737,1.292658906970411,0.11724137931034483,0.18909519915574569,1.0,16/57,32.86%,ID2;CDKN1A;CRIP1;CHD7;MICAL2;MEF2C;MTHFD1;PDGFB;PDLIM7;ZDHHC16;ALPK2;CACYBP;VEGFA;UTY;FOXF1;SMYD4
gsea,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.40089587021499773,-1.2918702796314705,0.125,0.23770005998162938,1.0,8/18,34.55%,RACK1;BCL2;PMAIP1;BCL2L1;DDIT3;BCLAF1;FBH1;BOK
gsea,positive regulation of DNA metabolic process (GO:0051054),0.3508306983549096,1.2913148682900961,0.13034188034188035,0.19008983507580607,1.0,18/39,40.36%,HMGB1;PCNA;RAD51;SMCHD1;RAD50;BRCA1;UBE2N;RNF168;DHX9;PDGFB;TIGAR;BRCC3;RTEL1;WRAP53;ERCC8;ABRAXAS1;RNF8;SIRT1
gsea,phosphorylation (GO:0016310),0.25934904651937024,1.288751115837829,0.06500956022944551,0.1921959839820784,1.0,99/196,50.51%,CDK6;STK39;BIRC5;PGK1;AKT1;CDK1;RUNX3;DGKH;LYN;BMP2K;PTK2B;AURKB;STAT3;GNPTAB;PRKCE;FAM20A;DAPK2;ERN1;CCNE1;MAPKAPK2;CDK14;NEK2;MAPK6;BCR;PLK4;PLK1;EIF2AK3;RYK;LMTK3;TXK;PIK3CG;TYK2;GMFB;PAK4;RNASEL;TEC;HK1;PDGFB;AURKA;BCKDK;MATK;HASPIN;DYRK3;WNT11;NEK6;BRD2;CAMKK2;MINK1;MTOR;EIF2AK2;RARA;PRKAG2;CSNK1E;TNK2;CHEK2;GRK5;SRPK1;CHEK1;PEAK1;GK;FGR;SYK;MAP4K1;CDK4;TKFC;CDK2;EIF2AK4;HUNK;CCL2;CTSG;CHUK;SPHK2;PPP3CB;FAM20B;PPP4R1;OXSR1;PIK3CD;CAMK1;PI4KA;CDKL3;TAF1;CDK8;PIM1;MELK;GAS6;NADK;LIMK1;PANK3;LATS1;TAOK2;MAST1;SNRK;MAP3K11;DAPK1;DGKG;PASK;BTK;RPS6KA5;TBCK
gsea,ERBB2 signaling pathway (GO:0038128),-0.4275893017136211,-1.2886193010569047,0.17088607594936708,0.2406510950632166,1.0,5/15,18.51%,CPNE3;PRKCA;PIK3R1;ERBIN;HBEGF
gsea,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.463507463928404,1.28812185167301,0.20909090909090908,0.19251197249594865,1.0,9/15,25.73%,CDK1;FBXO5;CCNB1;ATAD5;CDC7;DYRK3;DTL;RAD51C;CDC25C
gsea,fatty acid beta-oxidation (GO:0006635),0.3701403991373897,1.2879837279223254,0.13673469387755102,0.192357437234825,1.0,10/28,53.38%,ACADL;ETFB;ACOXL;ECHDC2;CRAT;HSD17B10;ACAT2;GCDH;ABCD1;CPT2
gsea,response to lipid (GO:0033993),0.36154617047895693,1.2863300936741782,0.11874105865522175,0.19364154404557843,1.0,17/46,30.89%,SPP1;HMGB2;F2R;ANXA1;MAPKAPK3;STAT3;MAPKAPK2;PCK2;ADAM17;ABCA2;SLC11A1;RARA;SOCS2;NOS1;TLR4;CD36;IL1B
gsea,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3832811958637223,1.2857617839186333,0.11978465679676985,0.19393966844349297,1.0,15/46,26.32%,RGS1;ADGRG1;GNA15;CALCA;ADGRG5;AKAP12;GPR65;ADGRG3;VIPR2;ADRB2;GNA11;S1PR4;GRK5;ADGRE5;S1PR2
gsea,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.333371477447687,-1.285168625899209,0.1163895486935867,0.24369574761865243,1.0,42/42,98.26%,FAM162A;FAS;JAK2;RACK1;ATP2A3;SENP1;HSPE1;DLC1;DAP;TNFRSF10B;CASP4;EGLN3;VCP;F3;BCL2L13;BOK;AIFM1;XDH;TNF;SMAD3;BBC3;IFT57;PPARG;CASP12;FADD;APAF1;PIDD1;TNFSF10;RIPK1;BID;ANP32B;TRAF2;HSPD1;HIP1;HIP1R;EIF2AK3;CASP8AP2;CASP1;BAX;CYCS;F2R;RPS27L
gsea,negative regulation of macroautophagy (GO:0016242),0.43403666932360585,1.2845638853280041,0.1619718309859155,0.1948009916535413,1.0,3/15,23.51%,AKT1;LZTS1;MTOR
gsea,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.41854029520434743,1.283767667853138,0.14939024390243902,0.19533120677738663,1.0,7/21,16.31%,AKT1;AREG;HIP1R;HIP1;NUP62;CNOT9;ADAM17
gsea,plasma membrane bounded cell projection organization (GO:0120036),0.314739059478429,1.283312485486061,0.10551948051948051,0.19549748591894694,1.0,27/59,52.38%,NEDD4;STMN1;PLEK;HMGB1;MANF;LYN;L1CAM;CYFIP1;RYK;CFAP126;ODF2;PLEKHA1;MNS1;RB1;MAP4;MAP2;PRMT1;PPP1R9B;NPY;CEP78;CSF1R;RAPGEF2;TPM1;RASGRF1;RAB25;BLOC1S5;FLRT3
gsea,response to glucose (GO:0009749),-0.3893254480062597,-1.2831165016099984,0.13259668508287292,0.24525187881144075,1.0,8/22,30.79%,RACK1;ZBTB20;IRS2;SOX4;SELENOS;EIF2B4;LPL;ZBED3
gsea,epidermal growth factor receptor signaling pathway (GO:0007173),0.38176257632842026,1.2812854571337982,0.17010309278350516,0.19714077813535713,1.0,7/26,29.16%,AKT1;PTK2B;AREG;GRB7;ADAM17;SHC1;BCAR1
gsea,regulation of exit from mitosis (GO:0007096),0.41020851725977286,1.2812241543954792,0.18764302059496568,0.19694914085610835,1.0,14/25,20.75%,UBE2C;UBE2S;ANAPC5;MAD2L1;BUB3;NEK2;ANLN;ANAPC15;KNTC1;CDCA5;BUB1B;CDC14A;ZW10;CDC20
gsea,regulation of nervous system development (GO:0051960),0.44746264144610015,1.2812099572119962,0.15780445969125215,0.19670133235568044,1.0,5/16,35.16%,HMGB2;CX3CR1;KIF14;IL1B;YAP1
gsea,response to calcium ion (GO:0051592),-0.3229727083966969,-1.2811728018026458,0.10679611650485436,0.2466865209504057,1.0,41/41,99.09%,CPNE3;CAMK2D;ITPKB;KCNMB4;TTN;AQP3;SYT11;HOMER1;D2HGDH;SYT4;KCNMB1;CPNE9;LGMN;PPIF;RASA4;SEC31A;SLC25A13;PRKAA1;ADAM9;THBS1;DMTN;RASGRP2;ALOX5AP;SYT7;CPNE7;RYR1;CALM2;ALG2;AHCYL1;ADD1;SLC25A24;CPNE2;CLIC4;CPNE1;ITPR3;ECT2;PLCG2;TRPC1;MEF2C;SMPD1;NEDD4
gsea,regulation of amyloid-beta formation (GO:1902003),0.40689552806353596,1.2807599451958345,0.1531986531986532,0.19687625727698632,1.0,7/21,32.27%,IFNG;PIN1;PICALM;ABCA2;CASP3;GSAP;SP1
gsea,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.412248370006336,-1.2805711153613974,0.12605042016806722,0.24661215237903744,1.0,5/17,24.49%,LEF1;NFATC1;CTNNB1;NLK;TNRC6A
gsea,negative regulation of MAP kinase activity (GO:0043407),-0.3695714133702809,-1.280027373831516,0.15560640732265446,0.2463769027853817,1.0,11/28,30.41%,PDCD4;SPRY1;DUSP1;SH2B3;DUSP10;SPRY2;NF1;DNAJA1;SPRY4;BMP7;DUSP7
gsea,regulation of protein phosphorylation (GO:0001932),-0.26688061731838403,-1.2785090336973486,0.06309148264984227,0.24727644244132924,1.0,126/126,99.67%,CD74;FAS;NTRK3;RACK1;NPM1;CCN1;PLAUR;PECAM1;PRNP;ENG;TTN;KDM4D;SOCS1;BST1;PINK1;C9ORF72;ZC3H12A;TSPYL2;AXIN2;RASGRP1;PAK1;MAVS;LRRK2;PTPN13;ABL1;CCDC88A;SLCO3A1;SESN2;FGF2;CLIP3;TERF2IP;FBLN1;CCND2;TNIK;STAT2;ATF3;AKTIP;DVL2;FNIP1;BMP7;ITGB3;PLXNB2;BRAT1;PML;FN1;AXIN1;PRKDC;KNDC1;ROCK2;MEN1;ZBED3;WDFY2;FBH1;DVL3;IBTK;APP;ATG14;DAB2;DAXX;LRP6;TRAF3IP1;PHIP;DNAJC10;AKAP8;SIRPA;WWTR1;PGF;XDH;TNF;CD40;FXR2;PPP2R5D;INSM1;C3;RALB;CDK2AP1;MMP9;GAS6;CSF1R;GPNMB;LIMCH1;SIRT1;SMG8;CCND1;PID1;VEGFB;TMEM119;ARRB1;CD4;IL1B;PDGFA;FGR;HSPB1;VEGFA;ATF4;IMPACT;PAQR3;CAMKK2;RIPK1;FMR1;TARDBP;MYADM;CORO1C;RAP2A;ADAM17;MYDGF;CACTIN;PARK7;ECT2;FLOT1;EIF2AK3;CCDC88C;DAB2IP;PRR5L;PIN1;TFRC;CCND3;FAM20A;HSP90AA1;HRAS;LYN;AKT1;IFNG;PPIA;MT3;CEBPB
gsea,regulation of defense response (GO:0031347),0.34077407094197903,1.2783715489274805,0.12299465240641712,0.19890964645442047,1.0,22/46,41.23%,TMSB4X;CCR2;ANXA1;PIK3AP1;ZBP1;CASP1;LRP8;PSMA6;PARK7;ERAP1;ZMPSTE24;SBNO2;BIRC2;ALOX5;UFL1;AKNA;FGR;SEMA7A;TKFC;LACC1;FCGR2B;CASP12
gsea,chordate embryonic development (GO:0043009),0.42069881404978937,1.2773132095516977,0.18781725888324874,0.19972961807593972,1.0,11/19,35.53%,ARNT2;CHD7;STIL;BRCA1;WNT11;VEGFA;FOXF1;SULF2;LIG4;HINFP;TGFB3
gsea,regulation of complement activation (GO:0030449),-0.4483911790018508,-1.2766887701838698,0.2089041095890411,0.24857061976632963,1.0,7/16,39.51%,CD81;C1QBP;C1QC;CFP;C1QA;PHB;C1QB
gsea,anterograde axonal transport (GO:0008089),-0.3850153450316322,-1.275946354688412,0.15876777251184834,0.24850783447289446,1.0,9/21,26.26%,AP3B1;KIF1B;NEFL;BLOC1S2;KIF3B;AP3S1;KIF5C;MGARP;TRAK1
gsea,positive regulation of interleukin-10 production (GO:0032733),-0.4022313412195643,-1.274866954414403,0.12626262626262627,0.2488700455039762,1.0,7/17,18.95%,XCL1;TNFSF4;IL23A;F2RL1;CD40LG;IRF4;PRKCZ
gsea,intracellular protein transmembrane transport (GO:0065002),0.3991833507403214,1.2730942235937643,0.18736842105263157,0.20352263295435957,1.0,6/22,25.15%,HSPA5;TIMM17A;HSPD1;PEX7;TIMM50;TIMM23
gsea,positive regulation of osteoblast differentiation (GO:0045669),0.44539677557901397,1.27293749936751,0.14730878186968838,0.2033885051061532,1.0,6/18,12.56%,FBXO5;NPNT;LTF;IFITM1;RUNX2;MEF2C
gsea,endosome organization (GO:0007032),0.3677987859754187,1.2702409557557381,0.15337423312883436,0.2057915757563046,1.0,7/24,20.42%,SNX10;RAB27A;PLEKHF1;PI4K2B;CORO1C;ALS2;EXOC8
gsea,positive regulation of protein localization to cell periphery (GO:1904377),0.36561910964978284,1.2698596660309218,0.1725417439703154,0.2058698454460763,1.0,10/30,29.84%,LGALS3;IFNG;AKT1;ATP2B4;PRKCE;GPSM2;KIF5B;ITGA3;PLS1;PTPN9
gsea,negative regulation of Ras protein signal transduction (GO:0046580),-0.36761590136387057,-1.2685550821496443,0.14678899082568808,0.2553582702010813,1.0,13/22,29.01%,SPRY1;RIPOR2;HEG1;ARHGAP24;SPRY2;DLC1;SPRY4;CCDC125;STAMBP;TGFB2;SCAI;MET;RASIP1
gsea,water-soluble vitamin metabolic process (GO:0006767),0.3346565953519398,1.268288430821508,0.1401151631477927,0.20706961450266084,1.0,17/40,35.17%,SLC2A3;SLC52A3;SLC2A1;GSTO1;DHFR;PDZD11;MTHFD1L;MTHFD1;ACP5;ENPP1;SHMT2;SLC25A19;MTHFD2;MMADHC;PDXK;SLC52A2;MTHFD2L
gsea,organelle transport along microtubule (GO:0072384),0.429258687546631,1.2676041019769138,0.18163672654690619,0.20750449693477777,1.0,8/16,30.93%,KIF5B;COPG1;BICD2;ARHGAP21;CLN3;NDE1;RHOT2;BICD1
gsea,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.35787382251791117,-1.2669163864194548,0.15777777777777777,0.25631337033561236,1.0,11/28,36.87%,RACK1;TRAF1;TNFAIP3;BIRC3;F2RL1;CASP4;CLIP3;MADD;SPHK1;HIPK1;SPPL2B
gsea,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.32632997917302714,-1.2663904790992844,0.1393939393939394,0.25609664880175065,1.0,20/42,36.45%,RACK1;TRIB1;SOCS5;RNF19A;NFE2L2;BAG2;RNF19B;DNAJB2;TRIB2;LRRK2;NUB1;ZER1;HERPUD1;CBFA2T3;DVL1;VCP;SMAD7;DAB2;NKD2;COP1
gsea,mRNA splice site selection (GO:0006376),0.42804501108801774,1.2646671902409365,0.1762208067940552,0.21013906892849477,1.0,8/17,19.45%,SRSF9;CELF4;LUC7L;SF3A2;SRSF6;PSIP1;SRSF1;SRSF10
gsea,regulation of dendrite morphogenesis (GO:0048814),0.43923763927317633,1.2629928239727164,0.17028985507246377,0.21155369628418888,1.0,5/15,31.32%,NEDD4;LZTS1;RAP2A;CAPRIN1;HECW2
gsea,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4074694989656528,1.2628128108690775,0.16738197424892703,0.2114741469042449,1.0,7/18,45.55%,HNRNPA2B1;SRRT;MRPL44;ZC3H7B;TARBP2;PRKRA;DICER1
gsea,regulation of telomere maintenance (GO:0032204),0.39408426951828845,1.262395443580146,0.1511879049676026,0.21155560222305195,1.0,6/20,28.27%,TINF2;HNRNPD;UPF1;RAD50;PIF1;RTEL1
gsea,generation of neurons (GO:0048699),0.3400147341965027,1.261404878604169,0.10785619174434088,0.21231737184469582,1.0,23/65,36.35%,CDK6;HMGB2;CX3CR1;RUNX3;RACGAP1;CIT;TUBGCP2;PIN1;RUNX2;RYK;ACSL4;MEF2C;CASP3;FZD4;WNT11;WNT10B;SIX3;IL1B;SDCCAG8;NR4A2;YAP1;WNT1;THOC2
gsea,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.2907192096158127,-1.259985034195846,0.12345679012345678,0.2629698762246307,1.0,30/68,35.90%,NR4A3;RORA;AR;NR4A1;TBL1X;POLR2A;HDAC10;MAML2;TAF4B;HDAC9;MAML3;HDAC7;CREBBP;NR5A2;POLR2E;TAF9;HDAC5;GTF2E2;KAT2B;RARG;GTF2H3;GTF2E1;NR2F6;NR1H3;POLR2H;MED23;THRB;GTF2A1;RORB;RXRA
gsea,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3582501872582674,1.259525514119943,0.14505119453924914,0.21405218276980156,1.0,13/34,29.16%,MAPKAPK3;ELMO2;PTK2B;HSP90AA1;CYFIP1;MAPKAPK2;DAB2IP;BAIAP2;NCF2;VEGFA;NCKAP1;HSPB1;BCAR1
gsea,cellular response to peptide (GO:1901653),-0.35407895525203986,-1.2590028978718852,0.14202898550724638,0.26329480969906177,1.0,12/28,35.42%,ZFP36L1;RIPK2;PRNP;VCAM1;ABCC1;CASP4;CACNA2D1;CACNA1A;GRIN1;APP;ARHGEF2;ATP1A3
gsea,negative regulation of GTPase activity (GO:0034260),0.4123366015083895,1.2587969305689668,0.17835671342685372,0.21451537788173441,1.0,6/16,27.39%,TMED2;HRAS;DAB2IP;RDX;RRP1B;CPEB2
gsea,leukocyte cell-cell adhesion (GO:0007159),0.45764379352725015,1.2579612804409797,0.19236883942766295,0.2150739969283646,1.0,5/15,33.89%,CCL5;EZR;CERCAM;SYK;ICAM1
gsea,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.3741922894953008,-1.2576521568960637,0.1262135922330097,0.2640290353688362,1.0,20/20,99.49%,NR4A3;JUN;PDCD4;SOD2;FGF2;FOXJ2;P2RY6;IGF1;MMP9;APLN;TPM1;PPARG;MFN2;TGFB3;IL10;PDGFB;MEF2C;ERN1;DNMT1;CDKN1A
gsea,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3825189450666745,1.2539549672602952,0.19298245614035087,0.2189387996554019,1.0,6/23,26.22%,NEDD4;PADI2;ZMIZ1;NR3C1;TRERF1;TADA3
gsea,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.4260254323460161,1.253397977205952,0.1896551724137931,0.21928809104257382,1.0,7/15,18.93%,EPAS1;EGR1;HSP90AA1;DCUN1D3;HSPA1B;ZMIZ1;HSPA1A
gsea,phosphate-containing compound metabolic process (GO:0006796),0.2817611908086554,1.2522770100693628,0.1154562383612663,0.22015873209573722,1.0,46/97,43.09%,ALDOA;DUSP5;GPD2;PFKP;PGK1;AKT1;STAT3;PSPH;SLC20A1;NUDT5;PIK3CG;PLCG2;ALDOC;AGPAT2;HK1;DUSP3;TIGAR;BCKDK;PXYLP1;NUDT10;GDE1;MTOR;ENPP1;TNK2;HK3;PDXP;PIP4K2B;GK;GFPT1;PGM2L1;INPPL1;HDHD2;PPIP5K1;NUDT11;PLPP2;SPHK2;PPP3CB;PGP;DUSP23;PIK3CD;IPMK;PI4KA;PLBD1;FRA10AC1;PPA1;G6PC3
gsea,negative regulation of transferase activity (GO:0051348),0.4118912348105585,1.2520889198943554,0.1670103092783505,0.22005962688573474,1.0,5/16,22.36%,FBXO5;HNRNPU;ZFP36;PARK7;PIF1
gsea,Notch signaling pathway (GO:0007219),0.3741636927836159,1.2519238804651949,0.1681109185441941,0.21992930024027768,1.0,8/26,25.05%,PLXND1;DLGAP5;YBX1;ADAM17;JAG2;NRARP;WWC1;STAT1
gsea,ncRNA metabolic process (GO:0034660),0.4088263914741015,1.2477894110485321,0.19011406844106463,0.2239895524797803,1.0,9/19,45.55%,RAN;PIWIL2;KHSRP;DTD2;NIFK;ZCCHC8;TARBP2;PRKRA;DICER1
gsea,regulation of interleukin-6 production (GO:0032675),-0.30257778074283953,-1.2470977198858442,0.14714714714714713,0.2756680673748774,1.0,58/58,98.93%,CD74;CD200;MBP;POU2F2;TNFAIP3;IL16;POU2AF1;TNFSF4;ZC3H12A;PTPN11;CX3CL1;F2RL1;C1QTNF4;MAVS;TLR7;SELENOS;IL17RA;SYT11;TWIST1;IFIH1;LPL;APP;ARHGEF2;MAPK13;HYAL2;SIRPA;RAB7B;TNF;IRAK3;GAS6;NOS2;NLRC3;AIF1;SPHK2;GHSR;ARRB1;TLR2;IL1B;SYK;TYROBP;TLR4;IL10;TMEM106A;SCIMP;IL33;DHX9;PLCG2;HSPD1;DDX58;XBP1;PTPN6;MAPKAPK2;SLAMF1;STAT3;CD200R1;HMGB1;F2R;IFNG
gsea,positive regulation of chemokine production (GO:0032722),-0.3593795850785108,-1.2467917997574898,0.19095477386934673,0.27507901367529664,1.0,14/28,33.07%,CD74;HIF1A;MBP;TNFSF4;AIRE;F2RL1;MAVS;TLR7;OAS3;IL17RA;DDX3X;TWIST1;LPL;APP
gsea,receptor signaling pathway via JAK-STAT (GO:0007259),-0.39298207635798005,-1.2464638764817673,0.2063157894736842,0.27457341753638265,1.0,9/18,30.40%,STAT4;JAK2;IFNAR2;STAT5A;STAT5B;STAT6;STAMBP;STAT2;SOCS6
gsea,maturation of SSU-rRNA (GO:0030490),-0.40388798585926033,-1.2460689801615104,0.22932330827067668,0.27415046341193994,1.0,9/24,35.26%,RPS8;SRFBP1;WDR46;TSR2;HEATR1;DHX37;DDX52;NOL11;NOB1
gsea,regulation of cellular catabolic process (GO:0031329),-0.3353388290273633,-1.2452060628034596,0.16136363636363638,0.27432808766458233,1.0,12/34,25.05%,PIK3R2;ITPR1;C9ORF72;USP33;WDR41;LRRK2;ABL1;MTMR3;ROCK1;ATM;KAT8;DDIT3
gsea,regulation of small GTPase mediated signal transduction (GO:0051056),0.3040614922911532,1.2451258725464096,0.10535405872193437,0.22646343759384657,1.0,31/68,42.54%,CHN2;ARHGDIA;RHOQ;PREX1;ABR;SH3BP1;RHOF;RACGAP1;RHOC;BCR;ARHGAP11A;NUP62;SRGAP3;ECT2;ARHGAP10;FOXM1;ITSN1;FGD3;ARHGEF5;ARHGAP19;ARHGAP21;RABL3;MYO9B;DEPDC1B;RHOT2;TRIP10;SRGAP2;KALRN;ARHGAP35;FGD2;ARHGAP39
gsea,protein glycosylation (GO:0006486),0.2859721367086931,1.2447377696939368,0.125,0.2265653140977668,1.0,41/72,40.28%,DDOST;RPN1;RPN2;MAGT1;ST3GAL6;FUT7;GALNT6;STT3A;MGAT4B;NUS1;ALG6;ALG8;DPAGT1;ST3GAL3;FUT4;B4GALT5;B3GALT5;ST3GAL4;ENTPD5;ALG3;NPC1;PLOD2;ALG10B;ALG9;GALNT1;MGAT4A;GFPT1;DOLPP1;ALG2;PMM1;B3GALT4;PLOD3;MPI;ST3GAL5;SERP2;GALNT10;ALG12;GOLGA2;GCNT2;EOGT;POMGNT1
gsea,striated muscle contraction (GO:0006941),0.4335408793260948,1.2432277271568715,0.20351390922401172,0.22789916575740818,1.0,4/19,28.79%,ALDOA;SCN1B;NOS1;RCSD1
gsea,positive regulation of epithelial cell migration (GO:0010634),0.32757013594720374,1.243051052789444,0.14896755162241887,0.22782851066828613,1.0,25/53,52.56%,PFN1;IFNG;AKT1;PTK2B;CALR;PRKCE;DOCK5;GLIPR2;PIK3CG;PLCG2;MTOR;ANXA3;VEGFA;IQSEC1;BCAR1;PIK3CD;ETS1;THBS1;CLASP2;ADAM9;MMP9;RAB25;CTSH;HDAC6;SPARC
gsea,epithelium development (GO:0060429),0.3407388785981582,1.24204780872105,0.15142428785607195,0.2286060718046058,1.0,17/44,25.94%,LGALS3;PGK1;TAGLN2;CDK1;ANXA4;UPK1A;PCNA;PIH1D1;STIL;ANXA7;ALDOC;MTHFD1;TIMELESS;ERRFI1;CPT1A;STAT1;VEGFA
gsea,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.34858674037981996,-1.2415973991063591,0.18571428571428572,0.2777622881320036,1.0,13/27,34.55%,RACK1;BCL2;PLAUR;PINK1;SGMS1;URI1;PMAIP1;DDX3X;HERPUD1;BCL2L1;DDIT3;BCLAF1;BOK
gsea,receptor signaling pathway via STAT (GO:0097696),-0.4003643767078322,-1.2395491119438709,0.2059447983014862,0.27940627476186203,1.0,8/17,22.36%,STAT4;JAK2;IFNAR2;STAT5A;STAT5B;STAT6;STAMBP;STAT2
gsea,amyloid fibril formation (GO:1990000),-0.37531616570115484,-1.2382805304857807,0.16747572815533981,0.28006750448871237,1.0,10/21,33.07%,RPS27A;FURIN;CST3;USP9X;TSPAN5;GSN;MFGE8;GGA2;TSPAN33;APP
gsea,maturation of LSU-rRNA (GO:0000470),-0.4220593446469525,-1.2381003235094525,0.23440453686200377,0.2794178603251745,1.0,10/24,26.29%,RPL10A;RPL7;WDR12;RPL7A;ZNHIT6;LAS1L;URB1;MRPL1;RRP15;NOP2
gsea,regulation of dendrite development (GO:0050773),0.4034599820607998,1.2364398570924215,0.18629173989455183,0.23433085283386307,1.0,5/18,16.86%,NEDD4;LRP8;LZTS1;DAB2IP;RAP2A
gsea,mitochondrial translational elongation (GO:0070125),0.35432442422131916,1.2363409499302458,0.19399538106235567,0.23414795151540377,1.0,29/52,37.32%,MRPL18;MRPL42;MRPL53;MRPL40;MRPL20;MRPL51;MRPL12;MRPS25;MRPL13;MRPL49;MRPL28;MRPL55;CHCHD1;MRPL39;MRPL19;MRPL17;MRPL15;MRPL16;MRPS12;MRPS7;MRPS18A;MRPL35;MRPS31;MRPL44;MRPS2;MRPS10;GFM1;MRPS22;MRPL47
gsea,positive regulation of cell death (GO:0010942),0.3485665177328414,1.2363180125107127,0.18181818181818182,0.23387682982999414,1.0,13/35,30.84%,MT3;IFNG;EGR1;EIF2S1;BNIP3;ITGAM;FAF1;PICALM;SLC6A13;RIPK1;EIF4G1;TYROBP;CD36
gsea,TOR signaling (GO:0031929),0.3892931668692749,1.2357097599898212,0.18336886993603413,0.2342761127283546,1.0,7/18,34.41%,AKT1;PRR5;PRR5L;MLST8;MTOR;LARP1;EIF4EBP1
gsea,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.401670130905865,-1.234929274321857,0.19844357976653695,0.28246686907962437,1.0,7/18,22.34%,FAS;TNFAIP3;SERPINE1;DDX3X;TNFRSF10B;GPX1;BCL2L1
gsea,cytoplasmic microtubule organization (GO:0031122),0.35479786964138227,1.233494800785852,0.18518518518518517,0.23653047902689542,1.0,13/29,33.98%,EZR;PLK3;TUBGCP2;FIGNL1;CCDC88C;DCTN1;SLK;KPNB1;CLIP2;TUBGCP5;CLIP1;DST;TUBGCP3
gsea,positive regulation of protein modification process (GO:0031401),0.276572710780188,1.2334058835700648,0.1216,0.23631627956584492,1.0,48/98,49.73%,MT3;PPIA;IFNG;AKT1;LYN;SMPD1;HRAS;HSP90AA1;FAM20A;CCND3;CDCA2;TFRC;PIN1;FLOT1;UBE2N;SVIP;PTBP1;MYDGF;ADAM17;RAP2A;FMR1;RIPK1;CAMKK2;VEGFA;ALG10B;IL1B;CALM2;PPP1R7;CD4;ARRB1;CEP295;TMEM119;ANKLE2;VEGFB;GOLGA2;CCND1;SIRT1;RAB3GAP2;CAMK1;LIMCH1;SYMPK;GPNMB;CSF1R;GAS6;MMP9;CDK2AP1;RALB;C3
gsea,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.3850178868956333,-1.232316685953052,0.2111650485436893,0.28496709263123116,1.0,11/19,33.07%,RIPK2;DDIT4;SPRY2;TNKS1BP1;SPRED1;BMP7;SPRED3;AXIN1;SPHK1;SMAD7;APP
gsea,negative regulation of DNA recombination (GO:0045910),0.3456213239957743,1.2321372057800035,0.2,0.23729458734671025,1.0,13/31,30.53%,TINF2;CGAS;SMCHD1;POLR2C;PARPBP;POLR2F;POLR2L;RIF1;RMI2;RTEL1;FANCB;BLM;HELB
gsea,negative regulation of response to DNA damage stimulus (GO:2001021),-0.39767534319139297,-1.2311542902865407,0.1977818853974122,0.28549764535210637,1.0,8/17,33.63%,CD74;TPT1;CD44;CDKN2D;TWIST1;BCL2L1;THOC5;DYRK1A
gsea,regulation of receptor-mediated endocytosis (GO:0048259),0.428763898045717,1.2308212818533169,0.19168173598553345,0.2384343200786426,1.0,8/15,30.93%,BMP2K;HIP1R;HIP1;FLOT1;PICALM;HNRNPK;TNK2;BICD1
gsea,regulation of cellular metabolic process (GO:0031323),0.3883380043114389,1.2296517750863503,0.2085661080074488,0.23934266206369859,1.0,9/19,22.91%,NCOR2;FLOT1;FOXM1;STUB1;ABCA2;COQ7;EIF6;VPS35;ACLY
gsea,positive regulation of autophagy (GO:0010508),0.29976923262654726,1.2288477661642894,0.16831683168316833,0.23993412047981474,1.0,28/50,51.72%,IFNG;HMGB1;PLK3;ATF6;SCOC;BNIP3;PLEKHF1;OPTN;SVIP;PARK7;MTDH;TRIM65;TFEB;CAMKK2;UFL1;TRIM21;LARP1;EIF2AK4;MAP3K7;HTT;PHB2;SIRT1;IKBKG;MEFV;DAPK1;PIK3C2A;TSC2;TRIM8
gsea,regulation of macromolecule metabolic process (GO:0060255),-0.2763921520206344,-1.2286402338034215,0.1440501043841336,0.28763235815171156,1.0,83/83,98.77%,AFF3;ZFP36L1;HIF1A;TOB2;FOXP1;NFKBIZ;NFKBID;ZC3H12A;ATP1B1;TOB1;FUBP3;MYC;AHR;MTMR3;PRDM2;KDM6B;AFF1;TRIM44;HMG20A;TRIM5;ROCK2;BMI1;APP;REST;TRIM14;ADNP2;IGF2BP2;SART3;SIRPA;APOE;MARF1;RASA1;MTMR4;TRIM39;SLC8A1;INSM1;KIF16B;TSKU;IGF2BP3;MEFV;IGF1;RO60;RNF39;PRDM5;PRDM4;AIF1;PRDM10;HINFP;UBAP2;CDK2;CDK4;KHSRP;CDH1;PEG3;HMG20B;UTY;TRIM21;IL10;HNRNPK;ALPK2;PCBP4;NPAT;TARDBP;COQ7;TFEB;YBX3;TCF19;HNRNPDL;CACTIN;TXK;MTMR1;FLOT1;CTCF;LDLR;PIN1;FUBP1;YBX1;HNRNPD;CRIP1;PCBP1;HNRNPAB;PRDM1;CDK6
gsea,regulation of lipid storage (GO:0010883),-0.4024889207327075,-1.2281245080296463,0.20137299771167047,0.28737818415880845,1.0,9/15,31.98%,NFKBIA;NFKB1;ZC3H12A;IKBKE;FTO;ITGB3;FBXW7;LPL;ALKBH7
gsea,purine ribonucleotide biosynthetic process (GO:0009152),-0.4246673122223775,-1.2277723999666237,0.22929936305732485,0.2869295939612414,1.0,5/15,23.10%,GUCY1A1;SLC26A2;GUCY1B1;IMPDH2;ADCY6
gsea,monocarboxylic acid biosynthetic process (GO:0072330),0.39183398830839594,1.2261595139076953,0.20611916264090177,0.24256648466495856,1.0,11/23,39.70%,GATM;NDUFAB1;XBP1;PARK7;OSBPL9;ACLY;ALOX5;HSD17B10;ALDH1A3;OSBP;MLYCD
gsea,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.38423155004446263,1.2261458227440682,0.18148820326678766,0.24167447373288609,1.0,8/22,33.37%,TMED2;SEC24D;AREG;LMAN1;CNIH2;SEC24A;PPP6R3;USO1
gsea,COPII vesicle coating (GO:0048208),0.38423155004446263,1.2261458227440682,0.18148820326678766,0.24167447373288609,1.0,8/22,33.37%,TMED2;SEC24D;AREG;LMAN1;CNIH2;SEC24A;PPP6R3;USO1
gsea,vesicle coating (GO:0006901),0.38423155004446263,1.2261458227440682,0.18148820326678766,0.24167447373288609,1.0,8/22,33.37%,TMED2;SEC24D;AREG;LMAN1;CNIH2;SEC24A;PPP6R3;USO1
gsea,transcription by RNA polymerase III (GO:0006383),0.38735667092880005,1.2259113780328468,0.20408163265306123,0.24162485378820373,1.0,12/19,46.36%,POLR2L;POLR3G;GTF3A;POLR3K;POLR3H;TBP;GTF3C4;ZC3H8;ELL;GTF3C2;GTF3C5;RO60
gsea,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.395392083951738,1.223889112354762,0.22736842105263158,0.24353922279170784,1.0,5/17,19.13%,STMN1;TPX2;MID1IP1;KATNB1;MAP2
gsea,positive regulation of actin filament bundle assembly (GO:0032233),0.3623779215363525,1.2219739930006193,0.19523809523809524,0.24548093999842405,1.0,14/28,46.52%,PFN1;PLEK;S100A10;RHOC;SYNPO2;GPR65;WNT11;ARHGEF5;FHOD1;TGFB3;ARHGEF10L;LIMCH1;TPM1;LIMK1
gsea,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4414831515927512,1.2219467827425243,0.22549019607843138,0.24520691075890427,1.0,4/15,12.56%,CDKN1A;IFNG;HMOX1;MEF2C
gsea,regulation of glycolytic process (GO:0006110),0.3263840423214516,1.2216489851708254,0.20204081632653062,0.24520500924886876,1.0,22/44,32.07%,IFNG;NDC1;AAAS;NUP93;NUP62;RANBP2;NUP85;NUP107;NUP43;TIGAR;EIF6;NUP35;ENTPD5;NUP160;NUP37;PRKAG2;NUP210;NUP54;NUP133;NUP88;NUP205;NUP155
gsea,mitochondrial transport (GO:0006839),0.35600516979724406,1.2215189486383908,0.18723404255319148,0.2450447095503476,1.0,15/29,40.59%,BAK1;TIMM17A;HSP90AA1;SLC25A5;BNIP3;COX18;SLC25A24;TIMM13;TIMM23;TOMM5;ABCB10;TIMM10;TOMM40;MFN2;SPG7
gsea,peptidyl-threonine phosphorylation (GO:0018107),0.3355823185392937,1.22042193573746,0.19874476987447698,0.24600746802374884,1.0,30/30,98.96%,STK39;AKT1;CDK1;CIT;DYRK3;CHEK1;CAD;OXSR1;CSNK2A2;TAF1;ACVR1;GSK3B;PDPK1;HIPK3;LMTK2;DYRK1A;HIPK1;ROCK2;PRKDC;ROCK1;PRKD2;ULK1;NLK;LRRK2;MAPK8;DYRK2;WNK1;HIPK2;CAMK2D;PRKCA
gsea,positive regulation of epithelial cell proliferation (GO:0050679),-0.2979243312895593,-1.2202083542021267,0.11935483870967742,0.29561372759675975,1.0,46/46,98.31%,NR4A3;PRKCA;HIF1A;NRP1;NR4A1;STAT5A;JAML;ECM1;EGR3;ARNT;MYC;NME2;FGF2;PRKD2;NRP2;ITGB3;FZD7;VASH2;F3;TCF7L2;PGF;GRN;EGFL7;TGFA;C5AR1;IGF1;SIRT1;NOTCH2;PIK3CD;VEGFB;YAP1;VEGFA;TNFSF12;NRARP;SRSF6;PDGFB;MYDGF;OSR2;XBP1;NRAS;AREG;HRAS;NME1;AKT1;LAMC1;HMGB2
gsea,response to peptide hormone (GO:0043434),-0.36174647749075267,-1.2199663437514097,0.20934579439252338,0.29496756598151663,1.0,12/26,30.79%,ZFP36L1;STAT4;STAT5A;STAT5B;TGFBR3;STAT6;CREB1;STAT2;ROCK1;EIF2B4;ROCK2;ZBED3
gsea,positive regulation of cell cycle (GO:0045787),0.34030918975541474,1.2199517101977366,0.19824561403508772,0.2462005805911993,1.0,19/39,34.41%,AKT1;ASNS;CALR;CCND3;CCNB1;RAD23A;MDM2;ADAM17;DUSP3;PDGFB;EIF4E;RARA;CHEK1;TRIM21;TTL;HCFC1;PSRC1;CDK4;EIF4EBP1
gsea,chemical synaptic transmission (GO:0007268),-0.272113911091755,-1.2197192335421216,0.1270718232044199,0.2943723020224306,1.0,68/68,95.48%,MBP;SLC1A2;KCNMB4;NAPB;NRGN;KIF1B;SLC12A7;HOMER1;CACNA1A;PDLIM4;FCHSD2;SLC12A6;DVL1;RPS6KA3;PNOC;APBA3;KCNQ3;GRIN1;KCNMB1;ATXN3;SYN1;SLC17A8;PENK;LRP6;LIN7A;LPAR3;HAP1;CACNA1B;PRKAR2B;APOE;CACNB3;AKAP5;STXBP3;MYCBPAP;GABRR1;DRD4;SLC12A5;PPFIA3;HTR7;SLC12A4;PMP22;GLRA1;SLC1A4;NPTX1;NAAA;HTR2A;PDE7B;ERC1;GABRB1;CAMK1;SPG11;NLGN2;NPY;CHRNE;DLG2;NSG1;SLC32A1;GIPC1;MINK1;HSPA8;CAMKK2;UNC13A;SLC17A6;EXOC4;PDZD11;PRKAR2A;UNC13B;RAPSN
gsea,secondary alcohol metabolic process (GO:1902652),0.3939634013022834,1.2195097227729323,0.18855218855218855,0.2463659024548448,1.0,9/18,33.48%,IDH3A;FDX1;SQLE;OSBPL5;SOAT1;NSDHL;IDH1;GBA2;SULT2B1
gsea,cholesterol homeostasis (GO:0042632),-0.3575494647567177,-1.2175658915463157,0.19142857142857142,0.2960925678819892,1.0,10/22,35.28%,GRAMD1B;RORA;ABCG1;HDAC9;SCARB1;LIPG;LPL;NR1H3;ABCA1;LIMA1
gsea,sterol homeostasis (GO:0055092),-0.35537038725955306,-1.217416981211742,0.20728291316526612,0.29536219862410007,1.0,10/23,35.28%,GRAMD1B;RORA;ABCG1;HDAC9;SCARB1;LIPG;LPL;NR1H3;ABCA1;LIMA1
gsea,positive regulation of synaptic transmission (GO:0050806),0.3944247682106919,1.2170922413422554,0.20214669051878353,0.24872389290085256,1.0,11/20,35.79%,CCR2;PTK2B;BAIAP3;ZDHHC2;FLOT1;FMR1;ZDHHC12;KCTD13;EIF2AK4;CCL2;NLGN2
gsea,regulation of immune effector process (GO:0002697),-0.43490916455560347,-1.2162701419391682,0.24253731343283583,0.2958591980316713,1.0,7/16,39.51%,CD81;IRF4;C1QBP;C1QC;CFP;C1QA;C1QB
gsea,extrinsic apoptotic signaling pathway (GO:0097191),0.33838614201422607,1.2150574000200147,0.18342151675485008,0.2507551702667692,1.0,15/35,30.64%,IFNG;SIVA1;BAX;BAK1;CASP8AP2;TNFRSF1A;DAB2IP;TRAF2;CASP3;BID;RIPK1;TNFSF12;DELE1;BAG3;FADD
gsea,positive regulation of type I interferon production (GO:0032481),0.29958669031616664,1.2136771895558445,0.17633928571428573,0.2519257338623064,1.0,23/54,38.55%,GAPDH;ISG15;ZBP1;HSP90AA1;CD14;CGAS;DDX58;FLOT1;HSPD1;G3BP1;POLR2F;POLR2L;POLR3G;DHX9;POLR3K;STAT1;TLR4;POLR3D;TLR2;POLR3H;CHUK;XRCC5;POLR3F
gsea,"DNA-templated transcription, initiation (GO:0006352)",-0.27212763018187575,-1.2126190471861362,0.12745098039215685,0.2995893690492262,1.0,38/86,36.38%,NR4A3;RORA;AR;NR4A1;TBL1X;POLR2A;HDAC10;MAML2;TAF4B;POLR1C;HDAC9;MAML3;HDAC7;TAF1D;CREBBP;NR5A2;POLR2E;TAF9;HDAC5;GTF2E2;KAT2B;POLR1B;RARG;POLR1E;GTF2H3;GTF3C1;POLRMT;GTF2E1;NR2F6;NR1H3;POLR2H;CAVIN1;MED23;THRB;GTF2A1;RORB;RXRA;POLR1A
gsea,membrane protein proteolysis (GO:0033619),0.37632907948695804,1.2095516840352043,0.2003968253968254,0.25632487387253716,1.0,8/21,25.66%,NAPSA;TMPRSS6;MYH9;ADAM19;AFG3L2;ERAP1;ADAM17;RBMX
gsea,mitochondrion organization (GO:0007005),0.2773621534366587,1.2085661068541134,0.16056910569105692,0.2571584694199673,1.0,46/102,42.18%,CYCS;BAX;CHCHD10;HIGD1A;TIMM17A;MTFR2;IFIT2;BNIP3;STOML2;HSPD1;AFG3L2;PARK7;AIFM2;NRF1;SAMM50;BID;TIMM50;TIMM13;GABPA;FANCG;AGTPBP1;DNM3;ESRRA;TIMM23;WDR81;NDUFS1;TOMM5;RHOT2;HCFC1;RAB32;CAV2;BIK;HSD17B10;MTFR1;MTX1;TIMM10;TOMM40;PID1;PTCD2;YME1L1;MFN2;PHB2;SPG7;PPRC1;MGME1;SIRT3
gsea,protein localization to cell periphery (GO:1990778),0.29691544637562095,1.2080822616992732,0.171875,0.2573905064451087,1.0,32/64,45.07%,S100A10;FLNA;TMED2;EZR;PKP3;EHD4;FLOT2;TNFRSF1A;PLEKHF1;ZDHHC2;FLOT1;PDZD11;TESC;RDX;MYO5A;DENND4C;RAP2A;MYADM;FAM126A;PACS2;PACS1;RAB3D;EHD2;JUP;CDH1;ACTN2;BSG;TSPAN15;GAK;RAPGEF2;CLASP2;GAS6
gsea,regulation of endocytosis (GO:0030100),0.3755031454722646,1.208032817120855,0.20987654320987653,0.25713452303532697,1.0,10/30,31.31%,LGALS3;PACSIN2;SMPD1;HIP1R;HIP1;FLOT1;PICALM;RUFY1;CD151;RAB4A
gsea,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3623407977344698,1.2072060151746093,0.21767241379310345,0.25775520847558225,1.0,12/23,46.52%,FBXO5;PIN1;PLK1;UBE2N;DCUN1D3;PARK7;TRIB3;ARRDC3;DTX3L;DCUN1D1;BAG5;LIMK1
gsea,regulation of Notch signaling pathway (GO:0008593),0.3542658543800416,1.2071926055898163,0.1883656509695291,0.2574513785634547,1.0,16/38,41.82%,AKT1;BMP2K;STAT3;SREBF2;ZMIZ1;JAG2;NRARP;CHAC1;LLGL1;ARRB1;YAP1;EPN2;WNT1;NOTCH1;TSPAN15;MMP14
gsea,positive regulation of protein binding (GO:0032092),-0.3307240860856763,-1.2071408182069827,0.1939252336448598,0.30551199168939003,1.0,13/32,36.23%,RIPK2;TIAM1;BAMBI;HIPK2;USP33;LRRK2;ABL1;EPB41;AKTIP;MEN1;HFE;APP;NVL
gsea,regulation of cilium assembly (GO:1902017),-0.34266078084217955,-1.2070379284839359,0.210752688172043,0.3046828738425178,1.0,13/29,31.21%,TBC1D1;TBC1D30;FUZ;RABGAP1;USP6NL;IFT88;IFT140;CCDC88A;TBC1D14;BBS4;CEP97;SGSM3;TBC1D5
gsea,peptidyl-tyrosine modification (GO:0018212),0.3906376801732002,1.2067677011074343,0.24077046548956663,0.2577014151442239,1.0,11/23,34.38%,TPST2;LYN;ABI3;PTK2B;PTPN6;TEC;PDGFB;TTL;FGR;SYK;FES
gsea,establishment of protein localization to mitochondrion (GO:0072655),0.3798164075169148,1.206707783008547,0.2345415778251599,0.2574448019975721,1.0,13/25,40.03%,AKT1;TIMM17A;RALA;HSPD1;HK1;TIMM50;TIMM13;TIMM23;TOMM5;TIMM10;GRPEL1;TOMM40;MFN2
gsea,protein localization to membrane (GO:0072657),-0.2666075296392963,-1.2062087941696638,0.15306122448979592,0.3048002677935875,1.0,90/90,98.39%,PACSIN1;CD81;ARL5C;TSPAN32;EHD3;RAMP3;ITGB7;PTCH1;SPTBN1;MAP7;ATP1B1;RAMP1;MADCAM1;FGF13;TTC7B;RFTN1;C2CD5;SCRIB;TSPAN5;SH3PXD2B;SYNE3;RAB34;TNIK;AP4M1;ROCK1;RAB13;CPE;DVL1;SAV1;RAB38;ROCK2;TM9SF4;SEC16A;TSPAN33;SLMAP;ANK1;NKD2;FAM126B;LRP6;LIN7A;ARL5B;CACNB3;RAMP2;PICK1;TNF;PKP2;ITGA4;GAS6;ZDHHC15;CLASP2;RAPGEF2;GAK;TSPAN15;BSG;ACTN2;NLGN2;NUP155;CDH1;JUP;RAB32;HGS;DLG2;EHD2;AP3D1;NUP54;RAB3D;PACS1;NPC1;PACS2;FAM126A;BID;MYADM;RAP2A;DENND4C;MYO5A;RDX;TESC;PDZD11;FLOT1;ZDHHC2;NDC1;PLEKHF1;TNFRSF1A;FLOT2;EHD4;PKP3;EZR;TMED2;FLNA;S100A10
gsea,positive regulation of neuron projection development (GO:0010976),0.35883047009006674,1.204043635956343,0.20033670033670034,0.26015408089689557,1.0,15/31,44.61%,ARSB;LYN;PTK2B;LRP8;DAB2IP;SCN1B;CAPRIN1;RAPGEF1;FES;BHLHB9;ARHGAP35;KIDINS220;CAMK1;RAPGEF2;ZDHHC15
gsea,response to molecule of bacterial origin (GO:0002237),-0.35498735175896257,-1.2036802275035852,0.2138157894736842,0.30715128242555173,1.0,30/30,98.31%,JAK2;FOXP1;GCH1;TRIB1;TNFAIP3;SELP;PRDX3;IRF5;ERBIN;LIAS;HNRNPA0;RPS6KA3;NOCT;SLPI;CXCL2;IRAK3;NOS2;ACOD1;FCGR2B;IL1B;TLR4;NOS1;IL10;SLC11A1;ADAM17;MAPKAPK2;CD14;MAPKAPK3;F2R;HMGB2
gsea,acylglycerol metabolic process (GO:0006639),0.4426777605702952,1.2031931224456043,0.22259136212624583,0.26080616730774103,1.0,5/15,27.60%,DGAT1;DGKH;APOBR;PGS1;GK
gsea,positive regulation of signaling (GO:0023056),0.4216393311155729,1.2004003950573439,0.24807692307692308,0.26368381022471793,1.0,15/15,97.45%,ANXA2;KCTD13;PTPN23;TNF;EDN1;CD80;ECE1;GATA3;WLS;CLSTN1;SCRIB;HOMER1;INPP5F;NSF;RAMP3
gsea,positive regulation of immune effector process (GO:0002699),0.3978349347906444,1.1986137296609747,0.23163841807909605,0.2653297764904924,1.0,8/18,30.89%,IFNG;CCR2;IL12RB1;XBP1;MYO18A;PTPRJ;IL10;IL1B
gsea,regulation of vesicle-mediated transport (GO:0060627),-0.3211260929237445,-1.1970496572346092,0.20105820105820105,0.31501787745029314,1.0,13/35,29.41%,PACSIN1;NRP1;STON1;STON2;NSF;LRRK2;ABL1;INPP5F;SCARB1;HCK;RAB13;DNAJC13;SPHK1
gsea,protein transport (GO:0015031),-0.2455205680105,-1.1940806252030545,0.16290726817042606,0.3180402854728093,1.0,144/144,99.60%,TBC1D4;CD74;ARL5C;NPM1;RAMP3;AP3B1;ARL4D;NAPB;STX11;SPTBN1;TBC1D1;TBC1D30;DNAJC27;SNX13;GRTP1;PRKCB;TICAM2;RAMP1;KIF3B;MACF1;ABCG1;NSF;RAB6B;RABGAP1;UNC93B1;USP6NL;ARRDC4;TBC1D14;ADPRH;LMAN2L;SCAMP1;MIA3;RCN3;SGSM2;SCG5;RAB34;AP4M1;TVP23B;GGA2;WLS;RAB13;RPGR;STX16;SGSM3;RAB23;SNX27;TXNIP;RAB38;ATP6V1G3;VAMP5;HERC2;TBC1D5;HFE;ABCA1;ARHGEF2;COG7;CTTN;CALCRL;ARL4C;LMTK2;TANGO6;WDR11;RAB5B;IFT22;ARL11;REP15;COPG2;PREPL;APOE;ARL5B;LRP1;RAMP2;PICK1;TRIM23;SEC31A;GGA3;ARFIP2;EVI5;STXBP3;EVI5L;ATP6V0E2;HDAC6;SIL1;TBC1D8;TBCK;SEC23IP;VPS45;STX19;TBC1D9;VPS33B;PPARG;CMTM6;TBC1D25;RAB3GAP2;STX2;TBC1D22B;CEP290;SCAMP4;STX17;COPZ2;ARRDC3;SCFD2;ARFGAP3;TBC1D13;COPA;TBC1D10B;USO1;TMED1;MYO6;CD36;VPS33A;RAB32;TCIRG1;AP3D1;RAB20;KIF3A;GOLGA4;RABL3;RAB3D;GCC2;ARCN1;VPS35;RUFY1;EIF2D;TBC1D8B;HIKESHI;COPG1;COPB2;ARL1;MIA2;OPTN;NDC1;IFT27;TFRC;PDIA4;CANX;CLTC;ATP6V0A2;CENPF;MYH9;IL10RA;TMED2;SNX9;HSP90B1
gsea,regulation of nucleic acid-templated transcription (GO:1903506),0.24371336022587148,1.192585770827661,0.13255360623781676,0.27222330953220214,1.0,77/177,45.87%,CEBPB;TBX21;ZBTB38;PTP4A3;HNRNPD;HINT1;RUNX3;ARNT2;NAB1;CALR;STAT3;CHD7;YBX1;E2F1;ACTN4;CREM;ATXN1;NSD2;NFIL3;MLF1;MYBL2;BRCA2;CNBP;MEF2C;NONO;TFEB;HMGN5;LIN54;NUP107;ZMIZ1;RB1;NFYB;MYCBP;SNAI3;NR3C1;SRSF10;APBB1;NUP35;ZNHIT3;WWC1;MYBL1;SAP30;SBNO2;MSC;CHEK2;ESRRA;ATF4;HCFC1;UTP4;BACH1;MAFA;SRRT;HIC1;NFYC;NAB2;GCFC2;SP1;FOXP3;HINFP;FOXN2;HCFC2;NOTCH1;CTR9;NFYA;PHF19;ASCC2;OGG1;TRIP4;SPI1;THAP1;DENND4A;ERC1;SFPQ;CCAR2;KAT7;FOXK2;HP1BP3
gsea,protein import (GO:0017038),0.3146347610665977,1.1919107247501601,0.20434782608695654,0.27264958533326855,1.0,27/52,40.30%,RAN;AKT1;STAT3;HSP90AA1;NUTF2;NUP93;NUP62;NUP85;NUP107;SAMM50;HIKESHI;HSPA4;KPNB1;E2F3;ALDH3A2;IPO7;NUP133;IPO9;NUP88;SYK;NUP155;RANBP6;IPO5;NXT1;NUP214;TNPO1;PHB2
gsea,regulation of cardiac muscle contraction (GO:0055117),-0.36337661437159974,-1.1918837429551292,0.1889763779527559,0.3200431576868535,1.0,8/16,32.25%,P2RX4;PDE4B;ZC3H12A;ATP1B1;PLN;CHGA;SMAD7;RNF207
gsea,regulation of apoptotic signaling pathway (GO:2001233),-0.3765395845437015,-1.191649205702602,0.2441860465116279,0.3193897394939745,1.0,18/18,98.95%,FAS;TRAF1;BCL2;CX3CL1;SGMS1;MADD;TNF;TRIM39;CSNK2A2;NR4A2;ING5;MAZ;PTPMT1;RB1;DAB2IP;DAPK2;CX3CR1;PPIA
gsea,monocarboxylic acid metabolic process (GO:0032787),0.3134126072027889,1.1911977257068644,0.17695473251028807,0.2732589134391117,1.0,29/61,47.10%,LDHA;AOAH;ME2;SLC16A3;MSMO1;GATM;PTGR1;ACSL4;PDZD11;DLAT;CKM;MTHFD1L;CPT1A;GOT2;NPC1;THEM4;GBA2;CD36;CYP2S1;ALDH1A3;GRHPR;BSG;PPARG;UGT1A9;PDHX;UGT1A8;NAAA;ALDH8A1;IGF1
gsea,chromatin organization (GO:0006325),-0.2783473484431057,-1.1901371688989901,0.20392156862745098,0.32040698698683184,1.0,40/90,37.02%,HMGN1;MYB;SATB1;NPM1;KDM5B;HMGN3;JARID2;KDM4D;BAZ2B;ATRX;HDAC10;BRWD1;PAK1;CHD1;MYC;BPTF;KDM4B;SUPV3L1;KDM6B;HDAC5;INO80;EHMT1;BAZ2A;KAT2B;SETD2;EZH2;ZBTB1;SMARCA2;BRDT;HMG20A;KDM4A;KDM5C;SAFB;SOX15;TAF6L;SETD7;HDAC4;DAXX;RUVBL1;KDM5D
gsea,lipid biosynthetic process (GO:0008610),0.3279103212145139,1.1889921021123442,0.20576923076923076,0.2756312259233215,1.0,17/37,39.70%,AGPAT4;FDFT1;NDUFAB1;HMGCR;XBP1;LSS;MVK;DHRS11;ACSL5;ACLY;PCYT2;ALOX5;DOLPP1;AGPS;PDSS1;MVD;MLYCD
gsea,chaperone-mediated protein complex assembly (GO:0051131),0.426055875686138,1.1889071852068802,0.265625,0.2753883966729161,1.0,7/15,19.74%,PTGES3;HSP90AA1;PFDN6;HSPD1;HSPA1A;HSPA4;PSMG2
gsea,positive regulation of phospholipase C activity (GO:0010863),-0.35569545576573647,-1.1885676665530478,0.20903954802259886,0.3215913968651011,1.0,17/17,97.31%,NTRK3;KIT;FGF2;PLCG1;P2RY6;FLT1;PHB;GPR55;PLCB2;C5AR1;HTR2A;PHB2;S1PR4;CD86;TXK;HRAS;GNA15
gsea,protein targeting (GO:0006605),0.29902885072690555,1.187804626122401,0.20208333333333334,0.2763930906534636,1.0,23/47,44.61%,EDEM1;KIF13B;TIMM17A;ZDHHC2;SPCS3;KATNB1;TIMM13;GIPC1;ZDHHC12;TIMM23;SRPRB;ZFAND2A;VPS37C;TOMM5;ZDHHC21;ZDHHC6;ICMT;TIMM10;TOMM40;MFN2;SEC61A1;AP4E1;ZDHHC15
gsea,histone monoubiquitination (GO:0010390),-0.41103187827466214,-1.1865902065922502,0.2447418738049713,0.3230544908780315,1.0,4/15,28.85%,KDM2B;RNF40;BCOR;CUL4B
gsea,endothelial cell migration (GO:0043542),0.37665339385412777,1.1841360411631245,0.2641843971631206,0.28055994892512737,1.0,8/20,25.94%,PTP4A3;MYH9;PLXND1;LPXN;GIPC1;STAT1;TNFSF12;VEGFA
gsea,negative regulation of cell differentiation (GO:0045596),0.2779351982230744,1.181150076978059,0.19148936170212766,0.2838550515534442,1.0,43/82,56.51%,ID2;IFNG;CDK6;PTK2B;CALR;HNRNPU;E2F1;DAB2IP;PTBP1;ZADH2;RB1;ANP32B;SINHCAF;WNT10B;LEO1;ENPP1;ANKRD26;SIX3;SPRED2;METTL14;SUZ12;TRIB3;EIF2AK4;SKI;YAP1;WNT1;NOTCH1;CTR9;ZFP36L2;ZBTB16;SIRT1;PPARG;NEPRO;MEIS1;TSKU;MED1;RIOX1;FOXA1;CDC73;SMAD3;PKP2;TNF;XDH
gsea,establishment of protein localization to organelle (GO:0072594),0.3091441049182789,1.1809355185557093,0.24053452115812918,0.2837671345320435,1.0,26/48,40.30%,RAN;AKT1;IL10RA;STAT3;NUTF2;RALA;NUP93;NUP62;NUP85;NUP107;HK1;HIKESHI;KPNB1;E2F3;IPO7;NUP133;IPO9;NUP88;SYK;NUP155;RANBP6;IPO5;NXT1;NUP214;TNPO1;PHB2
gsea,anterograde trans-synaptic signaling (GO:0098916),-0.2784424440440547,-1.1799321835511103,0.14754098360655737,0.33106766519518216,1.0,22/49,40.79%,MBP;SLC1A2;KCNMB4;NRGN;SLC12A7;HOMER1;CACNA1A;SLC12A6;RPS6KA3;PNOC;APBA3;KCNQ3;GRIN1;KCNMB1;ATXN3;SYN1;PENK;LRP6;LPAR3;HAP1;CACNA1B;PRKAR2B
gsea,negative regulation of proteolysis (GO:0045861),0.4106346291992908,1.1798063220933441,0.24503311258278146,0.2848217709847187,1.0,7/17,27.29%,SERPINE2;AKT1;CAMK2N1;CHAC1;IL10;CLN3;TRIM21
gsea,fatty acid catabolic process (GO:0009062),-0.3332347017657157,-1.178864392718126,0.22242647058823528,0.3315126318090143,1.0,18/31,33.94%,BDH2;DECR1;ACADM;ABCD3;MMUT;PECR;HACL1;MTLN;SLC25A17;MECR;MCEE;ECI1;PCCA;ACAD11;AIG1;PEX2;ECHDC1;MCAT
gsea,peptidyl-threonine modification (GO:0018210),0.3257779739381515,1.1788269493253725,0.22342733188720174,0.2856415747979977,1.0,12/32,42.37%,STK39;AKT1;CDK1;CIT;GALNT3;DYRK3;CHEK1;CAD;GALNT1;OXSR1;CSNK2A2;TAF1
gsea,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.33588833965511095,1.177625329730342,0.22617354196301565,0.28670320604304383,1.0,16/42,31.64%,ADRB1;LYN;MYH9;CALCA;RHBDF2;ADORA2B;PRKAR2A;CYSLTR2;PLCG2;VIPR2;ADAM17;ADRB2;IL10;FGR;SYK;RLN3
gsea,protein destabilization (GO:0031648),0.3824886154322661,1.177476867329932,0.24193548387096775,0.2865067018595362,1.0,8/18,40.36%,RAD23A;CCDC88C;PLK1;MDM2;TRIM21;KDM8;HTT;SIRT1
gsea,regulation of protein ubiquitination (GO:0031396),0.29642909442320364,1.176276549849019,0.19325842696629214,0.28757649615175684,1.0,19/51,27.91%,AKT1;ISG15;HSP90AA1;MALT1;HSPBP1;CENPS;BRCA1;UBE2N;PARK7;STUB1;HSPA1B;U2AF2;NXN;HSPA1A;TBC1D7;FANCI;BIRC2;UFL1;PAXIP1
gsea,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.2769934941089324,-1.1752095990299474,0.20273348519362186,0.33540205003009677,1.0,73/73,99.74%,NFKB1;JAK2;KLF4;NPM1;RGCC;LARP4;RPL5;IRS2;EEF2;AR;DYRK2;SOX4;SORBS1;MYC;DDX3X;UPF3B;FGF2;ZCCHC4;PYM1;PRKD2;PLXNB2;NAMPT;TGFB2;PRKDC;SLC6A9;BCL3;BRPF3;NSUN5;EPM2AIP1;METTL5;METTL3;FXR2;PASK;IGF1;KAT7;CIITA;THBS1;BCAR3;SIRT1;NAT10;SLC25A37;CCL2;CTC1;TLR2;IL1B;METTL14;ABCB10;TLR4;PRMT1;LARP4B;PIWIL2;MTOR;DNA2;TMEM106A;CDT1;FMR1;EIF6;PDGFB;IL33;DHX9;ATAD5;FAF1;HSPH1;XBP1;EIF3C;EIF3D;EIF4A3;PCNA;HNRNPD;AKT1;RPS27L;IFNG;VIM
gsea,pattern recognition receptor signaling pathway (GO:0002221),0.36562435914556757,1.175074639922551,0.2418831168831169,0.2886788664950478,1.0,15/27,43.78%,HSP90B1;HMGB1;MAPKAPK3;CD14;MAPKAPK2;PLCG2;TAB1;TLR4;CD36;TLR2;CLEC4E;MAP3K7;LACC1;CNPY3;CTSK
gsea,regulation of interleukin-10 production (GO:0032653),-0.33661970347197956,-1.1750308435041215,0.21635883905013192,0.33467898070220625,1.0,10/25,21.22%,XCL1;TNFSF4;IL23A;F2RL1;TRIB2;PDCD1LG2;CD40LG;IRF4;PRKCZ;DLL1
gsea,negative regulation of hydrolase activity (GO:0051346),0.33748633390205446,1.1733543885199684,0.24150943396226415,0.29036033586556975,1.0,12/29,27.54%,TMED2;HRAS;EGLN1;DAB2IP;RDX;PPP1R35;MAP2;RRP1B;SLC39A14;NOS1;CPEB2;MAPK7
gsea,regulation of ossification (GO:0030278),0.42444186466695594,1.1733221433935563,0.2613065326633166,0.2900596949682419,1.0,5/15,24.21%,CHSY1;BMP2K;MEF2C;KREMEN2;ENPP1
gsea,positive regulation of endothelial cell proliferation (GO:0001938),-0.30125344102986895,-1.1729707599655277,0.2033898305084746,0.33638899919912946,1.0,37/37,98.31%,PRKCA;HIF1A;NRP1;NR4A1;STAT5A;ECM1;EGR3;ARNT;FGF2;PLCG1;JCAD;PRKD2;NRP2;ITGB3;VASH2;F3;PDPK1;PGF;ITGA4;EGFL7;SIRT6;APLN;SIRT1;PIK3CD;VEGFB;SP1;VEGFA;TNFSF12;NRARP;PDGFB;ADAM17;MYDGF;HMOX1;NRAS;AKT1;HMGB1;HMGB2
gsea,regulation of cellular component movement (GO:0051270),0.3461236288563047,1.1721786549859385,0.24612403100775193,0.29114499778738917,1.0,15/24,52.19%,CDK6;DIAPH1;LYN;ACTN4;SP100;MEMO1;ADAM17;VEGFA;FES;ETS1;ZSWIM4;BTC;HDAC6;ZSWIM6;ARAP1
gsea,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.37893411201081284,1.1716708184261664,0.2661122661122661,0.29137427405867744,1.0,8/16,30.64%,BAX;CASP8AP2;TNFRSF1A;DAB2IP;BID;DELE1;BAG3;FADD
gsea,renal system development (GO:0072001),0.40162480556793784,1.1707688850844813,0.24912280701754386,0.2920888751238746,1.0,6/15,32.33%,CENPF;IFT27;STAT1;VEGFA;FOXF1;SULF2
gsea,cholesterol transport (GO:0030301),0.3877651685147109,1.1703970040298273,0.2544570502431118,0.29223077019083205,1.0,8/18,38.67%,LDLR;STARD4;OSBPL5;SOAT1;NPC1;CD36;OSBP;ABCA7
gsea,sphingolipid metabolic process (GO:0006665),-0.29651423939826793,-1.169808584696366,0.2176039119804401,0.33970211766932074,1.0,19/42,33.81%,ST6GALNAC3;PLPP1;CERK;HACD1;ENPP2;PPM1L;SGMS1;GLA;ELOVL6;HEXA;PRKD2;CERKL;SAMD8;GM2A;ST6GALNAC6;FA2H;SPHK1;CPTP;SGPL1
gsea,positive regulation of organelle assembly (GO:1902117),0.33326528682562945,1.1687818081836252,0.23529411764705882,0.29384681096002585,1.0,15/28,42.82%,LCP1;CAPG;KCTD17;PLK4;NUP62;GPSM2;G3BP1;SPAG5;CCP110;PIP4K2B;DYNC1H1;ARHGAP35;HTT;RAB3GAP2;FSCN1
gsea,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3865187856951327,1.168532161455605,0.2608695652173913,0.2938196028227352,1.0,5/15,25.94%,MT3;RUNX2;XBP1;ATF4;VEGFA
gsea,regulation of endothelial cell migration (GO:0010594),0.3292982985874573,1.1677182173473135,0.22753623188405797,0.2944758417651951,1.0,15/43,43.39%,AKT1;SH3BP1;PTK2B;CALR;SP100;DAB2IP;VASH1;PIK3CG;CEACAM1;ANXA3;VEGFA;BCAR1;PIK3CD;ETS1;THBS1
gsea,insulin receptor signaling pathway (GO:0008286),0.3341782939017677,1.1672271726512928,0.25662251655629137,0.29469235676169847,1.0,11/32,29.16%,RHOQ;AKT1;ATP6V0A2;GRB7;IDE;BAIAP2;SHC1;SLC39A14;TCIRG1;CAV2;BCAR1
gsea,plasma membrane organization (GO:0007009),-0.3240386708459383,-1.1665039422016021,0.229064039408867,0.34304604952417883,1.0,14/28,36.62%,PACSIN1;CXCR4;SERP1;SPTBN1;TLCD1;PLSCR3;NSF;PLSCR1;SYT11;MICALL1;TLCD2;FA2H;FNBP1L;PLSCR4
gsea,regulation of sodium ion transport (GO:0002028),-0.3872056140606635,-1.1645340800179966,0.24675324675324675,0.3446106116735438,1.0,16/16,99.09%,P2RX4;ATP1A1;PER1;RANGRF;WNK1;NKAIN1;CNKSR3;SLMAP;SCN4B;GPD1L;PKP2;NOS1;AHCYL1;SCN1B;ATP2B4;NEDD4
gsea,nucleocytoplasmic transport (GO:0006913),0.3435350998037673,1.1636683103845682,0.2550335570469799,0.29868125846792815,1.0,21/31,35.99%,SNRPD1;SNRPD3;MALT1;SNRPB;ATXN1;NUTF2;SNRPE;AAAS;HNRNPA1;NCBP2;XPO1;DDX20;GEMIN2;SNRPF;RBM15B;NCBP1;RSRC1;NUP205;NEMF;NXT1;SMN1
gsea,negative regulation of cellular metabolic process (GO:0031324),-0.3691961316135913,-1.1633934210926486,0.25225225225225223,0.3451755092477338,1.0,17/17,99.56%,NFKB1;TRAT1;ATXN2;PINK1;SIRT5;TRAP1;ITGB3;EDN1;EDNRB;APOE;AATF;UGT1A8;WDR54;ABCA2;BRCA1;OPTN;MT3
gsea,regulation of release of cytochrome c from mitochondria (GO:0090199),0.35446590763398966,1.1631311224811014,0.23224568138195778,0.2989875573847414,1.0,10/22,36.23%,PRELID1;BAX;AKT1;BNIP3;BCL2L11;FXN;BID;TNFSF10;BIK;MLLT11
gsea,regulation of cell morphogenesis (GO:0022604),0.36054349788249723,1.163089519404042,0.24719101123595505,0.2986864510341824,1.0,19/19,98.32%,CFL1;MOV10;STRIP1;PDZD8;SPARC;BCL9L;SH3D19;PHIP;MYO9A;VIL1;ZMYM3;FMNL2;CAMSAP1;MFSD2A;ZMYM4;MACF1;CD44;LARP4;ARC
gsea,glycoprotein biosynthetic process (GO:0009101),0.3149469437127383,1.1621279570915743,0.250936329588015,0.29941952281396705,1.0,24/36,39.12%,DDOST;ST3GAL6;FUT7;GCNT1;CHST10;NUS1;ST3GAL3;FUT4;B4GALT5;B3GALT5;ST3GAL4;ALG3;TMEM106A;NPC1;CHST11;ALG10B;B3GALT6;B3GALT4;MPI;ST3GAL5;SERP2;FAM20B;GOLGA2;GCNT2
gsea,regulation of osteoblast differentiation (GO:0045667),0.3401614550507612,1.1620375932932243,0.233983286908078,0.29919337559533576,1.0,16/36,47.62%,CDK6;FBXO5;NPNT;LTF;IFITM1;RUNX2;MEF2C;ATF4;SKI;YAP1;TMEM119;NOTCH1;PPARG;FFAR4;IGF1;WNT4
gsea,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.3731070418099461,1.161359540005492,0.26126126126126126,0.29969294595116264,1.0,6/20,19.29%,NCOR2;CALR;HDAC1;BRCA1;CNOT9;SMARCA4
gsea,membrane lipid biosynthetic process (GO:0046467),-0.33022494853139317,-1.1608253838662084,0.2573099415204678,0.34786997927302676,1.0,11/25,33.81%,PLPP1;HACD1;B3GNT5;PPM1L;SGMS1;ELOVL6;PRKD2;SAMD8;FA2H;SPHK1;SGPL1
gsea,amide biosynthetic process (GO:0043604),-0.3709278009813694,-1.1606632933688124,0.2096317280453258,0.34706568801150317,1.0,7/15,35.40%,PCSK1;ASS1;SGMS1;FURIN;SAMD8;FA2H;NMRAL1
gsea,regulation of regulatory T cell differentiation (GO:0045589),-0.38113354263344623,-1.1603099099334484,0.2731006160164271,0.34656660619097485,1.0,17/17,98.93%,BCL6;SOCS1;TNFSF4;TNFRSF18;DUSP10;IL2;NFATC2;IL4I1;RUNX1;IRF1;KAT2A;FOXP3;FANCA;VSIR;IL2RA;CTLA4;IFNG
gsea,cellular response to nutrient levels (GO:0031669),0.32615459629858773,1.1601272459286576,0.25882352941176473,0.3009587267796933,1.0,10/30,28.40%,KLF10;SREBF2;EHMT2;XBP1;CDKN2B;TFEB;HSPA8;EIF4G1;MTOR;RRAGB
gsea,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.30719813112057076,1.1596247885188973,0.241869918699187,0.3011957645196266,1.0,18/38,46.38%,PPIA;ENO1;AKT1;CREB3L1;NOC2L;MDM2;XBP1;PARK7;DDIAS;YBX3;HSPA1A;HYOU1;MAPK7;HSPB1;SIRT1;CCAR2;MMP9;BAG5
gsea,erythrocyte differentiation (GO:0030218),0.3506001452840915,1.1584563841807818,0.25888324873096447,0.30231518421291825,1.0,9/24,30.23%,ID2;LYN;SLC25A5;LYAR;CASP3;DYRK3;UFL1;VEGFA;ABCB10
gsea,regulation of nitric oxide biosynthetic process (GO:0045428),0.3737121660981201,1.1580442656366852,0.27545909849749584,0.3024657643650439,1.0,10/25,32.09%,IFNG;AKT1;CX3CR1;ATP2B4;HSP90AA1;TLR4;DDAH2;CD36;IL1B;KHSRP
gsea,regulation of nitric-oxide synthase activity (GO:0050999),-0.36167857007681525,-1.15438366224121,0.2803347280334728,0.35386325514456196,1.0,8/20,21.23%,HIF1A;GCH1;SPR;NOSTRIN;NOS1AP;SCARB1;GLA;TERF2
gsea,RNA stabilization (GO:0043489),-0.3795695784498257,-1.1535654733277931,0.287378640776699,0.3539944716962497,1.0,10/19,35.17%,TENT5A;TENT5C;EIF4ENIF1;PABPC1;AXIN2;THRAP3;PARN;NOCT;NAF1;TRDMT1
gsea,mitochondrial translation (GO:0032543),0.3062453047204467,1.1529467318962525,0.30155210643015523,0.30853091417535067,1.0,31/63,37.32%,MRPL18;MRPL42;MRPL53;MRPL40;MRPL20;MRPL51;MRPL12;MRPS25;MRPL13;MRPL49;MRPL28;MRPL55;CHCHD1;MRPL39;MRPL19;MRPL17;MRPL15;MRPL16;MRPS12;MRPS7;MRPS18A;QRSL1;MRPL35;MRPS31;MRPL44;MRPS2;MRPS10;GATC;GFM1;MRPS22;MRPL47
gsea,signal transduction in response to DNA damage (GO:0042770),0.31218377187759416,1.1528961655715488,0.26877470355731226,0.30823900205901145,1.0,17/36,36.09%,CLSPN;E2F7;E2F1;BRIP1;RAD9A;BID;HUS1;PRPF19;CHEK2;CHEK1;PAXIP1;DONSON;MYO6;HINFP;ATR;RAD17;WNT1
gsea,regulation of Rho protein signal transduction (GO:0035023),0.33063434817027665,1.1519523481703342,0.24854651162790697,0.30907587859183167,1.0,15/39,39.00%,STMN1;ADGRG1;ARHGDIA;F2R;F2RL2;BCR;GPR65;ITGA3;F2RL3;MYO9B;KCTD13;GPR35;ARRB1;ARHGEF28;ARHGAP35
gsea,organonitrogen compound catabolic process (GO:1901565),0.3294767904717679,1.1517687624446507,0.27087198515769945,0.30895758547524227,1.0,12/29,35.18%,UCHL3;GNPDA1;IDE;ERAP1;PRSS16;BCKDK;CLN5;NAGK;NPL;MTOR;PDXDC1;ADO
gsea,regulation of cell-substrate adhesion (GO:0010810),-0.3357885643724543,-1.1509748668366713,0.23717948717948717,0.35667442296173096,1.0,10/23,30.97%,JAK2;BST1;CX3CL1;PPM1F;NF1;NDNF;RSU1;FZD7;ARL2;ATXN3
gsea,regulation of erythrocyte differentiation (GO:0045646),-0.3519690400246414,-1.150784126325747,0.27388535031847133,0.3559094645870164,1.0,23/23,98.77%,ZFP36L1;HIF1A;ZFPM1;STAT5B;ARNT;MAFB;HSPA9;PRKDC;FOXO3;INHBA;MED1;ETS1;SPI1;ABCB10;PRMT1;STAT1;HSPA1A;HSPA1B;ZFP36;STAT3;LYN;HMGB2;CDK6
gsea,myelination (GO:0042552),-0.3728070310450209,-1.1484162948716554,0.2621359223300971,0.35825624038226533,1.0,6/18,25.06%,MBP;CXCR4;NF1;MARVELD1;GPC1;EIF2B4
gsea,regulation of glucose import (GO:0046324),-0.36873884440763005,-1.1481085155484811,0.2698412698412698,0.3576854317557237,1.0,10/16,38.68%,IRS2;GRB10;PIK3R1;PTPN11;C1QTNF12;SORBS1;SELENOS;APPL2;PRKCI;CAPN10
gsea,protein localization to plasma membrane (GO:0072659),0.28084173458468925,1.1478376289017405,0.23971377459749552,0.31374945028309276,1.0,32/64,45.07%,S100A10;FLNA;TMED2;EZR;PKP3;EHD4;FLOT2;TNFRSF1A;PLEKHF1;ZDHHC2;FLOT1;TESC;RDX;MYO5A;DENND4C;RAP2A;MYADM;FAM126A;PACS2;PACS1;RAB3D;EHD2;GORASP2;JUP;CDH1;ACTN2;BSG;TSPAN15;GAK;RAPGEF2;CLASP2;GAS6
gsea,lysosome localization (GO:0032418),-0.35299857418216257,-1.147744500020531,0.24190064794816415,0.3572167316949388,1.0,7/20,25.15%,NR4A3;KIT;BLOC1S2;MILR1;PLEKHM2;RAB34;CHGA
gsea,protein transmembrane import into intracellular organelle (GO:0044743),0.3796229071836078,1.1471601277887717,0.2826552462526767,0.31428040890921993,1.0,7/18,37.99%,TIMM17A;HSPD1;PEX7;TIMM50;TIMM23;GRPEL1;TOMM40
gsea,amino acid transport (GO:0006865),0.37286233973686855,1.147151091847046,0.2807017543859649,0.3139240059894963,1.0,9/20,48.28%,SLC3A2;SLC16A10;SLC7A5;SLC1A5;SLC7A3;SLC1A4;SLC3A1;SLC38A9;SLC7A6
gsea,regulation of focal adhesion assembly (GO:0051893),0.34967118463082814,1.1471312745481057,0.23964497041420119,0.3135953309295398,1.0,16/32,47.56%,ACTG1;S100A10;DUSP3;CORO1C;SLK;PTPRJ;VEGFA;PEAK1;DUSP22;LIMCH1;DMTN;THBS1;CLASP2;PHLDB2;COL16A1;SLC9A1
gsea,positive regulation of mitochondrion organization (GO:0010822),0.3177574736550615,1.146480999576978,0.236983842010772,0.3140807844009655,1.0,20/32,41.75%,BAX;CHCHD10;BAK1;RALA;BNIP3;BCL2L11;HIP1R;PARK7;AURKA;BID;VPS35;CAMKK2;TNFSF10;ZDHHC6;BIK;MLLT11;MCU;HTT;SPIRE1;DDHD1
gsea,regulation of generation of precursor metabolites and energy (GO:0043467),0.3303850918148558,1.1460887874677077,0.26371308016877637,0.31422743108290624,1.0,20/35,32.07%,NDC1;AAAS;NUP93;NUP62;RANBP2;NUP85;NUP107;NUP43;TIGAR;EIF6;NUP35;NUP160;NUP37;PRKAG2;NUP210;NUP54;NUP133;NUP88;NUP205;NUP155
gsea,sensory perception of sound (GO:0007605),-0.3127452103576064,-1.1446534904099157,0.2344632768361582,0.3605141334296303,1.0,13/28,35.72%,KIT;RIPOR2;GRAP;TBL1X;ATP2B2;CCDC50;MYO3B;TIMM9;USP53;PAX3;TMIE;COL11A1;CDH23
gsea,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.36352300150568057,1.1445571971289883,0.2570194384449244,0.3158245755584637,1.0,5/19,25.90%,GLMN;PTK2B;RAD23A;XPO1;UFL1
gsea,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.2987945860398977,-1.142946271337955,0.2330508474576271,0.36189652983858744,1.0,42/42,92.53%,RACK1;TRIB1;SOCS5;RNF19A;BAG2;RNF19B;DNAJB2;TRIB2;LRRK2;NUB1;ZER1;CBFA2T3;DVL1;FBXW7;VCP;SMAD7;ATXN3;DAB2;NKD2;COP1;ZYG11B;GSK3B;ANKIB1;TAF1;NUPR1;TRIB3;USP5;PSMC6;CSNK1E;FMR1;HSPA1A;HSPA1B;PSMC5;STUB1;PSMC2;MDM2;PLK1;DAB2IP;RAD23A;KEAP1;HSPBP1;SUMO2
gsea,COPII-coated vesicle budding (GO:0090114),0.3439544875736969,1.1413310057701713,0.26151012891344383,0.31954952840255185,1.0,9/25,33.37%,TMED2;SEC24D;AREG;LMAN1;SEC23B;CNIH2;SEC24A;PPP6R3;USO1
gsea,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.29634105201512195,-1.1409878856018019,0.2552204176334107,0.3636954804006126,1.0,38/38,98.93%,NTRK3;RIPK2;RAMP3;PINK1;CD44;LIF;SPRY2;PAK1;PFN2;TNKS1BP1;TERF2IP;PRKD2;FNIP1;HSP90AB1;AXIN1;APP;DOCK7;TNF;RPTOR;HDAC6;LATS1;GAS6;HAX1;BCAR3;CAMK1;OSM;NOS1;VEGFA;EIF4G1;SH2D3C;PARK7;CNOT9;TFRC;MIF;HSP90AA1;ATP2B4;AKT1;IFNG
gsea,toll-like receptor signaling pathway (GO:0002224),0.29484813353500183,1.1407536035051604,0.2653061224489796,0.31993160566033213,1.0,26/44,53.06%,HSP90B1;HMGB1;PIK3AP1;MAPKAPK3;CD14;MAPKAPK2;ITGAM;HSPD1;PLCG2;RIPK1;SCIMP;TAB1;BIRC2;TLR4;FADD;CD36;TLR2;CHUK;MAP3K7;IKBKG;CNPY3;CTSK;TRAF3;BTK;IRAK3;UBB
gsea,negative regulation of ERBB signaling pathway (GO:1901185),0.3481228770138739,1.140655319674838,0.2811918063314711,0.3196770813374456,1.0,11/22,28.07%,AREG;ITGA1;DAB2IP;PTPN12;RNF126;MVP;DUSP3;ERRFI1;STAM2;PTPRJ;HGS
gsea,negative regulation of protein kinase B signaling (GO:0051898),-0.36659819132971405,-1.140075382693644,0.2865853658536585,0.3639975885301416,1.0,6/18,25.05%,RACK1;SH2B3;PHLPP1;BANK1;DAG1;DDIT3
gsea,positive regulation of protein metabolic process (GO:0051247),0.296605114554095,1.13984277501754,0.2849557522123894,0.3203854760465551,1.0,23/49,36.22%,NEDD4;CSF1;AKT1;BARD1;UHRF1;TIPARP;DAB2IP;IDE;DDX58;CD86;FZR1;ABCA2;DTL;EIF4G1;TNFSF12;MAPK7;PRMT1;ABCB10;IL1B;HECW2;DDB1;SLC25A37;WWP1
gsea,7-methylguanosine RNA capping (GO:0009452),0.35699114090353945,1.139622799296725,0.2955032119914347,0.3199317981096757,1.0,11/20,38.52%,POLR2C;POLR2F;POLR2L;NCBP2;GTF2F1;NCBP1;CMTR1;GTF2F2;GTF2H2;POLR2B;GTF2H4
gsea,7-methylguanosine mRNA capping (GO:0006370),0.35699114090353945,1.139622799296725,0.2955032119914347,0.3199317981096757,1.0,11/20,38.52%,POLR2C;POLR2F;POLR2L;NCBP2;GTF2F1;NCBP1;CMTR1;GTF2F2;GTF2H2;POLR2B;GTF2H4
gsea,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.3996749740798447,1.1393488768185986,0.29790419161676646,0.31992484555785,1.0,11/21,30.84%,CDKN1A;RAB27A;ITGAM;PLCG2;PDGFB;RIPK1;DCXR;TLR4;TYROBP;SYK;CD36
gsea,negative regulation of multicellular organismal process (GO:0051241),-0.24670988140677771,-1.1389937078520178,0.18972332015810275,0.3646363503112408,1.0,88/88,98.93%,EVL;IL18R1;RGCC;SPRY1;PARP3;PTCH1;TLE3;RAB11FIP1;DUSP10;SPRY2;ABHD6;OVOL2;PFN2;ARNTL;TFE3;HDAC9;SYT11;TNNT1;ADM;SPRED1;KLF7;CIDEA;ROCK1;TIMP1;GATA3;PTGER4;WDR77;DDIT3;PROCR;SPRED3;USF3;ROCK2;SMAD7;NR1H3;TWSG1;PCTP;RPS6KA6;IL13;DOCK7;TIFAB;SLAMF8;SRF;GRN;TNF;GSK3B;FOXC2;LOXL2;FOXA1;PTPN23;RPS6KA5;ID1;GAS6;FFAR4;GPNMB;SPI1;FCGR2B;PLCL1;NOTCH1;MAP2K6;ARRDC3;FOXP3;IL1B;SPRED2;TLR4;SFMBT1;ATF4;IL10;ALPK2;WNT10B;SLC11A1;WWC1;WNT11;ASB1;SRSF6;CORO1C;RB1;ADAM17;KREMEN2;MEF2C;BRCA2;HMGCR;DAB2IP;CALR;ATP2B4;CHSY1;RGS2;F2R;IFNG
gsea,intracellular protein transport (GO:0006886),-0.23802741989042916,-1.1383880539923008,0.2127659574468085,0.3645630441192283,1.0,158/158,99.05%,TBC1D4;CD74;ARL5C;NPM1;FAM53B;AP3B1;ARL4D;NAPB;STX11;EIF4ENIF1;TBC1D1;RANGRF;TBC1D30;DNAJC27;SNX13;GRTP1;XPO6;TICAM2;HEATR3;NSF;RAB6B;RABGAP1;IPO4;UNC93B1;USP6NL;PPP1R10;TBC1D14;ADPRH;C2CD5;CLIP3;SGSM2;SCG5;EGR2;AP4M1;STRADA;GGA2;WLS;XPO5;FAM53C;TRAK1;RPGR;TNPO3;STX16;SGSM3;POM121;RAB23;SNX27;RAB38;HERC2;SEC16A;TBC1D5;AP4B1;MYO1C;ARHGEF2;COG7;APPL2;CTTN;NUP188;TNPO2;ARL4C;HAP1;WDR11;RAB5B;IFT22;ARL11;IPO11;ARL5B;PICK1;NUP153;TRIM23;SEC31A;CSE1L;GGA3;ARFIP2;EVI5;STXBP3;EVI5L;RPAIN;DESI1;HDAC6;STAM;TSC2;SIL1;TBC1D8;TBCK;SEC23IP;BCS1L;VPS45;STX19;TBC1D9;AP4E1;IPO8;VPS33B;TBC1D25;RAB3GAP2;XPO4;PHB2;TNPO1;STX2;TBC1D22B;NUP214;STX17;COPZ2;NXT1;SCFD2;ARFGAP3;IPO5;TBC1D13;COPA;TBC1D10B;USO1;RANBP6;NUP155;TMED1;MYO6;SYK;BAG3;NUP88;XPO7;IPO9;VPS33A;RAB32;NUP133;AP3D1;RANBP3;CCHCR1;IPO7;RAB20;RABL3;GIPC1;E2F3;ARCN1;VPS35;EIF2D;KPNB1;TBC1D8B;COX18;KATNB1;HIKESHI;COPB2;ANKLE1;NUP107;XPO1;NUP85;ARL1;NUP62;NUP93;NUTF2;LMAN1;IFT27;CLTC;STAT3;CALR;KIF13B;TMED2;AKT1;RAN;SNX9
gsea,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.33962519694910337,-1.1369498416768289,0.3090909090909091,0.36564994997090056,1.0,12/24,33.07%,PDCD4;NFAT5;TNFSF14;IL23A;C1QTNF4;TLR7;DDX3X;TERF2IP;TRIM44;SPHK1;RELA;APP
gsea,positive regulation of catabolic process (GO:0009896),0.33157835519688617,1.1353655054342386,0.2711864406779661,0.32465178763798586,1.0,13/27,36.22%,NEDD4;BARD1;TIPARP;DAB2IP;IDE;FZR1;VSIR;DTL;TNFSF12;IL1B;HECW2;DDB1;WWP1
gsea,ameboidal-type cell migration (GO:0001667),-0.33478047625400775,-1.1350415453322997,0.22790697674418606,0.36741378159919996,1.0,21/21,98.71%,PDLIM1;ITGB7;SEMA4C;SEMA4B;PHACTR4;AMOTL2;SGPL1;AMOT;SOX10;SOX8;ITGA4;AMOTL1;SRGAP2;SEMA6D;PDXDC1;SEMA7A;NANOS1;CORO1C;CENPV;AKT1;SEMA4A
gsea,positive regulation of monooxygenase activity (GO:0032770),0.37670642377460783,1.1349530206075231,0.2920517560073937,0.32476381740759347,1.0,7/17,30.89%,IFNG;AKT1;DHFR;PARK7;NUS1;POR;IL1B
gsea,tRNA methylation (GO:0030488),-0.33624674502931323,-1.1345387405707903,0.2706333973128599,0.36712087090670165,1.0,15/27,37.84%,THADA;TRMT1;TARBP1;DALRD3;PRORP;TRMT1L;METTL1;ALKBH8;THUMPD2;NSUN6;WDR6;TRMT61A;TRDMT1;TRMT10A;TRMT44
gsea,response to hydrogen peroxide (GO:0042542),0.3258961083984143,1.1337995326056844,0.27431906614785995,0.3258983597156508,1.0,10/28,27.54%,ANXA1;RIPK3;HMOX1;ECT2;PARK7;PLEKHA1;FXN;RIPK1;IMPACT;MAPK7
gsea,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.40421915550332965,1.1329353527437898,0.32310177705977383,0.32670559185447706,1.0,7/19,33.53%,SMPDL3B;LYN;CD14;DAB2IP;CACTIN;TLR4;LRRC14
gsea,phospholipid translocation (GO:0045332),0.38816298413787087,1.1324131629798397,0.28544423440453687,0.3270070360808703,1.0,4/15,38.69%,ATP8B4;ATP8B2;ABCA7;ANO6
gsea,oligosaccharide metabolic process (GO:0009311),-0.35048909611692713,-1.1277549022763758,0.2903885480572597,0.3761613133032362,1.0,20/20,92.34%,ST6GALNAC3;ST8SIA1;ST8SIA4;GLA;NAGA;ST6GALNAC6;MAN2C1;MAN1B1;NEU1;FUT8;B3GALT4;B4GALNT2;ST3GAL4;B3GALT5;ST6GALNAC4;MPDU1;FUT4;ST3GAL3;FUT7;ST3GAL6
gsea,negative regulation of innate immune response (GO:0045824),0.3722859871089346,1.126420720020642,0.3055555555555556,0.3344220372688467,1.0,7/19,27.29%,ISG15;LYAR;CACTIN;USP15;TRAFD1;TTLL12;TRIM21
gsea,cellular response to retinoic acid (GO:0071300),0.42295423513888053,1.1260123732240914,0.2978142076502732,0.3346154715541297,1.0,6/17,22.38%,LYN;PTK2B;TESC;FZD4;WNT11;WNT10B
gsea,positive regulation of histone acetylation (GO:0035066),0.3665387135566589,1.124491230974637,0.3062015503875969,0.3362777798291451,1.0,11/18,39.97%,PIH1D1;BRCA1;RUVBL2;NOS1;SMARCB1;PAXIP1;IL1B;FOXP3;ARRB1;SPHK2;MUC1
gsea,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3713421416027872,1.1233389668192415,0.3148148148148148,0.3374360385566201,1.0,12/21,37.55%,AURKB;NEK2;CCT7;HNRNPA1;CCT8;TCP1;MAP3K4;CCT6A;ATR;PKIB;XRCC5;CCT5
gsea,mitochondrial membrane organization (GO:0007006),0.3442149073930373,1.1226283832457333,0.3038229376257545,0.3380670307657915,1.0,11/21,40.59%,BAK1;SLC25A5;BNIP3;SAMM50;APOO;TIMM50;IMMT;DNAJC11;MTX1;MFN2;SPG7
gsea,protein K63-linked deubiquitination (GO:0070536),-0.3756915942459967,-1.1225037051693896,0.3162878787878788,0.3826584199124827,1.0,8/17,30.97%,TNFAIP3;USP33;OTUD1;STAMBPL1;OTUD7B;STAMBP;USP8;ATXN3
gsea,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.36406608229586446,-1.1195303226998736,0.2737864077669903,0.3861468760698513,1.0,10/19,32.89%,DUSP4;DUSP6;DUSP1;DUSP10;PTPN11;PTPN13;DUSP18;DUSP7;PTPRS;DUSP16
gsea,gene silencing by miRNA (GO:0035195),0.3635038623430842,1.1188349518396008,0.31634819532908703,0.34275366322966366,1.0,8/17,45.55%,RAN;ZFP36;EIF6;MOV10;ZC3H7B;TARBP2;PRKRA;DICER1
gsea,mRNA stabilization (GO:0048255),0.3497692518310304,1.1185521373788923,0.30062630480167013,0.3427515774295124,1.0,11/22,22.19%,YBX1;HNRNPU;E2F1;MAPKAPK2;SYNCRIP;TAF15;ZFP36;YBX3;DHX9;TARDBP;SLC11A1
gsea,sensory perception of mechanical stimulus (GO:0050954),-0.31385681098485907,-1.1184441299997177,0.2676470588235294,0.3867816526879972,1.0,13/27,35.72%,P2RX4;RIPOR2;GRAP;TBL1X;ATP2B2;CCDC50;MYO3B;TIMM9;USP53;PAX3;TMIE;COL11A1;CDH23
gsea,negative regulation of defense response (GO:0031348),-0.2912521259694094,-1.1150410169096139,0.2785714285714286,0.39084776273477584,1.0,38/38,98.43%,KLF4;RORA;TNFAIP3;MFHAS1;TNFAIP8L2;SELENOS;GATA3;PTGER4;DHX58;NR1H3;C1QBP;TRAF3IP1;IL13;SIRPA;FEM1A;APOE;IRAK3;MEFV;FFAR4;ACOD1;NLRC3;PPARG;GHSR;MAPK7;TRIM21;ALOX5;IL10;NLRP3;VPS35;MVK;TRAFD1;RB1;CACTIN;LYAR;TNFRSF1A;AOAH;SMPDL3B;METRNL
gsea,ceramide metabolic process (GO:0006672),-0.3623920715756487,-1.1147016977016015,0.2950108459869848,0.39026002611783756,1.0,8/17,33.81%,ST6GALNAC3;PLPP1;CERK;SGMS1;SAMD8;ST6GALNAC6;FA2H;SGPL1
gsea,negative regulation of cell adhesion (GO:0007162),-0.3006904425616621,-1.1134497406074315,0.2727272727272727,0.3911083935491226,1.0,30/30,98.27%,PLXNC1;DUSP1;RIPOR2;SERPINE1;CX3CL1;ARHGDIG;FBLN1;MIA3;PLXNB2;FZD7;PLXNA1;ACVRL1;GTPBP4;RASA1;NF2;DMTN;MUC1;TGFBI;GCNT2;NOTCH1;WNT1;CDH1;B4GALNT2;PDE3B;FZD4;DSCAM;SPN;LPXN;PLXND1;ARHGDIA
gsea,regulation of cellular amide metabolic process (GO:0034248),-0.33100364882457617,-1.1116882672776627,0.2951127819548872,0.3926571117608484,1.0,14/24,35.76%,RPL10;ATXN2;METAP1;GEMIN5;EIF2A;ROCK1;SAMD8;EIF2B4;RBM4B;FOXO3;PGAM1;APP;TCOF1;NANOS3
gsea,regulation of developmental growth (GO:0048638),-0.3658274205130119,-1.1103415461586637,0.314070351758794,0.39370195293197063,1.0,9/15,34.69%,STAT5A;STAT5B;ABL1;DLL1;SIN3A;MFSD2A;LATS2;APP;CTTN
gsea,negative regulation of oxidative stress-induced cell death (GO:1903202),0.37502980047156675,1.1064981056160634,0.32454361054766734,0.35847225404632865,1.0,7/15,28.61%,PPIA;AKT1;PARK7;ATF4;PYCR1;MAPK7;HSPB1
gsea,cilium organization (GO:0044782),-0.2437276600424393,-1.1043035985198866,0.24093816631130063,0.4018120162212835,1.0,92/92,98.17%,ASAP1;CCDC28B;EHD3;IFT80;RILPL2;RAB3IP;KIFAP3;PDE6D;DYNC2H1;NEK1;FUZ;KIF3B;CPLANE1;AHI1;B9D1;IFT81;IFT88;IFT140;SSX2IP;GSN;IFT74;TMEM216;CEP41;BBS4;LZTFL1;CLUAP1;PTPDC1;EXOC2;RPGR;RAB23;IQCG;ARL13B;KIF27;PIBF1;CATIP;IQCB1;POC1B;FNBP1L;CEP162;HSPB11;TTBK2;CEP164;GBF1;TRAF3IP1;HYLS1;WDR11;ABCC4;CEP19;MKKS;IFT46;PCM1;TMEM138;CCDC66;IFT43;CFAP298;PTPN23;WDR90;HDAC6;SPAG16;CEP290;NOTCH1;CEP78;RP2;CEP89;PCNT;CCNO;SCLT1;CEP83;TCTN3;OFD1;RTTN;EHD2;KIF24;KIF3A;TMEM237;CCP110;DYNLL2;EXOC8;CDC14A;MNS1;CEP250;ODF2;TMEM107;EXOC4;CENPJ;CFAP126;PLK4;EHD4;ACTR2;SNX10;FLNA;TTC39C
gsea,microtubule bundle formation (GO:0001578),0.36011912331321694,1.103246799586321,0.3193717277486911,0.36246016825407945,1.0,9/19,48.56%,KIF20A;PLK1;AAAS;PSRC1;CLIP1;TPPP3;SPAG16;GAS2L1;NAV1
gsea,RNA modification (GO:0009451),-0.2998852637202654,-1.1023526350982051,0.32629558541266795,0.4037592352949287,1.0,23/42,36.73%,NOP10;TRMT1;TRUB1;NSUN4;THG1L;MEPCE;DTWD1;QTRT2;QTRT1;PUS7L;METTL1;AARS2;NOP2;NSUN6;PUS3;PUS7;PARN;ADAR;NSUN3;TRMT61A;TRDMT1;THUMPD1;NSUN5
gsea,O-glycan processing (GO:0016266),-0.3319472474093276,-1.1014785916132548,0.3157894736842105,0.4039963912274541,1.0,22/22,94.25%,GALNT14;ST6GAL1;ST3GAL1;B3GNT5;XXYLT1;GALNT7;POFUT1;B3GNT3;POMGNT1;MUC1;MUC20;GALNT10;MUC6;GALNT1;ST3GAL4;ST6GALNAC4;B4GALT5;ST3GAL3;GCNT1;GALNT6;GALNT3;GXYLT1
gsea,sphingolipid biosynthetic process (GO:0030148),-0.3139462014367962,-1.1014006552451916,0.29878048780487804,0.4030578139244277,1.0,11/27,33.81%,ST8SIA1;PLPP1;HACD1;PPM1L;SGMS1;ELOVL6;PRKD2;SAMD8;FA2H;SPHK1;SGPL1
gsea,iron ion homeostasis (GO:0055072),0.32885812419034943,1.1011738814919192,0.3228346456692913,0.3648134118792283,1.0,12/26,34.39%,TMPRSS6;ATP6V0A2;TFRC;HMOX1;NUBP1;PICALM;FXN;CYB561A3;TMEM199;SLC11A1;GLRX3;NEO1
gsea,positive regulation of interleukin-8 production (GO:0032757),0.3480957931701393,1.0998992313075222,0.34539473684210525,0.3662497395262844,1.0,14/26,31.87%,F2R;HMGB1;STAT3;CD14;DDX58;PARK7;HSPA1B;HSPA1A;RIPK1;TLR4;SYK;FADD;IL1B;TLR2
gsea,extracellular matrix organization (GO:0030198),0.2801973345838916,1.096471693125522,0.3009592326139089,0.37067574834199674,1.0,51/105,52.56%,ADAM8;SPP1;LCP1;LAMC1;CAPN2;ADAMTS14;TMPRSS6;NPNT;CAPG;ADAM19;JAM2;CREB3L1;ITGA1;ITGAM;P4HB;COLGALT1;FLOT1;CRTAP;ITGA3;PDGFB;APLP1;EXOC8;LAMC2;PLOD2;PLEC;COL6A3;CD151;ITGAX;PDGFA;CDH1;PLOD3;DST;VCAN;ICAM1;P4HA1;CTSG;TGFBI;BSG;MMP14;COL1A1;THBS1;CTSK;COL16A1;GAS6;COL5A3;MMP9;MATN1;ITGAE;COL4A4;COL17A1;SPARC
gsea,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.3635930600365275,-1.095676695213104,0.3135802469135803,0.41097769794669925,1.0,17/17,98.93%,KLF4;P2RX4;ASS1;KLF2;NOS1AP;HSP90AB1;PTGS2;EDN1;TNF;SMAD3;IL1B;CD36;DDAH2;TLR4;HSP90AA1;AKT1;IFNG
gsea,establishment of mitotic spindle orientation (GO:0000132),-0.39255856718772714,-1.0953018015776097,0.3435804701627486,0.41047557233507376,1.0,17/17,94.98%,ITGB1;NUMA1;UBXN2B;CDK5RAP2;NSFL1C;HTT;INSC;SPDL1;NDE1;ZW10;DCTN1;GPSM2;CENPA;NDC80;PLK1;SAPCD2;MAD2L1
gsea,regulation of protein localization to cell surface (GO:2000008),-0.35259121885993816,-1.094697080101526,0.3431952662721893,0.4102739892710983,1.0,7/17,36.26%,GPM6B;RANGRF;CTNNB1;HSP90AB1;TM9SF4;HFE;GBF1
gsea,regulation of carbohydrate catabolic process (GO:0043470),0.3255994820031893,1.0946615841884846,0.3252212389380531,0.3727883294248167,1.0,19/30,32.07%,NDC1;AAAS;NUP93;NUP62;RANBP2;NUP85;NUP107;NUP43;EIF6;NUP35;NUP160;NUP37;PRKAG2;NUP210;NUP54;NUP133;NUP88;NUP205;NUP155
gsea,positive regulation of cell growth (GO:0030307),-0.274786078215404,-1.094537063370696,0.2904191616766467,0.4094510212069514,1.0,47/47,97.42%,DNPH1;BCL2;RNF157;PRSS2;MACF1;DDX3X;SUPV3L1;INO80;SLC25A33;MFSD2A;TGFB2;RPS6KA3;BRAT1;SPHK1;SYT4;IL2;EIF4G2;ADNP2;KLHL22;EDN1;MAP3K13;CPNE9;N6AMT1;CXCL16;RUFY3;RPTOR;PLAA;IGF1;LIMK1;USP47;MMP14;DDX49;SHTN1;HDGFL2;SEMA7A;NCBP1;EXOSC2;EXOSC4;GOLGA4;EIF4G1;UNC13A;EXOSC9;ADAM17;FXN;DERL2;L1CAM;AKT1
gsea,regulation of megakaryocyte differentiation (GO:0045652),0.3149414464728349,1.090576856184074,0.3079584775086505,0.3779550611296299,1.0,13/32,43.39%,HMGB2;DPY30;HDAC1;RBBP5;MEF2C;WDR5;TESC;EIF6;MOV10;PRMT1;MTURN;RBM15;THBS1
gsea,histone deacetylation (GO:0016575),-0.31593308848542623,-1.090542026910964,0.350597609561753,0.41469983157456664,1.0,12/28,35.43%,ELK4;TBL1X;PER1;HDAC10;HDAC9;HDAC5;BAZ2A;MORF4L2;SIN3A;MIER3;REST;HDAC4
gsea,regulation of defense response to virus by host (GO:0050691),0.36397464540837693,1.090309234191636,0.3139784946236559,0.377949429916053,1.0,9/16,42.52%,IL12RB1;HSP90AA1;CGAS;DDX58;DHX9;STAT1;EIF2AK4;TARBP2;DTX3L
gsea,tRNA aminoacylation for protein translation (GO:0006418),-0.3407144374338672,-1.0896125554325988,0.3333333333333333,0.4151042495693093,1.0,12/22,31.46%,FARS2;LARS2;WARS2;YARS2;TARS2;FARSB;AARS2;NARS2;DARS2;IARS2;RARS2;VARS2
gsea,positive regulation of nitric oxide metabolic process (GO:1904407),-0.35038494576884394,-1.088550476655554,0.3341584158415842,0.4156875439790605,1.0,18/18,98.93%,KLF4;P2RX4;ASS1;KLF2;NOS1AP;HSP90AB1;PTGS2;EDN1;TNF;SMAD3;IL1B;CD36;DDAH2;TLR4;TMEM106A;HSP90AA1;AKT1;IFNG
gsea,cellular response to insulin stimulus (GO:0032869),0.2732484728556921,1.086931908067067,0.3058823529411765,0.38228123449312107,1.0,26/61,32.55%,PKM;RHOQ;AKT1;ATP6V0A2;GRB7;LPIN2;PCK2;IDE;XBP1;BAIAP2;CEACAM1;MYO5A;DENND4C;GOT1;SLC27A1;SHC1;INSIG1;SLC39A14;ENPP1;TCIRG1;CPEB2;PDE3B;CAV2;BCAR1;TRIB3;OTOP1
gsea,cellular response to hydrogen peroxide (GO:0070301),0.32663776057678506,1.0864884614779466,0.35714285714285715,0.38240330577438236,1.0,9/24,27.54%,ANXA1;RIPK3;ECT2;PARK7;PLEKHA1;FXN;RIPK1;IMPACT;MAPK7
gsea,ERBB signaling pathway (GO:0038127),0.29628698212341975,1.0850528319625838,0.33512544802867383,0.3840395655876966,1.0,20/34,52.43%,AKT1;PTK2B;HSP90AA1;AREG;GRB7;PTPN12;MVP;STUB1;ADAM17;MATK;SHC1;CUL5;BCAR1;REPS2;BTC;PIK3C2A;RPS6KA5;KIF16B;TGFA;GAREM1
gsea,import into cell (GO:0098657),-0.3454512691868318,-1.0841586846434923,0.3632183908045977,0.4214859272250562,1.0,10/18,26.42%,LRRC8D;SLC5A3;SLC7A1;SLC38A1;SLC6A6;SLC12A7;GLUL;SLC12A6;SLC29A1;SLC19A1
gsea,protein targeting to mitochondrion (GO:0006626),0.3307722703590376,1.083374154600481,0.3592436974789916,0.3860742470303786,1.0,14/29,40.03%,TIMM17A;HSP90AA1;HSPD1;SAMM50;PMPCA;HSPA4;TIMM50;TIMM13;TIMM23;TOMM5;TIMM10;GRPEL1;TOMM40;MFN2
gsea,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.34355175648943725,1.082697700428137,0.3403361344537815,0.38658651154319795,1.0,8/19,46.21%,ACTR2;SMCHD1;AUNIP;TFIP11;RIF1;WRAP53;DTX3L;CYREN
gsea,neuron projection extension (GO:1990138),-0.3312148967526458,-1.0822112208878292,0.3474576271186441,0.42343619884030875,1.0,10/20,26.88%,NRP1;C9ORF72;TMEM108;ALCAM;CTNNB1;USP9X;ULK1;NRP2;HSP90AB1;ULK2
gsea,regulation of purine nucleotide metabolic process (GO:1900542),0.31979451047180746,1.0807225694665334,0.34521158129175944,0.3890028006370176,1.0,22/31,40.26%,NDC1;AAAS;NUP93;NUP62;RANBP2;NUP85;NUP107;NUP43;EIF6;NUP35;NUP160;NUP37;PRKAG2;NUP210;NUP54;NUP133;NUP88;NUP205;NUP155;NUP214;LACC1;SEH1L
gsea,peptidyl-tyrosine phosphorylation (GO:0018108),0.34943743697617163,1.0791907098013094,0.34913112164297,0.3908459638227267,1.0,13/23,41.90%,LYN;ABI3;PTK2B;PTPN6;TXK;TEC;PDGFB;FGR;IL21;SYK;FES;CSF1R;FLT3
gsea,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.37126270127918976,1.0791345191000967,0.35208711433756806,0.39048152810044856,1.0,8/15,34.65%,BRCA1;RUVBL2;NOS1;PAXIP1;DIP2A;IL1B;FOXP3;ARRB1
gsea,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.3920494146160066,1.0746770292427852,0.37649402390438247,0.39603296153129736,1.0,8/15,36.40%,CYCS;NDUFAB1;NDUFA5;SDHD;CYC1;NDUFS1;COX15;NDUFA12
gsea,aerobic electron transport chain (GO:0019646),0.3920494146160066,1.0746770292427852,0.37649402390438247,0.39603296153129736,1.0,8/15,36.40%,CYCS;NDUFAB1;NDUFA5;SDHD;CYC1;NDUFS1;COX15;NDUFA12
gsea,response to interferon-beta (GO:0035456),-0.3792116502138655,-1.0733965946368431,0.3778705636743215,0.43603824740750446,1.0,5/15,25.58%,IFNAR2;HTRA2;IKBKE;PLSCR1;SHFL
gsea,aggrephagy (GO:0035973),0.3617567941712669,1.0711152239031818,0.35684647302904565,0.4006570257597818,1.0,8/15,32.81%,VIM;UBE2N;PARK7;DYNC1LI2;DYNC1I2;DYNLL2;WDR81;PCNT
gsea,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.30056937384089344,1.0710515993726777,0.37627811860940696,0.4002915260340302,1.0,14/28,46.38%,AKT1;ISG15;DCUN1D3;PARK7;HSPA1B;U2AF2;NXN;HSPA1A;UFL1;TRIM21;ARRB1;PINX1;PIAS3;BAG5
gsea,interferon-gamma-mediated signaling pathway (GO:0060333),0.31550948011665453,1.070814757362961,0.3706422018348624,0.4001562287967524,1.0,11/30,36.33%,IRF8;IFNG;IFI30;SP100;CAMK2G;NCAM1;STAT1;GBP2;TRIM21;ICAM1;PTAFR
gsea,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.28340690998150925,1.0656362603308456,0.35429769392033544,0.40733514697522855,1.0,18/38,43.87%,RASD2;MALT1;SAE1;HSPBP1;CENPS;BRCA1;DCUN1D3;UBA2;STUB1;TBC1D7;FANCI;BIRC2;PAXIP1;WDR48;PIAS4;PIAS3;DCUN1D1;UBQLN1
gsea,fatty acid derivative biosynthetic process (GO:1901570),-0.3429154391061307,-1.0634133904747614,0.38308457711442784,0.4509370956019216,1.0,4/16,25.56%,BDH2;BDH1;FASN;CBR4
gsea,establishment of spindle orientation (GO:0051294),-0.36626065053921963,-1.0629365985664798,0.3889908256880734,0.45056064761081366,1.0,20/20,94.98%,ITGB1;NUMA1;CLASP1;UBXN2B;CDK5RAP2;NSFL1C;HTT;INSC;LLGL1;SPDL1;NDE1;ZW10;DCTN1;MAP4;GPSM2;CENPA;NDC80;PLK1;SAPCD2;MAD2L1
gsea,cytosolic transport (GO:0016482),-0.2611393911323975,-1.0619407701879207,0.34375,0.4510771221652078,1.0,23/53,41.13%,LAMP1;EHD3;EEA1;CCDC91;HOOK2;RAB6B;VPS13C;CORO7;HOOK1;HOOK3;AKTIP;AP4M1;TBC1D23;PIKFYVE;EPS15;STX16;TBC1D5;RHOBTB3;RGP1;GBF1;LMTK2;TMEM87A;PREPL
gsea,synapse assembly (GO:0007416),0.37067095485779955,1.061892262613366,0.3987034035656402,0.41246519481044347,1.0,8/15,37.72%,PLXND1;DSCAM;RYK;DNM3;LGI2;CDH1;NLGN2;FARP1
gsea,cellular response to heat (GO:0034605),0.3606650107050384,1.061300028159595,0.396484375,0.41291421353199087,1.0,11/19,33.69%,YWHAE;HSP90AA1;HMOX1;STUB1;HSPA1B;HIKESHI;HSPA1A;RBBP7;BAG3;HSBP1L1;CLPB
gsea,hematopoietic progenitor cell differentiation (GO:0002244),-0.34781292416371445,-1.060147195322406,0.4,0.4529505946212597,1.0,7/16,26.09%,KIT;MLLT3;BATF;PRRC2C;TNFRSF13B;PLD4;FLT1
gsea,spermatid development (GO:0007286),0.37745270220088695,1.059929501809808,0.39082278481012656,0.4144437892662157,1.0,7/15,46.33%,JAM2;CEP57;CDYL;SPINK2;RNF8;YTHDC2;DDX25
gsea,cellular amide metabolic process (GO:0043603),-0.25955463770872755,-1.059509035787207,0.3568075117370892,0.4528752933252151,1.0,29/51,40.42%,ST6GAL1;ACSL6;ST3GAL1;CPM;PLPP1;CERK;FPGS;MCCC2;SLC25A32;ABHD4;MCCC1;CPD;PCCA;THOP1;CPE;SLC19A1;ALDH1L1;DBI;CPXM1;BTD;GPAT4;ACOT1;MTHFR;SGPL1;HLCS;ACOT4;AEBP1;ACSF2;OXSM
gsea,prostaglandin metabolic process (GO:0006693),-0.35272851691698454,-1.0590590897245242,0.3974358974358974,0.4524102375439772,1.0,8/15,37.38%,CD74;PNPLA8;PTGR2;GSTM1;PTGS2;PTGDS;ACOX1;EDN1
gsea,defense response to Gram-negative bacterium (GO:0050829),0.40982342818106926,1.0577059455458109,0.398876404494382,0.41719935554508014,1.0,7/15,36.30%,HMGB2;LTF;OPTN;SLC11A1;TLR4;CTSG;MR1
gsea,regulation of Ras protein signal transduction (GO:0046578),0.28386428736698094,1.0537382035412914,0.3665158371040724,0.4226394979051224,1.0,25/45,48.44%,ARHGDIA;SH3BP1;LYN;BCR;DAB2IP;NUP62;RDX;FOXM1;DENND4C;DENND3;LRRC59;KIF14;SHC1;RABL3;MYO9B;RAPGEF1;NOTCH1;ARHGEF28;SHOC2;NOTCH2;MFN2;DENND4A;IGF1;RASGRF1;SYNGAP1
gsea,positive regulation of interleukin-6 production (GO:0032755),-0.27912253473456994,-1.0526954724785154,0.30939226519337015,0.4614507426324581,1.0,41/41,98.93%,CD74;MBP;POU2F2;IL16;POU2AF1;TNFSF4;PTPN11;F2RL1;C1QTNF4;MAVS;TLR7;IL17RA;TWIST1;IFIH1;LPL;APP;ARHGEF2;MAPK13;HYAL2;RAB7B;TNF;NOS2;AIF1;SPHK2;TLR2;IL1B;SYK;TYROBP;TLR4;TMEM106A;SCIMP;IL33;DHX9;PLCG2;HSPD1;DDX58;XBP1;STAT3;HMGB1;F2R;IFNG
gsea,response to insulin (GO:0032868),-0.2711574563850357,-1.0517251949484547,0.32054176072234764,0.46187688055274256,1.0,44/44,98.37%,ZFP36L1;TBC1D4;IRS2;PIK3R2;PIK3R1;SORBS1;SELENOS;HDAC9;FOXO1;C2CD5;HDAC5;SLC25A33;KAT2B;RAB13;PRKDC;ZBED3;PRKCI;EPM2AIP1;CAPN10;TSC1;PDPK1;PARP1;LPIN1;PPARG;SIRT1;OTOP1;TRIB3;PDE3B;CPEB2;ENPP1;SLC39A14;INSIG1;SLC27A1;EIF6;GOT1;DENND4C;MYO5A;CEACAM1;XBP1;PCK2;LPIN2;AKT1;RHOQ;PKM
gsea,establishment of mitotic spindle localization (GO:0040001),0.350810730819707,1.0493863273573782,0.4008810572687225,0.4287387095878678,1.0,13/22,28.86%,MAD2L1;NUSAP1;SAPCD2;PLK1;NDC80;CENPA;GPSM2;DCTN1;ESPL1;KPNB1;ZW10;NDE1;SPDL1
gsea,regulation of mRNA processing (GO:0050684),-0.3551281943963528,-1.0484318731141433,0.399624765478424,0.4663355209514204,1.0,18/18,97.59%,ZFP36L1;SAFB2;SAFB;METTL16;CWC22;PTCD2;CPSF4;SLTM;IWS1;NCBP1;JMJD6;SRPK1;AHCYL1;HNRNPK;LARP7;SRSF10;DHX9;SRSF3
gsea,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.3069678977747679,-1.048300989188985,0.41232227488151657,0.46537202275234946,1.0,27/27,98.79%,CD74;HIF1A;CXCR4;TICAM2;C1QTNF4;MAVS;CASP4;AXL;TRIM44;AGPAT1;EDN1;GFI1;CD300LF;PARP9;GAS6;FADD;PARP14;RIPK1;HSPA1A;ADAM17;HSPA1B;AGPAT2;CPNE1;TXK;CASP1;ZBP1;CSF1
gsea,integrin-mediated signaling pathway (GO:0007229),0.322730364466826,1.048215667618047,0.39705882352941174,0.43002906744034924,1.0,14/36,33.07%,NEDD9;PLEK;MYH9;PTK2B;ISG15;CDH17;TXK;CEACAM1;TEC;BCAR1;FGR;SYK;SEMA7A;DST
gsea,signal transduction by p53 class mediator (GO:0072331),-0.32969909222686067,-1.046624597438672,0.3968253968253968,0.46699481063944226,1.0,11/18,34.55%,BATF;ATRX;JMY;PDK2;PMAIP1;NBN;SESN2;NDRG1;MYBBP1A;BCL3;BOK
gsea,positive regulation of lipid biosynthetic process (GO:0046889),0.36375598695745437,1.0450753984513028,0.39447731755424065,0.43426033985769463,1.0,6/15,23.51%,AKT1;MID1IP1;LDLR;LPGAT1;SLC27A1;MTOR
gsea,tube closure (GO:0060606),-0.34428364709038484,-1.0450669719113028,0.3470873786407767,0.46725703246411754,1.0,12/17,35.84%,SEMA4C;FUZ;DLC1;SCRIB;PHACTR4;BBS4;DVL2;PLXNB2;TGFB2;MTHFR;LMO4;LRP6
gsea,primary neural tube formation (GO:0014020),-0.34428364709038484,-1.0450669719113028,0.3470873786407767,0.46725703246411754,1.0,12/17,35.84%,SEMA4C;FUZ;DLC1;SCRIB;PHACTR4;BBS4;DVL2;PLXNB2;TGFB2;MTHFR;LMO4;LRP6
gsea,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.34299441206128056,-1.0424249346379417,0.391304347826087,0.47023695348500105,1.0,21/21,85.43%,RPS8;WDR46;UTP20;KRI1;TSR2;HEATR1;DHX37;NOP14;PWP2;BMS1;RPP40;TSR1;NOL10;HELB;UTP4;TBL3;DCAF13;UTP3;UTP6;NOP9;RRS1
gsea,macrophage activation (GO:0042116),-0.3284949242342855,-1.0409548258496397,0.3783068783068783,0.4715516778613065,1.0,18/18,98.93%,JAK2;FOXP1;CX3CL1;APP;C1QA;IL13;TNF;C5AR1;AIF1;SYK;TLR4;SBNO2;TMEM106A;SLC11A1;CD93;PLCG2;ITGAM;IFNG
gsea,regulation of protein targeting to mitochondrion (GO:1903214),-0.345826354781195,-1.0395105400500133,0.41254752851711024,0.4728012089694008,1.0,10/16,35.59%,HTRA2;PINK1;LRRK2;NPEPPS;HUWE1;VPS11;FBXW7;BAP1;PARL;BAG4
gsea,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.29747635722839866,1.0386425167326154,0.402002861230329,0.4436400299629274,1.0,22/41,50.26%,ADRB1;LYN;MYH9;CALCA;RHBDF2;ADORA2B;PRKAR2A;CYSLTR2;PLCG2;VIPR2;ADAM17;ADRB2;IL10;FGR;SYK;RLN3;MC1R;CYSLTR1;HTR7;SCT;PTH1R;GPR83
gsea,protein autoubiquitination (GO:0051865),-0.31840396391903375,-1.037756736729769,0.4008097165991903,0.47437796010105693,1.0,22/22,91.62%,RNF157;KLHL24;SH3RF1;RNF19B;NFX1;RNF213;RNF141;TRIM37;CUL3;DDB2;ASB4;DTX3L;RNF8;ERCC8;RAD18;TRIM21;UBE2T;TRAF2;STUB1;BRCA1;MDM2;UHRF1
gsea,protein maturation (GO:0051604),-0.2664777941689078,-1.0374013720345072,0.3575,0.47379752132223574,1.0,46/46,97.97%,CTSS;TSPAN32;PCSK1;CPM;PTCH1;PSEN2;FURIN;TASP1;PITRM1;TSPAN5;CPD;LMF1;XPNPEP3;CPE;DDI2;F3;CPXM1;TSPAN33;ECE1;AEBP1;NAA10;PCSK4;LIPT2;MMP14;TSPAN15;TYSND1;NAA16;CIAO1;NAA35;NAA15;MMS19;GLRX3;CLN3;NAA40;ADAM17;NAA50;STUB1;GCSH;AFG3L2;TESC;HSPD1;LMF2;METAP2;NDUFAB1;ADAM19;DNAJB11
gsea,peptide metabolic process (GO:0006518),0.29435823762732305,1.035987174107828,0.3944954128440367,0.4472233864168042,1.0,9/30,43.56%,ABCB9;GSR;IDE;SPCS3;ERAP1;GSTM5;CLN5;NLN;CARNMT1
gsea,histone H3-K4 methylation (GO:0051568),0.340755577350742,1.0353723634044718,0.3888888888888889,0.4476037766393843,1.0,5/16,38.24%,DPY30;RBBP5;WDR5;PAXIP1;CTR9
gsea,phosphatidylcholine metabolic process (GO:0046470),-0.27416610877855846,-1.0340689018900573,0.4134366925064599,0.4782422754427328,1.0,16/30,36.11%,PLA2G4F;PNPLA8;CHKA;ENPP2;SLC44A1;ABHD4;STARD10;MBOAT1;MFSD2A;LPCAT1;DBI;NR1H3;GPAT4;PCTP;PLA2G12A;LPCAT2
gsea,negative regulation of inflammatory response (GO:0050728),0.2807462949409329,1.0317554881437838,0.42451612903225805,0.45269181611845916,1.0,39/73,48.37%,METRNL;SMPDL3B;ADRB1;AOAH;CD200R1;LYN;MYH9;CALCA;RHBDF2;TNFRSF1A;ADORA2B;PRKAR2A;CYSLTR2;PLCG2;VIPR2;ADAM17;RB1;ADRB2;MVK;VPS35;NLRP3;IL10;ALOX5;MAPK7;FGR;SYK;RLN3;GHSR;MC1R;PPARG;NLRC3;ACOD1;FFAR4;CYSLTR1;IGF1;HTR7;MEFV;SCT;PTH1R
gsea,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.33017990190508306,-1.0298625733375886,0.4066666666666667,0.4840787596810358,1.0,9/17,32.30%,KLF4;TBXA2R;HDAC9;HDAC7;FGF2;HDAC5;JCAD;MAP3K3;PTGS2
gsea,carboxylic acid transport (GO:0046942),0.30992424223736004,1.0285507090589208,0.40827338129496404,0.4571734672250319,1.0,8/26,28.12%,SLC3A2;SLC16A3;SLC7A5;SLC1A5;SLC25A10;SLC6A13;CLN3;SLC13A3
gsea,sulfur compound biosynthetic process (GO:0044272),0.26922452743200403,1.0244929205630544,0.42244224422442245,0.46296373825019144,1.0,15/43,34.99%,CHSY1;GSTO1;ST3GAL6;GGCT;MGST3;GGTA1;GSTM5;ST3GAL3;B4GALT5;ST3GAL4;CHST11;CHAC1;SLC35D2;VCAN;UST
gsea,negative regulation of mRNA catabolic process (GO:1902373),-0.342443185295488,-1.0236303605156045,0.42641509433962266,0.4934057550948147,1.0,17/17,95.65%,TENT5A;TENT5C;EIF4ENIF1;PABPC1;AXIN2;THRAP3;NOCT;NBAS;FUS;LARP1;SLC11A1;FMR1;TAF15;E2F1;HNRNPU;YBX1;PKP3
gsea,sensory perception of light stimulus (GO:0050953),0.3325186521086696,1.0233595507746762,0.4307909604519774,0.46416232890779985,1.0,9/27,37.47%,RGS16;ATF6;USH1C;CRYBG3;CRYBA4;SIX3;ROM1;RP2;CRYZ
gsea,regulation of supramolecular fiber organization (GO:1902903),-0.34387926769508337,-1.0231643107795803,0.4271047227926078,0.49302095718873834,1.0,8/15,36.95%,CAMSAP2;C9ORF72;ABL1;GPX1;CAMSAP1;ARL2;PIK3CA;AEBP1
gsea,ribonucleoprotein complex assembly (GO:0022618),-0.27873012851954765,-1.02312661121347,0.39664804469273746,0.4918901138320915,1.0,87/87,98.26%,RPLP0;RPSA;RPL10;RPL3;RPL5;CELF2;CELF1;GEMIN8;RPS15;EIF4B;EIF5;RPL23A;MDN1;DDX1;GEMIN5;WDR77;HSP90AB1;NOP2;COIL;PRKDC;NLE1;NAF1;DDX23;SETX;SART3;SHQ1;CPSF6;SNUPN;CDC73;PRMT7;PRMT5;PWP2;CELF5;DHX29;BRIX1;DICER1;GEMIN6;TARBP2;LUC7L3;PRPF6;ERAL1;SCAF11;SART1;SNRNP200;XRCC5;TXNL4A;SMN1;RRP7A;GCFC2;MRPS7;BOP1;CLNS1A;NCBP1;SRPK1;RSL24D1;SNRPF;RPF2;GEMIN2;STRAP;PPAN;EIF2D;PRPF19;USP39;SRSF10;SRSF1;EIF6;EIF4H;SRSF6;DHX9;SF3A2;DDX20;LUC7L;EIF3A;RRS1;EIF2S2;CELF4;SRSF9;DENR;SNRPE;MRPL20;DDX39B;SNRPB;HSP90AA1;PTGES3;SNRPD3;SNRPD1;RPS27L
gsea,phosphatidylinositol metabolic process (GO:0046488),-0.25592713674897644,-1.0215030611049174,0.4106382978723404,0.4934406325272074,1.0,53/53,98.83%,INPP4B;PIK3R6;PLA2G4F;PIK3R2;PIK3R1;LCLAT1;SYNJ2;PTPN13;INPP5F;MTMR3;FGF2;PLCG1;PIK3R4;PITPNM2;SYNJ1;PIKFYVE;PLEKHA8;PIK3R5;PLA2G12A;PIK3CA;SBF1;MTMR14;PIK3CB;INPP5B;PLCB2;PLA2G4A;MTMR4;PIK3C2A;MTMR12;FIG4;PI4KB;CSF1R;PLBD1;PI4KA;PIK3CD;PGAP3;PIP5K1C;VAC14;RAB4A;INPPL1;PIP4K2B;CDIPT;RUFY1;SLC27A1;SACM1L;LPGAT1;PLEKHA1;PGAP1;PLCG2;PIK3CG;MTMR1;PI4K2B;PLEK
gsea,amino acid transmembrane transport (GO:0003333),-0.33579910567636484,-1.0188771873777327,0.4157303370786517,0.49665654203181353,1.0,9/17,40.18%,LRRC8D;SLC7A1;SLC38A1;SLC6A6;SLC38A2;SLC25A22;SLC36A4;SLC7A8;SLC38A6
gsea,negative regulation of cell-matrix adhesion (GO:0001953),0.3843705271114056,1.0183339677406056,0.42994505494505497,0.4714520698303654,1.0,12/16,57.02%,CDKN2A;CORO1C;DUSP22;DMTN;THBS1;CLASP2;PHLDB2;NF2;PLET1;BCAS3;RCC2;RASA1
gsea,cellular response to glucose starvation (GO:0042149),-0.29871571026650673,-1.0180123251713218,0.4074074074074074,0.4969580458215774,1.0,12/26,33.19%,SESN3;ZC3H12A;SESN1;PMAIP1;MTMR3;SESN2;MYBBP1A;PIK3R4;SIK2;FOXO3;BHLHA15;ATG14
gsea,inner mitochondrial membrane organization (GO:0007007),0.3243775066452216,1.017935424957103,0.4117647058823529,0.4715340004520929,1.0,9/19,40.59%,AFG3L2;SAMM50;APOO;TIMM13;IMMT;DNAJC11;MTX1;TIMM10;SPG7
gsea,chromatin remodeling (GO:0006338),-0.2481751395378579,-1.0174420510860356,0.41359223300970877,0.49681159862752183,1.0,70/70,99.87%,MYB;SATB1;NPM1;KDM5B;CHD3;JARID2;KDM4D;BAZ2B;ATRX;CHD4;PAK1;GATAD2B;MYC;BPTF;KDM4B;KDM6B;HDAC5;INO80;BAZ2A;KAT2B;ARID1B;SRCAP;ZBTB1;SMARCA2;BRDT;KDM4A;KDM5C;TAF6L;HDAC4;DAXX;RUVBL1;BAHD1;KDM5D;ERCC6;MBD3;CHD8;TADA2B;KAT2A;INO80C;CHD1L;FOXA1;TADA2A;PBRM1;ARID1A;HDAC2;SIRT1;HNRNPC;HCFC2;FOXP3;SMARCA5;SMARCC1;HCFC1;MTA2;SMARCB1;RUVBL2;BAZ1B;SMARCA4;RBBP4;NPM3;SUV39H2;RB1;SMARCC2;POLE3;NUDT5;ACTL6A;HDAC1;PIH1D1;CBX3;BAZ1A;ACTB
gsea,protein acetylation (GO:0006473),0.3245713172118517,1.016999316476192,0.4130879345603272,0.47248158531949286,1.0,11/20,40.36%,ESCO2;DSCC1;HAT1;NAA50;NAA40;ING5;NAA15;NAA35;NAA16;NAT10;SIRT1
gsea,inositol lipid-mediated signaling (GO:0048017),-0.3155350878696874,-1.0158120778361737,0.4199029126213592,0.4984406257032527,1.0,7/20,26.92%,IRS2;PIK3R2;PIK3R1;INPP5F;PLCB4;PITPNM2;PLCH1
gsea,epithelial cell migration (GO:0010631),0.3267514260488364,1.015126999892667,0.4429065743944637,0.4749733953115956,1.0,9/19,25.86%,PTP4A3;PLXND1;LPXN;ANLN;ZEB2;GIPC1;NANOS1;STAT1;TNFSF12
gsea,positive regulation of protein ubiquitination (GO:0031398),0.2709557848163062,1.009880924344311,0.4587737843551797,0.48288773248863776,1.0,18/37,43.87%,MALT1;PIN1;HSPBP1;CENPS;PLK1;BRCA1;UBE2N;DCUN1D3;STUB1;TBC1D7;FANCI;BIRC2;PAXIP1;FANCM;TRIB3;ARRDC3;DCUN1D1;UBQLN1
gsea,regulation of microtubule polymerization (GO:0031113),0.30946357381127587,1.0093764803383236,0.4533333333333333,0.4831468075429801,1.0,8/21,34.38%,STMN1;DCTN1;MAP2;DRG1;PSRC1;GBA2;CLIP1;FES
gsea,positive regulation of telomerase activity (GO:0051973),0.3312733584114559,1.009039711156633,0.44353182751540043,0.48315656225032405,1.0,11/21,42.64%,AURKB;PTGES3;HSP90AA1;NEK2;TCP1;MAP3K4;WRAP53;PKIB;XRCC5;CCT2;DKC1
gsea,negative regulation of protein phosphorylation (GO:0001933),0.24161022131470655,1.0071482002029233,0.44901315789473684,0.48564078157813284,1.0,35/78,42.22%,PPIA;AKT1;CAMK2N1;LYN;PRR5L;SFN;DAB2IP;PTPN6;CEACAM1;PARK7;CACTIN;MVP;RB1;CORO1C;MYADM;DUSP19;ERRFI1;TARDBP;TAB1;YWHAG;EIF4G1;PRKAG2;PAQR3;ENPP1;IMPACT;PRKRIP1;HSPB1;SPRED2;CALM2;TRIB3;CEP85;SNX25;PID1;DMTN;TARBP2
gsea,negative regulation of developmental process (GO:0051093),0.28540529033523115,1.0052403728849149,0.4369885433715221,0.48810656427293375,1.0,19/36,50.57%,CDK6;MIF;TFRC;BNIP3;VASH1;FOXM1;ANP32B;WNT11;SINHCAF;ALPK2;SFMBT1;SUZ12;WNT1;NOTCH1;SPI1;GAS6;BCL11A;GRIN3A;VAT1
gsea,positive regulation of microtubule polymerization (GO:0031116),0.34820563950539735,1.003373681552304,0.4521072796934866,0.49047393647802673,1.0,8/15,34.38%,CKAP5;HSPA1B;DCTN1;HSPA1A;DRG1;PSRC1;CLIP1;FES
gsea,substrate adhesion-dependent cell spreading (GO:0034446),-0.33767044922741407,-1.0012695947099726,0.44387755102040816,0.5215145210869948,1.0,15/15,97.83%,NRP1;ITGB7;PIK3R1;ATRNL1;ITGB3;FN1;PARVB;ITGA4;SRGAP2;ANTXR1;PEAK1;KIF14;MEGF9;LPXN;LAMC1
gsea,snRNA transcription (GO:0009301),0.24949902336920274,1.000933246418956,0.416289592760181,0.4938218497676137,1.0,24/48,39.18%,NABP1;POLR2C;POLR2F;POLR2L;ELL2;NCBP2;GTF2F1;INTS5;INTS4;NCBP1;INTS10;RPRD1B;SRRT;GTF2F2;RPAP2;SP1;INTS2;TAF6;TBP;POLR2B;ZC3H8;INTS1;ELL;INTS8
gsea,endoderm formation (GO:0001706),0.4029183942342925,1.0008998708313104,0.46886912325285895,0.4933645869164335,1.0,5/16,46.32%,DUSP5;DUSP2;EOMES;MMP14;MMP9
gsea,response to light stimulus (GO:0009416),0.2907460156323446,1.000806079678761,0.45321100917431195,0.49298415010908353,1.0,13/32,51.28%,PCLAF;USP1;POLD1;DTL;COPS3;GTF2H2;PRIMPOL;ERCC8;CCAR2;ZRANB3;ERCC3;ERCC2;DDB2
gsea,glycolipid metabolic process (GO:0006664),0.2927245986782715,0.9987299489423533,0.46473029045643155,0.49577786937163093,1.0,11/22,41.43%,SMPD1;ST3GAL6;PGAP1;SMPD4;ABCA2;ST6GALNAC4;ST3GAL4;SCCPDH;GBA2;PGAP3;GALC
gsea,enzyme linked receptor protein signaling pathway (GO:0007167),0.29763908222938035,0.9986144792056394,0.458656330749354,0.4954531027781088,1.0,22/42,49.76%,NEDD9;CSF1;LYN;PTK2B;CD7;STYK1;RYK;SHC1;TNK2;RAPGEF1;BCAR1;FGR;SYK;CD4;FES;CASS4;GFRA2;CLNK;CSF1R;FLT3;CNKSR1;LIFR
gsea,snRNA transcription by RNA polymerase II (GO:0042795),0.2519797029870639,0.9985713312577393,0.4223744292237443,0.49500517518002723,1.0,24/47,39.18%,NABP1;POLR2C;POLR2F;POLR2L;ELL2;NCBP2;GTF2F1;INTS5;INTS4;NCBP1;INTS10;RPRD1B;SRRT;GTF2F2;RPAP2;SP1;INTS2;TAF6;TBP;POLR2B;ZC3H8;INTS1;ELL;INTS8
gsea,protein localization to Golgi apparatus (GO:0034067),-0.34142736245127236,-0.998039705160474,0.45454545454545453,0.5257516523166215,1.0,6/15,36.26%,ARL5C;VPS13C;GBP5;VPS13D;COG7;GBF1
gsea,alpha-amino acid metabolic process (GO:1901605),0.3131954399627193,0.9970076539025396,0.4444444444444444,0.4969544181281684,1.0,10/21,34.70%,ASNS;GOT1;MTHFD1;GLS;ALDH18A1;GOT2;KYAT3;PYCR1;DDAH2;GPT2
gsea,icosanoid metabolic process (GO:0006690),-0.32474881942870104,-0.99405467322596,0.4482758620689655,0.5311717647736706,1.0,6/16,34.87%,EPHX1;PNPLA8;ABCC1;GPX1;PTGS2;FADS1
gsea,phospholipid biosynthetic process (GO:0008654),0.3027943180109042,0.9909820175214428,0.4816247582205029,0.5059284012616426,1.0,15/25,39.11%,FDPS;AGPAT4;NUS1;CPNE1;DPAGT1;CRLS1;FAR1;IDI1;PCYT2;CLN3;DOLPP1;CPNE7;DHDDS;SPHK2;MVD
gsea,tRNA modification (GO:0006400),-0.26225727249570197,-0.9899854730282228,0.45054945054945056,0.5369798127666469,1.0,24/45,39.81%,THADA;TRMT1;TRUB1;TARBP1;THG1L;DTWD1;DUS2;QTRT2;QTRT1;METTL1;AARS2;ALKBH8;THUMPD2;NSUN6;PUS3;PUS7;WDR6;TRMT61A;TRDMT1;THUMPD1;TRMT10A;TRMT44;TYW5;TRMT13
gsea,phosphatidic acid metabolic process (GO:0046473),-0.2854613715153712,-0.9898999232177816,0.46220302375809935,0.5358445829685924,1.0,12/24,38.86%,DGKA;LCLAT1;DGKD;ACP6;ABHD4;GNPAT;LPCAT1;DGKE;GPAT4;AGPAT1;PLA2G12A;AGPAT5
gsea,visual perception (GO:0007601),0.31798853120330933,0.9894445342881586,0.4883401920438957,0.5077944166684574,1.0,9/28,37.47%,RGS16;ATF6;CEP250;CRYBG3;CRYBA4;SIX3;ROM1;RP2;CRYZ
gsea,vascular transport (GO:0010232),-0.2540548057788104,-0.98907186345348,0.4718826405867971,0.5359434629845178,1.0,40/40,98.14%,SLC1A2;ATP2A3;SLC5A3;SLC7A1;SLC38A1;ABCC5;SLC6A6;SLC15A2;SLC44A1;ABCC1;SLCO3A1;SLC16A1;SLC38A2;SLC12A2;ABCG2;SLC29A1;MFSD2A;ATP8A1;SLC19A1;SLC2A13;SLC6A9;SLC7A8;ABCC4;LRP1;SLC4A4;SLC1A4;ATP1A2;SLC7A3;KCNJ8;SLC13A3;SLC4A8;SLC27A1;ABCA2;SLC6A13;SLC1A5;SLC7A5;TFRC;SLC2A1;ATP2B4;SLC2A3
gsea,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.24601066316481507,-0.9885007914312582,0.4686868686868687,0.5356717559231484,1.0,53/53,95.53%,RACK1;TRIB1;SOCS5;RNF19A;BAG2;RNF19B;DNAJB2;TRIB2;LRRK2;NUB1;ZER1;TAF9;HERPUD1;CBFA2T3;HSP90AB1;DVL1;TLK2;VCP;SMAD7;HFE;DAB2;NKD2;COP1;UBQLN4;ZYG11B;GSK3B;USP7;TRIM39;RAD23B;DESI1;BAG5;ANKIB1;CCAR2;TAF1;TRIB3;MAP1A;USP5;UFL1;CSNK1E;GIPC1;HSPA1A;HSPA1B;XPO1;STUB1;PARK7;MDM2;PLK1;RAD23A;KEAP1;HSPBP1;SUMO2;UCHL5;GLMN
gsea,phosphatidic acid biosynthetic process (GO:0006654),-0.28936723629253625,-0.9868813434539452,0.485838779956427,0.5372458570869021,1.0,12/23,38.86%,DGKA;LCLAT1;DGKD;ACP6;ABHD4;GNPAT;LPCAT1;DGKE;GPAT4;AGPAT1;PLA2G12A;AGPAT5
gsea,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3058763845504435,0.9862985291107513,0.48158640226628896,0.5122710171225254,1.0,16/31,44.74%,NEDD4;ATP2B4;CREB3L1;DAB2IP;HHEX;HTRA3;SKIL;HGS;SULF2;SKI;EPN2;WNT1;NOTCH1;PPARG;THBS1;APLN
gsea,positive regulation of growth (GO:0045927),-0.26521693271366664,-0.9803201713639197,0.5,0.5472158221850884,1.0,18/35,36.28%,DNPH1;BCL2;PRSS2;PPM1F;DDX3X;RFTN1;SUPV3L1;INO80;SLC25A33;MFSD2A;TGFB2;RPS6KA3;BRAT1;SPHK1;IL2;EIF4G2;ADNP2;KLHL22
gsea,regulation of JUN kinase activity (GO:0043506),-0.30530274573910066,-0.9794931763818763,0.4406779661016949,0.5472903873218997,1.0,9/19,39.80%,PDCD4;DUSP10;PAK1;DNAJA1;DVL2;MAP3K5;DVL3;EDN1;HIPK3
gsea,selective autophagy (GO:0061912),-0.27735748472886723,-0.9787940346952758,0.4806201550387597,0.5473612386889215,1.0,29/29,99.74%,RPS27A;RETREG1;KLHL3;ATG2A;IFT88;ULK1;ATG2B;ATM;PEX5;ULK2;ARL13B;AMBRA1;USP30;ATG14;UBB;HDAC6;UBQLN1;PHB2;DYNC1H1;LGALS8;PCNT;WDR81;UFL1;DYNLL2;DYNC1I2;DYNC1LI2;PARK7;UBE2N;VIM
gsea,regulation of cell adhesion mediated by integrin (GO:0033628),-0.32082877403771215,-0.9785856859707561,0.49221183800623053,0.5464367572105977,1.0,16/16,95.85%,SERPINE1;DPP4;LIF;PTPN11;TGFB2;RET;FOXC2;ADAM9;MUC1;PLAU;SYK;PDE3B;ADA;TESC;PIK3CG;LYN
gsea,mitochondrial gene expression (GO:0140053),-0.2910390378567965,-0.9766272608691089,0.4616822429906542,0.5484829064678897,1.0,10/27,33.09%,MRPS6;LARS2;FASTKD2;GFM2;SLC25A33;POLRMT;FOXO3;IARS2;RARS2;PTCD3
gsea,transport across blood-brain barrier (GO:0150104),0.2654014656594232,0.9711028668679926,0.48509933774834435,0.5365494845138928,1.0,15/42,32.64%,SLC2A3;ATP2B4;SLC2A1;FABP5;TFRC;SLC7A5;SLC1A5;SLC6A13;ABCA2;SLC27A1;SLC4A8;SLC13A3;CD36;KCNJ8;SLC7A3
gsea,carboxylic acid transmembrane transport (GO:1905039),-0.31253630926407394,-0.9701918235217554,0.5034168564920274,0.5584440849725989,1.0,9/18,36.88%,SLC38A1;ABCC5;SLC23A2;ABCC1;SLC16A1;SLC38A2;SLC19A1;SLC36A4;SLC7A8
gsea,negative regulation of stress-activated MAPK cascade (GO:0032873),0.3210738635945372,0.9696649371250076,0.4944237918215613,0.5382828073515247,1.0,6/16,21.48%,PPIA;EZR;FOXM1;DUSP3;DUSP19;AIDA
gsea,regulation of androgen receptor signaling pathway (GO:0060765),-0.3283981402541434,-0.9696575710138123,0.4911111111111111,0.5580034729880464,1.0,8/16,38.18%,FOXP1;AR;PIAS2;NCOA2;SAFB2;DAB2;KDM5D;PHB
gsea,regulation of protein tyrosine kinase activity (GO:0061097),0.34773648702154003,0.9691149092799369,0.4807370184254606,0.5386239387020899,1.0,7/15,34.82%,NEDD9;LRP8;MVP;PDGFB;SHC1;RAP2C;CASS4
gsea,glycosaminoglycan metabolic process (GO:0030203),-0.30666897296236373,-0.9654109966425367,0.47619047619047616,0.563993168001891,1.0,8/19,38.46%,HGSNAT;SDC4;HS6ST1;SDC1;HEXA;GPC1;HS2ST1;HYAL2
gsea,regulation of centriole replication (GO:0046599),-0.3284030460216496,-0.9636863268908863,0.4908759124087591,0.5657458844545028,1.0,17/17,90.16%,NPM1;PLK2;KAT2B;SPICE1;TRIM37;KAT2A;CDK5RAP2;ALMS1;CEP295;CEP76;MDM1;RBM14;CENPJ;NUP62;BRCA1;STIL;PLK4
gsea,DNA methylation (GO:0006306),0.3127229800961168,0.9635847945729134,0.5161290322580645,0.547149851157527,1.0,9/17,57.29%,DNMT1;HELLS;EHMT2;METTL4;DMAP1;DNMT3B;MTRR;N6AMT1;PICK1
gsea,kidney development (GO:0001822),0.32006298083739043,0.9610029792042846,0.5268656716417911,0.5507300307872468,1.0,7/20,39.28%,CENPF;IFT27;OSR2;VEGFA;SULF2;ZBTB16;CEP290
gsea,positive regulation of MAP kinase activity (GO:0043406),0.27789137751955695,0.9601886948850425,0.5258064516129032,0.5515214452568177,1.0,13/31,41.90%,ADAM8;HRAS;DAB2IP;PIK3CG;TRAF2;PDGFB;DUSP19;ARHGEF5;VEGFA;PDGFA;MAP3K4;MAP3K7;FLT3
gsea,glycerophospholipid metabolic process (GO:0006650),-0.2540167710729481,-0.956874493218669,0.5113122171945701,0.5764157418617777,1.0,36/36,98.83%,CPNE3;PLA1A;PLA2G4F;ABHD6;ACP6;PIGL;PLCG1;PIGH;SYNJ1;PIGV;PLCB2;PLA2G4A;PIGB;PLA2G4B;AGK;PLA2G7;PIGQ;PNPLA6;PIGN;PLA2G6;CSF1R;PIGG;PGP;CPNE7;PIGA;CLN3;PDXP;FAR1;GDE1;CRLS1;PIGC;CPNE1;SMPD4;PIGF;DGKH;PLEK
gsea,phospholipid metabolic process (GO:0006644),0.2880781852443926,0.9555212126395568,0.5245346869712352,0.558767380243565,1.0,12/29,41.71%,AGPAT4;SMPD1;FDFT1;AGPAT2;ABCA2;GDE1;PCYT2;PDXP;PIP4K2B;PLPP2;PGP;PLBD1
gsea,diterpenoid metabolic process (GO:0016101),-0.3104899705254621,-0.9508175631020368,0.5090361445783133,0.5857322598698966,1.0,10/17,33.60%,ADH4;DHRS3;SDC4;RDH12;PECR;SDC1;GPC1;AKR1B10;LPL;RDH11
gsea,anion transmembrane transport (GO:0098656),0.26870659538426245,0.9482793600386326,0.5380333951762524,0.5703891718054988,1.0,16/31,40.82%,SLC35B1;SLC3A2;SLC25A5;SLC7A5;SLC25A10;SLC6A13;SLC27A1;SFXN1;SLC25A19;SLC25A30;SLC13A3;SLC35C2;SLC7A3;LRRC8B;SLC25A1;SLC35A3
gsea,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3063607649208966,0.946872314195266,0.5276595744680851,0.5715672246676724,1.0,9/19,42.10%,NDUFAB1;NDUFA5;TMEM126B;NDUFS1;ECSIT;NDUFA12;NDUFAF5;NDUFAF7;FOXRED1
gsea,NADH dehydrogenase complex assembly (GO:0010257),0.3063607649208966,0.946872314195266,0.5276595744680851,0.5715672246676724,1.0,9/19,42.10%,NDUFAB1;NDUFA5;TMEM126B;NDUFS1;ECSIT;NDUFA12;NDUFAF5;NDUFAF7;FOXRED1
gsea,negative regulation of cell-substrate adhesion (GO:0010812),0.35079528342396715,0.946862160229598,0.5476190476190477,0.5709879039875336,1.0,9/18,43.39%,CDKN2A;ACTN4;CORO1C;FZD4;WNT1;NOTCH1;GCNT2;DMTN;THBS1
gsea,cation transmembrane transport (GO:0098655),-0.3125149809467769,-0.9468341528149254,0.5233160621761658,0.5912572518701856,1.0,15/15,96.16%,TRPM1;SLC7A1;ATP1B1;SLC6A9;SLC36A4;ATP13A2;SLC7A8;SFXN2;ATP1A2;SLC7A3;KCNJ8;SLC25A19;SFXN1;SLC7A5;SLC3A2
gsea,regulation of protein autophosphorylation (GO:0031952),0.29755941982320866,0.9449850938582179,0.539622641509434,0.5734236464647922,1.0,11/19,31.08%,RAD50;MVP;RAP2A;PDGFB;ERRFI1;ENPP1;IMPACT;VEGFA;RAP2C;PDGFA;CALM2
gsea,negative regulation of protein secretion (GO:0050709),0.32444862773619193,0.9448445108331858,0.5359877488514548,0.5730651456551441,1.0,16/16,99.18%,F2R;RHBDF2;HMGCR;IL1B;DRD4;RSAD2;APOE;REST;NR1H3;MIDN;ADRA2A;CHGA;SIRT4;RHBDF1;RAB11FIP1;CD200
gsea,regulation of insulin receptor signaling pathway (GO:0046626),0.3069254970587566,0.9379803808098244,0.5355285961871751,0.5840213543237815,1.0,11/20,40.36%,PTPRE;GRB7;FUT7;NUCKS1;SNX5;ENPP1;PIP4K2B;GKAP1;IL1B;PID1;SIRT1
gsea,sensory organ development (GO:0007423),0.29079272529409317,0.9364852605613059,0.5769230769230769,0.5859337391103374,1.0,9/23,51.69%,CHD7;SMCHD1;ATF6;ZDHHC16;PBX3;SIX3;FREM2;MEIS1;SALL2
gsea,hippo signaling (GO:0035329),0.3227461233663128,0.9351453269558044,0.5424028268551236,0.5876187465287958,1.0,6/15,40.90%,YWHAE;CASP3;WWC1;YAP1;AMOTL1;TJP1
gsea,glutathione metabolic process (GO:0006749),0.30572482910903315,0.9346025676431804,0.553941908713693,0.5879866982772756,1.0,5/17,24.31%,GSR;GGCT;PARK7;GSTM5;CHAC1
gsea,positive regulation of double-strand break repair (GO:2000781),0.26277067566439044,0.9288434381214735,0.5723270440251572,0.5971456525426717,1.0,16/32,42.52%,ACTR2;SMCHD1;RAD51AP1;FOXM1;RIF1;TIMELESS;SPIDR;SLF1;SPIRE2;FANCB;WRAP53;MMS19;SLF2;WDR48;SPIRE1;DTX3L
gsea,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.29994050694987867,-0.9287794457866722,0.5560538116591929,0.622401846956888,1.0,8/18,33.63%,CD74;CD44;PMAIP1;TWIST1;SPRED1;ATM;SPRED3;DYRK1A
gsea,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3041210706952281,0.925819668985077,0.5310492505353319,0.601669701852335,1.0,8/17,33.08%,ISG15;ZBP1;PTPN6;CACTIN;RNASEL;TTLL12;FADD;ABCE1
gsea,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.28255910942519474,0.924779452872642,0.5706106870229007,0.6028356630261108,1.0,11/22,28.07%,AREG;ITGA1;DAB2IP;RNF126;MVP;DUSP3;CBLB;ERRFI1;STAM2;PTPRJ;HGS
gsea,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.3171056218627154,0.9202857334795221,0.5785498489425982,0.6095937433628322,1.0,11/22,45.07%,PADI2;ISG15;CACTIN;TTLL12;PARP14;TRAIP;OTOP1;IL1RN;PPARG;ARG1;GAS6
gsea,regulation of telomerase activity (GO:0051972),0.2757924487667753,0.9196664550214183,0.5441767068273092,0.6100462546454247,1.0,13/27,42.64%,AURKB;PTGES3;HSP90AA1;NEK2;PIF1;TCP1;MAP3K4;WRAP53;PKIB;XRCC5;PINX1;CCT2;DKC1
gsea,inorganic anion transmembrane transport (GO:0098661),0.2912195447369278,0.9149316924065506,0.580952380952381,0.6175244322080604,1.0,12/22,49.90%,SLC37A2;SLC20A1;SLC25A10;SLC25A30;SLC4A8;ANO6;GABRB1;GLRA1;SLC12A4;SLC25A14;SLC12A5;GABRR1
gsea,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.338066589477057,0.9146182509136026,0.6037463976945245,0.6173879702891487,1.0,8/18,43.39%,HMGB1;ATP2B4;VASH1;MEF2C;JUP;NOTCH1;PPARG;THBS1
gsea,regulation of ATP metabolic process (GO:1903578),0.2530399376508885,0.9138237765392087,0.5773420479302832,0.618081509969877,1.0,23/38,40.26%,NDC1;AAAS;NUP93;NUP62;RANBP2;NUP85;NUP107;NUP43;EIF6;NUP35;NUP160;NUP37;PRKAG2;NUP210;NUP54;SHMT2;NUP133;NUP88;NUP205;NUP155;SPHK2;NUP214;SEH1L
gsea,negative regulation of endothelial cell proliferation (GO:0001937),-0.28792987328544517,-0.9131425670824875,0.5805369127516778,0.6492313394957714,1.0,16/16,87.59%,RGCC;NF1;FLT1;PTPRM;APOE;XDH;DLL4;SPARC;THBS1;PPARG;CCL2;CAV2;ALOX5;STAT1;MEF2C;VASH1
gsea,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.28151982469228964,0.9126092828880701,0.6105834464043419,0.6195456363694173,1.0,15/37,48.37%,ADGRG1;ADRB1;CALCA;ADGRG5;GPR65;ADGRG3;ADRB2;S1PR4;ADGRE5;S1PR2;CXCL9;MC1R;RAPGEF2;ADGRE1;PTH1R
gsea,phosphatidylcholine biosynthetic process (GO:0006656),0.3151275169911325,0.9103655137660688,0.576,0.6226855176900605,1.0,8/15,51.86%,PCYT1A;LPIN2;SLC27A1;CSNK2A2;STARD7;ACHE;CHPT1;LPIN1
gsea,positive regulation of interferon-beta production (GO:0032728),-0.27715623037984294,-0.9090435552671904,0.5926680244399185,0.6552278225365278,1.0,12/24,28.75%,RIPK2;PTPN11;TRIM56;MAVS;TLR7;OAS3;DDX3X;IRF5;POLR3B;IRF7;IFIH1;DHX58
gsea,sprouting angiogenesis (GO:0002040),0.2916739925630294,0.9082449379235232,0.5818713450292398,0.6256386516959482,1.0,11/25,48.23%,AKT1;PTK2B;E2F7;E2F8;NRARP;ESM1;VEGFA;JMJD6;VEGFB;THBS1;ADGRA2
gsea,positive regulation of receptor-mediated endocytosis (GO:0048260),0.2900477077368778,0.9080943199668103,0.5824561403508772,0.6252565108781337,1.0,8/20,34.65%,ANXA2;HIP1;FMR1;SFRP4;HNRNPK;VEGFA;BICD1;ARRB1
gsea,inorganic anion transport (GO:0015698),0.2911429739827087,0.9069620204412857,0.6052202283849919,0.6264770341396806,1.0,12/21,48.76%,RACGAP1;SLC25A10;CLIC4;CLIC5;SLC11A1;ENPP1;SLC25A30;CLCN6;ANO6;ANO8;GLRA1;SLC25A14
gsea,positive regulation of erythrocyte differentiation (GO:0045648),0.3203145213325252,0.9041886048080642,0.5849056603773585,0.6305322643372586,1.0,7/15,30.23%,HMGB2;STAT3;HSPA1B;HSPA1A;STAT1;PRMT1;ABCB10
gsea,transcription by RNA polymerase II (GO:0006366),0.1843744489038241,0.901568238874082,0.6853002070393375,0.6343632236494015,1.0,83/172,42.67%,NABP1;NCOR2;ELOC;SNRPD3;DEK;SLBP;NELFE;PMF1;HDAC1;SNRPB;TFDP1;POLR2C;TRIP13;TAF15;SNRPE;XBP1;ELOF1;POLR2F;POLR2L;ELL2;NCBP2;NR2C2AP;TBL1XR1;GTF2F1;NR3C1;CPSF2;ADRM1;E2F3;LEO1;ELP2;RARA;INTS5;MAZ;SNRPF;ESRRA;INTS4;LSM11;ATF4;RBMX;NFIC;MED7;NCBP1;INTS10;TAF3;RPRD1B;SRRT;SSRP1;IWS1;TAF2;ELOA;CPSF1;TTF2;GTF2F2;RPAP2;SP1;INTS2;CPSF4;GTF2H2;CPSF3;TAF6;NR4A2;PCID2;YAP1;TAF1A;E2F2;TBP;NELFCD;MAF;POLR2B;ZC3H8;NOTCH1;INTS1;ELL;CTR9;NFYA;GTF2H4;INTS8;NOTCH2;CSTF1;SYMPK;PPARG;TAF1;CCNK
gsea,positive regulation of Notch signaling pathway (GO:0045747),0.2919573560976666,0.8993147372269599,0.6275659824046921,0.6375127038767224,1.0,10/23,46.80%,BMP2K;STAT3;ZMIZ1;JAG2;YAP1;EPN2;WNT1;NOTCH1;NEPRO;ENHO
gsea,fatty acid metabolic process (GO:0006631),0.242543959894972,0.898886734933301,0.6304347826086957,0.6375590464381892,1.0,25/55,53.38%,AOAH;MSMO1;NDUFAB1;LPIN2;PON3;ACSL4;XBP1;ACSL5;CPT1A;ACLY;ALOX5;THEM4;CRAT;CD36;NUDT19;ALOX5AP;MLYCD;PPARG;ELOVL4;UGT1A8;NAAA;LTC4S;ACACA;LPIN1;CPT2
gsea,positive regulation of myeloid cell differentiation (GO:0045639),-0.2771645825312962,-0.8987371083076431,0.5921375921375921,0.6722067634455318,1.0,21/21,98.31%,HIF1A;PITHD1;STAT5B;SCIN;ARNT;PRKDC;FOXO3;INHBA;RAB7B;MED1;ETS1;FES;MTURN;ABCB10;PRMT1;STAT1;HSPA1A;HSPA1B;TESC;STAT3;HMGB2
gsea,positive regulation of RNA metabolic process (GO:0051254),-0.26110625582813596,-0.8960971263675312,0.6068702290076335,0.6752790699267228,1.0,28/28,93.59%,NFKB1;PIK3R1;POLR2A;SUPV3L1;SLC38A2;GRSF1;RELA;HNRNPLL;DYRK1A;HEATR1;SETX;ZPR1;UTP15;PNPT1;WDR43;HABP4;DXO;WDR75;IL1B;RIOK2;BUD23;DIMT1;RIPK1;ZC3H18;HSPA1A;U2AF2;ERN1;HRAS
gsea,gland development (GO:0048732),0.28089735761195445,0.8927564480789013,0.606015037593985,0.6469761541468819,1.0,12/25,47.62%,ANXA1;EZR;RIPK3;XBP1;WNT11;PRKCSH;SIX3;FADD;TGFB3;ARHGAP35;FOXE1;WNT4
gsea,positive regulation of histone methylation (GO:0031062),-0.30976745888563084,-0.8915945417757957,0.6126482213438735,0.6817621917577094,1.0,15/15,96.52%,MYB;JARID2;CTNNB1;KMT2A;TET1;MTF2;DNMT3B;SIRT1;PHF19;CTR9;PAXIP1;RIF1;WDR5;BRCA1;DNMT1
gsea,protein K48-linked ubiquitination (GO:0070936),-0.275620854748472,-0.8803440419517748,0.6179159049360147,0.7006666329237959,1.0,21/21,97.17%,TNFAIP3;ZNRF1;KLHL3;TTC3;UBE2E2;UBR5;RNF152;IFI27;FBXO38;HACE1;SYVN1;CUL3;DTX3L;RNF8;SKP2;UBE2E3;UBE2T;CDC34;RNF5;RNF126;UBE2C
gsea,zymogen activation (GO:0031638),0.3174348066619629,0.8796561957811515,0.6080402010050251,0.6681530211082264,1.0,9/15,43.19%,PGK1;BAK1;PERP;VSIR;FADD;PLAU;ASPH;MMP14;PLAT
gsea,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.26171076807224797,-0.8731019551075002,0.6257545271629779,0.7120299328457343,1.0,24/24,99.23%,FAS;TNFAIP3;SERPINE1;PMAIP1;DDX3X;TNFRSF10B;GPX1;FEM1B;BCL2L1;MADD;ARHGEF2;GSK3B;THBS1;TMBIM1;ICAM1;FADD;TMC8;TNFSF10;RIPK1;TRAF2;BRCA1;SP100;HMOX1;LGALS3
gsea,tRNA aminoacylation (GO:0043039),-0.28479504130953653,-0.8706683177680142,0.6265306122448979,0.714904185753178,1.0,8/19,31.13%,FARS2;LARS2;WARS2;YARS2;FARSB;DARS2;IARS2;RARS2
gsea,response to retinoic acid (GO:0032526),0.2933926977116928,0.8648028856659359,0.6846473029045643,0.6922717293532408,1.0,7/24,23.58%,LYN;PTK2B;TESC;FZD4;WNT11;WNT10B;RARA
gsea,protein O-linked glycosylation (GO:0006493),0.213628487883297,0.8642073836685322,0.6722222222222223,0.6924845167661198,1.0,26/50,45.69%,SDF2L1;GXYLT1;B3GLCT;GALNT3;GALNT6;GCNT1;ST3GAL3;B4GALT5;ST6GALNAC4;ST3GAL4;PLOD2;SLC35C1;GALNT1;MUC6;POGLUT3;TMTC4;PLOD3;GALNT10;MUC20;EOGT;MUC1;POMGNT1;FKRP;PGM3;B3GNT3;OGA
gsea,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.27735953433148963,-0.8621365572990604,0.6691729323308271,0.7283016228473516,1.0,8/15,33.07%,SOCS5;NCF1;NCK2;HBEGF;CBL;FBXW7;ADRA2A;APP
gsea,cellular response to ketone (GO:1901655),0.27852589261377403,0.8595233738632979,0.6673040152963671,0.6995497148280283,1.0,9/18,46.39%,SPP1;PCK2;NR3C1;TRERF1;MAP4K1;LARP1;SPHK2;ACOD1;NDOR1
gsea,regulation of response to biotic stimulus (GO:0002831),-0.2672821335816157,-0.859114247737778,0.6434977578475336,0.7319040152909358,1.0,19/19,95.59%,FOXP1;BIRC3;CX3CL1;TRIM5;DHX58;APPL2;SAMHD1;IRF1;ELMOD2;TRAF3;FCGR2B;TKFC;CD36;FGR;BIRC2;ZMPSTE24;ERAP1;LRP8;CD55
gsea,organic anion transport (GO:0015711),0.2381178371888627,0.8567132621963606,0.6653620352250489,0.7035027637787079,1.0,14/27,47.66%,SLC52A3;SLC35B1;SLC25A24;CYB5R1;SLC25A19;SLC4A8;SLCO2A1;SLCO4A1;SLC4A2;SLC35C2;SLC52A2;SLC4A5;SLC35A3;MGST1
gsea,acyl-CoA metabolic process (GO:0006637),-0.2705843187353568,-0.8557091628501312,0.6621004566210046,0.7361410411873939,1.0,9/15,36.27%,ACSL6;MCEE;SUCLG2;OGDH;DBI;DLST;GPAT4;ACOT1;ACOT4
gsea,glutamine family amino acid metabolic process (GO:0009064),-0.2907536963571095,-0.8531677196082429,0.6487523992322457,0.7387375036245463,1.0,8/17,32.21%,FPGS;GLS2;PYCR2;NIT2;SIRT4;ALDH4A1;GLUL;DGLUCY
gsea,positive regulation of mitotic cell cycle (GO:0045931),0.2846655945971237,0.8504866941142994,0.6724738675958188,0.7129092996808376,1.0,7/18,34.41%,ASNS;CCNB1;MDM2;DUSP3;EIF4E;TTL;EIF4EBP1
gsea,cartilage development (GO:0051216),0.2921139970858313,0.8483539050436283,0.6632825719120136,0.7157220784645466,1.0,9/16,38.86%,RUNX3;RUNX2;MEF2C;OSR2;WNT10B;SLC39A14;SULF2;SNX19;ZBTB16
gsea,dicarboxylic acid metabolic process (GO:0043648),0.2431932557900723,0.8461555321569103,0.6875,0.7187179410795556,1.0,16/35,40.46%,ME2;MDH2;DHFR;GOT1;MTHFD1L;MTHFD1;ALDH18A1;GOT2;ACLY;IDH1;SHMT2;MTHFD2;SDHAF3;GPT2;MTHFD2L;SHMT1
gsea,histone acetylation (GO:0016573),0.2180231326259917,0.8447481811933591,0.7236842105263158,0.720333186167942,1.0,27/46,55.28%,ACTL6A;BRCA2;WDR5;POLE3;HAT1;NAA50;SGF29;APBB1;NAA40;BRPF1;RUVBL2;JADE1;TADA3;ING5;TAF6;MAP3K7;DMAP1;SPI1;KAT7;BRD8;KAT6A;TADA2A;EP400;EP300;KAT2A;TAF5;KAT14
gsea,positive regulation of developmental growth (GO:0048639),-0.28586700245407004,-0.8433952818230334,0.736231884057971,0.7540161679545222,1.0,15/15,94.11%,RNF157;MACF1;DLL1;SYT4;MAP3K13;CPNE9;RUFY3;PLAA;LIMK1;SHTN1;GHSR;SEMA7A;GOLGA4;UNC13A;L1CAM
gsea,retinoid metabolic process (GO:0001523),0.29185391324797194,0.8433801664581501,0.7120211360634082,0.7217357288479033,1.0,23/23,97.67%,BCO1;LRP8;DHRS13;CYP2S1;ALDH1A3;SDC3;AWAT2;UGT1A9;UGT1A8;ALDH8A1;LRP1;APOE;RDH11;LPL;AKR1B10;GPC1;SDC1;DHRS9;SCPEP1;RDH12;SDC4;DHRS3;ADH4
gsea,glycolipid biosynthetic process (GO:0009247),-0.2775313956911755,-0.8398624395597958,0.6817288801571709,0.7582792986920728,1.0,18/18,85.93%,ST8SIA1;B3GNT5;PIGL;PIGH;PIGV;PIGB;PGAP2;PIGQ;PIGN;PIGG;PGAP3;ST3GAL5;PIGU;PIGA;SCCPDH;ST3GAL4;PIGC;PIGF
gsea,regulation of cellular localization (GO:0060341),0.2584823169017723,0.839118792033501,0.7084942084942085,0.7277795522225978,1.0,11/23,38.19%,LYN;HSP90AA1;SPAG5;TRIM46;MAP2;MAD1L1;WWC1;CSNK1E;TTL;FES;DYNC1H1
gsea,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.28138009682385795,-0.8349448752889257,0.6640625,0.7648079604179456,1.0,17/17,92.86%,RPL5;HIPK2;TAF9;HSP90AB1;PML;TLK2;HFE;USP7;TRIM39;BAG5;CCAR2;TAF1;CSNK2A2;MAP1A;GIPC1;PARK7;UCHL5
gsea,histone H3 acetylation (GO:0043966),-0.24563482777344584,-0.8223494768485949,0.7533460803059273,0.7842929210965308,1.0,26/26,88.58%,LEF1;PER1;KAT6B;JADE2;TAF9;KAT2B;JADE3;BRPF3;TAF6L;YEATS2;KAT14;TAF5;KAT2A;TADA2A;KAT6A;KAT7;SPI1;MAP3K7;ING5;TADA3;JADE1;BRPF1;SGF29;POLE3;WDR5;BRCA2
gsea,histone methylation (GO:0016571),0.27374106347696153,0.8202183346235469,0.6915113871635611,0.7572693795344277,1.0,8/18,45.68%,EHMT2;SUV39H2;SMYD2;SUV39H1;PRMT1;SMYD3;PRMT2;SETD6
gsea,regulation of intracellular transport (GO:0032386),0.2618697087523623,0.8198860432907739,0.7208480565371025,0.7570403816818108,1.0,12/21,50.86%,LCP1;AAAS;SPAG5;MAP2;NEFH;WWC1;DYNC1H1;NUP214;ATPSCKMT;TTC21B;REEP6;RINT1
gsea,protein targeting to membrane (GO:0006612),-0.23583822737041588,-0.8195328870909684,0.7207920792079208,0.787137178285058,1.0,15/31,35.64%,PXMP2;RAB3IP;NCF1;ABCD3;SLC25A17;SGTB;MICALL1;CHM;PIKFYVE;PEX5;PEX3;PEX2;ZDHHC14;MYO1C;PRKCI
gsea,cellular amino acid catabolic process (GO:0009063),-0.20351210327909214,-0.8141048320575934,0.7968253968253968,0.7941856502820669,1.0,47/47,99.14%,HIBADH;BCKDHA;HIBCH;IVD;GLS2;BCAT1;MCCC2;ACADSB;ALDH4A1;KYNU;HAAO;MCCC1;ACAD8;ABAT;GLUL;OGDH;GSTZ1;DLST;DLD;CBS;IL4I1;PHYKPL;DBT;BCKDHB;SDSL;MTRR;GCDH;HAL;IDO1;ARG1;NOS2;CARNMT1;KMO;SHMT1;BLMH;HSD17B10;ALDH7A1;SHMT2;NOS1;BCAT2;GOT2;FAH;GLS;BCKDK;GOT1;GCSH;GLDC
gsea,chloride transport (GO:0006821),-0.23662114923692656,-0.812302084449528,0.8,0.7953407010284216,1.0,10/22,39.57%,TTYH3;ANO10;SLC12A7;SLC12A2;SLC12A6;ANO7;TTYH1;SLC12A3;FXYD3;FXYD1
gsea,positive regulation of TOR signaling (GO:0032008),0.27452708457244446,0.8118740053558355,0.7131782945736435,0.768838327285659,1.0,8/16,47.74%,PIH1D1;MLST8;RRAGB;GPR137B;SEH1L;GAS6;MIOS;SLC38A9
gsea,wound healing (GO:0042060),0.2418548609089501,0.8047963516216128,0.7642642642642643,0.77873826463794,1.0,15/30,47.10%,MYH9;SMPD1;HMOX1;DCBLD2;SLC11A1;HPSE;PLEC;PDGFA;DST;EVPL;DSP;SYT7;TPM1;SYTL4;IGF1
gsea,long-chain fatty acid transport (GO:0015909),0.2746893758347189,0.7959226758078991,0.7627677100494233,0.7915367546936121,1.0,11/17,53.38%,FABP5;MID1IP1;SLC27A1;CPT1A;PRKAG2;CD36;PPARG;FABP4;ACACA;ABCD1;CPT2
gsea,organic acid transport (GO:0015849),-0.20831932384287621,-0.7954233839615495,0.8028169014084507,0.8202236825777728,1.0,38/38,96.16%,LRRC8D;SLC7A1;SLC38A1;SLC6A6;SLC23A2;NCOA2;SLC25A32;SLC16A1;SLC25A17;SLC38A2;ABCG2;SLC43A2;MFSD2A;SLC19A1;NCOA1;SLC6A12;ACSL1;SLC25A45;RXRA;SLC7A8;SLC27A3;ABCC4;STARD5;SLC25A14;SLC7A6;SLC3A1;SLC1A4;SLC7A3;SLC13A3;SLC25A30;GOT2;SLC27A1;SLC6A13;SLC25A10;SLC1A5;CEACAM1;SLC16A10;SLC3A2
gsea,regulation of sprouting angiogenesis (GO:1903670),0.26123005145799205,0.7950697255838858,0.7555555555555555,0.7919943466159016,1.0,10/20,43.39%,PKM;CREB3L1;CEACAM1;ALOX5;VEGFA;CEMIP2;EPN2;E2F2;TJP1;THBS1
gsea,RNA methylation (GO:0001510),-0.20438403134949792,-0.7805220475036252,0.8273244781783681,0.8412131864448379,1.0,24/45,39.81%,THADA;METTL8;NSUN4;TARBP1;MEPCE;ZCCHC4;METTL1;ALKBH8;FBL;THUMPD2;NOP2;NSUN6;NSUN3;WDR6;TRMT61A;MTERF4;TRDMT1;METTL16;TRMT10A;NSUN5;TRMT44;METTL5;METTL3;TRMT13
gsea,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.29967503065470424,0.7798979386739432,0.70042194092827,0.8132113347360178,1.0,10/15,44.70%,NHP2;CCT7;CCT8;RUVBL2;TCP1;CCT6A;CCT5;CCT2;DKC1;CCT3
gsea,mitochondrial respiratory chain complex assembly (GO:0033108),-0.22325388493980175,-0.7770696582755264,0.793040293040293,0.8444605821998286,1.0,34/34,94.75%,SDHAF1;IMMP2L;NDUFAF6;NUBPL;SLC25A33;ACAD9;TIMM21;NDUFAF1;AIFM1;TIMMDC1;UQCC1;NDUFAF2;NDUFV1;SCO2;OMA1;FASTKD3;SCO1;NDUFAF4;BCS1L;CHCHD4;COX19;FOXRED1;NDUFAF7;NDUFAF5;NDUFA12;ECSIT;SDHAF3;NDUFS1;TMEM126B;COX18;SAMM50;NDUFA5;NDUFAB1;COX17
gsea,rRNA modification (GO:0000154),-0.26896279164661907,-0.7699658738599687,0.7528301886792453,0.8527309559301303,1.0,8/17,38.58%,NOP10;NSUN4;ZCCHC4;FBL;NSUN3;MTERF4;THUMPD1;METTL5
gsea,RNA phosphodiester bond hydrolysis (GO:0090501),-0.24298554372582115,-0.7670971612499048,0.7861507128309573,0.8549081032864646,1.0,19/19,92.66%,ZC3H12D;ZC3H12A;PCF11;LACTB2;PARN;CSTF3;NUDT16;RNASE6;XRN1;DICER1;CPSF3;RNASEH1;KHNYN;ZC3H12C;TOE1;POP1;RPP30;NHP2;ERN1
gsea,endocytic recycling (GO:0032456),-0.24526384385753858,-0.7610917865972638,0.7644787644787645,0.8612813626794148,1.0,17/17,92.73%,EHD3;ANKRD50;MICALL1;RAB13;EPS15;SNX27;ARL4C;LMTK2;ANKRD27;PTPN23;CMTM6;VPS50;EHD2;RAB11FIP4;VPS52;VPS35;EHD4
gsea,tRNA processing (GO:0008033),-0.20946872147688775,-0.7589173301557125,0.8148148148148148,0.862450474605019,1.0,21/42,39.78%,TRMT1;FARS2;TSEN2;TRUB1;THG1L;DTWD1;DDX1;POP5;QTRT2;QTRT1;METTL1;AARS2;ELAC2;NSUN6;PUS3;TRMT61A;TRDMT1;THUMPD1;TRMT10A;TYW5;TSEN34
gsea,monocarboxylic acid transport (GO:0015718),-0.22960393320356226,-0.7530808883742279,0.8144796380090498,0.8685137526662506,1.0,20/20,93.81%,SLC16A6;NCOA2;SLCO3A1;SLC16A1;ABCB4;SLC6A11;SLC16A11;ABCG2;NCOA1;SLC6A12;RXRA;ABCC4;STARD5;SLC16A13;CD36;SLCO2A1;SLC27A1;SLC6A13;CEACAM1;SLC16A3
gsea,regulation of neurotransmitter receptor activity (GO:0099601),0.26341782466421854,0.752619918883048,0.777947932618683,0.849887240042766,1.0,7/16,36.11%,PTK2B;MEF2C;CNIH2;MINK1;DLG2;NLGN2;ACTN2
gsea,Golgi to plasma membrane transport (GO:0006893),0.23512391549508213,0.7482319848213596,0.8233995584988962,0.8548668593507036,1.0,8/18,41.08%,OPTN;EXOC4;OSBPL5;EXOC8;GCC2;GOLGA4;LLGL1;ARFGEF2
gsea,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.2728203279913459,0.742936848658925,0.7505330490405118,0.8607754955363267,1.0,11/17,44.70%,NHP2;CCT7;CCT8;RUVBL2;TCP1;CCT6A;CCT5;EXOSC10;CCT2;DKC1;CCT3
gsea,macroautophagy (GO:0016236),-0.1893420003075199,-0.7384931704404465,0.8687050359712231,0.8853936482592761,1.0,44/44,97.26%,PINK1;TECPR1;KLHL3;HDAC10;VDAC1;ATG7;MTMR3;ULK1;PIK3R4;ATG10;VCP;AMBRA1;VPS16;TBC1D5;ATP13A2;ATG14;MFN1;TOMM20;MTMR14;SNX14;PRKAA1;STAM;PLEKHM1;PLAA;YOD1;UBQLN1;VPS33B;CSNK2A2;MFN2;STX17;TOMM40;VPS33A;HGS;TOMM5;TCIRG1;VPS37C;CLN3;PIP4K2B;PRKAG2;DYNLL2;STAM2;EI24;VAMP7;VAMP8
gsea,purine-containing compound biosynthetic process (GO:0072522),-0.2621777301567054,-0.7365558645006396,0.7842778793418648,0.8858300374701317,1.0,18/18,93.46%,ADK;PRPS1;PRPSAP1;GART;AMPD2;PRPSAP2;ADAL;SHMT1;GMPR2;PPAT;ADSL;SHMT2;ADA;DCK;PAICS;MTHFD1;GMPS;APRT
gsea,glycosaminoglycan biosynthetic process (GO:0006024),-0.19627299657174807,-0.735601446064922,0.8934624697336562,0.8850945279775155,1.0,34/34,96.94%,ST3GAL1;CHST15;ABCC5;SDC4;DSE;HS6ST1;CHST2;SDC1;HEXA;GPC1;B4GAT1;HS2ST1;CHSY3;CHPF;XYLT1;CHPF2;DSEL;CSGALNACT2;B4GALT4;B3GNT3;GCNT2;SDC3;UST;VCAN;IL1B;B3GALT6;SLC35D2;CHST11;ST3GAL4;PXYLP1;B4GALT5;ST3GAL3;ST3GAL6;CHSY1
gsea,protein monoubiquitination (GO:0006513),0.23529349518810228,0.7307058447773731,0.8484848484848485,0.8748119299568345,1.0,12/19,45.18%,UHRF1;RNF126;UBE2T;LEO1;DTL;FANCL;TRIM21;RAD18;ATXN7L3;CTR9;DTX3L;UBE2O
gsea,collagen fibril organization (GO:0030199),0.22920606123785658,0.7283622468368491,0.8681875792141952,0.8766532319373538,1.0,15/32,45.16%,ADAMTS14;P4HB;COLGALT1;CRTAP;LAMC2;PLOD2;PLEC;COL6A3;CD151;PLOD3;DST;P4HA1;COL1A1;COL16A1;COL5A3
gsea,protein lipidation (GO:0006497),0.20705537352352593,0.7272225882946085,0.8675496688741722,0.877102555578981,1.0,16/27,48.67%,ZDHHC2;PIGF;PIGC;ZDHHC16;ZDHHC12;ZDHHC21;ZDHHC6;PIGA;PIGU;PGAP3;PIGG;ZDHHC5;ZDHHC15;HHAT;PIGN;ZDHHC8
gsea,protein-containing complex disassembly (GO:0032984),-0.21839259447815954,-0.7266899376816756,0.8489795918367347,0.8940582640830538,1.0,12/23,35.84%,FRAT2;TECPR1;CTNNB1;MYC;PYM1;DVL2;DVL1;VCP;AXIN1;VPS16;DVL3;LRP6
gsea,negative regulation of organelle assembly (GO:1902116),-0.2153463222678687,-0.7265885516802467,0.8620689655172413,0.8922382071125224,1.0,22/22,88.54%,PINK1;TBC1D30;LRRK2;KAT2B;CEP97;TMEM39A;FEZ1;TRIM37;KAT2A;SMCR8;EVI5L;CDK5RAP2;PHF23;TCHP;NUPR1;YAP1;ODF2L;CCP110;MDM1;TBC1D7;RBM14;BRCA1
gsea,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.24083570099676566,0.7192754099316065,0.8351648351648352,0.8853891749232035,1.0,8/15,53.09%,CALR;PARK7;UFL1;UFSP2;PRMT2;LATS1;HDAC6;EP300
gsea,protein deacetylation (GO:0006476),0.2085833721948675,0.715472350077287,0.8648648648648649,0.8886488764857705,1.0,15/29,53.81%,FLNA;HDAC1;TBL1XR1;RBM14;TRERF1;MTA2;SIRT1;HDAC2;SIRT3;PRDM5;BRMS1L;HDAC6;RCOR3;SIRT6;MIER2
gsea,positive regulation of endocytosis (GO:0045807),-0.20825824040080365,-0.7055552238357788,0.8772845953002611,0.9136156378791522,1.0,22/22,93.74%,SERPINE1;SGIP1;F2RL1;AXL;CLIP3;DLL1;CBL;HFE;DAB2;APPL2;APOE;LRP1;C3;ANO6;ANKFY1;BICD1;CD151;CLN3;HNRNPK;FLOT1;HIP1;SMPD1
gsea,visual system development (GO:0150063),0.22987985604456965,0.703874529840558,0.8848484848484849,0.9001805021933423,1.0,9/19,51.69%,ATF6;ITGAM;ZDHHC16;PBX3;SIX3;FREM2;MEIS1;C3;SALL2
gsea,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.24175183706463002,0.6942992163809948,0.8663366336633663,0.90882992819383,1.0,9/17,43.39%,TRAF2;BID;RIPK1;PPP2R1B;TNFSF10;TNFSF12;FADD;WWOX;THBS1
gsea,histone H4 acetylation (GO:0043967),-0.1952875315022881,-0.690479132663311,0.8915441176470589,0.9270453451372783,1.0,32/32,89.54%,LEF1;PER1;JADE2;KMT2A;KANSL2;MSL1;BEND3;JADE3;ATF2;MORF4L2;KAT8;TRRAP;ZZZ3;RUVBL1;PHF20;EP300;EP400;BRD8;KAT7;MCRS1;DMAP1;ING5;HCFC1;TADA3;JADE1;RUVBL2;NAA40;APBB1;HAT1;WDR5;BRCA2;ACTL6A
gsea,regulation of TOR signaling (GO:0032006),0.18850593567342278,0.6865968023377843,0.9246031746031746,0.915421685377987,1.0,19/35,55.04%,FAM83D;PIH1D1;DYRK3;TBC1D7;MLST8;RRAGB;TTI1;SEH1L;SIRT1;DEPDC5;GAS6;MIOS;SLC38A9;TBCK;TSC2;MAPKAPK5;RPTOR;SMCR8;PRKAA1
gsea,snRNA processing (GO:0016180),-0.23816495851634945,-0.6824963375524565,0.8660550458715597,0.9327102925208594,1.0,15/15,76.24%,INTS6;INTS6L;INTS9;TUT1;INTS3;INTS11;INTS7;INTS14;INTS8;INTS1;INTS2;INTS10;INTS4;TOE1;INTS5
gsea,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.24355756131251546,0.6798104182121216,0.8923512747875354,0.9208183545975182,1.0,18/18,95.81%,PIN1;TTK;TGFB3;SNX25;GDF11;INHA;ACVR1;RBPMS;ACVRL1;INHBA;DAB2;HFE;TWSG1;SMAD7;TGFB2;BMP7;PMEPA1;ENG
gsea,eye development (GO:0001654),-0.1963353224042555,-0.6797433687808915,0.9115281501340483,0.9331583620746725,1.0,21/21,91.00%,HIPK2;RAB3GAP1;PBX4;SMG9;SH3PXD2B;TGFB2;SMOC1;HIPK1;PBX2;SCO2;SALL2;TSKU;MEIS1;FREM2;CEP290;SKI;SIX3;CRYBA4;PBX3;ZDHHC16;ATF6
gsea,response to organonitrogen compound (GO:0010243),0.22185114124870803,0.6763022668364372,0.888507718696398,0.9230184769358527,1.0,10/17,53.65%,DHFR;RNF5;MTOR;CCDC47;KAT7;DNAJB12;GLRA1;DRD4;IRAK3;SYVN1
gsea,DNA modification (GO:0006304),-0.22675869783341493,-0.6750004475024758,0.8816793893129771,0.9354843183851669,1.0,17/17,96.77%,PARP3;NEIL1;UNG;TERF2IP;TDG;TERF2;PARP1;NEIL2;PARP2;EXOSC5;OGG1;MUTYH;EXOSC4;MBD4;EXOSC3;NEIL3;TINF2
gsea,aminoglycan biosynthetic process (GO:0006023),-0.22885646472417806,-0.6745725253693845,0.8864628820960698,0.9339006989365098,1.0,15/15,80.49%,SDC4;HS6ST1;SDC1;HEXA;GPC1;B4GAT1;HS2ST1;XYLT1;B3GNT3;GCNT2;SDC3;B3GALT6;SLC35D2;PXYLP1;B3GALT5
gsea,snRNA metabolic process (GO:0016073),-0.23816495851634945,-0.6722999023990003,0.8773234200743495,0.9339301436481064,1.0,15/15,76.24%,INTS6;MEPCE;INTS9;TUT1;INTS3;INTS11;INTS7;ZCCHC8;INTS8;INTS1;MTREX;INTS2;INTS10;INTS4;INTS5
gsea,non-motile cilium assembly (GO:1905515),-0.21494315748867288,-0.6691612814478248,0.9158512720156555,0.934731624297802,1.0,19/19,86.12%,RPGRIP1;FUZ;IFT88;TOGARAM1;TMEM216;BBS4;ARL13B;PIBF1;PCM1;GORAB;C2CD3;RPGRIP1L;IFT57;CEP290;CEP89;TMEM80;DCTN1;CEP250;TMEM107
gsea,autophagosome organization (GO:1905037),0.2243555371455716,0.6627895698729037,0.912,0.9333075775755444,1.0,6/15,55.13%,ATP2A2;ATG9B;PACS2;NSFL1C;UBQLN1;UBXN2B
gsea,maturation of 5.8S rRNA (GO:0000460),0.22701385151653508,0.6468169726247942,0.8863157894736842,0.9444097902507136,1.0,8/15,42.50%,MPHOSPH6;MAK16;EIF6;EXOSC4;RPF1;MTREX;EXOSC10;PES1
gsea,establishment of protein localization to membrane (GO:0090150),-0.1841805938986752,-0.6439065277051376,0.9344894026974951,0.9525507369598396,1.0,28/28,88.98%,RAB3IP;NCF1;RAB3GAP1;RFTN1;SYNE3;MICALL1;CHM;REEP1;PIKFYVE;ZDHHC14;MYO1C;PRKCI;ZDHHC24;RTP4;AFDN;TAOK2;ZDHHC15;RAB3GAP2;ICMT;ZDHHC6;ZDHHC21;GORASP2;VPS37C;ZDHHC12;NPC1;COX18;BID;ZDHHC2
gsea,neurotransmitter transport (GO:0006836),0.20372817826397638,0.6393873813026136,0.9371900826446281,0.9487196769604466,1.0,12/24,53.70%,UNC13B;PDZD11;SLC17A6;GLS;UNC13A;HSPA8;SLC32A1;ATP1A2;NAAA;PPFIA4;PPFIA3;STXBP3
gsea,rRNA methylation (GO:0031167),0.20088332481999227,0.6174023376459216,0.9476987447698745,0.9611002304642001,1.0,5/18,32.01%,MRM1;DIMT1;BUD23;EMG1;FDXACB1
gsea,mRNA modification (GO:0016556),-0.20371048455999025,-0.6054505797724681,0.9375,0.9737352375733518,1.0,18/18,79.69%,METTL8;TRUB1;PUS3;PUS7;TRMT61A;METTL16;METTL3;PUS1;TRMT10C;TRMT61B;ZC3H13;TRUB2;DKC1;TRMT6;CMTR1;METTL14;VIRMA;NSUN2
gsea,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.20411990951225814,-0.6028037310501371,0.9309701492537313,0.9729992091174664,1.0,17/17,96.52%,JARID2;TASOR;SMYD5;DNMT3A;EZH2;AEBP2;BMI1;MTF2;DNMT3B;SPI1;PHF19;SUZ12;RBBP7;EED;RBBP4;PPHLN1;DNMT1
gsea,inorganic cation import across plasma membrane (GO:0098659),0.1918765057737165,0.6018484023321043,0.9675599435825106,0.9680326053595972,1.0,14/25,52.32%,ATP2B4;SLC39A6;SLC39A4;TRPV2;SLC39A14;KCNJ8;SLC39A10;ATP1A2;KCNJ10;SLC12A4;SLC9A1;KCNJ14;SLC12A5;SLC8A1
gsea,autophagosome assembly (GO:0000045),0.2022943613091805,0.6004547380775562,0.9666011787819253,0.9677773130721687,1.0,7/16,43.87%,ATP2A2;ATG9B;PACS2;STX17;NSFL1C;MFN2;UBQLN1
gsea,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.21393432571466994,0.5982042350159232,0.9511400651465798,0.9678853330740688,1.0,7/16,53.95%,BRCA1;CNOT9;UFL1;UFSP2;YAP1;LATS1;FOXA1
gsea,negative regulation of cell junction assembly (GO:1901889),0.22106864512766533,0.5661469753265024,0.9591240875912409,0.9797266400221862,1.0,8/15,44.22%,CORO1C;IL1B;TLR2;DUSP22;DMTN;THBS1;CLASP2;PHLDB2
gsea,RNA polyadenylation (GO:0043631),-0.19021473889702295,-0.5570857131602979,0.9588014981273408,0.9875041819166192,1.0,15/15,81.03%,PABPC1;PCF11;GRSF1;CSTF3;APP;TUT1;PNPT1;TENT4B;CDC73;SYMPK;CPSF3;CPSF1;AHCYL1;LEO1;CPSF2
gsea,mRNA polyadenylation (GO:0006378),-0.19021473889702295,-0.5570857131602979,0.9588014981273408,0.9875041819166192,1.0,15/15,81.03%,PABPC1;PCF11;GRSF1;CSTF3;APP;TUT1;PNPT1;TENT4B;CDC73;SYMPK;CPSF3;CPSF1;AHCYL1;LEO1;CPSF2
gsea,fatty acid biosynthetic process (GO:0006633),0.17269593943159778,0.5389007080879885,0.9912023460410557,0.9865523482409944,1.0,12/26,51.25%,NDUFAB1;XBP1;HACD3;ACLY;ALOX5;HACD2;MLYCD;ELOVL2;ELOVL4;LTC4S;ACACA;ABCD1
gsea,protein acylation (GO:0043543),0.1513295205347539,0.509591746905687,0.9979123173277662,0.9914381997625195,1.0,14/24,54.68%,ZDHHC2;ZDHHC16;ZDHHC12;ZDHHC21;ING5;ZDHHC6;NAT10;ZDHHC5;ZDHHC15;HHAT;ZDHHC8;KAT6A;EP300;KAT2A
gsea,termination of RNA polymerase I transcription (GO:0006363),-0.16166807685239598,-0.5002954874693868,0.9916839916839917,0.99844102583114,1.0,22/22,85.95%,POLR1C;TAF1D;POLR2E;POLR1B;POLR1E;TTF1;GTF2H3;POLR2H;CAVIN1;POLR1A;CDK7;GTF2H1;TAF1B;ERCC2;ERCC3;GTF2H4;TBP;TAF1A;GTF2H2;UBTF;POLR2L;POLR2F
gsea,internal peptidyl-lysine acetylation (GO:0018393),-0.1595264249969486,-0.4864997560707109,0.9962546816479401,0.9981583545510332,1.0,18/18,84.09%,KAT6B;CREBBP;KAT2B;MORF4L2;KAT8;TRRAP;TAF6L;RUVBL1;PHF20;KAT2A;EP300;KAT6A;BRD8;KAT7;TAF6;RUVBL2;SGF29;NAA50
gsea,transcription by RNA polymerase I (GO:0006360),-0.14196807813452544,-0.4539082143656909,0.993801652892562,0.9991262291174381,1.0,25/25,85.95%,POLR1C;TAF1D;POLR2E;POLR1B;POLR1E;TTF1;GTF2H3;POLR2H;CAVIN1;TCOF1;POLR1A;CDK7;GTF2H1;RRN3;TAF1B;ERCC2;ERCC3;TAF1;GTF2H4;TBP;TAF1A;GTF2H2;UBTF;POLR2L;POLR2F
gsea,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.1410600879335613,-0.44236178794822784,0.9979296066252588,0.9977737793456359,1.0,23/23,85.95%,POLR1C;TAF1D;POLR2E;POLR1B;POLR1E;GTF2H3;POLR2H;CAVIN1;POLR1A;CDK7;GTF2H1;RRN3;TAF1B;ERCC2;ERCC3;TAF1;GTF2H4;TBP;TAF1A;GTF2H2;UBTF;POLR2L;POLR2F
